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Abstract 
This study aims to evaluate a different approach to diabetes patient education. It begins 
with an overview of the epidemiology of Type 2 diabetes in recognition that although 
there have been major developments over the years in identifying and treating diabetes, 
people with diabetes are still dying prematurely and their quality of their life is still poor 
when compared to those without the condition. 
Chapter 2 reviews definitions of health, health behaviour models, relevant international 
literature and its impact on national policy. Most countries are currently at the 
experimental stage of developing therapeutic and self-management education 
programmes. However, routine patient education in Europe and the United States is still 
based largely on biomedical models. 
A systematic review of group-based, therapeutic and self-management education 
programmes for adults with Type 2 diabetes is presented in Chapter 3. This reveals that 
these approaches to diabetes education improve diabetes control, enhance patient 
knowledge of diabetes and reduce the requirement for diabetes medication. There is also 
some evidence to suggest there is increased self-management skills, self-empowerment, 
quality of life and treatment satisfaction, although further research is recommended to 
confirm those findings. 
The tutor's manual for the expert patient programme "X-PERT" is presented in Chapter 
4. This was written to encourage the delivery of the X-PERT programme to adults 
living with Type 2 diabetes. It is designed to illustrate the theories of empowerment and 
patient activation. Delivery and content of this six-session, group-based, health 
professional-led diabetes expert patient programme is described in detail. 
The research proposal for the randomised controlled trial is presented in Chapter 5. A 
brief background summary is followed by a full description of development of the 
X-PERT trial, demographic aspects of Burnley, Pendle and Rossendale and the research 
design. The intervention group was invited to attend the X-PERT programme whilst the 
control group received routine diabetes treatment. 
The X-PERT trial tests the hypothesis that delivery of a professional-led, community 
based, diabetes-specific expert patient programme for adults with Type 2 diabetes based 
iv 
on the theories of patient empowerment and patient activation would: (1) develop the 
skills and confidence needed for patients to be able to make informed decisions 
regarding their diabetes self-management; (2) improve biomedical, lifestyle and 
psychosocial outcomes both in the short term (four months) and longer-term (14 
months); (3) meet the International Diabetes Federation (IDF) structure and process 
standards regarding diabetes education. 
The results, presented in Chapter 6, support each of the three aspects of the hypothesis 
stated above. The expert patients, compared with the control group, improved their 
diabetes control, became more knowledgeable about their diabetes, had a greater sense 
of empowerment, increased their self-management skills and food related quality of life. 
Many of the IDF diabetes education standards were also addressed. 
Chapter 7 considers the strengths and limitations of the trial. It then concludes that a 
structured, group-based approach to patient education, using models of patient 
empowerment and activation, offers an improved approach to the treatment of Type 2 
diabetes, a serious, expensive and increasing international problem. Pressures on NHS 
resources from diabetes and its complications are large. Offering people living with 
diabetes the skills and confidence to self-manage their condition could bring immense 
benefits, both to those with the condition and to the NHS. 
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Chapter 1: Type 2 Diabetes Mellitus 
1.1 Introduction 
Diabetes is becoming a more common condition worldwide. It can affect people of all 
ages in every population. This chapter sets the scene for the thesis and begins with the 
definition and classification of, and the diagnostic criteria for, diabetes. An overview of 
the epidemiology of Type 2 diabetes follows, with discussions on prevalence, 
prevention and current treatments. The chapter draws to an end by discussing past 
developments, personal and NHS costs, and opportunities for the future. 
1.2 Definition 
Diabetes mellitus' is a condition where chronic hyperglycaemia occurs from defects in 
insulin secretion, insulin action or both. Characteristic symptoms may be thirst, 
polyuria, polydypsia, blurring of vision, weight loss and infections (WHO Working 
Group 1998), although some individuals remain symptom free. 
1.3 The history of diabetes 
The word "diabetes" is of Greek origin and denotes a siphon. The term "mellitus" is a 
descriptive adjective from the Latin word for honey. Medical historians have divided 
the history of diabetes into five periods, each characterised by advancing medical 
knowledge and scientific inquiry (Sanders 2001). These phases are: 
Q the Descriptive Period: describing and naming the disease; 
Q the Diagnostic Period: learning how to diagnose the disease; 
Q the Experimental Period: learning what causes the disease; 
Q the Therapeutic Era: learning how to treat the disease; 
Q the Era of Complications: learning about additional health problems. 
The first three periods are briefly described in Table 1.1. The treatment of diabetes and 
possible long-term complications are discussed in other sections of this chapter. 
In this thesis, the term diabctcs rcfcrs to diabctcs mellitus. 
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Table 1.1 The history of diabetes 
TILE DESCRIPTIVE PERIOD 
Ancient Egypt This earliest recorded reference to diabetes occurred around 1550 
(2000-1200BC) BC and described remedies "to eliminate urine which is too 
plentiful" (see figure 1.1 on page 5). 
Greek Medicine 
Hippocrates (460. This physician stressed the influence of diet, exercise and lifestyle 
377BC) on health and gave caution against fad diets. 
Claudius Galen Referring to diabetes as "diarrhoea of the urine", Galen incorrectly 
(130-201 AD) defined the kidney as the relevant site of action. 
Aretaeus The first physician to use the term "diabetes", this medic described 
(130-200 AD) the condition as `the melting down of the flesh and limbs into 
urine'. 
Hindu Medicine The Hindus described diabetes as "honey urine" approximately a 
(100BC - thousand years before the Europeans added "mellitus" to the term 
700 AD) "diabetes". (See William Cullen post). It was also noted that the 
condition could be inherited, or acquired as a result of obesity. 
Treatment consisted of generous administration of purgatives and 
emetics. The importance of prevention was emphasised and 
treatment involved weight reduction, physical activity and a diet 
rich in carbohydrates with added honey. 
Arabian Medicine 
Avicenna (980- This Persian physician described a wasting away of the body, 
1037) infections, non-healing wounds and diabetic gangrene. 
Moso Maimonides believed that the condition was more likely to occur in 
Maimonides warm countries, possibly as a result of the sweetness of the waters 
(1138-1204) of the Nile. 
THE DIAGNOSTIC PERIOD 
Paracelsus (1493- A Swiss physician, he believed that the human body was composed 
1541) of three basic substances: sulphur, mercury, and salt. When he 
evaporated diabetic urine he recovered what he thought was salt. 
He concluded that salt was the cause of diabetes and prescribed 
anodynes. He believed that the vapour from the anodynes would 
flow to the kidneys and extinguish the excessive thirst. 
Andreas Vesalius The Belgian physician correctly identified the pancreas and 
_ 
(1514-1564) described it as an organ comprising several glands. 
Regnier de Graaf In 1664, this Dutch anatomist provided the first modern description 
(1641-1673) of the pancreas and its external secretions. 
Thomas Willis An English physician, he referred to diabetes as "the pissing evil" (1621-1675) and provided what may be one of the earliest descriptions of 
diabetic peripheral neuropathy. He claimed that diabetes was 
primarily a disease of the blood and not the kidneys. Interestingly, 
he also cited other causes including "ill manner of living" and , depression. 
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Tabic 1.1 (continued) 
Matthew Dobson A Yorkshire man, he was the first to demonstrate the presence of 
(1735-1784) sugar in the urine and blood of patients with diabetes. His 
explanation for the emaciating effect of diabetes was the large 
proportion of "alimentary matter" being excreted by the kidneys 
before it could be absorbed and applied to nutrition. The 
observations made by Willis, along with Dobson's experiments, 
established the diagnosis of diabetes. 
William Cullen This physician was responsible for the introduction of the term 
(1710-1790) "diabetes mellitus". 
John Rollo This medic recommended nutrition therapy for the treatment of 
(d. 1809) diabetes. He proposed a diet low in carbohydrate and high in fat 
and protein following his observation that "vegetable matter" 
caused increased amounts of sweet urine (see figure 1.2 on page 4). 
Appolinaire This French physician observed, in the 19` century, that shortages 
Bouchardat of food and food rationing during the German siege on Paris had 
(1806-1886) resulted in a disappearance of sugar in the urine and an increased 
sense of well being. He recommended fasting and exercise for the 
treatment of the condition. 
Frederick Allen In the early 1900s, these physicians advocated that severe dietary 
(1869-1962) restriction ("starvation therapy") was the only hope for 
and Elliott Joslin management of diabetes. That remained the single approach to 
(1879-1964) prevention of the diabetic coma until the discovery of insulin in 
1921. 
THE EXPERIMENTAL PERIOD 
Claude Bernard During the first half of the 19 century, Bernard discovered that the 
(1813-1878) liver released a substance that affected blood glucose levels. 
Oscar Minkowski Minkowski demonstrated in an experiment with dogs that the 
(1858-1931) removal of the pancreas resulted in fatal diabetes. That was a 
turning point in determining the endocrine function of the pancreas. 
Claude Bernard A French physician, he discovered that glycogen, the precursor of 
(1813-1878) glucose, was stored in the liver and he discounted the role of the 
pancreas as the cause of diabetes. 
Paul Langerhans Although known to have identified the pancreatic islets, 
(1847-1888) Langerhans did not manage to pinpoint their function. Twenty-four 
years later those pancreatic islets were named "islets of 
Langerhans" by Laguesse, a French histologist. 
Joseph von In continuing experiments with dogs, Mering and Minkowski 
Mering (1849- discovered that the removal of the pancreas resulted in diminished 
1908) and ability to heal and decreased resistance to infection. The dogs fell 
Oscar Minkowski into a diabetic coma and died. Post mortem results indicated that 
(1858-1931) their livers contained very small quantities of glycogen. 
Eugene Lindsay In 1901, Opie established the association between failure of the 
Opie (1873-1971) islet cells and diabetes mellitus. 
Stanley Rossiter In 1907, Benedict introduced the first test to estimate the 
Benedict (1884- approximate amount of glucose in urine. It quickly became 
1936) common for people with diabetes to test their urine at home using 
Benedict's solution. 
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Table 1.1 (continued) 
Nicholas This Romanian biochemist prepared a pancreatic extract that he 
Paulescu (1869- named pancreine which, when injected into a dog, produced a 
1931) temporary reduction in blood glucose levels. Although he published 
his findings in August 1921, he failed to gain recognition for his 
contribution to the discovery of insulin. 
Frederick Banting These Canadian scientists identified the pancreatic extract, isletin 
(1891-1941) and and demonstrated a dramatic reduction in urinary and blood 
Charles Best glucose. In March 1922, they published a report detailing the 
(1899-1978) administration of isletin in seven cases of human diabetes. Leonard 
Thompson, a 14-year-old boy was later known as the first person to 
be treated with insulin. 
Figure 1.1 
"To eliminate urine which is 
too plentiful" 
A measuring glass filled with: 
Water from the bird pond 
Elderberry 
Fibres of the asit plant 
Fresh Milk 
Beer swill 
Flower of the cucumber 
Green Dates 
Make into one, strain, 
and take for four days 
Figure 1.2 
Early Nutrition Therapy (1798 AD) 
Breakfast 1'/s pints of milk and 'h pint 
of lime-water, mixed, and 
bread and butter 
Noon Plain blood-puddings, made 
of blood and suet only 
Diiu, er Game, or old meats, which 
have been long kept, and as 
far as the stomach may bear, 
fat and rancid old meats, as 
pork; to eat in moderation 
Supper The same as breakfast 
Figure 1.1 Diabetes remedy. 
Figure 1.2 A diet for people with diabetes, prescribed by Rollo in 1798 
Source: Sanders U. The Philatelic History of Diabetes. American Diabetes Association, 2001. 
1.4 Classification 
In 1965, the World Health Organisation (WHO) proposed a classification of diabetes 
mellitus based on the age of recognised onset (WHO Expert Committee 1965). That 
classification was later modified by the US National Diabetes Data Group (National 
Diabetes Data Group 1979) and the WHO (WHO Expert Committee on Diabetes 
Mellitus 1980) where two major classes of diabetes mellitus were proposed: insulin- 
dependent-diabetes-mellitus (IDDM), otherwise known as Type 1, and non-insulin- 
dependent-diabetes (NIDDM), or Type 2. However, that classification was further 
revised in 1985 (WHO 1985a) when the terms Type I and Type 2 were omitted, the 
terms IDDM and NIDDM being retained. Other types of diabetes included impaired 
glucose tolerance (IGT) and gestational diabetes mellitus (GDM). The 1985 report 
5 
became widely accepted and used internationally. It represented a compromise between 
clinical and aetiological classification, leading to the grouping of patients in a clinically 
useful manner, even when the specific cause or aetiology was unknown. 
Diabetes classifications were further revised in 1997 by the American Diabetes 
Association (ADA). It revised the diagnostic criteria and introduced another new 
category called impaired fasting glucose (IFG) (ADA Expert Committee on the 
Diagnosis and Classification of Diabetes Mellitus 1997). That most recent classification 
attempts to categorize diabetes according to disease aetiology rather than treatment. At 
around the same time, WHO also revised its 1980/1985 classification (WHO Working 
Group 1999). The aetiological classification again equated IDDM with Type 1 diabetes 
and NIDDM with Type 2 diabetes. The new classification has addressed the fact that 
many people with NIDDM require insulin to treat their diabetes. Table 1.2, below, 
summarises the current classification of diabetes mellitus (ADA Expert Committee on 
the Diagnosis and Classification of Diabetes Mellitus 1997). 
Table 1.2 Aetiological classification of diabetes mellitus 
AETIOLOGICAL CLASSIFICATION OF DIABETES MELLITUS 
o Type I diabetes, historically known as IDDM, results from absolute insulin 
deficiency and more commonly presents acutely before the age of 30. 
o Type 2 diabetes, historically known as NIDDM, results from a relative 
deficiency of, or insensitivity to, insulin and is more commonly diagnosed over 
the age of 40. It affects 75-90% of all people with diabetes. 
o Other specific forms of diabetes, such as genetic defects in ß-cell function (e. g. 
MODY syndromes*); genetic defects in insulin action (e. g. leprechaunism); 
diseases of the exocrine pancreas (e. g. pancreatitis); endocrinopathies (e. g. 
acromegly); drug or chemical induced diabetes (e. g. glucocorticoids); infections 
(e. g. congenital rubella); uncommon forms of immune-medicated diabetes (e. g. 
anti-insulin receptor antibodies), and other generic syndromes that are 
sometimes associated with diabetes (e. g. Down's syndrome). 
o Gestational diabetes mellitus 
*MODY = maturity-onset diabetes of the young due to specific genetic defects of 
glucokinase, or hepatic nuclear factors. 
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1.5 Diagnostic criteria 
The major difference in the diagnostic criteria for diabetes after revision was the 
lowering of the diagnostic value of the fasting plasma glucose concentrations from the 
former level of 7.8 mmol/l to 7.0 mmol/I and above. This lowered blood glucose level is 
thought to compare with equal diagnostic significance to the two-hour post-load 
concentration which remains the same at 11.1 mmol/1 (ADA Expert Committee on the 
Diagnosis and Classification of Diabetes Mellitus 1997; WHO Working Group 1999). 
The fasting glucose test is carried out by taking a blood sample in the morning after the 
patient has fasted from midnight. The post-prandial glucose assessment is based on an 
oral glucose tolerance test (OGTT). A 75g oral glucose challenge is given to the patient 
and blood samples are then taken to assess the two-hour plasma glucose response. 
Impaired glucose regulation includes IGT and IFG and refers to a metabolic state 
intermediate between normal glucose homeostasis and diabetes. However, IFG and IGT 
are not interchangeable and they represent different abnormalities of glucose regulation: 
one in the fasting state and one post-prandial. lFG is defined as a fasting venous plasma 
glucose 6.1-6.9 mmol/l, whereas IGT is two-hour plasma glucose 7.8 - 11.1 mmol/l. 
Table 1.3 Diagnostic criteria for diabetes mellitus, IGF and IGT 
Diagnostic Criteria for Diabetes Mellitus, IFG and IGT 
Venous plasma glucose, (mmol/1) 
Fasting 120 minutes after 
glucose load 
Normal < 6.0 < 7.8 
Impaired fasting glucose 6.1-6.9 
Impaired glucose tolerance < 7.0 7.8-11.0 
Diabetes mellitus > 7.0 > 11.1 
N. B. In the absence of symptoms, a diagnosis of diabetes must be confirmed by a 
second diagnostic test, i. e. a fasting, random, or repeat glucose tolerance test, on a 
separate day. 
The 1997 ADA criteria recommended that the OGTT should not be routinely used to 
identify either diabetes or IGT. That recommendation has led to a great deal of 
controversy (Gerstein 2001). Although both IFG and IGT have increased risks of 
progressing to diabetes and macrovascular disease, it has been demonstrated that IGT is 
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more sensitive than IFG and it would therefore identify more people who arc at risk of 
progressing to Type 2 diabetes (Shaw et al. 1999). Moreover, it has been suggested that 
post load hyperglycaemia is an early risk factor for cardiovascular disease and may be a 
stronger predictor of cardiovascular events than fasting hyperglycaemia (DECODE 
Study Group of the European Diabetes Epidemiology Group 2001). Shaw and 
colleagues have recommended that IFG be diagnosed at a lower limit of 5.8 mmol/l to 
define a group more similar to the group with IGT (Shaw et al. 2000). 
1.6 Epidemiology 
1.6.1 World prevalence 
Diabetes is now one of the most common non-communicable diseases in the world and 
is considered a global health problem. It is the fourth or fifth leading cause of death in 
developed countries and has become an epidemic in many developing countries (Sicree, 
Shaw, & Zimmet 2003). Prevalence of diabetes in adults worldwide was estimated at 
135 million (or 4.0% of the population) in 1995 (King, Aubert, & Herman 1998). In 
2003, it was estimated that 194 million people (5.1%) aged between 20 and 79 years 
have diabetes. That figure is expected to increase to 333 million adults (6.3%) by the 
year 2025 (Sicree, Shaw, & Zimmet 2003). It is thought that developing countries will 
experience the major part of the numerical increase (170%) compared to a 42% increase 
in developed countries (King & Rewers 1993). In 2003, the region with the greatest 
number of persons with diabetes was Europe. However, by 2025, that is expected to 
shift to the South-East Asian region, although the region's prevalence of 7.5% will still 
be lower than that of North America, estimated at 9.7%, and Europe at 9.1% (Sicree, 
Shaw, & Zimmet 2003). 
Mean prevalence (Type I and Type 2 diabetes) in the age range 30-64 years for 
different regions is shown in Table 1.4 on page 8 (WHO/OMS 2001). The African and 
Asian region includes Arab, Bantu, Creole, Chinese, Indian, Malay and Tai 
populations. The American region includes American Indians, Brazilian, Colombian, 
U. S. non-Hispanic white, U. S. non-Hispanic black and U. S Hispanic populations. The 
European region includes Italian, Maltese, Polish and Russian populations. Finally, the 
Pacific region includes Aboriginal Australian, Melanesian, Micronesian, and Part 
Polynesian and Polynesian populations. The data shows that although the mean 
prevalence is similar for each region there are large variations within regions. 
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It is felt that social and behavioural changes, with the rise in obesity and the decline in 
physical activity levels, together with an increased longevity, are the main factors for 
the recent global explosion of Type 2 diabetes (Campbell 2001). The condition has, in 
the past, been erroneously referred to as mild diabetes because it is often asymptomatic 
as far as the classical symptoms of diabetes are concerned, such as thirst and polyuria 
(Campbell & Leslie 1997). Prevention and control programmes are needed to stem the 
rising epidemic of diabetes and its complications (Amos, McCarty, & Zimmet 1997). 
Table 1.4 Mean prevalence of diabetes (per cent population) in the age range 30-64 years in their 
respective geographical regions, including highest and lowest prevalence populations 
stay Population Alen Women 
Crude rate Age-adjusted Crude rate Age-adjusted 
rate rate 
African and Asian 9.2 10.1 8.0 9.1 
Highest: Indian 
(Fiji) 19.4 23.6 18.1 20.3 
Lowest: Bantu 
(Mara) 1.1 1.0 0.4 0.4 
American 10.9 10.9 10.7 10.8 
Highest: American 
Indians USA (Pima & 47.6 49.4 48.9 51.1 
Papago) 
Lowest: American 0.00 0.00 1.1 1.4 
Indians Chile 
_(Mapuches) European 6.9 6.3 7.2 6.4 
Highest: Italian 
(Laurino) 11.4 10.7 13.0 9.8 
Lowest: Russian 
(Novosibirsk) 2.1 1.8 4.0 3.6 
Pacific 9.1 9.5 9.4 10.6 
Highest: Aboriginal 
(Bourke) 25.6 24.0 19.0 20.9 
Lowest: Melanesian 
(Papua New Guinea) 0.0 0.0 0.0 0.0 
Adapted from the WHO http: //www. who. int/ncd/dia/databases2. htm 
1.6.2 UK prevalence 
In the UK diabetes is recognised as one of the most common chronic disorders (Keen et 
al. 1995). Approximately 1.67 million adults aged between 20 and 79 years (or 3.9% of 
the population) have diabetes (Sicree, Shaw, & Zimmet 2003), although a further 
million are thought to have diabetes without yet knowing it (Diabetes UK 2003b). 
Approximately 85% of people diagnosed with diabetes in England have Type 2 diabetes 
(DOH 2001 a). 
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1.6.3 Children and adolescents 
Epidemiological changes arc not confined to Type 2 diabetes. Most population-based 
registers of Type 1 diabetes in children report significant increases in incidence with 
time, although the aetiology is not fully understood (Green & Patterson 2001). Also of 
concern, but not documented in the figures above, is the dramatic increase in the 
number of children developing Type 2 diabetes (Rosenbloom et al. 1999). Although 
there is a strong hereditary component to the disease, the recent increases observed in 
diabetes prevalence have occurred too quickly to be the result of increased gene 
frequency and altered gene pool, emphasising the importance of environmental factors 
such as physical inactivity and obesity in the development of Type 2 diabetes (ADA 
2000). This thesis focuses solely upon adults with diabetes and, from now on, reference 
will only be made to adults living with Type 2 diabetes. 
1.6.4 Obesity and diabetes 
Obesity is now commonly defined in adults as a Body Mass Index (BMI) ? 30Kg/m2. It 
is, in simple terms, an excess storage of body fat. It develops from an excess of energy 
intake compared with energy expenditure. In adult men of average weight, fat comprises 
15-20% of the total body weight, while in women that proportion is greater at 25-30%. 
The precise definition of obesity remains controversial for a number of reasons: firstly, 
because the distribution of weight within a given population forms a continuous curve 
rather than division into discrete populations of obese and non-obese individuals, and 
secondly, because differences in weight between individuals relate not only to variations 
in body fat but also to frame size and muscle bulk (Allahabadia & Kumar 2002). 
However, an excellent correlation has been made between BMI and percentage body fat 
in large populations (Deurenberg, Westrate, & Seidell 1991). WHO and the 
International Obesity Task Force (IOTF) definitions of obesity are shown in Table 1.5 
below. 
Table 1.5 Classification of 
BM1 (K Grade 
and obesity in adults according to BMI 
Classification 
< 18.4 -- --- Underweight 
18.5-24.9 Pre-obese Healthy: desirable weight 
25 - 29.9 Obesity Grade I Overweight: should lose weight 
30- 39.9 Obesity Grade II Obese: need to lose weight 
>_40 Obesity Grade III Very obese: must lose weight 
Source: (WHO/OMS 1998) 
The UK Health of the Natiorn targets (Nutrition and Physical Activity Task Forces 1994) 
were that by the year 2005 the percentage of people aged 16-64 years who were obese 
would be reduced from the 1986/87 baseline of 8% of men and 12% of women to no 
more than 6% and 8% respectively. However, by 1998 the respective figures had 
increased to 17% and 21% and those figures are predicted to rise further by 2005 (see 
figure 1.3 below). 
WHO, despite its historical focus on malnutrition and starvation, has raised concerns 
regarding the problem of over-nutrition. In 1998 WHO Consultation on Obesity 
proclaimed that, "the epidemic projections for the next decade are so serious that public 
health action is urgently needed" (WHO 1998a). Two years later it again called for 
urgent action as diabetes was, by then, affecting developing countries as well as 
industrialised countries (WHO 2000b). 
Even in the developing countries, a pattern of rapidly escalating obesity and its co- 
morbidities is becoming apparent in certain sections of society (Prentice 2000). 
Potential conditions associated with obesity are Type 2 diabetes, coronary heart disease, 
insulin resistance, dyslipidaemia, and some site-specific cancers, such as colorectal, 
uterine, cervical and ovarian cancer (Jung 1997). 
Figure 1.3 The UK rising epidemic of obesity 
[-25fý 
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X30 10 
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Source: (DOH 2003b) 
1980 1991 1997 2005 
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Type 2 diabetes is the most significant medical consequence of obesity (WHO/OMS 
1998). In a prospective study of 114,281 nurses aged 30-55 years, after adjustment for 
age, BMI was the dominant predictor of risk of developing Type 2 diabetes (Colditz et 
al. 1995). In women the risk was shown to: 
Q rise above a BMI of 22 kg/m2; 
Q increase fivefold at a BMI of 25 kg/m2; 
Q increase 28-fold at a BMI of 30 kg/m2; 
Q increase 93-fold above a BMI of 35 kg/m2. 
A weight gain of 8 -10.9 kg correlated to a 2.7 fold increase in the risk of developing 
Type 2 diabetes compared to those whose weight remained stable (Colditz et al. 1995). 
In a study of 51,529 men aged 40-57 years, there was found to be an increased risk of 
developing Type 2 diabetes above a BMI of 24 kg/m2. Having adjusted for age, the risk 
was shown to: 
Q increase two fold at BMI 25-26.9 kg/m2; 
o increase 6.7 fold at BMI 29-30.9 kg/m2; 
o increase 42-fold at BMI 35 kg/m2 or above (Chan et al. 1994). 
1.6.5 Insulin resistance and the metabolic syndrome 
The term "insulin resistance" indicates a situation where the biological effect of insulin 
is reduced. The presence of insulin resistance is implied when there is normo- or 
hyperglycaemia alongside hyperinsulinamia (Krentz & Bailey 2001). Insulin resistance 
is often associated with a clustering of clinical and biological features known 
collectively as the metabolic syndrome (see figure 1.4 on page 12). Other terms used to 
describe the metabolic syndrome are insulin resistance syndrome, syndrome X, or 
Reaven's syndrome. 
It is estimated that the metabolic syndrome affects 20-30% of the middle-aged 
population among US adults (Ford, Giles, & Dietz 2002). Key features of the metabolic 
syndrome were formally described for the first time by Reaven in 1988 (Reaven 1988). 
The following are generally viewed as key components of the syndrome: 
Q abdominal obesity; 
Q hypertriglyceridaemia; 
Q reduced HDL cholesterol; 
Q raised blood pressure; 
Q glucose intolerance or overt hyperglycaemia. 
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Figure 1.4 The metabolic sýndromc 
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Source: adapted from Krentz 
Impaired glucose tolerance 
Type 2 diabetes 
Insulin resistance is regarded as the central abnormality of the entire syndrome. 
Recommendations have been made to add that characteristic to the list of key 
components, as well as other common effects such as: microalbuminuria, 
hyperuricaemia, procoagulant changes in the blood and dysfunction of the endothelium 
(Ford, Giles, & Dietz 2002). A tool has been developed to identify the metabolic 
syndrome: the measurement of "hypertriglyceridaemic waist". It was found that, in 
middle-aged men, a new clinical phenotype defined by waist circumference greater than 
90 cm combined with fasting triglyceride levels of greater than 2.0 mmol/l suggested a 
high likelihood of finding the clustering features of the metabolic syndrome. It was 
concluded, therefore, that emphasis should be placed on the management of waist 
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measurement rather than weight and it was proposed that waist circumference was an 
inexpensive "vital sign" that should be measured in all patients (Lemieux et al. 2002). 
1.6.6 The role of fat and carbohydrate 
Although diet and nutrition are believed to play an important part in the development of 
Type 2 diabetes, much controversy exists about the relationship between the amount 
and types of dietary fat and carbohydrate consumption and the risk of diabetes. Current 
dietary recommendations promote low-fat, high-carbohydrate diets for the prevention 
and treatment of diabetes (Ha & Lean 1998; Tuomilehto et al. 2001). However, neither 
fats nor carbohydrates are homogeneous molecules and it is now appreciated that 
different types of fat and carbohydrate have different effects on glucose homeostasis 
and insulin sensitivity (Frost & Dornhorst 2000). 
In the Health Professionals Follow-up Study (HPFS), van Dam and colleagues assessed 
the association between diet and the development of diabetes over a 12 year period. 
They found that a high-fat diet with high intakes of saturated fat and frequent 
consumption of processed meats were associated with an increased risk of Type 2 
diabetes. However that association disappeared when they adjusted for BMI (van Dam 
et al. 2002). Review of dietary intervention and epidemiologic studies have indicated 
that neither total fat nor total carbohydrate as proportions of total energy play a major 
part in the development of Type 2 diabetes in humans, but that different types of fat and 
carbohydrate appear to be more important. In particular, a higher intake of 
polyunsaturated fat and long-chain n-3 fatty acids could be beneficial, if consumed 
instead of saturated and trans-fat, and could appreciably reduce the risk of developing 
Type 2 diabetes (Hu, van Dam, & Liu 2001). 
Glycaemic index (GI 
GI is the ranking of carbohydrate foods based on their post-prandial response on blood 
glucose levels. The clinical utility of the GI remains controversial (Pi-Sunyer 2002). 
However, current evidence indicates that the GI is a useful concept and the WHO 
nutritional body, WHO/FAO, now recommends that dietary carbohydrates be classified 
according to their glycaemic index (FAO/WHO 1997). An international table of 
glycaemic index and glycaemic load values is available and classifies over 750 types of 
food (Foster-Powell, Holt, & Brand-Miller 2002). Glucose load is the GI for a particular 
type of food multiplied by its dietary carbohydrate content. 
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However, the GI database needs further development and refinement particularly in 
different populations and in the context of mixed meals. Future epidemiological studies 
about the association between dietary glucose load and the prevention and treatment of 
diabetes should include large sample sizes and a longer follow-up to produce more 
robust results (Hu, van Dam, & Liu 2001). In the meantime, enough evidence does exist 
to support a theory that a low GI diet, incorporating a greater amount of fibre and 
minimally processed whole grain products, will lower the glycaemic and insulinaemic 
responses to carbohydrate. The traditional concept of "simple" versus "complex" 
carbohydrates is no longer useful in predicting the risk of Type 2 diabetes or in 
achieving optimum glycaemic control and this has been replaced with a proposed model 
incorporating glycaemic load (figure 1.5) (Willett, Manson, & Liu 2002). 
Figure 1.5 Proposed mechanisms for the development of Type 2 diabetes due to high glycaemic 
load 
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1.6.7 Prevention 
The prevention of Type 2 diabetes has been an area of interest for many years and has 
recently attracted increasing interest, possibly due to the escalating burden of Type 2 
diabetes upon resources worldwide. Also the results from several intervention trials 
have been published, many of which have demonstrated the potential for lifestyle 
changes or medication to reduce the development of diabetes in people with impaired 
glucose tolerance (Table 1.6). 
Table 1.6 Summary of the diabetes prevention trials 
Trial Intervention Patient N" in Follow- Incidence Risk 
Details Trial up of Reduction 
Mean Diabetes 
Da Quing' Diet IGT 577 6 years 44% 31% 
Exercise 41% 46% 
Diet & 
Exercise 46% 42% 
Control 68% 
FDP. Diet & IGT 522 3.2 11% 58% 
Exercise years 
Control 23% ----- 
Freeman Pravastatin Dyslipidaemia 5974 4.8 2.3% 30% 
et al. 3 Control years 3.4% --- 
Yusuf Ramipril Hypertension 5720 4.5 3.6% 34% 
et a14 Control years 5.4% --- 
STOP- Acarbose IGT 1429 3.3 32% 25% 
NIDDM5 Control years 42% ----- 
DPP Diet & IGT 3234 2.8 4.8% 58% 
exercise years 
Metformin 7.8% 31% 
Control 11% 
Buchanan Troglitazone Previous GD 266 2.5 5.4% 55% 
et all Control years 12.1% 
LIFE Losartan Hypertension 9193 4.8 6% 25% 
Atenolol years 8% ---- 
XENDOS Xenical Obesity 3304 4 years 6.2% 37% 
Control 9.0% 
IGT = Impaired Glucose tolcrancc NGT = Normal Glucose Tolerance GD = Gestational Diabetes 
'(Pan et al. 1997). 2(Tuomilehto et al. 2001). 3(Freeman et al. 2001). 4(Yusuf et al. 
2001). 5(Chiasson et al. 2002). 6(Knowler et al. 2002). 7(Buchanan et al. 2002). 
8(Dahlöf 
et al. 2002). 9(Sjostrom et al. 2002). 
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The intensive lifestyle approach to diabetes prevention appears to offer more protection 
than medication. The Da Qinq IGT and Diabetes study, the Finnish Diabetes Prevention 
Study (DPS) and the US Diabetes Prevention Programme (DPP) all clearly show that 
patients who participated in an individualised diet and exercise programme greatly 
reduced their risk of developing Type 2 diabetes. However, in reality, people may use 
drugs because they are easier and convenient. It is questionable whether diabetes 
prevention through medication is a sensible long-term option. Treatment by medication 
alone tends to be a life-long requirement and all medication has potential adverse 
effects. On the other hand, a healthier lifestyle offers patients potential benefits over and 
above the treatment of IGT. The question is whether healthcare professionals would be 
providing adequate treatment if they were to continue prescribing medication in place of 
encouraging an intensive lifestyle approach (Deakin 2003a; Marks 2003). 
In the DPS patients were set five targets: to reduce body weight by more than 5%; to 
reduce total fat intake to less than 30% of total calories; to reduce saturated fat to less 
than 10% of total calories; to increase fibre intake to at least 15g per 1000 calories, and 
to participate in physical activity for at least 30 minute each day. In those who achieved 
four or five of the targets, not one case of diabetes was diagnosed. However, in those 
who didn't manage to achieve any of the targets, 35% developed diabetes. Individuals 
who lost 5% body weight experienced a 47% risk reduction in developing diabetes and 
those who lost 11% body weight gained the benefit of a 63% risk reduction. Subsequent 
outcome collection and analysis at 12 and 18 months post study has shown that 
although there was initially a slight deterioration in the risk reduction at 12 months 
(58% down to 45%), that had stabilised by 18 months (risk reduction 44%) (Tuomilehto 
2002). 
Tuomilehto and colleagues have developed a `Diabetes Prediction Risk Score' that 
predicts the risk of an individual developing diabetes. It is based on age, BMI, diet, 
hypertension, previous gestational diabetes, glucose level, and family history. A score 
of less than seven indicates a less than 1% chance of developing diabetes and a score 
above seven suggests a greater than 50% chance of developing diabetes. That type of 
scoring system is thought to be a cheaper and more effective way of predicting diabetes 
than performing an OGTT on all high-risk patients (Tuomilehto 2002). 
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The intensive lifestyle approach in the DPP comprised 16 individual sessions followed 
by maintenance of individual and group sessions with supervised exercise sessions. The 
aim was to achieve a 7% weight loss by consuming between 1200-2000 Kcal/day with 
less than 25% fat and by taking 30 minutes of exercise each day. The lifestyle approach 
was more effective in leaner, older participants and the metformin medication 
intervention had better results for more obese individuals. Body weight reduction was, 
however, the strongest predictor for preventing diabetes; a 15 kg weight loss equated to 
zero risk of developing diabetes. Individuals who did not manage to lose weight had a 
15 times greater risk of developing diabetes. 
The DDP was expensive with each case costing $25,000. The `Number Needed to 
Treat' with the intensive lifestyle approach to prevent just one case of diabetes is seven 
people with IGT (Diabetes Prevention Program Research Group 2002). Outcomes were 
only achieved in a motivated selected sample of people with IGT. Initially 30,000 
people were identified for the trial, but only 3,000 of them provided written consent to 
participate. That suggested that 27,000 individuals were not interested in lifestyle 
change. Of the participating individuals, only 50% initially achieved the weight loss 
target and that percentage reduced to just 38% at the final data collection (Snoek 2002). 
Diabetes prevention could be a very costly health promotion strategy. Developed 
countries would find it very difficult to provide the resources to repeat the intensive 
lifestyle intervention from the DPP on a population level and, in developing countries 
where the diabetes epidemic is projected to be greater, it would be a colossal task. Even 
if resources were available, it would be interesting to monitor how many people at high 
risk of developing diabetes would carry out protective lifestyle behaviours. Another 
important factor to take into consideration is that the education and training of 
healthcare professionals would be an essential prerequisite to increasing public 
awareness of IGT and its consequences. A recent UK survey reported that 47% of GPs 
were unaware that IGT leads to Type 2 diabetes (Davis et al. 1987). 
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1.7 Principles of treatment 
1.7.1 Aims and objectives 
The current aim of treatment for Type 2 diabetes is focused upon optimising quality of life: 
To maximise the quality of life of all people with diabetes and reduce their risk 
of developing the long-term complications of diabetes (DOH 2001a). 
The active involvement of patients in their own care is the cornerstone of good diabetes 
management, for it is the person with diabetes who plays the most crucial role in the 
process, and hence their self-motivation is essential. 
International collaborations, such as the Saint Vincent Declaration in Europe in 1989, have 
set targets for improvements in care. That declaration resulted from a meeting between 
various representatives of European government health departments and patient 
organisations under the aegis of the European Regional Office of WHO and the 
International Diabetes Federation. The meeting produced unanimous agreement on a series 
of general goals and five-year targets. 
The following targets were agreed in the St Vincent Declaration (DOH & Diabetes UK 
1995): 
Q reduce cases of new blindness by at least one third; 
Q reduce numbers of people entering end stage renal failure by at least one 
third; 
o reduce the rate of limb amputations for diabetic gangrene by at least a half, 
o cut mortality and morbidity from coronary heart disease in people with 
diabetes; 
Q improve the outcome of pregnancies in women with diabetes. 
Diabetes UK has made recommendations for the standard of healthcare that people with 
diabetes should expect (Diabetes UK 2001b) (see figure 1.6 on page 19). 
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Figure 1.6 Diabetes UK standards "what care people should expect" 
When diagnosed with diabetes people should receive: 
"a full medical examination; 
"a talk with a registered nurse with a special interest in diabetes; 
"a talk with a state registered dietitian; 
"a discussion of the implications of diabetes e. g. occupation, driving, 
insurance, prescription charges etc; 
" information about Diabetes UK services and the local branch; 
" if treated with oral hypoglycaemic agents, discussion about the 
possibility of hypoglycaemia and how to treat; 
" if treated by diet alone, or a combination of diet and tablets, instruction 
on blood or urine testing, what the results mean and supplies of 
equipment. 
Once the diabetes is reasonably controlled, there should be: 
" on going education about diabetes and the positive effects of exercise; 
" access to the diabetes team at regular intervals (ideally every 4-6 
months); 
" contact with any member of the healthcare team for specialist advice; 
" education sessions at a rate appropriate to an individual's ability to 
assimilate the information; 
"a formal medical review by a doctor experienced in diabetes; 
At the annual review, the following should be undertaken: 
" weight record and calculation of BMI; 
" urine test for protein; 
" blood sample to measure long-term diabetes control; 
" discussion of home monitoring results, if appropriate; 
" blood pressure check; 
" vision check and examination of the back of the eyes; 
" legs and feet examined to check circulation and nerve supply; 
" injection sites examined if on insulin; 
" an opportunity to discuss coping measures for diabetes. 
Source: Diabetes UK, 2001 
1.7.2 Organisation of care 
Diabetes care is increasingly being delivered, not only in hospitals, but also in primary 
and community care settings. Existing information, infrastructure, systems and services 
do not always meet the needs of people with diabetes. A review of diabetes services in 
England and Wales focused mainly on a small sample of hospitals but also included 
surveys of health authorities, general practices and patients. The results showed variable 
levels of care, with many services struggling to cope with the current demand. It is 
predicted that pressure upon current services will increase as patient numbers rise. 
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Summaries of some of the findings are presented in figure 1.7 below (Audit 
Commission for Local Authorities and the National Health Service 2000). 
Figure 1.7 Testing Times: some key findings 
More patients are now being managed within primary care, but standards vary: 
" practice nurses working alone operate one third of clinics; 
" less than one third of practices have routine access to a dietitian or 
chiropodist; 
" four in 10 practices lack referral guidelines to secondary care; 
" health professionals delivering services in community settings do not 
always have the training or support that they need; 
" many primary care organisations are unable to establish the number of 
people with diabetes in their care; 
" only a quarter of general practices are able to provide patient held 
records for people with diabetes. 
Hospitals are not always providing the best care: 
" patients report delays in clinics and insufficient time with staff; 
" patient education was inadequate at half of the hospitals visited; 
" ethnic minority patients are twice as likely to report gaps in their 
knowledge and understanding of diabetes; 
" numbers of doctors and nurses vary fourfold; 
" two thirds of patients report that they have received no education in the 
last year; 
" one fifth of patients report a lack of opportunity to talk to other patients. 
Source: The Audit Commission, 2000 
The Delivery Strategy for the National Service Framework for Diabetes in England 
(DOH 2003a) is attempting to address these findings in a variety of ways: 
o by encouraging Primary Care Trusts (PCTs) to develop clinically-led, managed 
diabetes networks. These will be an extension to the Local Diabetes Services 
Advisory Group (LDSAG) and will bring together all the key players in 
diabetes care, including people with diabetes, clinical champions and healthcare 
managers. The managed networks will have direct accountability to the PCTs 
and will be a major step towards a situation where diabetes care is managed 
mainly within primary care; 
o by supporting an education and training programme for all healthcare staff 
involved in the treatment and management of people with diabetes to ensure 
that people with diabetes receive evidence-based and appropriate education and 
advice by a named contact within the healthcare team; 
Q by encouraging all PCTs to develop group-based structured and ongoing 
education programmes that provide accurate and consistent education and 
advice to people with diabetes and their carers; 
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Q by setting up practice-based registers that will provide the basis for call and 
recall for regular review, clinical care, monitoring and clinical audit; 
by providing patients with access to their medical records so that they can work 
in partnership with healthcare professionals. 
Those objectives, if achieved, will improve the quality and consistency of diabetes care. 
However, there have been concerns regarding the availability of resources to implement 
the delivery strategy. Extra resources for the NHS were announced in the 2002 Budget. 
Although that provided for the largest ever sustained increase in NHS funding, no 
resources have been ring-fenced for diabetes services. Local decisions about health 
priorities will influence whether adequate resources are made available for the 
development and improvement of diabetes services. 
1.7.3 Education 
Effective ongoing education, matched to each patient's ability and capacity to learn, can 
enable people with diabetes to take responsibility for their own health. People with 
diabetes should also be empowered to obtain the maximum benefit from healthcare 
services so that, as far as possible, they develop the skills and the confidence to make 
informed decisions regarding their diabetes self-care. Health behaviour models and 
theories will be discussed in detail in Chapter 2. 
4 . 7.4 Importance of glycaemic control 
Type 2 diabetes has a major impact on health and survival and could be termed a silent 
killer (Campbell 2001). People living with Type 2 diabetes are two to four times more 
likely to develop cardiovascular disease (IDF 2001) and have significantly higher 
cardiovascular death rates than people without diabetes (Roper et al. 2001). Coronary 
heart disease and stroke are thought to be the result of persistently raised blood glucose 
that exacerbates both atherosclerosis and arteriosclerosis of the arteries supplying the 
heart and brain, and raised blood pressure. Foot ulceration, (`diabetic foot') is the most 
common reason for people with diabetes to be admitted to hospital in the UK (Young et 
al. 1994). It is a result of nerve damage (neuropathy) and lack of blood supply 
(ischaemia). If an ulcer becomes infected and gangrenous, amputation can become 
necessary. People with diabetes are 15 times more likely to need amputation than 
people without the condition (Bild et al. 1989). Diabetic retinopathy is an eye disease 
caused by damage to the small blood vessels at the back of the eye. It is considered to 
be the leading cause of blindness in people of working age (Evans 1995). Diabetic 
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nephropathy, (kidney disease caused by diabetes), is one of the most serious 
complications of diabetes and is a major cause of fatal kidney failure (Cameron & 
Challah 1986). It is caused by excess blood glucose damaging the small blood vessels in 
the kidneys, and by raised blood pressure. 
The United Kingdom Prospective Diabetes Study (UKPDS Group 1998b) has provided 
evidence that the life threatening complications of Type 2 diabetes can be reduced by 
ensuring optimum levels of both blood glucose and blood pressure. A more recent 
observational study of complications in Type 2 diabetes has demonstrated that for every 
per cent reduction in glycated haemoglobin, there was a corresponding reduction in risk 
of 21% for any end point related to diabetes, a reduction of 21% for deaths related to 
diabetes, 14% for myocardial infarction and 37% for microvascular complications 
(Stratton et al. 2000). Each 10 mmHg decrease in systolic blood pressure was associated 
with reductions in risk of 12% for any complication related to diabetes, 15% for deaths 
related to diabetes, 11% for myocardial infarction and 13% for microvascular 
complications (Adler et al. 2000). Therefore, any reduction in glycated haemoglobin 
and blood pressure is likely to reduce the risk of complications, with the lowest risk 
being in those cases where with HbAlc values are in the normal range (< 6.0%) and 
systolic blood pressure values less than 120 mm Hg. 
The National Institute for Clinical Excellence (NICE) is the Clinical Guidelines 
Programme for England and Wales. It is the independent organisation responsible for 
providing guidance about treatments and services for those in England and Wales 
eligible for NHS care. Its guidance is for healthcare professionals and patients and their 
carers and it is designed to help them make decisions about treatment and healthcare. 
NICE has written or commissioned a series of guidelines on the clinical management of 
Type 2 diabetes and its associated problems: prevention and management of foot 
problems (Hutchinson et al. 2000); retinopathy - early management and screening 
(NICE 2002d); renal disease - prevention and early management (NICE 2002c); 
managing blood glucose levels (NICE 2002b); management of blood pressure and blood 
lipids (NICE 2002a). 
1.7.5 Diet and physical activity 
UK dietary guidelines for the management of diabetes have recently been updated 
(Nutrition Subcommittee of the Diabetes care Advisory Committee of Diabetes UK 
2003). Important changes from previous recommendations of Diabetes UK (formerly 
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the British Diabetic Association) (BDA Nutrition Sub-Committee 1992) include greater 
flexibility in the proportions of energy derived from carbohydrate and monounsaturated 
fat, further liberalisation in the consumption of sucrose, more active promotion of foods 
with low glycaemic index, and greater emphasis on promoting physical activity levels. 
Those recommendations are more in line with the European (Ha & Lean 1998) and 
American (ADA 2003) nutritional and physical activity recommendations for the 
management of diabetes. Table 1.7 provides a brief overview of those 
recommendations. 
Tablc l. 7 Summary of the dietary and physical activity recommendations for adults with diabetes 
Recomm- European American UK 
cndation 
Energy If overweight: energy Standard weight 
deficit of 500 Kcal 
per day aiming for a 
10Kg weight loss. 
reduction diets. Added 
exercise and behaviour 
strategies are essential 
If overweight: energy 
deficit of 500 Kcal 
per day aiming for 1- 
2 Kg weight loss per 
for long-term success. month. 
CHO Carbohydrate (CHO) with monounsaturated fat (MUFA) should provide 
60-70% of total energy. 
CHO rich in dietary The total CHO in More active 
fibre or with low GI meals/snacks is more promotion of 
is recommended important than GI. CHO carbohydrate foods 
along with veg, from whole grains, fruits, with a low glycaemic 
legumes, fruits and vegetables, and low fat index. 
cereal-derived CHO. milk is recommended. 
Sucrose As sucrose does not produce a greater rise in plasma glucose than 
isocaloric amounts of starch, sucrose and sugary food does not have to be 
restricted and may provide up to 10% of the daily energy derived from 
carbohydrate. 
Protein 10-20% of total Kcal 15-20% total daily Not> Ig per kg body 
(should not exceed energy. Protein weight. 
this level). 0.8 Kg per requirement may be 
Kg of body weight if greater than 
micoalbuminuria or Recommended Daily 
nephropathy. Allowance (RDA) if poor 
diabetes control exists 
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Fat Saturated (SFA) and trans-unsaturated fatty acids should provide less than 10% 
total energy. Polyunsaturated fats (PUFA) should not exceed 10%. Olive and 
rapeseed oils recommended (Dietary cholesterol les s than 300mg/day in US 
and European recommendations only). 
Oily fish consumption encouraged in all recommendations with oily fish 
supplements to reduce plasma triglyceride levels in the US recommendations 
but not in the European and UK recommendations. 
Alcohol A daily amount No more than two Sensible drinking as 
equivalent to one or alcohol drinks per day. recommended to the 
two glasses of wine One drink (15g alcohol) general population: 
per day is acceptable. is equivalent to 12 oz maximum 14 units 
Those on insulin / beer, 5 oz wine or 1.5 oz per week for women 
sulphonylureas need distilled spirits. and 21 units per week 
to consume alcohol for men, with 1-2 
with CHO food to alcohol-free days 
prevent hypo's. each week. 
Physical Walking for four Thirty minutes of 20-30 minutes of 
activity hours per week to moderate physical physical activity on 
achieve a 2000 Kcal / activity on most days of most days. 
week deficit. the week. 
The benefit of physical activity on the metabolic syndrome and Type 2 diabetes has 
already been documented. Larsen et al demonstrated the beneficial effect of exercise on 
glycaemia and insulin levels (Larsen et al. 1997) and Lehmann et al. reported a 20% 
reduction in fasting plasma triglyceride concentrations, an increase in HDL cholesterol, 
a significant lowering of both systolic and diastolic blood pressure and a fall in the waist 
to hip ratio (Lehmann et al. 1995). The best time to promote physical activity is at the 
stage when the individual is newly diagnosed, because that is when motivation for 
behaviour change is at its highest (Legge 1997). However, the duty to recommend an 
increase in physical activity does not fall to any single healthcare professional: it is the 
responsibility of all, and consequently it is easy for such advice to become overlooked 
within the current clinic consultations process. 
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1.7.6 Medication and insulin 
When non-pharmacological treatments are unable to achieve or maintain adequate 
glycaemic control, oral hypoglycaemic agents are indicated. Figure 1.8 below briefly 
describes the different types of medication available. 
Figure 1.8 Oral hypoglycacmic agents 
Sulnhonylureas 
These are the most commonly prescribed diabetes tablets. They work mainly by stimulating 
the ß-cells in the pancreas to release more insulin. They are therefore dependent on the 
patient having adequate residual ß-cell function. The principal difference between the 
various types of sulphonylureas is the duration of action. There are few side effects but 
weight gain is common. Regular meals and snacks are necessary to prevent hypoglycaemia. 
Bieuanides 
Metformin is the only biguanide currently prescribed in the UK. This drug works by 
reducing hepatic gluconeogenesis and hepatic glycogenolysis and by enhancing insulin 
stimulated glucose uptake and glycogenesis by skeletal muscle. It does not, as a rule, cause 
hypoglycaemia or weight gain, although gastrointestinal complaints such as diarrhoea and 
nausea are common. Patients are advised to begin on a small dose and increase as tolerated 
to reduce the impact of side effects. 
Alpha-Glucosidase Inhibitors 
Acarbose competitively inhibits the activity of alpha glucosidase enzymes in the brush 
border of the small intestine. It slows down digestion of carbohydrates and extends the 
digestive process lower down into the gut. Some carbohydrate malabsorption often occurs 
causing excessive flatulence, diarrhoea and abdominal discomfort. 
Thiazolidinediones (Glitazones) 
A relatively new class of agents, these tablets have been developed to enhance insulin 
sensitivity. They achieve a slow blood glucose-lowering effect in Type 2 diabetes, often 
taking two or three months to achieve maximum benefit. NICE has published technology 
appraisals for the use of rosiglitazone and pioglitazone. They are not indicated unless the 
patient is unable to take metformin and insulin secretagogues as combination therapy or 
where diabetes control remains unsatisfactory despite taking combination therapy (NICE 
2000; NICE 2001). 
Prandial Glucose Regulators 
The normal acute phase of insulin release is diminished or absent in Type 2 diabetes. Two 
types of prandial glucose regulators are available in the UK: repaglinide and nateglinide. 
They are both rapidly absorbed and offer a prompt but short-lived stimulatory effect on 
insulin secretion. Taking the drug just before a meal enables peak insulin secretion to 
coincide with meal digestion. 
bourcc: tc; aasby 2001) 
When oral agents in combination are unable to achieve or sustain optimum metabolic 
control, it is often necessary to switch to insulin. However, statistics from the Diabetes 
Audit and Research in Tayside Scotland (DARTS) database has shown that only one in 
three people with Type 2 diabetes have adequate adherence to a single oral 
hypoglycaemic agent. Poor adherence with complex drug regimens are likely to be a 
major obstacle in the treatment of optimum metabolic control (Donnan, MacDonald, & 
Moms 2002) and many people may commence insulin treatment for this reason Figure 
1.9 presents an algorithm for the treatment of Type 2 diabetes. 
Figure 1.9 The current treatment of T, pe 2 diabetes 
Confirmed 
diagnosis of Type 
2 diabetes 
Advice 
Diet 
Physical 
activity 
diabetes 
Diet 10 
Physical 101. 
activity 
Single OHA e. g. metformin 
or sulphonylurea 
Diet 
Physical Io. 
activity 
Uncontmllod 
I Metformin & Sulphonylurea I 
combination 
Diet 
Physical 
activity Ho 
Added Thiazolidinediones 
or Prandial Glucose Regulators 
Diet 
Physical -----f llad f- Uncontro 
activity 
Insulin treatment +/- 
metformin 
In the UK about 20-25% 
of adults with Type ? 
diabetes are estimated to 
require insulin within 10 
years of diagnosis, 
although a greater 
proportion of patients 
would probably benefit 
from the administration 
of insulin in any event 
(Krentz & Bailey 2001) 
There is a vast choice of 
insulin available in the 
UK, ranging from rapid- 
acting analogues and 
short, medium and long- 
acting varieties to mixed 
insulin and analogue 
mixtures Different types 
of insulin have unique 
'onset, peak and 
duration' levels and can 
remain effective from a 
minimum of four hours 
up to a maximum of 36 
' hours Each patient 
requiring insulin should have a full assessment to prescribe a suitable blend of insulin 
and to ensure a regimen that will improve metabolic control and quality of life with 
minimum disruption and inconvenience to the patient 
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1.8 The economics of diabetes care 
Two recent studies have estimated the economics of diabetes and diabetes care 
(Diabetes UK 2000; Williams et al. 2001; Williams et al. 2002). CODE-2 and T2ARDIS 
are landmark studies of the economics of diabetes and diabetes care. The CODE-2 
initiative brought researchers together from eight European countries. They agreed a 
common protocol and used that to measure the health care costs of diabetes in their 
countries. CODE-2 UK used data from medical records to identify NHS resource use 
over a 12 month period (1998/1999) and collected data on clinical outcomes (glycaemic 
control, lipid levels and blood pressure). Patients were grouped according to whether or 
not they were free from diabetes complications, or had developed microvascular, 
macrovascular or both types of complications. The main contribution of T2ARDIS was 
to provide information on a wider set of costs than had been available before. Data 
about the quality of life of people with diabetes and about loss of earnings experienced 
by patients due to their diabetes were collected. The main findings are summarised in 
Table 1.8 on page 28. 
Average annual NHS costs for treating Type 2 diabetes are equivalent to more than 
twice the per capita NHS expenditure in the UK. Having regard to current costs, the 
data above may already be an underestimate. Publication of the UKPDS findings 
(UKPDS Group 1998b) and the National Service Framework for diabetes (DOH 2001 a) 
are likely to display an increase in medication costs for Type 2 diabetes. Also, with the 
growing epidemic of diabetes, if more than half the people living with the condition 
remain poorly controlled, costs are likely to escalate further. 
Interestingly, only 9% of patients who reported extreme problems with mobility or self- 
care reported using social services and those with diabetes complications did not receive 
any extra state benefits compared to those with no complications. That may indicate that 
the people most in need of financial assistance either do not know that they may be 
eligible for benefit or are not able to complete the relevant forms. Although 
approximately 70% of patients who lost earnings as a result of their diabetes received 
state benefits, such as Incapacity Benefit, the value claimed was more than £10,000 
below the value of the lost income. More than 80% of carers reported financial strain 
and the majority of them were assuming a carer role for more than 60 hours each week. 
That level of responsibility could well suggest that financial strain may be only one 
aspect of the overall burden facing people who care for those with diabetes (Holmes et 
al. 2003). 
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Table 1.8 Summary of the findinis from T=ARDIS and CODE-2 %tudics 
Variable Main finding 
Metabolic control More than half of the Type 2 diabetes population remained poorly 
controlled (i. e. HbA1,, > 7.5%) 
Diabetes Comorbidity was high with one in four patients having 
complications microvascular complications and one in eight having 
macrovascular complications 
Outpatient On average, a person with diabetes had 17.4 encounters with a 
appointments health professional in a year. That equated to three hours of contact 
each year. 
Annual patient Average annual NHS costs for the care of someone with Type 2 
costs diabetes were £1,500 - £1,700. Those experiencing both micro- and 
macrovascular complications cost 2.6 times more (£2,277) than 
those with no such complications. 
Hospital Costs of all admissions and day cases amounted to £545 - £721 per 
admission costs patient per annum, which translated to between 36% and 41% of 
total annual spend per patient with Type 2 diabetes. Those with 
micro- and macrovascular complications were 6.4 times more 
expensive than those without. 
Personal costs Annual expenditure by people with diabetes amounted, on average, 
to £230 per person. Their carers incurred additional costs of around 
£160 per year. 
Lost earnings For patients of working age and their carers, 6% of patients and 
12% of carers reported either an inability to work or a need to work 
part time due to their diabetes. The average lost income for patients 
was £14,000 per year, and for carers £11,000 per year. 
Quality of life People with diabetes reported a significantly poorer quality of life 
compared with that of the general population. That was mainly due 
to mobility problems, pain and discomfort. Quality of life 
deteriorated considerably more for those patients experiencing 
diabetes complications. 
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1.9 Summary 
There is no question that there have been major developments over the years in 
identifying, treating and improving the quality of life for people with diabetes. 
However, people with diabetes are still dying prematurely and their quality of life can 
still be poor in comparison with that of people without the condition. Recent studies 
have shown that there is scope to delay the development of Type 2 diabetes and 
possibly to prevent it altogether. It has also been shown that mortality and morbidity can 
be dramatically reduced if effective treatment that ensures optimum blood glucose 
levels and blood pressure readings is provided. Nevertheless, it is predicted that the 
prevalence of diabetes worldwide will more than double during the next 20 years, 
primarily as a result of the rising epidemic of obesity and the metabolic syndrome. It is 
clear that diabetes has been shown to be a costly condition, not just for the NHS but also 
for patients and their carers. In England and Wales, the National Service Framework for 
Diabetes is a recent public health document that addresses these concerns. Innovative 
healthcare delivery arrangements are urgently required in the 21" century to implement 
the Framework and result in real benefits for people with diabetes, their carers and the 
health service. 
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Chapter 2: Health Behaviour Change 
2.1 Introduction 
Health is a complex issue and "being healthy" has many definitions. This chapter gives 
a brief review regarding the components of health, health behaviour models, relevant 
international literature and its impact on national policy. These will then be related to 
the varying models available for the practice of patient education. The routine approach 
to diabetes patient education within Europe and the United States will then be compared 
and contrasted. Components of health behaviour and patient education models will then 
be linked to the development of the intervention which is the subject of this thesis, the 
diabetes expert patient programme, X-PERT. 
2.2 Society and health 
Good health is a fundamental goal for people and the societies in which they live. 
Individuals hope for a life free from illness and pain, and societies, through the acts of 
government, promote policies designed to counteract ill health (Moon 1995). 
2.2.1 Definition of health 
The World Health Organisation (WHO) defined health as "a state of complete physical, 
mental and social well-being, and not merely the absence of disease or infirmity" (WHO 
1946). However, that definition has been criticised as idealistic because it suggests that 
people are unhealthy unless they have attained complete physical, mental and social 
well-being (Aggleton 1990). The definition also implies a static state whereas life is 
anything but static. A more recent definition encapsulates a holistic view of health by 
suggesting that emotional, spiritual and societal aspects of health need to be considered 
(Ewles & Simnett 2003). 
Q Physical health is the most obvious dimension of health, and is concerned with 
the mechanistic functioning of the body. 
Q Mental health is the ability to think clearly and coherently. 
Q Sexual health is concerned with the practice of safe sex in the prevention of 
sexually transmitted diseases and unwanted pregnancies. 
o Social health means the ability to make and maintain relationships. 
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o Spiritual health for some people is connected with religious beliefs and 
practices; for others it is to do with principles of behaviour and being at peace 
with oneself. 
Q Environmental health is influenced by public health policy. Examples of 
determinants of health affected by policies are poverty, education, transport, 
housing, a safe workplace, legislation, and immunisation. 
Q Societal health considers the society in which people live. Women cannot be 
healthy when their contribution to society is undervalued, neither black nor 
white people can be healthy in a society where racism undermines human worth; 
unemployed people cannot be healthy in a society that values only people in 
paid employment 
Figure 2.1 denotes the varying dimensions of health and is adapted from the work of 
Aggleton (Aggleton 1990). 
Figure 2.1 The determinants of health 
Environmental 
Spiritual 
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The identification of those different aspects of health verifies the complexity of defining 
health. However, dividing people's lives into categories such as `physical' and 
`spiritual' is impractical, as all aspects of health are interrelated and interdependent 
(Ewles & Simnett 2003). 
To the general public, being healthy may just mean `not being ill'. Health can be taken 
for granted and only appreciated when lack of health interferes with everyday life. 
Health means different things to different people and it has been shown (Calnan 1987) 
that middle-class women associate good health with being fit, active and able to cope 
with a crisis whereas working class women perceive good health as never being ill and 
the ability to `get through the day'. 
A more recent WHO definition of health encompassed both an individual and a societal 
responsibility, and envisaged self-empowerment as a means of improving quality of life. 
WHO's current definition is: `the exteni to which all individual or group is able, on the 
one hand, to realise aspirations and Satisfy deeds: and, on the other hand, to, change or 
cope with the environment. Health is, therefore, a resource for everyday life, not the 
objective of living; it is a positive concept emphasizing social and personal resorurces, 
as well as physical capacities' (WHO 1985h). 
2.2.2 Demographic and epidemiological change 
Society is moving through a demographic transition (figure 2.2). 
Figure 2.2 The demographic transition 
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The demographic transition is a simplistic model that can be used to compare `real- 
world' situations. During the high stakte phase, the population remains stable with new 
births replacing deaths. The next phase is early Irui, silion where birth rate is maintained 
but death rates decline steadily. The consequence of early transition is a rapid natural 
increase in the population. Population growth levels off as the birth rate begins to fall 
and this is called the late transition. The final stage of the transition is the low stable 
phase where there are substantial numbers of elderly people in the population and little 
or no population growth. Although most industrialised countries are well advanced 
through the transition, some less developed countries exhibit the characteristics of 
earlier phases, cultural factors may influence a high birth rate and economic and 
political factors may result in raised death rates due to poverty, famine, war, 
environmental degradation and poor availability of health care (Moon 1995). 
The late transition in developed countries resulted mainly from social and public health 
measures and immunisation programmes prior to the development of the NHS. In more 
recent years, developed countries have moved through another transition: the 
epidemiological or mortality transition (Moon 1995). That transition is a linear process, 
showing the shift from a situation dominated by infectious disease to one of 
degenerative or chronic diseases (see figure 2.3 below). That model incorporates four 
stages: the age of epidemics, where infectious disease resulted in a greatly reduced life 
expectancy; receding epidemics where infectious diseases were controlled and therefore 
had less of an impact on the mortality; the age of chronic disease where a reduction in 
infant mortality and an increase in life expectancy was seen, and delayed degenerative 
disease, which resulted in a further rise in life expectancy but quality of life was 
impaired due to increased chronic disease. 
Figure 2.3 The epidemiology transition 
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Developed countries are presently experiencing the fourth stage of the epidemiology 
transition, with chronic diseases being the major cause of present-day mortality and 
morbidity, and the aetiology being multifaceted. Modern industrialised life, with 
excessive consumption of calories especially in the form of fat, reduced physical 
activity, easy access to alcohol, tobacco and transport, and stress are but a few of the 
determinants. Life expectancy has increased from 48 years to 80 years for women, and 
from 44 years to 75 years for men. However, large numbers of people still suffer 
premature death, or have their quality of life impaired, by avoidable ill health (D011 
1999). 
2.3 Health education/health promotion 
2.3.1 Comparing health education and health promotion 
During the 1970s, the term "health education" emphasised an individual approach to 
behaviour change and was based on the theory that individuals were responsible for 
their own health (Ewles & Simnett 2003). Health education has been defined as 'ally 
intentional activity that is designed to achieve health or illness related learning, i. e. 
some relatively permanent change ill all individual's capability or disposition. Effective 
health education may, thus, produce changes in knowledge and understanding or ways 
of thinking; it may influence or clarify values; it may bring about some shift in belief or 
attitude; it may facilitate the acquisition of skills; it may evert effect changes in 
behaviour or lifestyle' (Tones & Tilford 1994, page 11). In recent years health 
education has been criticised for being too focused on individual lifestyle and too quick 
to lay blame on the individual for health conduct and lifestyle choices (Ewles & Simnett 
2003). 
In line with more recent definitions of health and a growing emphasis upon social and 
environmental dimensions as well as physical capacities, the term "health promotion" 
has become widely used and accepted. Health promotion has been defined as `the 
process of enabling people to increase control over, and to improve, their health' (WHO 
1986). 
Health education is however, thought to be an important contributor to health 
promotion. An anatomical analysis of health promotion is shown in figure 2.4 on page 
35. Tones and Tilford proclaim that health education has a powerful role in health 
promotion which is essentially four fold: in the education of the individual which 
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empowers them to make informed decisions, in the development and appropriate use of 
health services, in agenda setting, and in raising consciousness which can result in 
public pressure on health and social policies. It has been suggested (Tones & Tilford 
1994, page 7) that it is possible to condense the concept of health promotion into an 
essential formula: 
Health Promotion = Health Education x Healthy Public Policy 
Figure 2.4 The contribution of health education to health promotion 
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2.3.2 International perspective 
Changes in the practice of health promotion and health education are the result of 
historical developments that have had profound effects, first on health education and 
then on health promotion. Fifty years ago, the creation of the WHO as part of the United 
Nations provided an international mechanism for the systematic collection, validation 
and development of experience relevant to survival and for an improvement in quality 
of life. The transmission of that experience to society was the responsibility of health 
education and health promotion (WHO 2002b). The development of health 
education/promotion was carried out at world conferences, and the findings have been 
published in a number of resolutions, charters, declarations and reports. 
Numerous developments in the conceptualisation of health and in the delivery of health 
care followed the declaration that emerged from the Alma Ata, Primary Health Care 
Conference (WHO 1978). The most important feature of that declaration was that: 
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o health is a basic human right. (That principle took some aspects of health out of 
the remit of the medical profession and into that of politicians and the legal 
profession); 
o inequalities in health among population groups and regions are not acceptable. 
The concept of `health for all' was adopted; 
Q primary care, with the national health system bringing health care as close as 
possible to where people live and work, is essential health care. Primary care is 
the first level of contact for individuals, the family and the community. 
The First International Conference on Ilealth Promotion met in Ottawa, Canada in 
1986. It was strongly influenced by contributors from Toronto who introduced the 
concept of `Healthy Cities'. The conference produced a charter for action to achieve 
`Health for All by the Year 2000' (WHO 1986). The conference was a response to 
growing expectations of a new public health movement, namely to build a healthy 
public policy, create supportive environments, strengthen community action, develop 
personal skills and re-orientate health services. 
The Second International Conference on Health Promotion was held in Adelaide, 
Australia in 1988. It was concerned with the development of healthy public policies, 
characterised by a concern with health and equity in all areas of policy including the 
accountability for the policy impact on health (WHO 1988). The main aim was to create 
a supportive environment that would enable people to more easily make healthy choices 
and develop a healthier lifestyle. The value of health was redefined to link economic, 
social and health polices into an integrated action plan characterised by equity, easy 
access and positive developments. 
The Third International Conference on Health Promotion was held in Sundsvall, 
Sweden (WHO 1991) The main topic was the creation of supportive environments for 
health. A statement was issued that stated that communities, countries and governments 
should all participate in creating a supportive environment by addressing inequality, 
poverty, and access to essential health care. The theme remained focused on health 
promotion and emphasised the importance of community participation. 
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The next development for a supportive environment was the United Nations Conference 
on Environment and Development (United Nations General Assembly 1992) that was 
held in Rio de Janeiro. Agenda 21 was a leading document that emerged and was signed 
by 179 Heads of Government. It continued the theme of community participation and 
advised that all local councils should consult with the community to produce a focused 
plan, a "Local Agenda 21". It was recognised that local people have the requisite local 
knowledge to make sensible decisions for the future local population (WHO 2002a). 
The fourth health promotion conference was held in Jakarta, Indonesia and was the 
first international conference on health promotion to be held in a developing country. 
Evidence was presented to show that health education and health promotion strategies 
contribute to health improvement and disease prevention in both developing and 
developed countries. The Jakarta Declaration Leading Health Promotion into the 218` 
Century (WHO 1997) identified five priorities, which were confirmed in the Resolution 
on Health Promotion adopted by the 51" World Health Assembly (WHO 1998b): 
1) to promote social responsibility for health 
2) to increase investments for health development 
3) to consolidate and expand partnerships for health 
4) to increase community capacity and `empower' the individual in matters of 
health 
5) to secure an infrastructure for health promotion. 
The fifth global conference on health promotion: bridging the equity gap was held 
in Mexico City in June 2000. Termed "Bridging the gap", it was the last in a series of 
ground breaking international conferences on health promotion. Health promo/ion: 
bridging the equity gap aimed to tackle the priorities for health promotion in the 21" 
century that had been identified at Jakarta. It was recognised that continued efforts will 
always be required to strengthen the evidence base on which health promotion polices 
and practices are founded, to reinforce political skills and actions for health promotion, 
and to re-orientate health services towards health promotion and primary prevention 
(WHO 2000a). 
2.3.3 National public health approaches 
Since the NHS was first established, political rule has fluctuated. In 1964 the Labour 
party started to plan the NHS reforms that were finalised by the Conservative 
government and put into effect by the Labour government in 1974. It has been 
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suggested that changes in government did not yield major changes in policy and the 
NHS reforms have been categorised as the `post-war consensus' (Kendall 1995, page 
166). The election of Mrs Thatcher as Prime Minister has been identified as the end of 
the `post-war consensus'. That is because she developed within the Conservative party, 
a particular political ideology. First, there was a belief in the virtues of the market and 
that the market was more efficient and more responsive to people's needs than state 
provision. Secondly, there was emphasis upon individualism and a belief that the 
individual was wholly self-reliant and responsible for her or his own actions (Kendall 
1995). 
Speculation arose that the themes addressed at the Alma Ata conference in 1978, 
namely the concept of health promotion and addressing the issue of inequalities in 
health, were far removed from the government's priority agenda. Indeed, when the 
Black Report (DHSS 1980), was submitted to the Secretary of State, he refused to 
endorse the reports' recommendations on the grounds of what he perceived to be 
unrealistic and unnecessary costs (Kendall 1995). However, as international concern 
with health inequalities continued, more evidence to support the need for action became 
available (HEC 1987). The government continued to advocate the importance of 
individual responsibility for health behaviour and failed to support the strengthening of 
health policy to address health inequalities (Kendall 1995). The NHS experienced its 
most significant cultural shift since its development with the introduction of the internal 
market, outlined in the Working for Patients White Paper (DOH 1989) and the NHS and 
Community Care Act (DHSS 1989). The government encouraged, but did not enforce, 
the establishment of self-governing NHS Trusts and General Practice Fund Holders 
(GPFHs). Many health service employees believed that the structure was effectively a 
two-tier system and that it promoted lack of uniformity in patient care. 
The need for healthy public policy was finally recognised with the publication of the 
Health of the Nations White Paper (DOH 1992). Although, the paper recognised the need 
to concentrate on health promotion as much as health care, its theme centred on the pre 
Alma Ata era with an individualised health education approach. The clear and 
challenging targets were unrealistic. For example, the target for reducing the incidence 
of obesity by one third by 2005, (from 8% in men and 12% in women, to 6% in men 
and 8% in women) will not be met. By 1997, the incidence of obesity increased to 17% 
in men and 20% in women and the prevalence is still escalating in epidemic proportions 
(DOH 2003b). 
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In 1997 there was a change in government with a resulting change in approach. The 
New NHS Modern & Dependable (DOH 1997) abolished the internal market, and 
replaced contracting with commissioning. 
The government also supported recommendations from the international health 
promotion conferences. The second health inequalities report, Indepeiidenl inquiry into 
Inequalities in Health, (Acheson 1998) stated that there were unacceptable inequalities 
in health and that the health gap between the ditlerent socio-economic groups had 
widened since publication of the Black Report in 1980. The government addressed 
many of the health inequality issues in the White Paper Saving Lives: Our Healthier 
Nation (DOH 1999). That White Paper was similar to The Health of the Nation White 
Paper (DOH 1992) in respect of the challenging targets it set for improving the nations' 
health. 
There were however substantial differences in the theories underpinning the 1992 White 
Paper and the 1999 White Paper. The latter: 
u recognised that some factors that harm people's health are beyond the control of 
the individual and that health policy requires action from a joint partnership 
between central government, local government and the individual; 
o proposed the development of National Service Frameworks for specific 
conditions and groups of individuals. Those were anticipated to ensure high and 
consistent standards of care across the country and to work towards meeting the 
targets set out in the White Paper, 
Q emphasised the increase in people living with chronic disease and recognised 
that those people were experts at living with their condition. Expert J)aIient 
programmes were put forward as a new initiative for the future. 
Since the 1999 White Paper, further publications have built on the philosophy outlined 
above and there has been a gradual transformation and re-organisation of healthcare 
services and healthcare delivery. The NHS Plan (DOH 2000) set clear objectives for a 
patient-centred service, with all components of the NHS working together to develop 
partnerships at all levels of care: between patients, their carers and NHS staff, between 
the health and social care sectors; across different government departments; between the 
public sector, voluntary organisations and private providers. The discussion document 
Shifting the Balance of Power with!,, the NHS: Securing Delivery (DOH 2001b) 
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proposed organisational changes required to deliver the reforms set out in the NHS 
Plau 
. The main `shit 
in power' was that Primary Care Trusts (PCTs) would take the 
lead in assessing the need for healthcare and planning, securing health services and 
health promotion initiatives. The latest National Service Framework to be published 
(DOH 2001a) (DOH 2003a) continues with the empowering vision set out during the 
international health promotion conferences by setting standards and delivery strategies 
to enable people to increase control over, and to improve, their health. 
2.3.4 Health care settings 
The budget for health education and health promotion activities remains at less than 1% 
of the total health budget, health programmes are often ad hoc and issue based, using 
health education in isolation from health promotion. Modern training in health 
promotion is lacking and many health education approaches lack evaluation (WHO 
1997). 
Health promoting activities range from health education programmes (primary, 
secondary or tertiary); preventative health services, such as, immunisation; community- 
based work (with differing degrees of community participation); organisational 
development; healthy public policies; environmental health measures; economic and 
regulatory activities. The competencies for those activities are taxing: managing, 
planning and evaluating; educating, facilitating and networking; influencing policy and 
practice; marketing and publicising and communicating effectively (Ewles & Simnett 
2003). 
In order for a health promotion initiative to be successful, communication needs to 
reach the individual, gain his or her attention and be understood and accepted before 
behaviour change can occur. At each stage, failure is possible. Probably one of the most 
difficult stages of communication is for the individual to accept the health promotion 
message. If the individual has beliefs or traditions that contradict the message, or if they 
lack confidence that they can make the change, the initiative will be unsuccessful. The 
type of approach or model that the health promoter uses to deliver the message will 
influence the outcome and the success of the health promotion initiative. Table 2.1, 
overleaf, provides a brief overview of five approaches to health promotion. 
The health promoter using the medical approach would define health as freedom from 
disease and would use a didactic/persuasive or paternalistic method to ensure that the 
recipient complied with the prescribed advice. Those using the behaviour change 
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approach aim to change people's individual attitude and behaviour so that they adopt a 
healthy lifestyle. The health educator of that approach believes that a healthy lifestyle is 
in the best interests of society and sees it as their responsibility to encourage people to 
adopt the lifestyle they advocate. The educational approach concerns the delivery of 
information to ensure knowledge and understanding of health issues, which in turn 
enable well-informed decisions to be made. Those using the patie»t or client-centred 
approach work with individuals, using the process of empowerment, to help them to 
identify what they want to know and to take action to achieve their desired result. 
Table 2.1 Five annroachcs to health promotion 
Aim 
Health 
Promotion 
Activity 
Important 
Values 
Example: 
Diabetes 
Medical Freedom from Promotion of Patient Aim: optimum 
medically medical compliance diabetes control 
defined disease intervention to with Activily: instruct 
and disability prevent or preventive patients what to 
ameliorate ill medical do to achieve 
health procedures optimum control 
Behaviour Individual Attitude and Healthy Aim: behaviour 
Change behaviour behaviour lifestyle as changes to adopt a 
conducive to change to defined by the healthier lifestyle 
freedom from encourage health Activity: 
disease adoption of promoter persuasive 
healthier life education to 
promote change 
Educational Individual with Information Individual Aim: Individual 
knowledge and sharing, right of free understanding of 
understanding exploration of choice. the importance of 
enabling well- values/attitudes, Health optimum diabetes 
informed development of promoter's control 
decisions to be skills required responsibility Activity: sharing 
made and acted for healthy to identify diabetes aims and 
upon living educational building self- 
content management skills 
Patient- Working with Only address Patients Aint: Issues only 
Centred patients on their health issues treated as considered and 
own terms identified by equals. Self- discussed if 
the patient. empowerment patient identifies it 
as a concern 
Societal Physical and Political/social The right and Aim: Develop 
Change social action to need to make policies to allow 
environment change the healthy living to 
that enables physical/social environment be possible for all 
choice of environment health- Activity: Lobby 
healthier 
lifestyle 
enhancing the government to 
reduce the cost of 
healthier food 
Source: Ewles & Simnctt (2003) 
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Finally, in the societal approach, the health promoter believes that poor health is 
attributable to society and not to the behaviour of the individual. The aim is therefore to 
change the physical, social and economic environment in order to make it more 
conducive to good health (Ewles & Simnett 2003). 
2.4 Models of behaviour change 
Health-related behaviour change is a very complex process involving many 
psychological, social and environmental factors. Models of behaviour change are 
derived from theory and attempt to provide an explanation of behaviour change. They 
provide frameworks to simplify the theory and to enable it to be put to practical use. 
The models and theories of health behaviour represent a significant step towards an 
understanding of why some people actively seek out health care and others do not. 
However, there are two main drawbacks to reliance upon models of behaviour change 
(Conner & Norman 1995): 
o the theories assume that people think about risks in a detailed, rational fashion. 
In fact, people may modify their behaviour for vague and illogical reasons; 
o with the various reformations of the models and theories, the distinction between 
many of them has become blurred. 
There is, therefore, still considerable uncertainty in predicting the circumstances under 
which people will, or will not, engage in healthy behaviour. Four widely used health 
behaviour models are discussed below. 
2.4.1 The Health Action Model 
Tones suggests that health decisions and actions are influenced by an individual's 
beliefs, values, motivation, self-esteem and expectations (Tones & Tilford 1994). The 
health action model was initially developed as a framework for health education; it has 
also been shown to be compatible with health promotion theory (Ewles & Simnett 
2003). 
The Health Action Model is essentially a three-stage model (refer to figure 2.5 
overleaf). The initial stage is an interactive system incorporating routine behaviour, 
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motivation, self-esteem, beliefs, and perceived costs and benefits for taking action to 
improve health. It assumes that if an individual has high self-esteem, that individual will 
be more motivated to identify a behaviour intention and make a decision for health 
action. The second stage demonstrates how the physical, cultural and socio-economic 
aspects of the environment may affect the health intention decision and the final stage 
demonstrates how skills and knowledge may influence health action. 
Figure 2.5 The Health Action Model 
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The feedback mechanism may be positive or negative and has the potential to change 
the normative system and stage one (Tones & Tilford 1994). For example, if an 
individual resolves, as a health action, to start walking for 30 minutes each day, and 
achieves that health action, their routine behaviour will have improved which may then 
positively impact on the components in all stages of the health model. The model is 
based on empowerment: increasing the control that people have on their lives. 
2.4.2 Stages of Change Model 
The Stages of Change Model was originally developed by Prochaska and DiClemente in 
1986 to explain behaviour change in relation to addictive behaviours such as smoking. 
It has since been adapted for use in lifestyle behaviour change (HEA 1994). 
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Many people in receipt of primary health care services are not interested in changing 
unhealthy lifestyle behaviour. It is important to have an understanding of behaviour 
change to be familiar with the numerous phases that an individual has to master in order 
to make the transition from contemplating a change to implementing and maintaining a 
changed behaviour. There are seven stages of change (see figure 2.6 below) and it is 
assumed that the individual moves through discrete stages in the process betöre fully 
adopting the new behaviour. Individuals do not necessarily proceed in a linear fashion 
and they may fluctuate through the different stages. 
2.6 The Stases of Chance Model 
Action 
Stable healthier 
lifestyle 
tintenance 
.e 
Source: adapted from HEA 1994 
Pre-contemplation 
The pre-contemplation stage precedes entry into the change circle itself. There may be 
no awareness of the need for change or alternatively, a failure to accept that change is 
necessary. A primary feature is, therefore, that motivation to change habits or lifestyle is 
lacking. Information and feedback from the health promoter may raise awareness but a 
prescriptive approach would be less likely to be effective. 
Contemplation 
At this stage, there may be some awareness of the problem but also have a marked 
ambivalence towards doing anything about it. Behaviour may fluctuate between 
considering a change and rejecting change. The role of the professional is to encourage 
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the decisional process towards change. Motivational interviewing has been shown to be 
successful in these circumstances (Skills Development Service 1999). 
Preparation 
The preparation stage is engaged when the perceived benefits of change seem, to the 
individual to outweigh the costs of the change and when there is a belief that change is 
not only possible but also worthwhile. The preparation stage is characterised by 
obtaining extra knowledge, skills and support in order to move into the action phase. 
Action 
The action stage is when the individual takes action to change behaviour. The early days 
of implementing behaviour change may be challenging, especially if ingrained habits 
need to be addressed. A clear goal, a realistic plan, ongoing support and reward for 
achievement are features of success (Skills Development Service 1999). 
Maintenance 
The maintenance period begins after six months of continuous successful behaviour 
change and typically lasts between three and five years, throughout which time there 
will still be temptation to relapse (Redman 2001). 
Relapse 
The relapse stage occurs when a person is unable to maintain the behaviour change. 
(Lorig 2001). Relapse is a recognised stage of the model and it may occur several times 
before the individual stabilises on a consistently healthier lifestyle. Some individuals 
might never exit the behaviour change model with a permanent health change. Relapse 
is more likely to happen when the cost/benefit balance has shifted as a result of other 
influences in the individual's life and change is no longer perceived as worthwhile. 
Sometimes the environment or carer support has been withdrawn or become less 
effective thus making it seem too difficult to maintain the change (Ruggiero 2000). 
2.4.3 The Health Belief Model 
A diagrammatic picture of the health belief model is shown in figure 2.7 on page 46. 
Redman (2001) discusses how readiness to take action and engage in health-related 
behaviours depends on a number of factors: 
o susceptibility. An individuals beliefs about whether lie or she is likely to contract 
an illness; 
Q severity. The degree to which an individual perceives the consequences of 
having an illness to be severe; 
Q benefits. The potential to be gained from a particular course of action that will 
reduce the health threat; 
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Q harriers. Any decision to act will have consequences that may cause distress, 
whether physical, psychological, social or financial; 
Q self-efficacy. The confidence of the individual to carry out the action and be 
successful; 
Q cues !o actioar. Cues are stimuli that trigger appropriate health behaviour. These 
can be either internal (for example, perception of body health) or external (for 
example, mass media); 
Q diverse factors. These include demographic, ethnic, social and personality 
factors that may influence health behaviour. 
Figure 2.7 The Health Belief Model 
2.4.4 The Theory of Planned Behaviour 
The Theory of Planned Behaviour states that the actual performance of a particular 
behaviour is largely dependent on three beliefs: attitude and beliefs towards a 
behaviour, subjective norm and perceived behavioural control (Ogden 2000) (see figure 
2.8 on page 47). Therefore the individual would only change behaviour if they believed 
that the new behaviour would lead to outcomes that they valued. Behaviour change 
would also depend on their perception of social norms and pressures to perform a 
behaviour, for example, if another person such as a health professional recommended 
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them to carry out the health action, they would only carry it out if they valued the health 
professional's recommendations, and had the motivation to comply with the 
recommendation. Finally, internal control factors such as skills, knowledge and 
information, and external control factors, such as resources and opportunities, relate to 
perceived behavioural control. This model suggests there is high correlation between 
intention and behaviour (Lorig 2001) and assumes that people usually behave in a 
rational manner being in control of their health behaviour (Conner & Norman 1995). 
Figure 2.8 The Theory of Planned Behaviour 
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Source: adapted from Ogden 2000 
2.5 The practice of patient education 
Patient education is defined as all the educational activities directed 10 patients, 
including aspects of therapeutic education, health education and clinical health 
promotion (Visser, Deccache, & Bensing 2001). Patient education is a central part of 
the practice of all health professionals. While the modern movement of patient 
education into healthcare is now 35 years old, the field has evolved slowly because it 
faced a history of paternalism in not sharing information with patients (Redman 2001). 
Previously, patient education was not theory based because there was not enough 
evidence that the use of theories made any difference to the effectiveness of patient 
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education. However today if education programmes are planned without theotical 
underpinnings it is considered to be poor practice (Lorig 2001). 
Five factors influencing the development and improvement of patient education have 
been identified. Those are. training and methodological support; research and evidence- 
based practice, funding and a place in health care policy; professional value and 
acknowledgement; and the organisation of care and education (see figure 2.9 below) 
(Deccache & Aujoulat 2001). 
Figure 2.9 Five factors influencing the development and improvement of patient education 
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DEVELOPMENT AND IMPROVEMENT OF PATIENT EDUCATION 
Source: Deccachc & Aujoulat 2001 
Most countries are still at an experimental stage of patient education development and 
still require it to become formalised and acknowledged as an official part of the health 
care system. Table 2.2 (below) summarises the present situation regarding patient 
education in Europe and the United States. 
Table 2.2 The practice of patient education in Europe and the United States 
Country Present Situation Identified Poýssihie solutions and 
Problems Future plans 
United Awareness of Gap between Encourage practice of 
Kingdom limitations but patient theory and evidence based patient 
(Skelton education still practice. Patient education. Identify key 
2001) dominated by medical- education falls providers. Encourage lay 
centred approach behind patient- involvement. Raise the 
centred models. status of patient 
education. 
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(Table 2.2 Present Situation Problems Possible Solutions 
continued) continued continued continued 
The Special coordinators Effective use of Two-way communication Netherlands for patient education information and counselling. Clear (Bensing, available. Patient- materials. The role definitions for health Visser, & centred information need for providers. Saan 2001) materials developed. counselling and Communication training. 
Diabetes education coordination of Quality control of patient 
included on care. education. Empowerment 
government policy and of patient organisations. 
legal papers Theoretical base for 
education programmes. 
France Patient education 93% of health Rely on clarification and 
(Fournier et become more wide institutions affirmation of patients' 
al. 2001) spread and structured, identify patient rights to allocate 
but, several definitions education as resources for development 
of patient education priority but only of professional/financial 
and many schools of 39% allocate acknowledgement of 
thought. budget to its patient education. 
development. 
Germany Changes to health Lack of quality Reform of statutory health 
(Keller & policy/legal settings research on long- insurance system to 
Basler 2001) led to development of term effectiveness increase access to patient 
evidence based/ & cost health information, 
structured education effectiveness. strengthen patients' rights 
programmes but Lack of trained & prevention 
mainly inpatient not health programmes. Sickness 
outpatient professionals. funds to support 
programmes. outpatient patient 
education and training. 
Belgium Support from French in Flemish region- Ministry of Health to pay 
(Deccache Ministry of Health & no government more attention to patient's 
& Ballekom 98% of hospitals in support and rights. Patient 
2001) French regions provide patient education participation and 
patient education programmes rare. responsibility in health. 
programmes. Move Little professional Training health 
from patient value of patient professionals. 
instruction to patient education Fund patient education 
participation. programmes. 
Finland Patient education seen No national A shift from health 
(Ojanlatva as health education. mandated polices/ education and patient 
2001) Initiatives locally practices/ education based on 
planned and delivered procedures of medical model to a model 
but not based on patient education. based on self-care. 
hospital polices or Education didactic Further development of 
strategies. in nature. peer education initiatives. 
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(Table 2.2 Present situation Identified Possible solutions 
Cont. ) problems 
Patients have a legal Health Training of physicians 
entitlement to full professionals and health care staff in a Sweden information about their working within patient-centred approach 
gvist (Rosen illness and take an medical-centred leading to patient-centred 2001) 2001) active role in decisions patient education education & patient 
about care. Example model. reflection & action. 
of good practice is 
group study circles 
with facilitators 
Italy Delivery of therapeutic Poor evaluation of Systematic evaluation & 
(Marcolongo patient education education acknowledgement of 
et al. 2001) (TPE) aiming for programmes. TPE. Financial resources, 
patient empowerment. Lack of time and education & training for 
health care staff to TPE. Development of 
deliver TPE. national & regional centre 
for TPE. 
Switzerland The lead in TPE is not an Joint international 
(Assal & development/delivery international collaboration to develop 
Golay 2001) of TPE. Postgraduate standard. variety of curricula for 
training of health training health care 
professionals. providers in TPE. 
Publication of WHO (WHO Working 
report on TPE Group 1998). 
Hungary Organised and Most medical Training of health 
(Trinn & effective system of personnel lack professionals and 
Molnar in/out-patient patient- theoretical development of 
2001) centred education knowledge and competencies to deliver 
resulting from Health technical skills for effective patient 
Promoting Hospital effective patient education. 
initiative. education. 
Estonia Patient-oriented No problems Development of high 
(Härm 2001) approach to health identified. No quality health promotion 
promotion/patient mention of programmes and 
education involving evaluation, audit, intensified preventive 
multi-professional and research. activities with trained 
teamwork in primary nurses integrated with 
care and hospitals. physicians and health 
education coordinators 
United Patient education Lack of `quality of Transformation of patient 
States evolved from life' outcomes education will depend on 
(Roter, medically dominated Difficulties in the success of 
Stashefsky- origin to one engaging empowerment agenda. 
Margalit, & supporting patient elderly/poor/ethnic Challenge health 
Rudd 2001) empowerment. A minorities. professionals to test 
move from compliance Literacy level of commitment in meeting 
terminology and more Internet patient patient needs & 
emphasis on patient education higher encouraging patients to 
autonomy, reflection than average identify own needs and 
and problem solving. reading ability. goals. 
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2.5.1 Comparison with health education 
The field that patient education is most closely related to is health education. Redman 
(2001) compared those two fields, a summary of which can be found in Table 2.3 
below. 
Table 2.3 Comparison of patient education and health education 
Focus Patient Education Health Education 
Philosophy Medical referral for Self-referral and behaviour 
behaviour change to change to promote good 
address specific conditions health 
Unit of service Patients and their families Specific populations 
Delivery system Part of clinical care Campaigns including mass 
media and the workplace 
Content Individualised advice, Population awareness of 
instruction, development risk factors and health 
of self-management skills behaviours 
Theory base Biomedical and chronic Health education/health 
disease models promotion theory 
Ethical concerns Scientific stability and Scientific stability and 
cultural basis regarding cultural basis regarding 
what patients are asked to what patients are asked to 
do. Prescriptive approach do. Manipulation by 
resulting in over-reliance government and victim 
on the health service and blaming if activity not 
loss of confidence carried out 
Literature Diseaselcondition specific Public health literature 
Challenges Development of patient More initiatives including 
education standards and scientific enquiry with 
the uniform adoption of a evaluation 
patient-centred aaoroach 
Source: adapted from Redman 2001 
2.5.2 Group versus individual approach 
Most patients receive education about their condition through individual consultations. 
Although such consultations may address clinical problems, they are unlikely to induce 
long-term health behaviours, especially if the information and knowledge offered during 
those visits is perceived to be in conflict with daily actions and habits. In that situation 
the advice may be easily ignored or forgotten by the patient. Introducing group 
education programmes to the healthcare system may benefit patients because they 
would receive longer exposure to interactive techniques and positive dynamics, and they 
may identify with other members of the group (Trento et al. 2001). For the health care 
providers, group education programmes would take the same amount of time, or 
potentially less time, than seeing the patient on an individual basis. Targeted one-to-one 
medical interventions would become more rewarding and less repetitive (Trento et al. 
2001). 
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There have been recent recommendations in the UK for group based education 
programmes to be made available for all people with diabetes (DOH 2003a, NICE 
2003b). However, scientific evaluation of group education programmes is in its infancy. 
Chapter 3 reports on a systematic review that was undertaken to evaluate the 
effectiveness of group based self-management strategies for people with Type 2 
diabetes. 
2.5.3 Principles of adult learning 
Adult learners perform better when they are involved in the learning process. Effective 
educators therefore appreciate the importance of participatory learning methods 
(Knowles 1978). An old Chinese proverb is a simple way to summarise the importance 
of active participation: I hear, I forget; I see, I remember; I do, I widerstand. A 
significant finding from research literature is that when adult learners learn something 
from `doing' as opposed to traditional didactic methods, they become highly self- 
directing (Doman & David 2000). Figure 2.10 on page 53 states the principles of adult 
learning. 
The importance of reflection in adult learning is paramount. People make decisions and 
act as a result of two types of conduct: routine action and reflective action. Routine 
action involves carrying out routine activities in an automatic fashion whereas reflective 
action is concerned with weighing up all aspects of the situation and making a 
conscious decision about what to do. Reflection, therefore, means learning from past 
experience and taking active control over what is done and how it is done (see figure 
2.11 below) (Girot 2001). 
Figure 2.11 Principles of reflection 
Reflection consists of 
o thinking about an experience; 
o exploring that experience in terms of feelings and 
significant features; 
o processing the significance features and identify 
learning; 
o effects on future practice 
Of all the characteristics that affect a patient's achievements within adult education, 
self-esteem is perhaps the most influential. It seems that, in order to encourage a 
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conceptual shift from a passive, absolutist acceptance of `external' knowledge to a more 
questioning, reflective, evaluative mode of operation, the patients have to believe in 
themselves. Patients who are used to didactic presentation methods become dependant 
upon the external source of knowledge and so undervalue their own experience. Those 
patients are often unable to see the value of an adult-centred approach and may insist 
upon returning to the secure world of the didactic prescription by encouraging the health 
professional to resume a leadership role (Department of Educational Studies 1997). 
Figure 2.10 Principles of adult learning 
1) It is important for adults to direct themselves. They learn most effectively 
when they identify their own learning needs and set their own goals. 
2) The teacher's role is thus to enable or facilitate learning rather than to direct 
it. Teachers who adopt this approach often refer to themselves as facilitators. 
3) Adult learners are generally most ready to learn things that they can apply 
immediately to existing problems or to their own situation. They do not, on 
the whole, learn if it is not meaningful to them or their family. 
4) Adult learners bring with them a wealth of experience, which should be seen 
as a resource, and to which new learning should be related. 
5) Adult learners can help each other, because of their experiences, and should 
be encouraged to do so. 
6) Adults learn best from being active (not passive), by doing and experiencing, 
for which they need a safe environment where they feel accepted. 
7) Adult learners should be encouraged to carry out continuous evaluation of 
their own learning. Teachers should use this evaluation to fit the learning 
process to the learners needs. 
Source: adapted from Ewles & Simnctt 2003 
2.5.4 Patient-centred approach 
It has been said that there are two principal models of patient education, the traditional 
medical-centred model and a patient-centred approach (Fahrenforrt 1987). The two 
models are distinct with respect to their underlying assumptions and concerns. Patient 
education within the medical model focuses on `the problem' of patient control or non- 
compliance. The patient-centred model, by contrast, seeks to elicit and satisfy those 
needs that patients express themselves, and views that as the first step towards 
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encouraging patients to take greater control over their own health. Health professionals 
plan `for' patients in the first model; they plan `with' patients in the second (see Table 
2.4 below). 
Table 2.4 Comparison of medical-centred and patient-centred approaches 
Medical-centred model Patient-centred model 
Compliance Autonomy 
Adherence Patient participation 
Planning for patients Planning with patients 
Behaviour change Empowerment 
Passive patient Active patient 
Dependence Independence 
Professional determines needs Patients define needs 
Source: adapted from (Skelton 2(X)1) 
Overall, there is fairly strong evidence to suggest that some interventions promoting 
patient-centred care in the clinical consultation may lead to significant increases in the 
patient centeredness of the consultation process. There is currently, however, no gold 
standard measure for patient centeredness, and that area needs further work if the 
patient-centred approach is to be properly assessed (Lewin et al. 2003). Another area of 
neglect in the patient centeredness approach is the development of patient information 
materials. A recent review has shown that current information materials for patients 
omit relevant research-based data, fail to give a balanced view of the effectiveness of 
different treatments, ignore uncertainties, adopt a patronising tone, and do not promote a 
participative approach to decision making (Barth et al. 1991). 
In order for the patient-centred approach to be universally accepted, health care 
providers need to be trained in chronic disease management and therapeutic patient 
education (TPE) (WHO Working Group 1998). The WHO report acknowledges that 
health professionals tend to talk to patients about their disease rather than to train them 
in the daily management of their condition, and although physicians are competent in 
diagnosis and selection of medication, they have not had the opportunity to develop 
skills to address the educational, social and psychological aspects of the condition. 
TPE is designed to train patients in the skills of self-managing or adapting treatment to 
their particular chronic disease. Different types of i'PF have been introduced in various 
health care settings but they have often been arbitrarily designed and poorly taught. 
There is an obvious need for better quality educational programmes with a therapeutic 
content (WHO Working Group 1998). In order to meet that need, health professionals 
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would first have to be trained in how to deliver the programmes and it has been 
recommended that by 2010, all Member States should have ensured that health 
professionals have acquired appropriate knowledge, attitudes and skills to protect and 
promote health (WHO Working Group 1998). Figure 2.12 below lists the competencies 
expected of health care providers of TPE. 
Figure 2.12 Competencies required for therapeutic patient education 
Health care providers should be able, individually and in teams, to: 
1. adapt their professional behaviour to patients and their disease, whether 
acute or chronic; 
2. adapt their professional behaviour to patients, individually, and in their 
families and groups; 
3. constantly adapt their roles and actions to those of the health care and 
education teams with whom they cooperate; 
4. communicate empathetically with patients; 
5. recognise the needs of patients; 
6. take account of the patients' emotional state, their experience and their 
representations of the disease and its treatment; 
7. help patients to learn; 
8. educate patients in managing their treatment and in using the available 
health, social and economic resources; 
9. help patients to manage their way of life; 
10. educate and advise patients about the management of crises and about 
factors that interfere with the normal management of their condition; 
11. select patient-education tools; 
12. use and integrate the above tools in the care of patients and in the patients' 
learning process (contract with patients); 
13. take account of the educational, psychosocial and social dimensions of 
long-term care; 
14. evaluate patient education for its therapeutic effects (clinical, biological, 
psychological, educational, social, economic) and make the indicated 
adjustments; 
15. periodically evaluate and improve the educational performance of health 
care providers. 
Source: Report of a WHO Working Group on Therapeutic Patient Education, 1998 
The following obstacles have, however, been identified, which may delay or prevent 
healthcare professionals attaining the recommended competencies (WHO Working 
Group 1998): 
v lack of human resources i. e. the lack of healthcare professionals trained in TPE 
or learner-centred education to guide projects in TPE. That may be linked with 
their professional tradition and culture; 
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o tradition and culture of the healthcare professionals. Basic training of most 
health care providers favours acute medicine and results in a pervasive 
biomedical approach, based principally upon diagnosis and the selection of the 
therapeutic regimen. The introduction of TPE is a challenge to the established 
culture of health care professionals; 
Q insufficient teamwork. TPE requires effective teamwork. However, in practice, 
health professionals may work in the same programme but do not always share 
the same values about the care and education of patients. There is little 
consensus among leading health care specialists regarding patient-centred 
education; 
o insufficient motivation within institutions and among policy-makers and 
health professionals. The career-success and promotion of health care providers 
is dependant to a greater degree upon the number of their publications in 
professional journals than upon positively impacting on the quality of life of 
their patients. There are too few models available for how to overcome the 
resistance of health professionals to stimulate a demand for TPE. Little is also 
known about the most effective methods of motivating health authorities to 
instigate continuing education programmes for health professionals; 
Q conservatism of educational institutions. Teachers in educational institutions 
make traditional decisions regarding future education programmes. They also 
bemoan the fact that they have too little time for their own training. Once again, 
little is known about how to motivate organisations to teach health professionals 
the requisite competencies to enable them to deliver TPE to patients; 
o difficulty in assuring valid evaluation. TPE has not been sufficiently evaluated 
or validated, and there are no criteria against which to measure the quality of 
TPE. That deficiency is linked with the lack of teaching staff competent in TPE 
and in the process of evaluation. It is therefore difficult to substantiate the 
expected decrease in expenditure on health care; 
Q lack of educational resources. The lack of training centres and competent 
teachers specialised in TPE is a major obstacle to training vast numbers of health 
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professionals. There is ignorance of suitable existing centres and the creation of 
new centres would require considerable funding; 
o lack of financial resources. Although assigned the lowest priority among the 
obstacles, the health care culture of `time is money' means that not enough 
professional time is reserved for training. So long as TPE remains a low priority, 
financial resources will remain scarce. 
2.5.5 Empowerment 
Patient empowerment means different things to different people and therefore many 
definitions exist, some of which are stated below: 
Q `helping people discover and use their innate ability to gain mastery over their 
diabetes'(Anderson & Funnell 2000a); 
o `believing that it is possible to, and having the abilities to, identify the 
alternatives in any situation, to choose one on the basis of one's values, 
priorities, and commitments'(Brown & Piper 1995); 
o `involving five key features: acceptance, affect, autonomy, alliance and active 
participation' (Skinner & Cradock 2000); 
Q `encouraging people to participate as equal partners in decisions about the health 
care they receive' (Paterson 2001); 
o `having the knowledge, skills, attitudes and self-awareness to influence 
behaviour and that of others in order to improve quality of life' (Funnell, 
Anderson, & Arnold 1991). 
Although these and many more definitions vary in detail, the overriding philosophy is 
the same: empowerment cannot be given or taught, it is a process that people do for 
themselves (Rodgers & Walker 2002). The root of empowerment is to recognise that 
every person is an autonomous being, living an individual daily existence in which 
choices about actions and activities are constantly being made. The influence of health 
professionals is to recognise and emphasise that principle, while enabling the person to 
have enough knowledge to make informed choices about his or her actions and 
activities (Walker 1998). A diagrammatical model of empowerment has been devised 
by the author of this thesis and is shown in figure 2.13, overleaf. 
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Figure 2.13 The Empowerment Model 
education 
and patient 
activation 
It has been recommended that patient empowerment be adopted as a new philosophical 
approach to patient care (Anderson 1995). Traditional patient education is built around 
the medical-centred model of care. The patient is viewed as a recipient of the 'health 
expert's' knowledge and is expected to accept and comply with prescriptive regimens. 
Although patient self-management is increasingly recognised as being important the 
lack of parity results in a trend towards unchecked reliance and dependency on the 
health educator (Brennan 1996a). 
During the routine conduct of their lives, however, patients make a series of choices 
about eating, physical activity, stress management, safety when driving etc. Those 
choices combined have a far greater impact on patients' overall health and quality of life 
than the decisions made by the health professionals providing their care. Health 
professionals may plead, persuade, cajole, threaten or advise patients regarding their 
health care, but once the patient leaves the clinic, that professional has no control over 
the patient's self-management choices. The patient can ignore any recommendation no 
matter how important the educator believes that recommendation to be (Anderson & 
Funnell 2000c). 
Knowledge I Skills 
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It is not always the case that people are unwilling to change; they may be unwilling to 
be changed (Anderson & Funnell 2000c). If advice was framed from the health 
professional's perspective and not the patient's, the patient may perceive the 
recommendation to be inappropriate for incorporation into their life (Wolpert & 
Anderson 2001). Lack of change is often attributed to poor compliance. Blaming or 
labelling a patient as "non-compliant" can damage self-esteem and can create a barrier 
to future behaviour change (Brennan 1996b). Non-compliance could be described as 
two people working towards different goals (page 163) (Anderson & Funnell 2000a). 
When patients do make changes using the compliance approach, the change is often 
externally motivated i. e. carried out solely to please the health professional, and the 
effect may not be long-lasting. If the patient was unable to make the behaviour change 
they believed was necessary to win the approval of the health professional, they may 
either become a non-attendee at the clinic, fabricate information to tell the health 
professional, or become angry and defensive (Anderson & Funnell 2000c). 
Clearly, an empowerment approach calls for health professionals to `unlearn' their 
traditional approach to education by becoming empowering rather than controlling. 
They would need to develop the ability to facilitate and enable, rather than instruct and 
persuade. However, the underlying assumption of many practitioners is that an 
invitation to patients to participate as equal partners in the consultation is sufficient to 
guarantee their empowerment. Paterson investigated that assumption and found that 
health professionals may believe they are facilitating patient self-empowerment by 
inviting patients to engage in participatory decision-making, but their behaviours and 
practices may actually inhibit or negate their intended goal. Paterson concluded that 
health professionals might talk of empowerment in interactions with people but then act 
according to the traditional education model where he or she is the ultimate decision 
maker (Paterson 2001). 
Tools to aid health professionals facilitate patient self-empowerment (Anderson & 
Funnell 2000b) and measure the change in individual empowerment scores are available 
(Anderson et at. 2000). Empowerment is the underpinning theoretical base for the 
diabetes expert patient programme and therefore those tools and strategies will be 
discussed in the diabetes expert patient programme chapter (Chapter 4) and the methods 
chapter (Chapter 5). 
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2.5.6 Discovery Learning 
Discovery learning means that the tools and information needed to solve a problem or 
learn a concept are provided and the learner makes sense of them (Bruner 1966). 
Bruner believed that students learn best by discovery and that the learner is a problem 
solver who gains knowledge through discovery. His theory has four components and is 
based on constructivism i. e. that by reflecting on experiences, learners construct their 
own understanding (Bruner 1960): 
o curiosity and uncertainty. Experiments should be designed in a way that helps 
learners to be motivated and able to learn. One way of encouraging a desire to 
learn and to undertake problem solving is by devising problem solving activities 
in which learners explore solutions; 
Q structure of knowledge. The tutor must specify the ways in which a body of 
knowledge should be structured so that it can be most readily grasped by the 
leaner. Any idea or problem or body of knowledge can be presented in a form 
simple enough so that any particular learner can understand it in a recognisable 
form. 
Q sequencing. Effective sequences of instruction should be specified and this 
should lead the learner through the content in order to increase their ability to 
grasp, transform and transfer what is learned to their personal needs and 
circumstances. 
Q motivation. Movement from extrinsic rewards, such as tutor's praise, toward 
intrinsic rewards inherent in solving problems or understanding the concepts is 
desirable. 
2.5.7 The expert patient concept 
As discussed in section 2.2.2, people are living longer. But for many, long periods of 
time pass with a reduced quality of life due to the development of a chronic condition. It 
is clear that the doctor patient relationship is changing and has to change further. The 
historic `doctor knows best' approach is being replaced with a doctor patient 
partnership. When acute diseases dominated as the main cause of ill health, the doctor 
was the best judge of the health of the patient. Patients knew nothing of clinical matters 
and they could not be expected to know what was best for them (Kennedy 2003). 
As chronic conditions have replaced acute disease as the major cause of mortality and 
morbidity, increasing volumes of health information have become available through the 
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media and on the Internet. On average, people with diabetes spend around three hours 
per year with a health professional. That means that the patient is left to manage his or 
her own condition for the other 8757 hours of the year (DOEl 2002). That further 
demonstrates why helping patients with chronic disease to understand and take 
responsibility for their condition is so important if patient outcomes are to be optimised. 
Patients are becoming more interested in their own health and in making sure that the 
treatment they receive meets their needs. They are no longer passive receivers of health 
care, but consumers with choices who are entitled to expect good quality care (Illman 
2000). 
Health professionals have often reported, "my patient understands their condition better 
than I do". The knowledge and experience held by patients and the potential they have 
to improve their quality of lives has only recently been recognised (DOH 1999) and the 
emphasis is beginning to shift. Patients are beginning to become key decision-makers in 
the treatment process. By ensuring that knowledge of their condition is developed to a 
point where they are empowered to take some responsibility for its management and 
that they work in partnership with health and social care providers, patients can develop 
greater control over their lives (DOH 2001b). 
It is not enough to assume that patients will receive accurate information through the 
media and Internet. Promising interventions for the empowerment of patients require 
further evaluation (Wensing & Grol 1998). Patient self-management programmes are 
not simply about educating or instructing patients about their condition and then 
measuring success on the basis of patient compliance. They can be designed to build 
skills, confidence and facilitate the process of patient empowerment. The `expert' 
patient would then be equipped to take effective control and make informed decisions 
regarding their chronic condition (DOH 2001 c). 
There are two types of empowering self-management programmes (DOH 2001c). First 
are those delivered by health professionals. They are condition-specific and aim to 
develop knowledge and skills associated with that particular condition. Second are the 
lay-led programmes that address how the illness impacts on daily life. 
Dose adjustment for normal eating (DAFNE) (DAFNE Study Group 2002) is an 
example of a professional-led, self management programme specific for adults with 
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Type 1 diabetes. Although the programme is known as DAFNE throughout the UK, the 
original model was developed in Germany (Berger & Muhlhauser 1995). Self- 
management programmes are common practice in many parts of Europe and have led to 
improved health status and quality of life. 
The Centre for Patient Education Research, Stanford University, California developed a 
model for lay-led self-management programmes over 30 years ago. The course aimed to 
develop five, core self-management skills: problem solving, decision-making, resource 
utilisation, development of effective partnerships with health care providers, and taking 
action. The self-management programme is characterised by three distinct features: 
Q it has been developed using the experiences of people living with long-term 
illnesses; 
Q it is run in communities with a heterogeneous group of people; 
o it is lay-led, which means lay tutors all of whom are living with a long-term 
condition deliver the programme. 
The chronic disease self-management programme is presently being piloted as the 
Expert Patients Programme within the NHS in England. The project is funded by the 
Department of Health and is being evaluated by the University of Manchester with the 
intention that generic self-management programmes will become mainstreamed within 
all NHS areas by 2007 (DOH 2001 c). 
2.5.8 The theoretical basis of the X-PERT programme 
The four behaviour change models discussed in section 2.4 (page 42) have several 
components in common, such as self-efficacy, motivation, education, belief and 
costs/benefits. Those components were considered in the design and development of the 
intervention (diabetes expert patient programme, see Chapter 4). The principles of adult 
learning, group education, the patient-centred approach, empowerment and discovery 
learning were the main contributors to the theoretical component of the programme. The 
evaluation of this diabetes education, self-management programme is the basis of this 
thesis and is reported in Chapters 5,6 and 7. 
Self-efficacy, motivation and belief were addressed by delivering, group-based, 
patient-centred education that encouraged the participants to become actively 
involved in discovery learning and identify individual costs and benefits from 
adopting certain health promoting behaviours. Empowerment has been described as 
having five components: acceptance, active participation, affect, autonomy, and alliance 
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(Skinner & Craddock 2000). These were integral to the design of the education 
programme. Participants with diabetes were valued and accepted as being experts at 
living with their condition. Participants were encouraged to take active participation in 
the learning process and to discuss their feelings towards living with their condition and 
the affect it has on their day-to-day lives. They were encouraged to have autonomy by 
working in alliance with health care professionals to identify successful strategies for 
diabetes self-management. 
2.6 Summary 
It has been shown that although the WHO definition of health has changed over time to 
encapsulate a more holistic view, health is still a very complex issue and being healthy 
means different things to different people. International conferences have taken a 
leading role in health promotion concepts and principles, in the recognition of the 
relationship between health and self-empowerment. The resulting declarations, charters 
and reports have taken time to impact on national polices and the health promoting 
empowerment philosophy has only just begun to emerge. 
Currently, the success of health education or health promotion initiatives in changing 
health behaviour frequently depends on the type of approach that the educator has 
chosen to use. However, there are few evidence-based guidelines on which to base 
recommendations. There is, furthermore, a shortage of staff trained in health promotion 
and funding to deliver and evaluate initiatives is scarce. A number of models that 
attempt to explain health behaviour and illustrate the impetus for health action have 
been identified. Components from those models with the principles of adult learning, 
group education, the patient-centred approach, empowerment and discovery learning 
were the main contributors to the theoretical component of the diabetes expert patient 
programme described in Chapter 4. 
Patient education in Europe and the United States is still based on the biomedical model 
and although recommendations from international conferences on health promotion are 
gradually being integrated into health and legal policy, most countries are still in the 
experimental stage of developing therapeutic and self-management education 
programmes. Although recent literature encourages the evolution of the expert patient, 
the evidence base for the expert patient concept is in its infancy and further evaluations 
are necessary before expert patient programmes can be recommended as routine 
practice. 
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Chapter 3: Systematic Review: 
group-based self-management strategies in people 
with Type 2 diabetes 
3.1 Introduction 
A systematic review of group-based, self-management education programmes for adults 
with Type 2 diabetes has been carried out and is presented in this chapter. A brief 
review of previous work carried out in this field was undertaken in 2001 and a 
systematic review protocol was written, which was then accepted by the Cochrane 
Metabolic Disorder and Endocrine Review Group and published on the Cochrane 
Collaboration website (Deakin et al. 2001). The review was completed in September 
2003 and is currently awaiting peer review by the Cochrane review group prior to 
publication. The chapter is organised in the format of a standard research paper starting 
with an abstract and concluding with implications for practice and future research. 
3.2 Abstract 
Background: diabetes mellitus is one of the most common chronic disorders in the 
western world and it is now clear that Type 2 diabetes is a progressive condition that 
should never be considered the 'mild' form of diabetes. It has been recognised that 
adoption of self-management skills by the person with diabetes is necessary in order to 
manage their diabetes. However, the most effective method for delivering education and 
teaching self-management skills is unclear. 
Objectives: to assess the effects of group-based, patient-centred education on: clinical 
outcomes (diabetes metabolic control, blood pressure, body weight and body mass 
index and lipid profile); lifestyle outcomes (self-management skills and diabetes 
knowledge); psychosocial outcomes (quality of life, empowerment/self-efficacy and 
treatment satisfaction). 
Search strategy: the following electronic databases were searched from the beginning of 
each database up until January/February 2003: The Cochrane Library; MEDLINE; 
CINAHL; ERIC; ASSIA; AMED; PsycINFO; EMBASE; LILACS: Database of 
Abstracts of Reviews of Effectiveness (DARE); NHS Economic Evaluation Database 
(NHS EED); British Education Index (BEI); British Nursing Index (BNI); Web of 
Science and National Research Register. Conference proceedings and reference lists of 
articles were also searched and contact was made with experts in the field. 
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Selection criteria: randomised controlled trials (RCTs), controlled clinical trials (CCTs), 
controlled before-and-after studies (CBAs) and interrupted time series (ITS) which 
evaluated group-based education programmes for adults with Type 2 diabetes compared 
with routine treatment, waiting list control or no intervention. Studies were only 
included if the length of follow-up was six months or more and the group education 
programme was at least one session with the minimum of six participants. 
Data collection & analysis: two reviewers independently extracted data and assessed 
study quality with high interrater agreement. A meta-analysis was performed if there 
were enough homogeneous studies reporting an outcome at either four to six months, 
12-14 months, or two years, otherwise the studies were summarised in a descriptive 
manner. 
Main results: thirteen papers describing 11 studies were included, involving 1532 
participants. Nine studies were RCTs and two, CCTs. The methodological quality of the 
studies was moderate to poor due to unclear allocation concealment, lack of intention- 
to-treat analyses, and unclear blinding of the outcome assessor. Heterogeneity was low 
for the majority of meta-analyses. However, if significant heterogeneity was present, the 
source was identified by a sensitivity analysis. The results of the meta-analyses in 
favour of group-based diabetes education programmes were: reduced glycated 
haemoglobin at four to six months (1.08%; 95% Cl: 0.40% to 1.76%, P=0.002), at 12-14 
months (0.82%; 95% CI: 0.65% to 0.99%, P<0.00001) and two years (0.97%; 95% Cl: 
0.54% to 1.40%, P<0.00001); reduced fasting blood glucose levels at six months (1.66 
mmol/l; 95% CI: 0.74 mmol/1 to 2.58 mmol/l, P=0.0004), at 12 months (1.17mmol/l; 
95% CI: 0.72 mmol/l to 1.63 mmol/l, P<0.00001), and two years (1.57 mmol/l; 95% Cl: 
1.05 mmol/I to 2.10 mmoVl, P<0.00001); reduction in diabetes medication (odds ratio 
11.79,95% Cl: 5.17 to 26.90, P<0.00001); reduced body weight at 12-14 months 
(1.16Kg; 0.25Kg to 2.97Kg, P=0.02); improved diabetes knowledge at four-six months 
(SMD 0.70; 95% CI: 0.22 to 1.18, P=0.004), at 12-14 months (SMD 0.83; 95% Cl: 0.52 
to 1.14, P<0.00001) and two years (SMD 1.27; 95% Cl: 0.82 to 1.73, P<0.00001); 
reduced systolic blood pressure at four to six months (5.37mmHg: 95% Cl: 1.21 mmHg 
to 9.53mmHg, P=0.01), borderline statistical significance for diastolic blood pressure 
(2.65 mmHg; 95% CI: -0.28 to 5.57mmHg, P=0.08); and borderline statistical 
significance for triglyceride level at four-six months (0.24 mmol/l; 95% CI: -0.04 
mmol/l to 0.52 mmol/l, P=0.09). 
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No adverse effects were reported. There was no evidence of group-based education 
programmes having an effect on the following outcomes: body weight (P=0.11) and 
body mass index (BMI) (P=0.71) at four-six months or BMI at 12-14 months (P=0.70); 
total mortality (P=0.77); systolic and diastolic blood pressure at 12-14 months (P=0.22, 
P=0.95 respectively); total cholesterol level at four-six months (P=0.71) and 12-14 
months (P=0.34) and triglyceride level at 12-14 months (P=0.31). 
For the results analysed in a descriptive manner, there was some evidence that group 
education programmes led to patient empowerment at both four months (P<0.001) and 
14 months (P=0.006) and increased freedom to eat and drink at four months (P=0.05 to 
P<0.001) and 14 months (P=0.05 to P=0.01). However, there was no evidence of a 
generalised improvement in quality of life until two years (P<0.001) and four years 
(P<0.009) with every point gained for quality of life costing just US$ 2.12. There was 
some evidence that participants who had attended group education sessions increased 
their physical activity levels, increased self-monitoring of blood glucose levels and 
urinanalysis, improved dietary intake with less percentage energy from saturated fat and 
more fruit and vegetables, improved health behaviour conduct, and increased foot care 
and monitoring. They were found to be more satisfied with treatment and, at four years, 
had less progression to diabetic retinopathy. 
Reviewers' conclusions: group-based self-management strategies in people with Type 2 
diabetes are effective by improving fasting blood glucose levels, glycated haemoglobin 
and diabetes knowledge at four to six months, 12-14 months and two years. Reductions 
in the requirement for diabetes medication is also apparent as are reductions in blood 
pressure at four to six months, body weight at 12-14 months and a tendency for reduced 
triglyceride levels at four to six months. There is also some evidence that group 
education participants experience greater empowerment, better quality of life, increased 
self-management skills and treatment satisfaction. However, due to the small numbers 
of studies included in the review, their moderate to low research design quality scores 
and the small number of studies measuring blood pressure, quality of life, 
empowerment/self-efficacy, improved treatment satisfaction and cost effectiveness, 
further research evaluating patient-centred group-based diabetes education programmes 
is needed to confirm these findings. 
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3.3 Background 
3.3.1 Diabetes mellitus and its complications 
Diabetes mellitus is one of the most common chronic disorders in the western world. 
Type 2 diabetes affects large numbers of people from a wide range of ethnic groups and 
at all social and economic levels. It is estimated that 194 million people worldwide, or 
5.1% of the adult population, currently have diabetes and that will increase to 333 
million (6.3% of the adult population by 2025) (Sicree, Shaw, & Zimmet 2003). It is felt 
that lifestyle changes, with diets high in saturated fat and decreased physical activity, 
together with an increased longevity, are the main factors in the dramatic increase of 
Type 2 diabetes. Type 2 diabetes, previously referred to as non insulin dependent 
diabetes mellitus (NIDDM) or mature onset diabetes is more commonly diagnosed over 
the age of 40. It affects 75-90% of all those with diabetes (Keen et at. 1995). An 
economic study 'Type 2 diabetes: Accounting for a major Resource Demand in Society 
in the UK' (Diabetes UK 2000) has shown that microvascular and macrovascular 
complications increase UK NHS costs more than five fold and diabetes presently 
consumes 9% of NHS inpatient resources. The annual direct healthcare costs of diabetes 
worldwide for people aged between 20 and 79 is estimated to be at least 153 billion 
international dollars. If predictions for diabetes prevalence are correct, total direct 
healthcare expenditure on diabetes worldwide will be between 213 and 396 billion 
international dollars in 2025, which will be between 7% and 13% (Williams 2003) of 
total healthcare expenditure. 
Diabetes mellitus is a metabolic disorder resulting from a defect in insulin secretion, 
insulin action, or both. A consequence of this is a chronic hyperglycaemia (i. e. elevated 
levels of plasma glucose) with disturbances of carbohydrate, fat and protein 
metabolism. Although the onset of Type 2 diabetes is usually less dramatic than that of 
Type 1, both types of diabetes carry a risk of multiple, disabling, yet potentially 
preventable complications (DCCT Research Group 1993; UKPDS Group 1998b). 
Diabetes greatly increases the risk of coronary heart disease and stroke. Cardiovascular 
disease is the primary cause of death in industrialized countries. It is also set to overtake 
infectious diseases as the most common cause of death in many parts of the less 
developed world. People with diabetes are between two and four times more likely to 
develop cardiovascular disease than people without diabetes, making it the most 
common complication of diabetes (IDF 2001). Between 70 and 80% of people with 
diabetes die from cardiovascular disease (Tapp, Shaw, & Zimmet 2003). Other long- 
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term consequences of diabetes mellitus include retinopathy, ncphropathy and 
neuropathy; it is a leading cause of blindness, end-stage renal failure and limb 
amputation. For a detailed overview of diabetes mellitus, please see 'Additional 
information' in the information about the Metabolic and Endocrine Disorders Group on 
the Cochrane Library (see 'About the Cochrane Collaboration', 'Collaboration Review 
Groups'). For an explanation of the methodological terms, see the main Glossary on the 
Cochrane Library. 
It is now clear that Type 2 diabetes is a progressive condition and ought never to be 
considered the 'mild' form of diabetes. It should always be taken seriously and the 
objective of treatment should be to achieve and maintain long-term near-normal blood 
glucose and blood pressure levels. As already discussed in Chapter 1, the United 
Kingdom Prospective Diabetes Study (UKPDS Group 1998b), the largest clinical 
research study of diabetes ever conducted, has provided evidence that the life 
threatening complications of Type 2 diabetes can be reduced by a combination of 
optimal blood glucose and blood pressure levels. More recent studies have shown that 
each 1% reduction in glycated haemoglobin was associated with the reductions in risk 
of 21% for any end point related to diabetes, 21% for deaths related to diabetes, 14% for 
myocardial infarction and 37% for microvascular complications (Stratton et al. 2000). 
Each 10 mmHg decrease in systolic blood pressure was associated with reductions in 
risk of 12% for any complication related to diabetes, 15% for deaths related to diabetes, 
11% for myocardial infarction and 13% for microvascular complications (Adler et al. 
2000; Stratton et al. 2000). Therefore, any reduction in glycated haemoglobin and blood 
pressure is likely to reduce the risk of complications with the lowest risk being in those 
with HbAlc values in the normal range (< 6.0%) and systolic blood pressure values less 
than 120 mmHg. 
3.3.2 Self-management skills 
It has been recognised that adoption of self-management skills (i. e. the learned ability to 
perform an act competently) by the person with diabetes is necessary to enable them to 
manage their diabetes (WHO Working Group 1998). Nutritional intake and 
modification of lifestyle are the cornerstone of treatment for Type 2 diabetes. Although 
the provision of effective ongoing education and support is necessary to equip people 
with the knowledge, skills, attitudes and motivation required to manage their diabetes 
care effectively (DOH & Diabetes UK 1995), the most effective method for delivering 
education and teaching self-management skills is unclear. 
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Effective management lies almost entirely in the hands of the patient who lives with the 
condition. However, a health professional-centred approach based on the medical model 
is still traditionally used. That model of care may neglect the psychosocial and 
emotional aspects of the disease and could be one of the main reasons why only 7% of 
adults with diabetes manage to follow all the steps deemed by practitioners to be 
necessary for optimal management and good glycaemic control, including dietary 
modification, physical activity regime, compliance with medication and monitoring 
diabetes control (Griffin et al. 1998). 
3.3.3 Standards 
Individual countries have developed their own standards. The United States of America, 
for example, has developed 'National Standards for Diabetes Self-Management 
Education' (Mensing et al. 2003). The American standards define structure 
(organisation, needs assessment, program management, program staff, curriculum and 
participant access), process (assessment, plan and implementation, follow-up) and 
outcomes (program outcome evaluation, participant outcome evaluation) as the core 
components to diabetes education programmes, along with skilled and experienced 
health care professionals with recent education in diabetes, educational principles, and 
behaviour change strategies. The German model, `intensified insulin treatment' 
prescribed as routine treatment for Type 1 diabetes, has been developed by Michael 
Berger in Düsseldorf and is based on the Assal model of therapeutic education 
(Muhlhauser, Jorgens, & Berger 1983). It is a five-day structured in-patient training 
programme in intensive insulin therapy and self-management. This programme has 
since been adapted and delivered as an out-patient course (Kronsbein et al. 1988) and 
formed the basis of the DAFNE (Dose Adjustment For Normal Eating) project in the 
UK. Although the model was originally developed for people with Type I diabetes, 
there are now papers evaluating its effectiveness for people with Type 2 diabetes 
(Domenech et al. 1995; Gruesser et al. 1993; Pieber et al. 1995). 
The International Diabetes Federation has published 'International Curriculum for 
Diabetes Health Professional Education' (IDF Consultative Section on Diabetes 
Education (DECS) 2002). A curriculum is a detailed plan with overall aims and 
evaluation process for the education programme. The mission of the Diabetes Education 
Consultative Section (DECS) is to provide access to expertise in diabetes education, 
both for people with diabetes and for health professionals. The DECS publication 
provides a collection of modules designed to train health professionals to the 
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appropriate level so that they feel competent to deliver the education required by people 
with diabetes. Diabetes experts developed those modules with input from educators 
around the world. The DECS has more recently published 'International Standards for 
Diabetes Education' (IDF Consultative Section on Diabetes Education (DECS) 2003), 
which has been organised into structure standards, process standards and outcome 
standards. The standards serve to assist in the planning of health services, to prioritise 
resource allocation, to lend support to the lobby for the funding and recognition of 
diabetes education, to identify competencies required by those who deliver diabetes 
education, to provide a benchmark against which the quality of care can be evaluated 
and improved, to provide a basis for accrediting organisations and to assist individual 
diabetes educators to acquire the necessary credentials. 
In the UK, a report with recommendations and examples of good practice (Naqib 2002) 
was followed shortly afterwards by guidance for the use of patient education models for 
diabetes (NICE 2003b). The guidelines recommended that educational interventions 
should reflect established principles of adult and active learning, be provided through an 
appropriately trained multidisciplinary team to groups of people with diabetes (unless 
group work was considered unsuitable for a particular individual) and take into account 
culture, ethnicity, disability and geographical issues. The UK public health document 
'Saving Lives: Our Healthier Nation (DOH 1999) acknowledged that in the past, too 
little has been done to help people with chronic disease play a part in managing their 
own condition. The Chief Medical Officer set up a task force to design an expert 
patients programme to address the needs of one in three of the total population who will 
suffer from a chronic disease or disability in their lifetime (DOH 2001). The term 
'expert patient programme' suggests that the patient will have an opportunity to become 
an 'expert' in self-managing their condition. Based on the work of Long in the United 
States (Lorig et al. 1999) and the UK Challenging Arthritis programme (Barlow, 
Turner, & Wright 2000), there is increasing evidence that people have improved self- 
efficacy and general health and reduced incapacity upon becoming empowered to take 
the lead themselves in managing their chronic disease. People are empowered when 
they have knowledge, skills, attitudes and self-awareness necessary to influence their 
own behaviour and that of others in order to improve the quality of their lives (Funnell, 
Anderson, & Arnold 1991). The World Health Organisation alluded to empowerment in 
its paper on health promotion as "the process of enabling people to increase control 
over, and to improve, their health" (WHO 1978). Self-efficacy is a belief. People who 
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have self-efficacy expectations believe that they are capable of performing a given 
activity. 
The World Health Organisation Report (WHO Working Group 1998) on therapeutic 
patient education also recognised the importance of patient-centred education in the 
effective management of chronic disease. Patient-centred education is the close 
involvement of patients and carers in the planning of the education, such as soliciting 
the patient's opinions, concepts, ideas, feelings and questions, offering support, and 
allowing the patient to be involved in decision making. In contrast, traditional education 
is didactic in nature and tends to be delivered in lecture format. The report makes 
recommendations about the ideal content of a specific education programme for health 
care providers in the field of prevention of chronic diseases and therapeutic patient 
education. 
3.3.4 Systematic reviews and other evidence 
Diabetes UK (formerly the British Diabetic Association) commissioned a review of the 
educational and psychosocial interventions for adults with diabetes (Griffin et at. 1998). 
It reviewed seven meta-analyses (Brown 1988; Brown 1990; Brown 1992; Mazzuca 
1982; Mullen, Green, & Persinger 1985; Padgett et at. 1988; Posavac 1980), one review 
(Wing 1993) and 57 published controlled trials. More than 3000 papers were identified 
by a more general search unconstrained by search terms relating to study design. The 
three reviews by Brown underlined the volume of work in diabetes patient education 
and have shown that education is beneficial but that the size of the effect depends on the 
outcome, the nature of the measure, the length of the study and the age of the 
participants. The degree to which the approach to educational intervention affected the 
outcome was not addressed. It was concluded that evaluations of education have been of 
variable, but frequently poor, quality and prone to selection and measurement bias. 
There has also been inadequate description of each intervention. Attrition rates were 
reported in about half of the studies and only 8% performed an intention-to-treat 
analysis. Those omissions led to bias, misunderstanding and poor generalisability of 
findings. Self-reported measures were shown to overestimate effects and important 
health outcomes, such as quality of life and cardiovascular disease risk. Cost seemed 
rarely to have been assessed. In the meta-analysis there was a large degree of 
heterogeneity, as broad classes of patient variables were grouped together to produce 
effect sizes. Posavac undertook a meta-analysis of education programmes for patients 
with chronic disease (not restricted to diabetes). The search strategy was less rigorous 
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than that undertaken by Brown and studies were included if the title suggested that 'an 
empirical evaluation', including a control or comparison group, had been carried out. As 
with the Brown reviews, patient education emerged as beneficial but the effect varied 
according to the outcome measure. As a consequence of the limited search strategy and 
the small number of identified trials, publication bias was a worry and reduced the 
quality of the review. 
Mazzuca made more effort to differentiate the educational interventions and to assess 
relative as well as absolute effect sizes. That report added further weight to the notion 
that education is beneficial and supported the belief that some forms of education 
(behavioural) were more effective than others (didactic). However, there were several 
limitations, with the search strategy missing many studies identified by Brown. Mullen 
also reviewed different interventions for all people with chronic disease. Studies were 
included if they had a control group or pre-test/post-test design and measured 
knowledge and/or adherence. Seventy studies were identified and a scoring system 
divided the studies into seven educational principles. The underlying message was that 
education was beneficial, particularly if based on sound educational principles. As with 
the other reviews, interventions were poorly described in the individual trials and 
educational, psychological, or behavioural science theory was rarely discussed. The 
final meta-analysis was that of Padgett and colleagues. They estimated the overall 
effectiveness of educational and psychosocial interventions for people with diabetes. 
One hundred and ten studies met the inclusion criteria and those were scored for 
methodological quality. Effect sizes were calculated for 94 studies of which 14% were 
randomised trials. The finding that education was beneficial was confirmed once more. 
Dietary instruction produced the largest efects, but tended to be evaluated in the short 
term with physical measures such as weight and metabolic control. Although the review 
by Wing was not a meta-analysis, it described the lessons learnt from 15 years of trial 
work, looking at behaviour modification for obesity with Type 2 diabetes. Wing 
concluded that behavioural approaches were required, rather than simple education, and 
that health professionals may need training in behaviour modification techniques. 
Therefore, the Diabetes UK literature review showed that an increasing number of trials 
have been undertaken, mainly in secondary care in the United States. There were 
important differences in culture, social structure and health care delivery. Those 
differences could threaten generalisability of the results to other parts of the world. The 
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studies tended to be small and short-term; the education programmes were more likely 
to be based on a lecture format, and the studies had many methodological weaknesses. 
However, trials that appeared to incorporate a social cognition model or involved 
patient activation tended to produce more positive results. The meta-analyses have 
many limitations with poor descriptions of the sample characteristics, the interventions 
and the underpinning theoretical model. Publication bias was almost certainly present in 
some of the reports, but it has not been formally assessed with techniques such as a 
funnel plot. The quality of the design and measurement used in each study was 
associated with the size of the outcome, yet none of the meta-analyses attempted a 
sensitivity analysis to gain a clearer idea of the true effect of the interventions. Although 
the age of participants, the type of diabetes and so on was associated with effect size, 
authors continued to review heterogeneous studies. Consistent conclusions run through 
the seven reports but that may be because the authors were all subject to similar biases 
(Griffin et al. 1998). 
The NHS Centre for Reviews and Dissemination, University of York reviewed the 
evidence for the effectiveness of self-management interventions for Type 2 diabetes. 
The Effective Health Care bulletin is divided into two sections, the first dealing with 
renal complications and the second half with the promotion of self-management (Khan 
et al. 2000). The interventions considered in the bulletin were generally provided in 
addition to the information sharing that should be an integral part of routine patient care. 
The interventions included in the review were assigned to three broad categories: 
information and skills, cognitive-behavioural, and patient empowerment. Both 
individual and group methods were included. It was concluded that further research is 
necessary to determine whether interventions to promote self-management had positive 
significant long-term effects. 
More recent reviews have evaluated the effectiveness of self-management training in 
Type 2 diabetes (Norris et al. 2002; Norris, Engelgau, & Narayan 2001; Steed, Cooke, 
& Newman 2003; van Dam et al. 2003). Norris 2001 evaluated 72 studies and found 
short-term (less than six months) positive effects of self-management on knowledge, 
frequency and accuracy of self-monitoring blood glucose, self-reported dietary habits 
and glycaemic control. With longer follow-up, interventions that used regular 
reinforcement were sometimes effective in improving glycaemic control with patient 
collaboration possibly being more effective than didactic prescription. No studies 
demonstrated the effectiveness of self-management training on cardiovascular disease- 
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related events or mortality and no economic analyses included indirect costs. 
Performance, selection, attrition, and detection bias were common in studies reviewed, 
limiting external generalisability. Norris 2002 performed a meta-analysis of the effect of 
self-management training on glycaemic control. On average, glycated haemoglobin 
decreased by 0.76% (95% CI: 0.34%-1.18%) more than the control group at immediate 
follow-up and by 0.26% (95%CI: 0.05%-0.48%) at four months or longer follow-up. 
Metabolic control improved in line with additional contact time between participant and 
educator; there was a decrease in glycated haemoglobin of 1% for every 23.6 hours 
(95% CI: 13.3hr-105.4hr) of contact. Norris 2002 concluded that although self- 
management training improved diabetes control at immediate follow-up, the benefit 
declined between one and three months after the intervention ceased, suggesting that 
learned behaviours can change over time. Steed 2003 reviewed 36 self-management and 
psychosocial interventions on psychosocial outcomes and found that depression seemed 
to be particularly improved following psychosocial interventions, whereas quality of life 
showed greater improvement following self-management interventions. There was no 
convincing evidence to further support the use of didactic education programmes. Van 
Dam 2003 reviewed eight publications evaluating the effects of the modification of 
provider-patient interaction and consulting style on diabetes self-care and diabetes 
outcomes. Patient behaviour-focused interventions, the enhancement of patient 
participation by assistant-guided patient preparation for visits to doctors, empowering 
group education and automated telephone management were found to be more effective 
than focusing on provider behaviour to change health professional consulting style into 
a more patient-centred one. However, although there was evidence that self- 
management training was effective, all four recent reviews called for further research by 
way of well-designed and long-term studies. 
Educational programmes are frequently defined as complex interventions where it is 
often difficult to define the 'active ingredient'. If a programme is shown to be effective, 
that may be due to any combining theoretical model used, the skills of the educator, the 
venue, the rapport between the participants and so on. If it is clear to those who read the 
results of a trial how the intervention can be transported and put into operation in other 
contexts, then it may not be essential to discover the precise mechanisms of action 
(Medical Research Council 2000). However, if sufficiently homogeneous good quality 
complex interventions are systematically reviewed, the active ingredient is more likely 
to become apparent. 
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3.4 Aims 
As a result of the increasing prevalence of diabetes and increasing pressure on staff 
resources, more patients are receiving diabetes education by attending group-based 
programmes. None of the above reviews have evaluated the effectiveness of self- 
management training delivered in a group format. This systematic review aims to 
evaluate previous research into group-based, patient-centred educational programmes 
for people with Type 2 diabetes. Particular attention will be placed on programmes that 
attempted to increase self-management skills, self-efficacy or self-empowerment and to 
measure their impact on metabolic control, patient satisfaction and quality of life. 
Information gained will be used to further develop expert patient programmes for 
people with Type 2 diabetes. 
3.5 Objectives 
To assess the effects of group-based (six or more people), patient-centred diabetes 
education on clinical, lifestyle and psychosocial outcomes both in the short (four to six 
months) and longer-term (>12 months) compared with routine care delivered on a one- 
to-one basis, or a combination of the two. 
To observe whether the setting (primary/secondary care), the educator (physician, nurse, 
dietitian, other health professional, peer educator), the type of educational model or the 
duration/intensity of the group-based education programme affects the outcomes. 
3.6 Criteria for considering studies for this review 
Types of studies 
The Cochrane Effective Practice and Organisation of Care (EPOC) review group 
guidelines were used for study type. Studies were included if they were a randomised 
controlled trial (RCT), a controlled clinical trial (CCT), a controlled before and after 
study (CBA) or interrupted time series (ITS) and then only if they fulfilled the inclusion 
criteria. 
Interventions involved a single or series of group sessions. Only studies that assessed 
outcome measures six months or more from baseline were included in this study. 
Types of participants 
Participants were all adults with diagnosed Type 2 diabetes, regardless of gender or 
ethnicity. Ideally, the diagnostic criteria for Type 2 diabetes should have been described 
76 
in the trial. In order to be consistent with changes in classification and diagnostic 
criteria of the disease through the years, the diagnosis should have been established 
using the standard criteria that were valid at the beginning of the trial (ADA Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus 1997; National 
Diabetes Data Group 1979; WHO 1985a; WHO Expert Committee on Diabetes Mellitus 
1980; WHO Working Group 1999). 
The review excluded interventions that were specific for maturity onset diabetes of the 
young (MODY) or for pregnant women. 
Types of interventions 
Group-based educational programmes that met the following criteria: 
o specific for people with type 2 diabetes; 
o delivered in primary or secondary care; 
o based on learner/patient-centred education; 
o included or excluded family and friends; 
o had a minimum of six participants in each group; 
o was a minimum of one session lasting for one hour. 
Comparison Group: 
The intervention group was compared with participants that were either: 
o undergoing routine treatment (receiving the standard of care recommended in 
that country e. g. regular follow-up with the required health professionals and a 
full diabetes annual review); 
o remaining on a waiting list; 
o experiencing no intervention i. e. the present healthcare was continued. 
Types of outcome measures 
Clinical outcomes: 
o glycated'haemoglobin (%) (primary outcome); 
o fasting blood glucose (mmol/1); 
o body weight (Kg)/body mass index (BMI)(Kg/m2); 
o blood pressure (systolic/diastolic) (mmHg); 
o lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) 
(mmol/l); 
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o diabetes complications (myocardial infarction, angina, heart failure, stroke, renal 
failure, neuropathy, retinopathy, peripheral vascular disease); 
o diabetes-related mortality (death from myocardial infarction, stroke, peripheral 
vascular disease, renal disease, hyper- or hypoglycaemia or sudden death; 
o adverse effects e. g. increased hypoglycaemia. 
Lifestyle outcomes: 
o self-management skills (including dietary habits and physical activity levels); * 
o diabetes knowledge; * 
o psychosocial outcomes; 
o quality of life; * 
o empowerment/self-efficacy; 
o patient treatment satisfaction. * 
(Diabetes education studies are generally too short-term to assess incidence of diabetes 
complications and mortality. Therefore, the main outcome will be glycated 
haemoglobin. It has been shown (UKPDS-35 2000) that a 1% reduction in glycated 
haemoglobin reduces the risk of developing diabetes complications by 21%). 
* ideally measured using standard (validated) questionnaires 
Timing Of Outcome Assessment: 
Short term: four to six months 
Long term: 12 months or more 
3.7 Search strategy for identification of studies 
Electronic searches 
The following electronic databases were searched from the date on which records began 
up until January/February 2003: The Cochrane Library; MEDLINE; CINAIIL; ERIC; 
ASSIA; AMED; PsycINFO; EMBASE; LILACS: Database of Abstracts of Reviews of 
Effectiveness (DARE); NHS Economic Evaluation Database (NHS EED); British 
Education Index (BEI); British Nursing Index (BNI); Web of Science and National 
Research Register. Conference proceedings and reference lists of articles were also 
searched and contact was made with experts in the field. 
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The following MEDLINE search strategy was adapted for use with the other databases. 
TYPE 2 DIABETES (The Cochrane Metabolic and Endocrine Disorders Group search 
strategy) 
1. "diabetes mellitus, non insulin dependent" [MeSH Terms] 
2. "insulin resistance" [MeSH Terms] 
3. "obesity in diabetes"[MeSH Terms] 
4. "impaired glucose tolerance" [Title/Abstract] 
5. "glucose intolerance" [Title/Abstract] 
6. "insulin resistance" [Title/Abstract] 
7. "mody" [Title/Abstract] 
8. "dm2"[Title/Abstract] 
9. "niddm"[Title/Abstract] 
10. "iidm"[Title/Abstract] 
11. "non insulin dependent"[Title/Abstract] 
12. "noninsulin dependent" [Title/Abstract] 
13. "noninsulindependent" [Title/Abstract] 
14. "type 2 diabet*"[Title/Abstract] 
15. "type ii diabet*"[Title/Abstract] 
16. "nonketotic diabet*"[Title/Abstract] 
17. "non ketotic diabet* 
18. "adult onset diabet*"[Title/Abstract] 
19. "late onset diabet* 
20. "metabolic syndrom*"[Title/Abstract] 
21. "plurimetabolic syndrom*"[Title/Abstract] 
22. or/1-21 
23. dermatomyositis[MeSH Terms] 
24. Myotonic dystrophy[MeSH Terms] 
25. Diabetes insipidus[MeSH Terms] 
26. dermatomyositis[Title/Abstract] 
27. myotonic dystroph*[Title/Abstract] 
28. diabet* insipidus[Title/Abstract] 
29. or/23-28 
30.22 not 29 
EDUCATION 
31. "education" [MeSH Terms] 
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32. "self care" [MeSH Terms] 
33 "patient education" [MeSH Terms] 
34"self efficacy"[MeSH Terms] 
35"behavior therapy"[MeSH Terms] 
36"empowerment"[Title/Abstract] 
37"self care" [Title/Abstract] 
38"education*"[Title/Abstract] 
39"self efficac*"[Title/Abstract] 
40"program*" [Title/Abstract] 
41 "group method" [Title/Abstract] 
42"group management" [Title/Abstract] 
43 "evaluation*"[Title/Abstract] 
44"lifestyle"[Title/Abstract] 
45"behavio? r* therap*"[Title/Abstract]] 
46or/31-45 
TRIAL DESIGN (adopted from the Cochrane Effective Practice and Organisation of 
Care Review Group (EPOC)) 
47. "randomized controlled trial"[Publication Type] 
48. "randomized controlled trials"[MeSH Terms] 
49. "random allocation" [MeSH Terms] "random"[Title/Abstract] 
50. "allocat* [Title/Abstract 
51 
. 
"assign" [Title/Abstract] 
52. "controlled clinical trial" [Publ i cation Type] 
53. "clinical trial"[Publication Type] 
54. "clinical trials"[MeSH Terms] 
55. "clinical trial*"Title/Abstract] 
56. "double blind method"[MeSH Terms] 
57. "single blind method"[MeSH Terms] 
58. "single blind* [Title/Abstract] 
59. "single mask* [Title/Abstract] 
60. "double blind*"[Title/Abstract] 
61. "double mask*" [Title/Abstract] 
62. "placebos" [MeSH Terms] 
63. "placebo" [Title/Abstract] 
64. "research design"[MeSH Terms] 
80 
65. "comparative study" [MeSH Terms] 
66. "evaluation studies" [MeSH Terms] 
67. "follow up studies"[MeSH Terms] 
68. "prospective studies" [MeSH Terms] 
69. "control stud* [Title/Abstract] 
70. "volunteer study" [Title/Abstract] 
71. "intervention studies" [MeSH Terms] 
72. "intervention stud* [Title/Abstract) 
73. "pretest*"[Title/Abstract] 
74. "pre test* [Title/Abstract] 
75. "posttest" [Title/Abstract] 
76. "post test" [Title/Abstract] 
77. or/47-77 
78.30 and 46 and 78 (limit to human) 
Handsearchin 
Attempts were made to identify additional studies by searching the reference lists of 
relevant trials and reviews. 
Other search strategies 
Some of the authors of relevant identified studies and other experts (authors of reviews 
and well known diabetes educators) were contacted in order to obtain additional 
references, unpublished trials, or ongoing trials. 
3.8 Methods of the review 
3.8.1 Trials selection 
Two independent reviewers (TD and CM) scanned the titles, abstract sections and 
keywords of every record retrieved. Full articles were retrieved for further assessment if 
the information suggested that the study: 
1. included patients with Type 2 diabetes mellitus, and 
2. evaluated a patient-centred group-based education programme, 
Wherever there was any doubt regarding the existence of these criteria, the complete 
article was retrieved for clarification. Interrater agreement for study selection was 
measured using the kappa statistic (Cohen 1960). Any differences in opinion were 
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discussed and, if necessary, resolved by a third party (JC). There were no instances 
where it was necessary to contact the authors or the review group editorial base. 
3.8.2 Quality assessment of trials 
The quality of reporting of each randomised trial was assessed largely on the quality 
criteria specified by Schulz and by Jadad (Jadad et al. 1996; Schulz et al. 1995). In 
particular, the following factors were studied: 
1. Minimisation of selection bias - a) was the randomisation procedure adequate? b) was 
the allocation concealment adequate? 
2. Minimisation of attrition bias - a) were withdrawals and dropouts completely 
described? b) was analysis by intention-to-treat? 
3. Minimisation of detection bias - were outcome assessors blind to the intervention? 
Based on those criteria, studies were broadly subdivided into the following three 
categories (see Cochrane Handbook): 
A- all quality criteria met: low risk of bias. 
B- one or more of the quality criteria only partly met: moderate risk of bias. 
C- one or more criteria not met: high risk of bias. 
3.8.3 Data extraction 
1. General information: published/unpublished, title, authors, reference/source, contact 
address, country, urban/rural etc., language of publication, year of publication, duplicate 
publications, sponsoring, setting. 
2. Trial characteristics: design, duration, randomisation (and method), validated 
questionnaires, allocation concealment (and method), blinding (patients, outcome 
assessors), check of blinding. 
3. Intervention(s): Comparison group included (routine treatment, waiting list, no 
intervention), intervention(s) (theoretical model, duration, timing), 
4. Participants: sampling (random/convenience), exclusion criteria, total number and 
number in comparison groups, sex, age, ethnicity, Body Mass Index, pre-existing 
medical conditions, educational history, standards of diabetes care, intervention 
delivered by primary or secondary care, diagnostic criteria, duration of diabetes, 
similarity of groups at baseline (including any co-morbidity), assessment of compliance, 
withdrawals/losses to follow-up (reasons/description), subgroups. 
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5. Outcomes: outcomes specified above (also: what was the main outcome assessed in 
the study? ), any other outcomes assessed, other events, length of follow-up, quality of 
reporting of outcomes. 
6. Results: for outcomes and times of assessment (including a measure of variation), if 
necessary converted to measures of effect specified below; intention-to-treat analysis. 
A template data extraction form was developed and tested for suitability. Minor 
amendments were made before use. Before final data extraction, the data extraction 
form was sent to the Metabolic and Endocrine Disorders Group Editorial Base for 
approval. Data extraction and data entry were performed independently in duplicate by 
two evaluators (TD and CM). Differences in data extraction were discussed and if 
necessary resolved by consensus with a third reviewer (JC) referring back to the original 
article. If data was missing in a published report (see data extraction list), the reviewers 
tried to contact the first author. 
3.8.4 Data analysis 
Data was summarised statistically only if it was available, sufficiently similar 
(homeogeneous), and of sufficient quality. Assessment of the consistency of effects 
across studies is an essential part of a meta-analysis without which the generalisability 
of the findings of the meta-analysis cannot be determined. Heterogeneity can be caused 
by the variability or differences between studies in key characteristics (clinical 
heterogeneity) quality (methodological heterogeneity) and effects (heterogeneity of 
results). Outcomes that were not significantly homogeneous for meta-analysis due to 
variations in measurement design, baseline characteristics, validated questionnaires, 
length of follow-up or missing data were summarised in a descriptive nature. 
A popular test for heterogeneity (Cochran's Q) examines the null hypothesis that all 
studies are evaluating the same effect. The test is known to be poor at detecting true 
heterogeneity among studies as significant, especially when there arc only a small 
number of studies included in the meta-analysis. In this instance, heterogeneity was 
tested for using a new quantity, 12, which described the percentage of total variation 
across studies that was due to heterogeneity rather than chance. It was a better measure 
of consistency between trials in the meta-analysis (Higgins et al. 2003). 12 values of 
25%, 50% and 75% were classified as low, moderate, and high heterogeneity 
respectively. 
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The dichotomous data (e. g. mortality, medication reduction) used a random effect 
approach (it is unreasonable to assume that there is one 'true' effect underlying the data 
that is constant across different populations) and the odds ratio (O-E) summary statistic 
with the DerSimonian and Laird method. The meta-analytical model for the continuous 
data (e. g. weight, blood pressure, glycated haemoglobin) used a random effect approach 
with the weighted mean difference by the DerSimonian and Laird method. however, if 
the results across studies were conceptually the same but measured in a different way 
(e. g. scores on depression could be reported as means or as the percentage of patients 
who were depressed at some point after an intervention), standardised mean differences 
were used. 
Subgroup analyses 
Ideally a subgroup analysis would have been performed for the following confounding 
factors: 
1. ethnicity e. g. strategies for South Asian compared to those for white Caucasian 
people. 
2. theoretical model underpinning the education programme e. g. empowerment versus 
didactic model. 
3. duration of education programme e. g. single session compared to series of sessions. 
4. age e. g. 30 to 60 year olds compared with those aged above 60 years. 
5. gender e. g. single sex versus mixed sex sessions. 
6. education delivered within primary or secondary care. 
In fact, subgroup analyses were performed only if, in the meta-analysis, there were 
sufficient studies and the results for the primary outcome were significant. 
Sensitivity analyses 
Sensitivity analyses were performed (if appropriate and if a sufficient number of studies 
were included in the meta-analysis) in order to explore the influence of the following 
factors on effect size: 
Repeating the analysis: 
1. excluding unpublished studies; 
2. taking account of study quality, as specified above; 
3. excluding any very long or large studies to establish how much they dominate the 
results; 
4. excluding studies which had been published in a foreign language and then 
translated; 
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5. excluding studies with less than 100 participants and length of follow-up less than 12 
months. 
A funnel plot was also performed in order to assess small study or publication bias for 
glycated haemoglobin at 12 to 14 months follow-up. 
3.9 Description of studies 
Trials identified 
Electronic searches undertaken in January and February 2003 identified 5497 citations 
of which 899 were duplicates. The titles and abstracts of 4598 citations were 
independently reviewed by TD and CM and 183 citations either met the inclusion 
criteria or required sight of the full paper before a decision could be made. Thirteen 
abstracts required translation, of which eight were written in Spanish, three in 
Portuguese and two in German. A further 10 papers were identified by hand searching 
and by contacting experts in the field, which gave a total of 193 papers required for data 
extraction. Of these, three foreign language papers were unobtainable through the 
British Library or through inter-library loans. Two of these were written in Spanish 
(Luna Arriola & Merino Ramirez 1994; Saenz Hernaiz et al. 1992) and one in Chinese 
(Fan, Zhu, & Zhang 1999). Twelve papers required translation: five were written in 
Spanish (Bundo 1993; Cabrera-Pivaral et al. 2000; Cabrera-Pivaral et al. 2001; Llamas 
et al. 2002; Lozano et al. 1999; Lozano del Hoyo et al. 1996), six in German (Maisch ct 
al. 1996; Haisch & Remmele 2000; Hanefeld et al. 1996; Hardinghaus et al. 1996; 
Jungmann & Jungmann 1997a; Rebell et al. 2002) and one in French (Girard, Dauzat, & 
Moinade 1986). Of the 190 full papers obtained, 19 were duplicates reporting either the 
same data or follow-up data (Arauz et al. 1997; Arauz et al. 2001; Domenech ct al. 
1994; Domenech et al. 1995; Hanefeld et al. 1991; Hanefeld et al. 1996; Hansen & 
Drivsholm 2002; Jungmann & Jungmann 1997b; Jungmann & Jungmann 1997a; 
Keyserling et al. 2000; Keyserling et al. 2002; Miller et al. 2002a; Miller et al. 2002b; 
Norris, Engelgau, & Venkat Narayan 2001a; Norris, Engelgau, & Venkat Narayan 
2001b; Renders et al. 2000; Trento et al. 1998; Trento et al. 2002; Trento et al. 2001). 
Interrater agreement 
Agreement between the two reviewers (TD and CM) was high with a Kappa statistic of 
0.85. Some data was unclear and discussion and differences of opinion were resolved 
via discussion without the need to involve a third independent assessment (JC). 
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Excluded studies 
The systematic review of the 190 full papers led to the exclusion of 177 papers 
involving 172 studies. Reasons for exclusion were: lack of control group; length of 
follow-up being too short; absence of the pre-specified outcomes; intervention group in 
receipt of individual appointments in addition to the group programme; delivery of 
group-based education programme to the control group; not all participants having Type 
2 diabetes; narrative papers, and group-based education programme that did not focus 
on diabetes self-management education. Several studies were excluded on more than 
one ground as can be seen in the excluded studies table (Appendix Ia and lb). 
Included studies 
A total of 14 papers, reporting 11 studies, met the inclusion criteria. However, one 
duplicate paper was a conference proceeding written in Spanish (Domenech et al. 1994). 
The abstract was translated and, as it contained the same data as the English language 
paper, it was deemed unnecessary to have the full paper translated. Thirteen papers were 
therefore analysed (Brown et al. 2002; Deakin et al. 2003a; Domenech et al. 1995; 
Heller et al. 1988; Holtrop et al. 2002; Kronsbein et al. 1988; Lozano et al. 1999; Pieber 
et al. 1995; Rickheim et al. 2002; Trento et al. 1998; Trento et al. 2002; Trento et al. 
2001; Zapotoczky et al. 2001) in order to evaluate the 11 studies. Three trials were 
carried out in the United States (Brown et al. 2002; Holtrop et al. 2002; Rickheim et al. 
2002), two in the United Kingdom (Deakin et al. 2003a; Heller et al. 1988), two in 
Austria (Pieber et al. 1995; Zapotoczky et al. 2001), one in Argentina (Domenech et al. 
1995), one in West Germany (Kronsbein et al. 1988), one in Spain (Lozano et al. 1999) 
and one in Italy. The Italian trial had three published papers which reported follow-up at 
12 months, two and four years (Trento et al. 1998; Trento et al. 2002; Trento et al. 
2001). Only one of the translated papers (Lozano et al. 1999) met the inclusion criteria 
sufficiently to contribute to the review. 
From this point forward, those 13 included papers, which provide data on 11 
studies, will be referenced with the primary author and date of publication only. 
Study design 
The studies included in the review were randomised controlled trials, with the exception 
of two studies that were clinical controlled trials (Domenech 1995; Pieber 1995). The 
length of follow-up was six months for three of the trials (Iloltrop 2002; Pieber 1995; 
Rickheim 2002), 12 to 14 months for six of the trials (Brown 2002; Deakin 2003; 
Domenech 1995; Heller 1988; Kronsbein 1988; Zapotoczky 2001), and two years for 
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one trial (Lozano 1999). As stated above, the Trento study reported follow-up at one 
year (Trento 1998), at two years (Trento 2001) and at four years (Trento 2002). 
Participants 
A total of 1532 participants were included in the 11 trials with 742 (48%) in the 
intervention group. The smallest study included 36 participants (Zapotoczky 2001) and 
the largest study, 314 participants (Deakin 2003). The proportion of men and women 
was roughly the same in each group with the exception of one trial (Holtrop 2002) that 
recruited only women. All trials recruited adults with Type 2 diabetes and the mean age 
of participants was between 51 and 65 years. Seven papers (Brown 2002; Deakin 2003; 
Heller 1988; Rickheim 2002; Trento 1998; Trento 2001; Trento 2002) evaluating five 
trials reported age range. The age ranges were similar with the lower age bracket being 
30-35 years and the highest age bracket being 71-85 years. One trial recruited Mexican 
Amercians (Brown 2002); another recruited 25% South Asians and 75% white 
Caucasians (Deakin 2003). Two other trials (Holtrop 2002; Rickheim 2002) reported 
that 95% of participants were Caucasian but did not report ethnicity of the other 5% of 
participants. Duration of diabetes was reported in nine trials; in seven of those, it was 
between six and nine years (Brown 2002; Deakin 2003; Domenech 1994; Kronsbein 
1988; Lozano 1999; Pieber 1995; Trento 1998); in one trial it was less than a year 
(Rickheim 2002) and in another trial (Heller 1988) participants were newly diagnosed. 
Inclusion criteria for entry into individual trials is outlined in the 'characteristics of 
included studies' table (Appendix 2). 
Interventions 
All trials evaluated a group-based diabetes education programme. Programmes varied in 
duration with the least intensive being three hours per year for two years (Lozano 1999) 
and three or four hours per year for four years (Trento 1998; Trento 2001; Trento 2002). 
Eight trials described programmes that ranged from six to fifteen hours of group-based 
education over a period of between four weeks and 10 months (Deakin 2003; 
Domenech 1995; Heller 1988; Holtrop 2002; Kronsbein 1988; Pieber 1995; Rickheim 
2002; Zapotoczky 2001) with the most intense education programme being 52 hours 
over one year (Brown 2002). Seven of the 11 group education programmes were held in 
primary care (Brown 2002; Deakin 2003; Domenech 1995; Holtrop 2002; Kronsbein 
1988; Lozano 1999; Pieber 1995) with the remaining four being delivered in hospital 
diabetes centres (Heller 1988; Rickheim 2002; Trento 1998; Trento 2001; Trento 2002; 
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Zapotoczky 2001). The educators were all health professionals, with the exception of 
one study where the educators were lay health advisors (Holtrop 2002). Three of the 
group education programmes were delivered by physicians (Domenech 1995; Pieber 
1995; Trento 1998; Trento 2001; Trento 2002) with Picbcr 1995 securing additional 
help from office staff and Trento 1998; Trento 2001; Trento 2002 incorporating two 
physicians and an educationalist. Three group education programmes were delivered by 
a dietitian and a nurse (Brown 2002; Heller 1988; Rickheim 2002) with Brown 2002 
also involving community workers. Two programmes were delivered by dietitians 
working alone (Deakin 2003; Zapotoczky 2001), one by a nurse working alone (Lozano 
1999) and one by paramedical staff (physician assistants) (Kronsbein 1988). Five 
studies reported that a family member or friend was also invited to attend the 
programme (Brown 2002; Deakin 2003; Domenech 1995; Heller 1988; Trento 1998; 
Trento 2001; Trento 2002), one study stated that the programme was for patients only 
(Pieber 1995) and in the remaining five studies, participation of family or friends was 
unclear. 
The theoretical model that was used to plan the group-based education programme was 
only reported in five studies. Three of those (Domenech 1995; Kronsbein 1988; Pieber 
1995) had adapted the Diabetes Treatment and Teaching Programme (DTTP) which 
was originally developed in Germany for adults with Type I diabetes (Muhlhauser, 
Jorgens, & Berger 1983) and was based on therapeutic patient education (WIIO 
Working Group 1998). One study (Deakin 2003) was based on patient-centred 
education and used an empowerment model developed in the US (Anderson & Funnell 
2000a). Another study based the education on four different models: an adult learning 
model, a public health model, a health belief model and a transtheorctical model 
(Rickheim 2002). Lozano 1999 stated that the group education programme was 
'participatory' and Trento 1998 described their programme as 'structured'. Eight studies 
(Deakin 2003; Domenech 1995; Heller 1988; Kronsbein 1988; Pieber 1995; Rickheim 
2002; Trento 1998; Trento 2001; Trento 2002; Zapotoczky 2001) provided information 
about the number of patients invited to attend the group education programme. The 
smallest groups comprised four to six participants (Heller 1988; Kronsbein 1988) and 
the largest groups comprised 16 to 18 patients (Deakin 2003) and (Zapotoczky 2001). 
In seven studies, the comparison group received routine treatment (Deakin 2003; 
Domenech 1995; Heller 1988; Holtrop 2002; Lozano 1999 Trento 1998; Trento 2001; 
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Trento 2002; Zapotoczky 2001). In one study, the control group was placed on a 
waiting list to receive the group education programme after the study (Brown 2002). 
Two studies stated that the control group received routine treatment as well as being 
placed on a waiting list for the education programme (Kronsbcin 1988; Pieber 1995), 
and in one study (Rickheim 2002) the comparison group received five hours of 
individual appointments. Routine treatment was defined as separate individual 
appointments with a dietitian, practice nurse and general practitioner (Deakin 2003), 15 
to 20 minutes with a multidisciplinary diabetes team every three months (Trento 1998; 
Trento 2001; Trento 2002) or an individual appointment with a dietitian every three 
months (Zapotoczky 2001). 
Outcome measures 
All trials included in the review assessed the primary outcome that was glycated 
haemoglobin (HbAlc). Those assessments were made at either four to six months 
(Brown 2002; Deakin 2003; Heller 1988; Holtrop 2002; Pieber 1995; Rickheim 2002), 
12-14 months (Brown 2002; Deakin 2003; Domenech 1994; Heller 1988; Kronsbcin 
1988; Lozano 1999; Trento 1998), two years (Lozano 1999; Trento 2001) or 4 years 
(Trento 2002). Eight studies stated that the HbAlc measurement was standardised 
(Brown 2002; Deakin 2003; Domenech 1995; Heller 1988; Kronsbein 1988; Pieber 
1995; Rickheim 2002; Trento 1998; Trento 2001; Trento 2002) and in three studies it 
was unclear whether HbAlc was standardised or not (Holtrop 2002; Lozano 1999; 
Zapotoczky 2001). Only one study identified HbAlc in the inclusion criteria, with 
participants requiring a HbAlc reading of more than 7% to participate in the study. 
Only two trials assessed fasting blood glucose at six months (Brown 2002; Heller 
1988); four trials assessed it at 12 months (Brown 2002; Heller 1988; Lozano 1999; 
Trento 1998), two trials at two years (Lozano 1999; Trento 2001) and one trial at four 
years (Trento 2002). For the other main outcomes, four trials assessed diabetes 
knowledge at four to six months (Brown 2002; Deakin 2003; Piebcr 1995; Rickheim 
2002), six at 12-14 months (Brown 2002; Deakin 2003; Heller 1988; Kronsbein 1988; 
Lozano 1999; Trento 1998), two at two years (Lozano 1999; Trento 2001) and one at 
four years (Trento 2002). Domenech 1995 assessed diabetes knowledge only in the 
intervention group. All knowledge questionnaires were validated except for two studies, 
where it was unclear whether the questionnaire had been validated or not (Brown 2002; 
Domenech 1995). The level of participant empowerment/psychosocial self-efficacy was 
assessed in only two studies (Deakin 2003; Rickheim 2002) and different measurement 
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tools were used. Quality of life was assessed in three studies (Deakin 2003; Rickheim 
2002; Trento 1998; Trento 2001; Trento 2002), again using different validated 
measures. 
With regard to additional outcomes, five studies assessed body mass index (BMI) at 
four to six months (Brown 2002; Deakin 2003; Holtrop 2002; Pieber 1995; Rickheim 
2002), four studies at 12-14 months (Brown 2002; Deakin 2003; Lozano 1999; Trento 
1998), two studies at two years (Lozano 1999; Trento 2001) and one study at four years 
(Trento 2002). Four studies assessed body weight at four to six months (Deakin 2003; 
Heller 1988; Pieber 1995; Rickheim 2002), five at 12-14 months (Deakin 2003; Heller 
1988; Kronsbein 1988; Trento 1998; Zapotoczky 2001) and the long-term follow-up 
studies of Trento assessed body weight at two years (Trento 2001) and four years 
(Trento 2002). Systolic and diastolic blood pressure was assessed in only two studies; at 
four to six months (Deakin 2003; Pieber 1995) and at 12-14 months (Deakin 2003; 
Zapotoczky 2001). Lipid profile was assessed between four to six months in three 
studies (Brown 2002; Deakin 2003; Pieber 1995) and between 12-14 months in three 
studies (Brown 2002; Deakin 2003; Zapotoczky 2001) with one study assessing 
triglyceride level only (Kronsbein 1988). 
Diabetes self-management skills were assessed in six studies as follows: 
1. self-care activities questionnaire (validated) and dietary intake using a validated food 
frequency questionnaire (Deakin 2003); 
2. a validated health behaviour conduct questionnaire (Trento 1998; Trento 2001; 
Trento 2002); 
3. self-reported activity levels (frequency and duration) (Rickheim 2002); 
4. self-monitoring of blood glucose levels (Lozano 1999); 
5. self-monitoring of urinanalysis (Kronsbein 1988); 
6. a `stages of change' questionnaire (Holtrop 2002) assessed confidence to make 
changes in diet and activity. Outcomes were, however presented, as a pre-test/post-test 
comparison within the intervention group and no data was shown for the control group. 
Satisfaction with treatment was assessed in only one study (Deakin 2003) and change in 
diabetes medication was assessed in five studies (Domenech 1995; Kronsbcin 1988; 
Pieber 1995; Rickheim 2002; Deakin 2003). A cost-effectiveness analysis was 
performed at a four year follow-up (Trento 2002) and the cost of delivering the 
programme was estimated in Brown 2002. 
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Three studies recorded the number of deaths (Deakin 2003; Kronsbein 1988; Trento 
1998; Trento 2001; Trento 2002) but did not identify whether the deaths were diabetes 
related. One study recorded diabetes complications (creatinine, albuminuria, diabetic 
retinopathy, foot ulcers) at two years (Trento 2001) and four years (Trento 2002). 
3.10 Methodological quality of included studies 
Based on the quality criteria outlined in the section entitled `Quality assessment of the 
trials' on page 81, two studies were classified as having a moderate risk of bias (Deakin 
2003; Zapotoczky 2001), and seven studies as having a high risk of bias (Brown 2002; 
Heller 1988; Holtrop 2002; Kronsbein 1988; Lozano 1999; Rickheim 2002; Trento 
1998; Trento 2001; Trento 2002). Both clinical controlled trials were identified as being 
at risk of having one or more of the quality criteria not met (Domenech 1995; Pieber 
1995). Interrater agreement of trial quality was 0.63 and agreement was reached 
following discussion between the two reviewers. 
Method of randomisation 
Only three of the randomised controlled trials described the method of randomisation. 
Two used random permuted blocks (Deakin 2003; Rickheim 2002) and one used 
random table numbers (Trento 1998; Trento 2001; Trento 2002). 
Allocation concealment 
Allocation concealment was only noted in one study (Deakin 2003). The remaining 
eight randomised controlled trials made no reference to allocation concealment (Brown 
2002; Heller 1988; Holtrop 2002; Kronsbein 1988; Lozano 1999; Rickheim 2002; 
Trento 1998; Trento 2001; Trento 2002; Zapotoczky 2001). 
Intention-to-treat analysis 
Three studies reported analysis to be by intention-to-treat (Deakin 2003; Heller 1988; 
Trento 2002). The Trento study however, only reported the intention-to-treat analysis at 
the four year assessment and not in the two earlier papers (Trento 1998; Trento 2001). 
An intention to treat analysis was not needed for one study since the drop-out rate was 
nil and all participants were re-assessed at follow-up (Zapotoczky 2001). Intention to 
treat analysis was not performed in six studies (Brown 2002; Domenech 1995; Holtrop 
2002; Kronsbein 1988; Lozano 1999; Pieber 1995) and it was unclear whether such 
analysis had been undertaken by Rickheim 2002. 
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Losses to follow-un 
Losses to follow-up were described in all studies except one (Brown 2002). Losses to 
follow-up ranged from 0% in one study (Zapotoczky 2001) to 25% in the intervention 
group and 45% in the control group in another study (Domenech 1995). 
Blindness of treatment 
It was not possible to blind participants as to their allocation to the respective groups. 
However, two studies attempted to blind the control group to the fact that they were the 
controls by presenting 'routine treatment' as an individual appointment intervention 
(Deakin 2003; Rickheim 2002). 
Outcome assessment 
Details of blinding of the outcome assessors were not described in any of the trials. 
Number of participants in the-stud y 
Only three studies presented a power calculation and based recruitment numbers on the 
calculation (Deakin 2003; Kronsbein 1988; Lozano 1999). A further two studies 
referred to a power calculation but the data was not provided (Holtrop 2002; Trento 
2002). The number of participants recruited in each study ranged from 36 (Zapotoczky 
2001) to 314 (Deakin 2003). 
Other comments on quality 
One study reported different outcomes at baseline than at follow-up. For example, BMI 
was assessed at baseline but weight was assessed at the one year follow-up (Domcnech 
1995). Another study compared knowledge score and fasting blood glucose levels 
between the intervention and control group at follow-up but did not present baseline 
data for those (Heller 1988). Holtrop 2002 presented some outcomes without standard 
deviations and reported P-values without presenting the actual data. Although baseline 
data was presented by Zapotoczky 2001, statistical tests were not performed to detect if 
the two groups were similar at baseline. 
3.11 Results 
3.11.1 Heterogeneity 
A test for heterogeneity, 12 value (Higgins et al. 2003) was performed for each outcome 
before a meta-analysis was carried out. Outcomes that had significant heterogeneity 
(>50%) were subject to a sensitivity analysis to detect, if possible, the source of 
heterogeneity. Outcomes that could not be analysed statistically were summarised in a 
descriptive manner. 
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3.11.2 Effect of the intervention (meta-analysis) 
Mort "fit 
At the 12-14 month outcome assessment, there had been a total of' 15 deaths reported 
from three studies with a combined total of 525 participants. There was low 
heterogeneity (12 = 36.3%). One study reported more deaths in the control group 
(Deakin 2003), whereas two studies reported more deaths in the intervention group 
(Kronsbein 1988, Trento 1998). Overall there were eight deaths in the intervention 
group and seven deaths in the control group. Participation in a group-based diabetes 
education programme, therefore, did not affect mortality rate (odds ratio 1.24,95% ('I 
0.28 to 5.56, Z=0.29, P=0.77) (figure 3.1). 
Figure 3.1 Mortality rate 
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Reduction in Diabetes Medication 
Five studies (Domenech 1995; Kronsbein 1988; Pieber 1995; Rickheim 2002, Deakin 
2003) with a combined total of 654 participants reported outcomes on diabetes 
medication and with no heterogeneity between the studies (12 = 0%). A medication 
decrease was classed as a reduction in the type or quantity of OHAs prescribed or the 
number of units of insulin injected. Group-based diabetes education programmes led to 
a significant reduction in diabetes medication at 12-14 months (odds ratio 1 1.79,95% 
Cl. 5.17 to 26.90, Z=5.87, P<0.00001) (figure 3.2). 
Figure 3.2 Reduction in diabetes medication at 12 to 14 months 
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Glycated Haemoglobin 
Four studies assessing glycated haemoglobin at four to six months and involving 700 
participants were included in a meta-analysis (Brown 2002; Deakin 2003, Heller 1988; 
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Pieber 1995) (figure 3.3). There was an overall significant reduction in glycated 
haemoglobin of 1.08% (95% Cl: 0.40% to 1.76%, Z=3.12, P=0.002) for participants 
who had been allocated to the group-based diabetes education programme. However, 
there was high heterogeneity between the studies (12 = 77.7%) and that was investigated 
via a sensitivity analysis to explore reasons for the heterogeneity. Deakin 2003 had 
reported a significant reduction in glycated haemoglobin of 0.4% at four months 
whereas the other three studies had reported significant reductions at six months 
(between 0.92% and 2.00%). When the Deakin 2003 study was removed from the 
equation and the meta-analysis repeated, heterogeneity reduced significantly (12 
36.7%) and the overall reduction in glycated haemoglobin was greater (1.35%; 95% Cl' 
0.78% to 1.93%, Z=4.60, P<0.00001). Holtrop 2002 and Rickheim 2002 also assessed 
glycated haemoglobin at six months and observed a difference in glycated haemoglobin 
between the two groups in favour of the group education programme, of 0.4% (P=0.7) 
and 0.8% (P=0.05) respectively. However, because there were differences in baseline 
readings, the original data in the paper had been analysed as the mean difference 
between pre- and post-intervention measures and therefore the data could not be entered 
into the meta-analysis. 
Figure 3.3 Glycated haemoglobin at 4 to 6 months 
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At the 12-14 months' follow-up, seven studies involving a total of 1044 participants 
were included in a meta-analysis (Brown 2002, Deakin 2003; Domenech 1995; Heller 
1988, Lozano 1999, Trento 1998; Zapotoczky 2001) (figure 3.4). There was an overall 
significant reduction in glycated haemoglobin of 0.82% (95% Cl: 0.65% to 0.99%, 
Z=9.63, P<0.00001) with low heterogeneity between the studies (12 =18%). Kronsbein 
1988 also assessed glycated haemoglobin at 12 months but those results could not be 
entered into the meta-analysis, as there was a difference between the groups for mean 
glycated haemoglobin at baseline (intervention group 7.1% and control group 6.5%). 
The mean glycated haemoglobin level was adequate, especially for 1988 when the study 
was published, and therefore much more emphasis was placed on withdrawal of 
diabetes medication. A funnel plot for glycated haemoglobin was performed at the 12- 
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14 months follow-up to detect any small sample or publication bias. The plot resembled 
a symmetrical inverted funnel and it was therefore concluded that bias was absent (see 
figure 3.5 below). 
Figure 3.4 Glycatcd haemoglobin at 12 to 14 months 
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Figure 3.5 Funnel plot for glycated haemoglobin 
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Two studies involving 333 patients assessed glycated haemoglobin at two years 
(Lozano 1999; Trento 2001) with no heterogeneity between the studies (12 = 0%). There 
was a significant reduction in HbA 1c for the patients allocated to the group-based 
diabetes education programme as compared to the control group (0.97%, 95% Cl: 
0.54% to 1.40%, Z=4.44, P<0.00001). At the four years follow-up, one study involving 
90 patients assessed glycated haemoglobin (Trento 2002) and found a significant 
reduction in the group education group compared to the control group (I. 6%, 95% Cl: 
0.91% to 2.29%, Z=4.53, P<0.00001). 
Fasting Blood Glucose 
One study (Brown 2002) with 229 participants reported lower fasting blood glucose 
levels at six months in the group education programme participants compared to the 
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control group (difference 1.66 mmol/l, 95% Cl: 0.74 mmol/I to 2.58 mmol/l, !. 3.53, 
P=0.0004. Four studies assessed fasting blood glucose at 12 months (Brown 2002; 
Heller 1988; Lozano 1999; Trento 1998) with no heterogeneity between studies 02- 
0%) (see figure 3.6 below). There was an overall significant improvement in patients 
allocated to the group education programme compared with those in the control group 
(difference 1. l 7mmol/l, 95% Cl- 0.72 mmol/l to 163 mmol/l, Z=5.06. P'0.00001) Two 
studies assessed fasting blood glucose at two years (Lozano 1999, "Trento 2001) and 
although the meta-analysis revealed significant improvement of 1.57 mmol/l in favour 
of the group education programme (95% Cl- 1.05 mmol/I to 2.10 mmol/I, Z=5.88, 
P<0.00001), there was moderate heterogeneity between the two studies (12 = 63.6%). 
Trento 2002 reported a significant difference between groups at the four years follow-up 
in favour of the group education programme (difference 1.70 mmol/I; 95% Cl: 0.16 
mmol/I to 3.24 mmol/l, Z=2.16, P=0.03). 
Figure 3.6 Fasting blood glucose at 12 months 
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Body Weight/Body Mass Index 
At four to six months there was no evidence that group-based diabetes education 
programmes had an impact on body weight or BMI. Four studies, having a combined 
total of 566 participants, assessed body weight (Deakin 2003, Heller 1988, Pieber 1995, 
Rickheim 2002) (see figure 3.7 overleaf). There was low heterogeneity (12 - 31.3%). 
Overall reduction in body weight was 2.13 Kg more than in the control group but that 
difference was not statistically significant (95% Cl: -0.45 Kg to 4.71 Kg, Z=1.62, 
P=0.11). Four studies involving 718 participants assessed BMI (Brown 2002; Deakin 
2003; Pieber 1995; Rickheim 2002) with no heterogeneity between studies (12 = 0%) 
(see figure 3.8 on page 96). There was a difference between groups of 0.16 Kg/m2 in 
favour of group education but, as in the case of body weight, that difference was not 
statistically significant (95%CI: -0.68 Kg/m2 to 1.00 Kg/m2, Z=0.37, PA. 7 I ). 
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Figure 3.7 Body weight at 6 months 
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Figure 3.8 BMI at 6 months 
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At 12-14 months there was a small amount of evidence in favour of the group education 
programme improving body weight but not BMI. Five studies, involving 591 patients, 
assessed body weight (Deakin 2003; Heller 1988, Kronsbein 1988, Trento 1998; 
Zapotoczky 2001) (see figure 3.9 below) with no heterogeneity between studies (12 _ 
0%) and a difference between groups of 1.61 Kg (95% Cl: 0.25 Kg to 2.97 Kg, Z=2.32, 
P=0.02). Only two studies (with a total of 418 participants) that assessed BMI at 12-14 
months were included in a meta-analysis (Brown 2002, Deakin 2003) (see figure 3.10 
on page 97). There was a benefit to the participants in the group programme of 0.24 
Kgm2 but that was not statistically significant (95% Cl-. -1.01 Kg/m2 to 1.49 Kg/m2, 
Z=0.38, P=0.70). Lozano 1999 also assessed BMI at 12 months, but because the 
baseline data for BMI was different, it could not be included in the meta-analysis. The 
mean difference between pre-and post-intervention measures was 0.4 Kg/m2 at one year 
in favour of the group education programme but that had diminished by the two year 
follow-up. Baseline differences were also present for BMI in Trento 1998, Trento 2001, 
Trento 2002. The mean difference between pre-and post-intervention measures was 0.6 
Kg/m2 at one year, 0.5 Kg/m2 at two years and 0.8 Kg/m2 at four years in favour of the 
group-based diabetes education programme. 
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Figure 3.10 BMI at 12 to 14 months 
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study (Deakin 2003) measured waist circumference at both four and 14 months. 
There was no significant difference between the two groups at four months (difference 
1.27cm; 95% Cl- -1.78cm to 4.06cm, P=0.44) but there was statistical borderline 
significance in favour of the group education programme at 14 months (difference 
2.79cm, 95% Cl: -0.25cm to 5.59cm, P=0.06). 
Diabetes Knowledge Score 
Four studies with a combined total of 708 participants measured diabetes knowledge at 
four to six months (Brown 2002; Deakin 2003, Pieber 1995, Rickheim 2002) (see figure 
3.11 below). Participants allocated to the group programme had greater diabetes 
knowledge scores (standardised mean difference [SMD] 0.70; 95% Cl: 022 to 1.18, 
Z=2.87, P=0.004). As the studies had used different validated questionnaires to measure 
knowledge, the statistical method used was the standardised mean difference. However, 
there was still high heterogeneity between studies (12 = 88.6%). A sensitivity analysis 
was performed by removing each study, one by one, from the meta-analysis but 
heterogeneity remained high (12 = 80-90%). 
Figure 3.11 Diabetes knowledge at 4 to 6 months 
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Six studies measured diabetes knowledge at 12-14 months (Brown 2002; Deakin 2003. 
Heller 1988, Kronsbein 1988, Lozano 1999, Trento 1998) (see figure 3.12 on page 98) 
The 1,015 patients allocated to the group education programme had increased diabetes 
knowledge (SMD 0.83; 95% CI: 0.52 to 1.14, Z=5.26, P<0.00001). However, as a result 
of significant heterogeneity (12 = 81.2%), a sensitivity analysis was performed. When 
the data from Brown 2002 and Deakin 2003 was removed, those being the least positive 
studies for this aspect of the analysis, heterogeneity reduced (12 = 57.8%) and a meta- 
analysis was performed involving 507 participants. Knowledge score remained 
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significantly greater in participants allocated to the group programme (SMD 1.05,0.74 
to 1.35, Z=6.73, P<0.00001). When Heller 1988 was also removed, on the ground that it 
had a slightly more positive score than the other studies, heterogeneity reduced to a very 
low level (12 = 18.7%) and the meta-analysis was repeated using the remaining three 
studies (Kronsbein 1988, Lozano 1999; Trento 1998, combined total of 432 
participants). Diabetes knowledge remained significantly greater for the participants in 
the group education programme (SMD 0.95: 95% Cl: 0.72 to 1.18, Z--8.18, P<0.00001). 
Figure 3.12 Diabetes knowledge at 12 to 14 months 
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Two studies measured diabetes knowledge at two years (Lozano 1999; Trento 2001) 
and both gave significant results. When those studies were summarised statistically in a 
meta-analysis the intervention participants were shown to have a significantly greater 
knowledge score than the controls (SMD 1.58,95% Cl: 0.16 to 3.00, Z=2.18, P=0.03). 
There was, however, significant heterogeneity (12 = 96.4%). At four years Trento 2002 
measured diabetes knowledge and found that increased diabetes knowledge remained in 
the patients allocated to the group programme (SMD 1.27,95% Cl: 0.82 to 1.73, 
Z=5.48, P<0.00001). 
Blood Pressure 
Two studies measured systolic and diastolic blood pressure at four to six months 
(Deakin 2003; Pieber 1995) and a meta-analysis was performed including 399 
participants. There was no heterogeneity between the studies for systolic blood pressure 
(I' = 0%) and low heterogeneity for diastolic blood pressure (12 = 28.3%). Systolic 
blood pressure significantly reduced in patients allocated to the group education 
programme (5.37mmHg: 95% Cl: 1.21 mmHg to 9.53mmHg, Z=2.53, P=0.01). There 
was a small difference, of borderline significance, for diastolic blood pressure (2.65 
mmHg; 95% Cl: -0.28 to 5.57 mmHg to 0.28 mmHg, Z=0.38, P=0.08). 
At 12-14 months, two studies measured blood pressure (Deakin 2003, Zapotoczky 
2001). There was no heterogeneity between the studies for systolic blood pressure (12 = 
0%) but significant heterogeneity for diastolic blood pressure (12 = 67.9%). Although 
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there was a small reduction in respect of systolic blood pressure, it was not statistically 
significant (2.61mmHg; 95% Cl: -1.52mmHg to 6.74 mmllg to 1.52, Z=1.24, P=0.22). 
There was no significant difference between groups for diastolic blood pressure (-0.13 
mmHg; 95% CI: -4.75 mmHg to 4.48 mmHg, Z=0.05, P=0.95). No studies reported 
blood pressure measurements beyond 14 months. 
Lipid Profile 
There were no significant differences between the two groups in respect of total 
cholesterol. At four to six months, three studies (Brown 2002; Deakin 2003; Pieber 
1995) showed moderate heterogeneity (12 = 55.7%) and included 629 participants in a 
meta-analysis. There was a 0.05 mmol/I difference in favour of the group education 
programme but that was neither clinically nor statistically significant (95% Cl: -0.22 
mmol/l to 0.30 mmol/l, Z=0.38, P=0.71). At 12-14 months, three studies (Brown 2002; 
Deakin 2003; Zapotoczky 2001) involving 552 patients displayed no heterogeneity 
(12=0%) with no effect between groups (0.09 mmol/1,95% CI: -0.09 mmol/1 to 0.26 
mmol/l, Z=0.95, P=0.34). 
With regard to triglyceride levels at four to six months, three studies (Brown 2002; 
Deakin 2003; Pieber 1995) with a total of 628 patients and low heterogeneity (12 = 
10.5%) were included in the meta-analysis with a borderline effect for the group 
education programme (0.24 mmol/l; 95% Cl: -0.04 mmol/l to 0.52 mmol/1, Z=1.68, 
P=0.09). Four studies measured triglycerides at 12-14 months (Brown 2002; Deakin 
2003; Kronsbein 1988; Zapotoczky 2001) with low heterogeneity between studies (12 = 
15.1%) and including 652 participants with no effect between groups (-0.14 mmol/1; 
95% CI: -0.41 mmol/l to 0.13 mmol/1, Z=1.01, Pß. 31). 
3.11.3 No meta-analysis 
Empowerment/self-efficacy 
Deakin 2003 assessed the level of empowerment and psychosocial self-efficacy 
experienced by the 314 participants using a validated questionnaire (Anderson 2000b). 
At four months there was a significant difference in total empowerment score between 
the two groups in favour of the group education programme (difference 0.3; 95% CI: 0 
to 0.6, P<0.001). That was the case for the three sub scales: psychosocial adjustment to 
diabetes (difference 0.3; 95% CI: 0 to 0.6, P=0.002); readiness to change (difference 
0.4; 95% CI: 0.2 to 0.5, P<0.001); and setting and achieving goals (difference 0.3; 95% 
CI: 0.2 to 0.5, P<0.001). At 14 months, empowerment scores were still significantly 
higher amongst patients allocated to the group education programme: the total 
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empowerment score was 3.5 for the group education programme participants as 
opposed to 3.2 for the control group (difference 0.3; 95% Cl: 0.04 to 0.6, P=0.006); 
psychosocial adjustment to diabetes (difference 0.3; 95% Cl: 0.02 to 0.7, P=0.005); 
readiness to change (difference 0.3; 95% CI: 0.1 to 0.5, P=0.001); and setting and 
achieving goals (difference 0.2; 95% Cl: 0.05 to 0.4, P=0.02). 
Rickheim 2002, a study involving 92 patients, measured psychosocial adjustment to 
diabetes with a validated questionnaire and evaluated at six months. Both the 
intervention and control group significantly improved their psychological adjustment to 
diabetes (P<0.01) but there was no statistical significance between the two groups 
(P=0.64). 
Quality of Life 
Two studies measured quality of life at 4-6 months (Deakin 2003; Rickheim 2002) 
using different validated questionnaires (Bradley 1999; Ware 1994 respectively). It was 
not possible to synthesize and summarise those statistically, as the scales were too 
dissimilar. Deakin 2003 found no overall improvement in general quality of life but in 
respect of the sub-scales there was highly significant improvement in participants 
allocated to the group education programme: freedom to eat (difference 1.7; 95% CI: 
0.8 to 2.5, P<0.001); enjoyment of food (difference 1.2; 95% CI: 0.2 to 2.1, P=0.046); 
and freedom to drink (difference 1.5; 95% CI: 0.4 to 2.5, P=0.005). Rickheim 2002 
found that participants in both the intervention and control groups significantly 
improved their score on the SF-36 mental scale (P<0.01 for the group allocated to group 
education and P=0.04 for the control group), but there was no significant difference 
between the groups (P=0.82). Neither group had a higher score for the SF-36 physical 
score at six months (Intervention group P=0.63, control group P=0.93) and there was no 
significant difference between the groups (P=0.69). 
At 12-14 months, two studies measured quality of life. Deakin 2003 used the same 
validated questionnaire as that used at six months; Bradley 1999 and Trento 1998 used a 
translated and revalidated diabetes quality of life questionnaire from the Diabetes 
Control and Complications Trial (DCCT 1988). It was not possible to synthesize and 
summarise those statistically because the scales were ranked in opposite directions. At 
14 months Deakin 2003 reported similar results to those at four months, namely no 
significant improvement in overall quality of life, but significant improvements for the 
sub-scales: freedom to eat (difference 1.1; 95% CI: 0.2 to 2.1, P=0.04); enjoyment of 
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food (difference 1.1; 95% CI 0.1 to 2.0, P=0.05); and freedom to drink (difference 1.5; 
95% CI: 0.5 to 2.6, P=0.01). Trento 1998 did not find a significant difference in quality 
of life at 12 months but reported a significant improvement in quality of life at two 
years (Trento 2001, P<0.001) and at four years (Trento 2002, P<0.009). 
Self-management 
Six studies measured some aspect of self-management (Deakin 2003; Holtrop 2002; 
Kronsbein 1988; Lozano 1999; Rickheim 2002; Trento 1998; Trento 2001; Trento 
2002). However, the variety of self-management tasks and measures resulted in a 
descriptive summary of the findings. 
Deakin 2003 measured self-care activities using a validated questionnaire (Toobert 
1994) and reported that at four months, participants allocated to the group education 
programme had significantly increased their self-management scores for exercise 
(P<0.001), foot care (P=0.008) and self monitoring of blood glucose levels (P=0.009). 
At 14 months, self-management scores had remained significant in respect of exercise 
(P=0.02) and foot care (P=0.003) but there was no significant difference between the 
groups for self-monitoring of blood glucose levels (P=0.17). Food intake was measured 
with a validated food frequency questionnaire (Little 1999) and, at four months reported 
that the participants allocated to group education had increased energy intake from 
carbohydrate (difference 4.1%; 95% CI: 0.4% to 7.9%, P=0.03), total sugars (difference 
5.1%; 95% CI: 2.4% to 7.9%, P<0.001) and fruit and vegetables (difference 1.0 portion; 
95% CI: 0.2 to 1.8 portions, P=0.01) when compared with the control group. At 14 
months the participants were likely to be consuming more fibre than the participants in 
the control group (difference 3.8g; 95% CI: 0.03g to 7.6g, P=0.05), more sugars 
(difference 6.6%; 95% CI: 3.4% to 9.9%, P<0.001) possibly from the extra 2 portions of 
fruit and vegetables per day (difference 2.2 portions; 95% CI: 1.1 portions to 3.2 
portions, P<0.001); and less saturated fat (difference 1.1%; 95% Cl: 0.0% to 2.3%, 
P=0.05). 
Rickheim 2002 measured self-reported physical activity and found no difference within 
groups (intervention group, P=0.38; control group, P=0.39) or between the two groups 
(P=0.83). Lozano 1999 measured the percentage of participants who carried out self- 
monitoring of blood glucose levels and found a significant difference between the two 
groups in favour of the group education programme at both one and two years 
(P<0.005). Kronsbein 1988 measured the percentage of participants who were carrying 
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out urinanalysis at 12 months and reported a significant difference between participants 
allocated to the group programme and those in the control group (72% versus 2%; 95% 
CI: 57% to 83%, P<0.0001). Holtrop 2002 reported that the group programme 
participants made positive movement in stages of change for five behaviours: physical 
activity (P=0.003); reduction of high fat foods (P=0.008); consumption of five portions 
of fruit and vegetables (P<0.0001); consumption of three meals daily (P=0.9); limitation 
of refined sugar intake to one product per day or less (P=0.001). However, the statistical 
analysis was preformed on pre-test means versus post-test means for the intervention 
group and no data was provided for the control group. Trento developed and validated a 
health behaviours questionnaire and reported that the score was significantly greater for 
the group education participants than for the controls at one year (Trento 1998, 
P<0.005), two years (Trento 2001, P<0.001) and four years (Trento 2002, P<0.001). 
Treatment Satisfaction 
One study (Deakin 2003), using a validated questionnaire, measured change in 
treatment satisfaction and found that participants in both the group education 
programme and the control group were more satisfied with their treatment than they 
were at baseline. However, the group education participants were significantly more 
satisfied with treatment at four months (difference in score 4.4: 95% CI: 2.6 to 6.1, 
P<0.001) and 14 months (difference in score 3.7; 95% CI: 1.5 to 6.0, P=0.002). 
Cost Effectiveness 
Brown 2002 reported that the cost of providing the intervention (52 contact hours over 
12 months) was US $384 per person assuming that costs of monitoring supplies were 
eligible for third-party reimbursement. However, a cost effectiveness analysis was not 
carried out. Trento 2002 calculated that, over the study period, group care required 196 
minutes and US $756.54 per patient, compared with 150 minutes and US $665.77 for 
the control patients. That finding indicated that an additional US $2.12 was spent per 
point gained in the quality of life score. 
Complications 
Only one study monitored the presence of diabetes complications and it reported no 
significant differences between the group education participants and controls in respect 
of diabetic retinopathy and foot ulcers at two years (Trento 2001). It found however, 
that at four years, diabetic retinopathy had progressed more slowly amongst participants 
that had attended the group education programme (P<0.009). 
103 
3.11.4 Adverse effects 
No adverse effects were reported for the group education participants or the controls. 
3.11.5 Subgroup analyses 
Ethnicity 
Six studies did not provide data about the ethnic background of the participants 
(Domenech 1995; Heller 1988; Kronsbein 1988; Lozano 1999; Pieber 1995; Trento 
1998; Trento 2001; Trento 2002; Zapotoczky 2001). Although two studies (Domenech 
1995; Rickheim 2002) stated the percentage of white Caucasian participants, no 
information was provided about the ethnic background of the other participants. Deakin 
2003 reported that 80 out of 314 (25.5%) participants were from a South Asian 
background, the remaining 234 participants being white Caucasian. A subgroup analysis 
was carried out for the primary outcome, glycated haemoglobin, at four months and 14 
months. Both analyses showed statistically significant differences between the 
intervention and control group in favour of the group-based education programme. All 
participants recruited in the Brown 2002 study were Mexican Americans. However, 
there was not enough data provided for any ethnic group to perform a subgroup analysis 
for ethnicity. 
Theoretical model 
Only five studies identified the theoretical model underpinning the group education 
programme and those were based around therapeutic patient education, patient 
activation and empowerment (Deakin 2003; Domenech 1995; Kronsbein 1988; Pieber 
1995; Rickheim 2002). A subgroup analysis was performed with two studies that had 
reported glycated haemoglobin at four to six months (Deakin 2003; Pieber 1995). A 
significant reduction in glycated haemoglobin was present in favour of the group 
education participants and this was in line with the results of the main meta-analysis on 
glycated haemoglobin (Heterogeneity, 12 = 45.8%) (0.57%; 95% Cl: 0.09% to 1.05%, 
Z=2.34, P=0.02). A subgroup analysis was performed with two studies that had reported 
glycated haemoglobin at 12-14 months (Deakin 2003; Domenech 1995) and had 
resulted in similar findings to those of the main meta-analysis, namely significantly 
improved diabetes control for participants allocated to the group education programme 
(0.88%; 95% CI: 0.59% to 1.17%; Z=5.99, P<0.00001). However, moderate 
heterogeneity was present (12 = 61.9%). It was not possible to include Kronsbein 1988 
or Rickheim 2002 in the subgroup analysis as they had not been included in the original 
meta-analysis owing to baseline differences in glycated haemoglobin. 
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Duration of education programme 
The least intensive group education programmes delivered by Lozano 1999 and Trento 
1998, both of which incorporated only three to four hours of education during the first 
year, had similar results in respect of glycatcd haemoglobin as those resulting from the 
most intensive programme that delivered 52 hours of education and support in the same 
time period. 
Gender 
All studies included an even mix of males and females except for lloltrop 2002 that 
recruited females only. That study was not included in the meta-analysis for glycated 
haemoglobin because of baseline differences and no subgroup analysis was therefore 
performed. 
Primary/secondary care 
Three of the four studies included in the glycated haemoglobin meta-analysis at four to 
six months were delivered in primary care (Brown 2002; Deakin 2003; Pieber 1995). 
One was delivered at a hospital diabetes unit (Heller 1988). The latter reported a slighter 
greater improvement in glycated haemoglobin. However, when a subgroup analysis was 
performed on the primary care studies, the significant reduction in glycated 
haemoglobin remained for group education participants (0.83%: 95% Cl: 0.25% to 
1.44%, Z=2.70, P=0.007). When the studies based at a hospital diabetes unit (secondary 
care) were removed from the 12 - 14 month meta-analysis on glycated haemoglobin 
(Heller 1988; Trento 1998; Zapotoczky 2001) and a subgroup analysis was carried out 
on the four studies delivered in primary care (Brown 2002; Deakin 2003; Domenech 
1995; Lozano 1999), there was very low heterogeneity between studies (12 = 8.8%) and 
the significant reduction in glycated haemoglobin remained (0.89%: 95% Cl: 0.74% to 
1.04%, Z= 11.58, P<0.00001). 
Number of participants in the group education programme 
Two of the studies (Deakin 2003; Zapotoczky 2001) had larger groups comprising 
between 16 and 18 patients (and some carers) in each diabetes education programme. A 
subgroup analysis was performed to detect whether large groups reduced the 
effectiveness of the intervention and that was shown not to be the case. There was no 
heterogeneity between the two studies (12 = 0%) and glycated haemoglobin at 12-14 
months remained significantly reduced in respect of the group education participants 
(0.70%; 95% CI: 0.40% to 1.00%, Z=4.54, P<0.00001). 
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Educator 
Three of the group-based education programmes were delivered by physicians trained in 
adult education principles (Domenech 1995; Pieber 1995; Trento 1998; Trento 2001; 
Trento 2002). Two studies evaluated glycated haemoglobin at 12 months (Domenech 
1995; Trento 1998). A sub-group analysis excluding those studies resulted in there 
being no heterogeneity between the remaining studies delivered by a nurse (Lozano 
1999), a dietitian (Deakin 2003; Zapotoczky 2001) or a combination of the two (Brown 
2002; Heller 1988 ). The effect size for nurses and/or dietitians delivering the group 
education programme was shown to be similar to that of the full meta-analysis; 0.75% 
reduction (P<0.00001) compared to 0.82% reduction (P<0.00001). The two studies that 
had not been included in the 12-14 month meta-analysis for glycated haemoglobin 
because of baseline differences in HbAlc were the study that had used trained lay health 
advisors to deliver the group education programme (Holtrop 2002) and the study in 
which physician assistants had delivered the programme (Kronsbein 1988). 
3.11.6 Sensitivity analysis 
Sensitivity analyses have been performed as required to detect and explain the source of 
heterogeneity between studies. All studies were published papers with the exception of 
one (Deakin 2003) which was, at the time of the review, published as three conference 
abstracts and submitted as a full paper for publication. When the Deakin 2003 study was 
excluded from the meta-analysis at four to six months and the meta-analysis repeated, 
the effect size for glycated haemoglobin was slightly better in favour of the group 
education programme with a 1.35% reduction (P<0.00001) compared with the 1.08% 
reduction (P=0.002) calculated in the main meta-analysis. However, at 12-14 months 
the effect size remained the same, 0.84% reduction (P<0.00001) compared with the 
0.82% reduction (P<0.00001) calculated in the main meta-analysis. None of the studies 
were graded 'A' for quality and only two studies were graded 'II' (Deakin 2003; 
Zapotoczky 2001) (see quality assessment of trials in the section entitled "Methods of 
the review" starting on page 80). When the meta-analysis was repeated including only 
those studies assessed as being of better quality (Deakin 2003; Zapotoczky 2001), the 
effect size (reduction in glycated haemoglobin for the group education participants) at 
12-14 months remained highly significant, 0.70% reduction (P < 0.00001) compared 
with the 0.82% reduction (P<0.00001) seen in the main meta-analysis. None of the 
studies included were large multi-centre trials and therefore a sensitivity analysis was 
not carried out in respect of trial size. One of the studies was written in Spanish and was 
translated before being included in the review (Lozano 1999). Removal of that study 
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from the 12-14 month meta-analysis for glycated haemoglobin did not change the effect 
size or statistical significance, 0.79% reduction (P<0.00001) compared to the 0.82% 
reduction (P<0.00001) calculated in the main meta-analysis. Removal of all studies 
having less than 100 participants from the 12-14 month meta-analysis on glycatcd 
haemoglobin left three studies to be re-analysed (Brown 2002; Deakin 2003; Lozano 
1999). The effect size for reduction in glycated haemoglobin in the group education 
participants remained constant, 0.75% reduction (P<0.00001) compared to the 0.82% 
reduction (P<0.00001) calculated in the main meta-analysis. 
3.12 Discussion 
3.12.1 Summary 
The review systematically evaluated 13 papers, that provided data for 11 studies, 
looking at group-based, patient-centred educational programmes for people with Type 2 
diabetes and found that these programmes resulted in clinically and statistically 
significantly improved health outcomes. The studies showed that patients attending 
group education programmes had reduced glycated haemoglobin of 1.08% (95% Cl' 
0.40% to 1.76%, P=0.002) at four to six months and when the source of heterogeneity 
was removed, (Deakin 2003) the reduction in glycated haemoglobin was 1.35% (95% 
CI: 0.78% to 1.93%, P<0.00001). Deakin 2003 reported a smaller effect size at four 
months (two months post-intervention) than the other studies at six months and that may 
be due to the fact that glycated haemoglobin is a measure of diabetes control over a 
period of approximately three months, and therefore, the four month assessment may 
have been too close to baseline for improvements in diabetes control to be apparent. 
Reduced glycated haemoglobin was 0.82% (95% Cl: 0.65% to 0.99%, P<0.00001) at 
12-14 months. Two of the studies followed up at two years and the results indicated that 
the improved metabolic control was still apparent (0.97%; 95% Cl: 0.54% to 1.40%, 
P<0.00001) One study showed continued benefit at four years (1.60%; 95% Cl: 0.91% 
to 2.29%, P<0.00001). The two studies that were not included in the meta-analysis at 
four to six months due to baseline differences had smaller effect sizes (0.4%, 0.8%) than 
the meta-analysis result (1.08%) but still favoured the group-based diabetes education 
programme. The study not included in the meta-analysis at 12-14 months (Kronsbcin 
1988) only had a very small effect size of 0.2% in favour of the group programme. 
However, that study had been published in 1988 before the benefits of optimal 
glycaemic control had been established. The mean baseline glycated haemoglobin level 
in that study was good (7.1%) and participants were encouraged to reduce diabetes 
medication rather than to improve their diabetes control. There was also a significant 
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reduction in fasting blood glucose levels amongst group programme participants at four 
to six months (1.66 mmol/1; 95% CI: 0.74 mmol/l to 2.58 mmol/l, P=0.00004), 12-14 
months (1.17 mmol/l; 95% CI: 0.72 mmol/1 to 1.63 mmol/I, P<0.00001), two years 
(1.57 mmol/1; 95% CI: 1.05 mmol/l to 2.10 mmol/l, P<0.00001) and four years (1.70 
mmol/1; 95% CI: 0.16 mmol/1 to 3.24 mmol/l, P=0.03). Five studies showed that by 
attending a group education programme, patients were able to significantly reduce their 
diabetes medication (odds ratio 11.79; 95% CI: 5.17 to 26.90, P<0.00001). 
There was no indication that group-based diabetes education programmes impacted on 
body weight or body mass index at four to six months. However at 12-14 months, there 
was some evidence that the group education programme reduced body weight (1.61 Kg; 
95% CI: 0.25Kg to 2.97 Kg, P=0.02) but that was either insufficient weight loss to 
affect body mass index, or alternativley no effect may have been seen in 13MI because 
only two studies were included in the meta-analysis whereas five studies were included 
for the body weight meta-analysis. One study (Deakin 2003) presented data to suggest 
that the programme could reduce waist circumference (2.8cm; 95% Cl: -0.3cm to 
5.6cm, P=0.06). Diabetes knowledge was significantly improved in the group education 
participants at four to six months (P<0.00001), 12-14 months (P<0.00001), two years 
(P=0.03) and four years (P<0.00001) although significant heterogeneity existed between 
the studies at four to six months and two years. At four to six months patients allocated 
to the group education programme experienced a significant reduction in systolic blood 
pressure (5.37mmHg; 95% CI: 1.21mmHg to 9.53mmHg, P=0.01) and a borderline 
significant reduction in diastolic blood pressure (2.65mmHg; 95% CI: -0.28mmHg to 
5.57mmHg, P=0.08). However, there were no clinical or statistically significant 
reductions in systolic or diastolic blood pressure at 12-14 months. 
There was no evidence at any of the time periods that group-based diabetes education 
programmes positively impact on total cholesterol levels. There was a borderline 
clinically and statistically significant result for reduction in triglyceride level at four-six 
months (0.24mmoV1; 95%CI: -0.04mmol/1 to 0.52mmol/l, P=0.09) but not at 12-14 
months. 
There was strong evidence from one study (Deakin 2003) that measured patient self- 
empowerment, that attending a patient-centred, group-based diabetes education 
programme significantly improved empowerment and psychosocial self-efficacy at both 
four months (P<0.001) and 14 months (P<0.00I). Only two studies measured quality of 
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life and there was no evidence that the group education participants experienced overall 
improved quality of life at four to six months or 12-14 months, although they did 
experience a significantly better quality of life for the food and drink variables (Deakin 
2003). One study reported significantly improved quality of life at both two years 
(Trento 2001, P<0.001) and four years (Trento 2002, P<0.009). There was evidence that 
the group education programme improved self-management skills as a result of self- 
monitoring of blood glucose levels (Deakin 2003; Lozano 1999) and urinanalysis 
(Kronsbein 1988), consumption of a healthier diet (Deakin 2003; Iloltrop 2002), foot 
care (Deakin 2003) and improved health behaviours (Trento 1998; Trento 2001; Trento 
2002). There was conflicting evidence in respect of physical activity. Deakin 2003 
reported a positive effect at both four months (P<0.001) and 14 months (P=0.02); 
Rickheim 2002 reported no effect (P=0.83). Treatment satisfaction was only measured 
in one study (Deakin 2003) but that study indicated improved satisfaction amongst 
group participants (P<0.001). Although Brown 2002 estimated the cost per patient of 
attending the programme, there was only one study that reported a cost effectiveness 
analysis. In that study US $2.12 was spent per patient for every point gained on the 
quality of life score (Trento 2002). There was no evidence that group-based diabetes 
education programmes reduced the incidence of acute complications 
(hypoglycaemia/hyperglycaemia) but there was a small amount of evidence for a 
reduction in chronic complications: Trento 2002 reported a reduced progression to 
diabetic retinopathy at four years. 
The studies were carried out in various developed countries within Europe and in the 
United States, but there were no studies from developing countries. Although ethnicity 
was reported in some of the studies, there was not enough information to perform a 
subgroup analysis for ethnicity. However, there is evidence that delivery of the 
programme to ethnic minority groups in a language that they are familiar with still 
delivers the benefits for glycated haemoglobin (Brown 2002; Deakin 2003). Although 
the theoretical model underpinning the programme was not always visible, there is 
evidence that if the programme is based on therapeutic patient education with 
participatory/empowering and adult-centred principles, it is likely to be effective. 
However, only one study measured patient empowerment and further research would be 
necessary to confirm those findings. Only three studies measured blood pressure and 
that may reflect on the year that studies was undertaken, as the benefits of optimal blood 
pressure for people with Type 2 diabetes have only been evident since the publication of 
the United Kingdom Diabetes Prospective Study (UKPDS-33 1998). The two studies 
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that followed up beyond 12-14 months were the only studies that repeated the 
intervention on an annual basis and that may be why they continued to obtain 
significant clinical and statistical results. Subgroup analysis provided evidence that 
group-based diabetes education programmes were equally effective when delivered in 
primary and secondary care by any health professional who was trained to deliver the 
programme. There was less evidence for the delivery of the programme by trained lay 
health workers or physician assistants. There was no evidence to suggest that group 
education programmes were less effective when delivered to larger groups of 16 to 18 
participants. It was not possible to detect whether programmes were more successful if a 
family member or friend was also invited to participate, as four studies did not indicate 
whether patients were accompanied or not. Ten studies compared the group programme 
with a waiting list control and/or routine treatment. One study (Rickheim 2002) 
delivered the group education programme to the control group except that delivery was 
via individual appointments rather than a group environment. It resulted in the control 
group having five hours of one-to-one education. However, a significant improvement 
in glycaemic control of those allocated to the group education programme was apparent 
when compared to those receiving the intensive individual education (P=0.05). 
Therefore an intensive individual approach, which is probably unrealistic given the 
prevalence of diabetes and the projected epidemic (Sicree 2003), was shown to be less 
effective than a group education programme. 
4.12.2 Limitations of the review 
The quality of studies included in the review were assessed as either moderate or poor 
quality based on the criteria by Jadad 1996 and Schulz 1995. The randomisation 
procedure was generally adequate, as were the descriptions of drop-outs. There was a 
lower percentage of drop-out compared to the findings from other reviews of diabetes 
education (Griffin 1998; Norris 2001). The three factors that impacted on quality were 
(1) only one study stated that there was allocation concealment, (2) only two studies 
analysed the data by intention to treat and (3) it was unclear whether outcome assessors 
were blind to the intervention. However, unlike a drug/placebo trial, it is very difficult 
to provide allocation concealment and blind the outcome assessors for a group-based 
educational intervention and several of the studies were delivered before analysis by 
intention-to-treat was recommended. 
The review included only 13 papers, which reported 11 studies and involved 1532 
patients. Because of variety in programme content, outcomes and length of follow-up, 
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when it was possible to perform a meta-analysis the number of studies included in each 
analysis was small. It was not possible to carry out a meta-analysis for several of the 
main outcomes of the review (such as self-management skills, empowerment/self- 
efficacy and quality of life) due to significant heterogeneity between studies. 
Educational interventions are complex interventions and it is difficult to identify the 
active ingredient(s) with any precision. Therefore, although the review has shown that 
group-based diabetes education programmes result in clinical, and statistically 
significant health outcomes, the exact mechanism of action can be contemplated but not 
identified. 
3.12.3 General isability and applicability of results 
As with all clinical trials, it is possible that patients who participated in the studies may 
not be truly representative of the local adult population with Type 2 diabetes, as people 
who volunteer to take part in clinical trials tend to be a more committed and motivated 
subgroup and generally receive more attention when participating in a clinical trial. 
Although having motivated participants will not affect differences between the two 
groups, as both the intervention and control groups are part of the motivated subgroup, 
it may affect the generalisability of the results if group education programmmes are 
provided as routine treatment. Delivering group-based diabetes education programmes 
to the general adult population with Type 2 diabetes may result in a bigger drop-out rate 
and smaller effect sizes. The 11 studies were carried out in different developed countries 
throughout Europe and the United States. Although not clearly stated, it is presumed 
that the majority of participants were mainly white Caucasians with others being of 
South Asian and Mexican American descent. There will, therefore, have been lingual 
and cultural diversity as well as differences in the respective healthcare systems. The 
results of this review are therefore generalisable to adults with Type 2 diabetes in many 
different developed countries and there is no evidence to suggest that group-based self- 
management strategies would not be suitable for developing countries as long as the 
group-based diabetes education programme was delivered in a familiar language and 
was sensitive to the culture of the population. The funnel plot represented the studies 
that assessed glycated haemoglobin at 12-14 months and reported almost perfect 
symmetry. That indicates that small study or publication bias was not present, 
suggesting that the results are generalisable. 
Routine diabetes education is still dominated by the traditional model in which doctors, 
nurses, dietitians and other members of the health care team interact with patients on a 
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one-to-one basis. That style of treatment leads to active prescription of diet, medication 
and advice about healthy practices but may not stimulate effective patient motivation 
and behaviour change (Trento 2002). However, the scarcity of time and resources have 
led to more diabetes teams in primary and secondary care contemplating and 
commencing group-based diabetes education programmes. Many national (DOII 2001b; 
DOH 2003; NICE 2003; Mensing 2003) and international (DECS 2003) standards now 
recommend group education programmes. However, this is the first systematic review 
to evaluate their effectiveness. If the results from this review can be translated to routine 
care, the 1% reduction in glycated haemoglobin may reduce the risk of developing 
secondary complications of diabetes by 21% (UKPDS-35 2000). 
3.13 Reviewers' conclusions 
3.13.1 Implications for practice 
The 11 studies included in this systematic review provide evidence that group-based 
diabetes education programmes for adults with Type 2 diabetes result in clinically 
important improvements in health outcomes for glycated haemoglobin, fasting blood 
glucose levels and diabetes knowledge at four to six months and 12 months follow-ups. 
If the group education programme is repeated on an annual basis, benefits in glycated 
haemoglobin, fasting blood glucose and diabetes knowledge may be longer-term (two to 
four years). Adults with Type 2 diabetes attending a group education programme may 
also benefit from reduced blood pressure and triglyceride level at four to six months but 
those effects are likely to be much more short-term than, for example, small reductions 
in body weight, which were apparent at 12-14 months. There is some evidence that 
group education programmes can, both at four to six months and 12-14 months, reduce 
the requirement for diabetes medication, improve diabetes and healthy living self- 
management skills, increase patient self-empowerment and improve food related aspects 
of quality of life. At longer-term follow-up (two to four years), group education 
programmes may still result in improved quality of life and reduce the progression to 
diabetic retinopathy. 
There is no evidence to suggest that programmes delivered in either primary or 
secondary care are more effective. There is also no evidence to suggest that the 
programme is more effective if delivered by a physician, dietitian or nurse as long as the 
health professional is trained to deliver a diabetes education programme. However, 
there is less evidence to support delivery of group education programmes by trained lay 
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health workers or physician assistants. Programmes based on therapeutic patient 
education using the principles of empowerment, participation and adult learning have 
proved to be effective. Delivery of the group-based diabetes education programme to 
groups of 4-6 participants or 16-18 participants does not appear to alter the effectiveness 
of the education, nor does the duration of the programme impact on effectiveness. It has 
however been observed that repeating the programme on an annual basis results in long- 
lasting benefits to health and psychosocial outcomes. 
3.13.2 Implications for research 
As the review is based on only 11 studies and many outcomes resulted from the 
synthesis of just two or three studies, further studies are required to confirm: 
1) the theoretical model underpinning the programme. Are group education programmes 
more effective if based on therapeutic patient education incorporating empowerment, 
participation and adult learning principles? 
2) the effect of group education programmes on blood pressure readings. Findings 
concluding the benefits of optimum blood pressure are relatively new due to the more 
recent findings regarding the benefits of optimum blood pressure; 
3) the degree of treatment satisfaction. As the patients' voice has become much more 
important in the delivery of healthcare interventions, more information is required as to 
whether patients find group education programmes acceptable; 
4) the effect of group education programmes on quality of life; 
5) the effectiveness of the programme for ethnic minority groups. Further research is 
required before it can be confirmed that diabetes group education is appropriate for all 
people from all ethnic backgrounds; 
6) the reduced risk of developing the secondary complications of diabetes; 
7) the cost effectiveness of delivering group-based self-management strategies for 
people with Type 2 diabetes; 
8) the effectiveness of peer educators in delivering group based diabetes education 
programmes. 
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Chapter 4: The Expert Patient (X-PERT) 
Programme 
4.1 Introduction 
A diabetes self-management education programme for adults with Type 2 diabetes has 
been designed and developed by the author of this thesis. The expert patient programme 
"X-PERT" is a six-session, group-based, health professional-lcd programme. This has 
been written to encourage the delivery of the X-PERT programme to adults living with 
Type 2 diabetes. It is designed to illustrate the theories of empowerment and patient 
activation. This chapter commences with details regarding the development of the 
diabetes expert patient programme (X-PERT), tutors manual and visual aids. The 
content of the tutor's manual is then presented. 
4.2 Development of the X-PERT Programme 
Experience gained since qualifying as a state registered dietitian in July 1993, working 
as a diabetes specialist dietitian from 1996 and completion of a Post Graduate 
Certificate in Education (PGCE) in adult education in 1998, led to a conviction that 
dietetic input and general education of people with diabetes was not as effective as it 
could be. Standard care, as stated above, is generally provided on an individual one-to- 
one basis and, within Burnley, Pendle and Rossendale, adults with newly diagnosed 
diabetes receive dietetic appointments lasting thirty minutes. Regular follow-ups were 
infrequent and only 24% of people with diabetes were currently receiving an annual 
review (Deakin 2000a). Even then the duration of an appointment averaged only 15 
minutes. 
With this in mind, it seemed appropriate to move away from the traditional dietetic 
review to experiment with more patient-centred approaches. Initially `one-off' group 
education sessions lasting for two hours were organised to provide up-to-date 
information to a group of between 15 and 20 people. Family members or friends were 
also invited. Supermarket tours for groups of people with diabetes were also well 
received. The local branch of Diabetes UK was involved with both developments. 
Evaluations were extremely positive. In 1999,28 group-based diabetes education 
sessions were delivered to 404 people with diabetes and their carers. The majority of 
participants found the sessions had benefited them (36% a great deal; 59% quite a lot). 
The most useful aspects of the sessions were thought to be obtaining information on: 
diet; medication; what is diabetes?; future developments; meeting people with similar 
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problems. Requests for more information about food and diabetes, causes of diabetes, 
coping with diabetes and physical activity were received and suggestions made that 
there should be a series of sessions (Deakin 2000b). Public meetings held by local 
Primary Care Groups confirmed the popularity of the group education sessions and 
those evaluations were fed back verbally to the Nutrition and Dietetic Department. 
The concept of a diabetes expert patient programme was then developed. Initially it was 
thought that a multi-disciplinary team would deliver the structured diabetes self- 
management programme. However, as a result of funding difficulties, the current 
shortfall in staff resources and the fact that the secondary care diabetes team was 
dubious about the empowerment approach to diabetes education, the proposal was 
amended to involve a single diabetes educator. That had advantages as well as 
disadvantages and will be discussed further in Chapter 7 (section 7.3.2). The original 
proposal described a 10 week diabetes expert patient programme that included sessions 
with a psychologist, a diabetes specialist nurse, a podiatrist and physical exercise 
instructor. After having to relinquish inputs from the first three professionals, it was 
decided to reduce the length of the programme to six weeks but to still invite an 
exercise facilitator from the local `exercise on prescription' scheme to attend one 
session to inform participants about the referral system and the contents of the exercise 
scheme. 
The education programme is based on two theoretical models. The first is an 
empowerment model developed in America. That is a five step model that encourages 
participants to (1) identify their own problems concerning lifestyle and self- 
management of diabetes, (2) explore the problem, (3) identify possible solutions, (4) 
commit to action by choosing one possible solution and (5) evaluate whether the 
solution worked for them and if it didn't why it didn't and what could be learnt from the 
experience (Anderson & Funnell 2000b). The second model on which the education 
programme is based is patient activation and uses the proverb 'I hear, I forget; I see, I 
remember; I do, I understand' to encourage interactive patient centred exercises. 
"There is an intimate and necessary relation between the processes of actual 
experience and education. There are many ways to learn and for many of us ire learin 
better by doing" (Dewey 1938). The models of empowerment and discovery learning 
are discussed in Chapter 2. 
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The contents of the information sharing aspects are based on national and international 
evidence-based guidelines and will be updated as and when new guidelines and 
literature are published. Several visual aids have been created to aid learning through 
vision and to help develop an understanding of complex and scientific information in a 
simplistic but accurate manner to aid self-management of diabetes. Their development 
was derived from theories of discovery learning and constructivism (Chapter 2, section 
2.5.6. ). 
Although the approach has been developed as a scripted manual, it will be necessary for 
the tutor to have expertise in the treatment and management of diabetes and a good 
grounding in skills required to deliver adult education. Many participants have queries 
and questions, which may not have been covered in the manual and these will need to 
be addressed to satisfy the individuals need and provide a patient-centred service. It is 
anticipated that if the X-PERT programme is implemented as routine treatment, health 
professional competence-based training modules will also be required. 
The X-PERT Programme is a specially designed patient education programme to 
provide patients with the confidence, knowledge and skills necessary to self-manage 
their diabetes. It is not a set of strict instructions that dictate behaviour change and then 
measure success based on levels of compliance, but a new tried and tested approach to 
patient education based on the theories of empowerment and patient activation. 
Participants with Type 2 diabetes and a supportive family member or friend are invited 
to attend six, two-hour sessions of empowering education, experimentation, 
demonstration and discussion. Each participant gets a blank copy of the newly devised 
"Diabetes Health Profile" which they themselves will complete to monitor their own 
progress by self-testing and obtaining the relevant information from their diabetes care 
team. 
Health professional tutors require a copy of the scriped X-PERT manual and a CD 
ROM containing patient handouts and access to the relevant visual aids. It is 
recommended that 15-18 people with Type 2 diabetes be registered onto each course, 
which, including family members and friends who choose to attend, will result in a 
group size of between 20 and 24 people. Patients also receive a manual that includes 
background reading, exercises and information on the content covered in each session. 
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4.3 The Expert Patient (X-PERT) Programme manual 
Healthy living with diabetes: taking control 
Scripted manual for tutors 
As a tutor of the X-PERT Programme, you will deliver the six-week programme. You 
may wish to involve a health or dietetic assistant to help organise group activities, 
facilitate discussions and serve refreshments. 
Preparatory reading 
o NICE guidelines for the management, treatment and education of people with 
diabetes (NICE 2000; NICE 2001; NICE 2002a; NICE 2002d; NICE 2002b; 
NICE 2002c; NICE 2003a; NICE 2003b) (Health professional and patient 
versions available www. nice. org. uk); 
o Local diabetes management protocols and guidelines; 
o Balance for Beginners (Diabetes UK 2003a); 
o Diabetes UK. `Recommendations for the management of diabetes in primary 
care'. 2000; http: //www. diabetes. org. uk/infocentrelcarerec/primary. htm; 
o UK, European and American nutritional recommendations (Diabetes UK 
2003d); (ADA 2003; Ha & Lean 1998) 
o Gylcaemic index (Colagiuri, Foster-Powell K, & Miller JB 2000); (Diabetes UK 
2001a; Foster-Powell, Holt, & Brand-Miller 2002; Frost & Dornhorst 2000; 
Leeds et al. 1998; Willett, Manson, & Liu 2002) 
Q Type 2 Diabetes in Practice (or similar book) (Krentz & Bailey 2001); 
o The Art of Empowerment: Stories and Strategies for Diabetes Educators 
(Anderson & Funnell 2000a). 
Aim 
To develop self-empowerment in people with Type 2 diabetes to enable them to develop 
the knowledge, skills and confidence to make informed decisions regarding lifestyle and 
diabetes self-management. 
Objectives 
By the end of the six-week programme, group members will be able to: 
Q state what a diabetes health profile is and supply a meaning, purpose and normal 
range for each health result. Part of that process is to encourage group members 
to have more confidence to discuss test results with the diabetes care team; 
Q describe what `blood glucose' is, where it comes from and how blood glucose 
levels are controlled with lifestyle, tablets and insulin; 
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Q recognise that the only long-term solution to weight loss/weight maintenance is 
permanent and sensible lifestyle changes and not quick-fix diets; 
Q acknowledge that different carbohydrate foods digest and release glucose into 
the blood at different rates. They should also be able to differentiate between at 
least one high, medium and low glycaemic index food; 
Q state the main differences between that which is generally perceived as the 
correct diet for people with diabetes and a life-long sensible eating plan; 
Q appreciate not only why increased physical activity is good for health but also 
how it can especially help to improve healthy living with diabetes; 
Q identify why blood pressure control is as important as blood glucose control in 
preventing the long-term complications of diabetes; 
Q recognise what the short-term complications of diabetes are and how these may 
be avoided and treated if necessary; 
Q recognise what the longer-term complications of diabetes are and how 
individuals can reduce their risk of developing them; 
Q increase self-management of diabetes by setting individual goals and action 
plans to address individual problems. 
Materials 
QA blank name badge for everyone (reusable). 
o Visual aids (listed below). 
Q Pencils. 
Q Flipchart stand with paper and pens. 
o Patient manual with practical exercises and evidence-based information sheets. 
o Glucose tablets and/or LucozadeTN to treat hypoglycaemia if necessary. 
Q Blood glucose meters: participants may find that testing their blood glucose 
improves their self-management skills and overall diabetes control. If possible 
obtain sponsorship from a pharmaceutical company to provide blood glucose 
meters. Organise a 30-minute session after the first, second or third week and 
invite the representative to demonstrate the correct testing technique and provide 
meters to participants who require them. 
Visual aids 
Q `What is diabetes' interactive poster. 
Q Carbohydrate (starch, sugar and glucose) models. 
Q Glycated haemoglobin (HbAlc) model. 
Q Blood pressure balloon model. 
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Q Seesaw energy balance model. 
o Body Story `Fat Attack' video. 
o Balance of good health model. 
o Glycaemic index display. 
o Glycaemic index quiz. 
Q British Heart Foundation: Guide to Food Labelling leaflet. 
Q Longer-term complications display board. 
o Longer-term complications poster. 
Q Atherosclerosis model (drinking straw, lard and black treacle). 
Q Atherosclerosis plaque. 
o Physiology of the eye model. 
Q The function of the kidney model. 
LEARNING METHODS 
o Discussion 
o Group exercises with active participation 
o Free-thinking 
ROOM ORGANISATION 
o Have the seating organised so that the participants are sat in a semi-circle facing 
the tutor. All participants should be able to see the flip chart and visual aids. 
MATTERS OF GENERAL IMPORTANCE 
During this programme give the group plenty or opportunity to work things out 
for themselves since that process is fundamental to self-empowerment. As a guide, 
for every piece of information you give them, you should ask them at least one 
question. 
Self-empowerment is about ENCOURAGEMENT not EMBARRASSMENT. 
Never label an answer as incorrect; instead encourage the participants to provide 
an alternative response. 
Read out the open question and allow the group to discuss it before reading the 
answer you were looking for. 
119 
General time plan for each week 
Information sharing activities 
Information sharing & skill development: 75 minutes 
Break 
Communicating & networking: 15 minutes 
Lifestyle experiment 
Empowerment and goal setting: 30 minutes 
TOTAL 2 hours 
120 
4.3.1 Week one - what is diabetes? 
Overview 
The group exploºes the process of caºhoIº)diatc food digestion and tlºc ºculting use in 
blood glucose levels. The visual aids (illustrated in figure 4I above) help people to 
identify the symptoms of diabetes and how these may be alleviated by lifestyle changes 
and, if necessary, medication and/or insulin. The role of obesity and physical inactivity 
are also discussed in the aetiology of Type 2 diabetes with the emphasis on lifestyle 
change. 
Introduction (10 minutes) 
Firstly, hand out the manuals, name badges and a felt-tipped pen as the participants 
enter the venue and ask them to write their first name on both the manual and the name 
badge visible to other participants. Secondly, introduce yourself and the expert patient 
programme. A sample introduction appears below 
Tutor: Hello, I am (name) and / wi// he dt'livermg the chabeie. s ex/x'r! 1kolie1N 
programme over the ilext six weeks. I am a (. Male qualifications . dato. e. g. 
diabetes 
specialist dietitian nurse, practice hurst') curd have heeiu working in diabetes care . 
for 
the past (how many? ) years. You have all hee u given the dates curd times of the . six- 
week programme. Me programme is di., plgtied on 1hc'. first page of your maimal. lI ººvll 
he advantageous to attend every session but if for whate've'r reason von rammt attend, 
please let me kiroKw aiad l will keep the written material. /or 1-ou and if Ixo. wswhle give voa 
a brief summary of the subjects discussed. All lxtrln"ilxaiil. s who complete the toure u, dl 
receive a certificate of alle, uda, ace. 
Thirdly, you should point out that you will be conducting a supermarket tour on the 
forth session. Identify local supermarkets and explain that you can only take up to 10 
people on a single tour. Explain that if there are 20 people you can do two tours and 
these can be at different supermarkets Confirm the chosen supermarket(s) and the time 
of the tour(s) and ask the participants to write their names against the supermarket of 
Fil,, tnr 4.1 Visual aid% ii ed in %%eck one 
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their choice during the break. Make sure that you are not over-subscribed for any tour. 
Keep the list to remind people about the dates and times of their chosen tour at the end 
of week three. Arrange the tours by liasing with the supermarket manager. 
Fourthly, tell the group about the expert patient programme manual. A sample 
explanation appears below: 
Tutor: You all received a pack whew you arrived today. In the front you is ill notice a 
programme for the six-weck expert patient programme. Every week you will receive 
written background information to place in the relevant section hi the mallual 711e 
manual is for you to keep, refer to, and share with others. At the moment the 
information is up-to-dale, but like all health recommendations, new evidetsce is 
constantly being published. To remain informed you may wish to become a member of 
Diabetes UK and receive regular mailings written for people tivith diabetes. 77, is will 
currently cost you between £8 and £20, depending on i/idividual circumstances, for a 
year membership. I have informations regarding Diabetes UK and applicatiomt forms - 
feelfree to take orte when we break for refreshmeirts. 
Identifying common problems (10 minutes) 
The purpose of this exercise is to demonstrate that the problems people experience with 
their diabetes are common to many participants. 
1. Ask the participants to organise themselves into pairs (ideally they should not 
already know the other person). 
2. Each participant has just one minute to introduce themselves to their partner 
and state the two main problems they have with their diabetes. 
3. Each person in turn will then introduce their partner to the whole group and 
identify their partner's two main problems (If carers are involved in the group 
they should state two main problems that arise from living with somebody with 
diabetes). 
4. Write on your flipchart the problems identified e. g. tiredness, difficulty losing 
weight, fear of hypos, inconsistent treatment messages, remembering 
medication, perceived restricted diet etc. 
5. Read aloud to the group the list of problems from the exercise. 
6. Tell the group that the programme intends to address these problems and to help 
the group to deal with them. State also that individuals will have an opportunity 
to address these problems further in the goal-setting activity at the end of each 
session. 
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Activity one: Exploring diabetes (30 minutes) 
Ask the question `what is diabetes? ' and write down the comments of the participants 
on the flip chart. You will probably get responses such as `too much sugar' or `not 
enough insulin'. Thank the participants and commence the group exercise. 
Using `visual aid 1', which is a large poster with stick-on labels/images (see figure 4.2 
below which is a diagram of the completed poster) start the group exercise by sticking 
the food label and food onto the poster. Spread the rest of the labels either on the floor 
or on a low table. Throughout the following 30 minutes, work through the group 
exercise encouraging the participants to be actively involved in placing the labels in the 
correct places. This exercise must be carried out whilst paraphrasing leading questions 
to help participant understanding. 
Figure 4.2 What is diabetes interactive poster 
Ov, crwci&ht 
Mouth 
Fat Cell 
Insulin doesn't 
Food work properly 
Insulin Resistance 
Digestion 
Carbohydrate, 
Liver Protein & Fat 
Blood Vessel 
8 mmol/I 
I 
tom h 
Glucose OO 
Insulin 
O 
Normal 
ancreas Fat Cell 
4 mmol/l 
Bowel KEY 
Insulin acts 93 C= Glucose as a key, 
unlocks the/ 
Insulin cell door and 
Anus lets glucose j .ý 
into the cell 
T. Deakin 2002 
(visual aid 1) 
An example of the type of discussion you need to encourage appears below: 
Tutor: Lets start from the beginning. When we eu/ food what happ, ceýl. ý to i1'' 
Answer: Digestion (Ask for a volunteer to stick the digestion label on the poster). 
Tutor: Ok, tio we know that food digests ill the stomach and gilt. Doe. anyone kluntw the 
three main nutrients that the food breaks dowel 111(0? Participants will either read the 
answer from the `digestion' label or know the correct answer. 
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Answer: 'Carbohydrate (starch and sugars), protein and fat' 
Tutor: Which nutrient is important in diahete. v" 
Answer: Carbohydrate- Carbohydrate includes both starchy and sugary 
. 
foods. ; 1// 
starchy and sugary foods break down into glucose and raise blood glucose levels. 
Tutor: Why do I sav blood glucose levels instead c? f blood sugar levels' 
Answer: It is glucose that is found in the blood and not sugar. People commonly 
refer to diabetes as `too much sugar' and healtheare professionals also tend to use the 
tern: `blood sugar levels' in an attempt to simplify things. However, this can he 
misleading as it gives the impression that diabetes is all about the quantity of table 
sugar in the blood 
Tutor: Please raise your hand if you thought that diabetes was all about ! he quantity (? f 
table sugar in your blood? 
Probably quite a few or the majority of participants will respond. 
Tutor: As you can see this is a very common concept. llowever, we now know it is 
'glucose 'in the blood and not table sugar. For the rest of this activi1v we ºs-ill explore 
where glucose comes from and how it arrives in the hhxxl 
Tutor: I)o protein or fatly foods raise blcxx1 glucose level v? 
Answer: No, protein foods, for example meat, fish and eggs and fatty 
. 
foodV, for 
example, margarine and oils, do not directly affect blood glucose levels. However, if 
people eat too many of these foods they may gain weight. We will discuss shortly how 
weight gain can affect blood glucose levels. 
Tutor: Lets recap, both starchy and sugary fixx1 are called carbohydrates. All 
carbohydrate. food digests into glucose, which raises blood glucose levels. 
Hold up `visual aid 2', which comprises small ping-pong balls stuck together with 
cocktail sticks (see figure 4.3 below). 
Tutor: Starchy fcxxl is just lots of glucose stuck together'. When starrte digests the 
glucose is set free. Alternatively, sugar (or sucrose to give it it's correct i(ame) is one 
glucose and one fructose stuck together and when sugur digests the glucose and 
fructose become free '. 
Figure 4.3 Carbohydrate models 
Glucose 
0 
G= Glucose 
F= Fructose 
(visual aid 2) 
Sugar 
(D-0 . 
tilurc"/i 
GG 
GG 
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Now demonstrate this by pulling a few ping-pong balls free and explain that this is what 
happens when carbohydrate digests in the gut. 
Tutor: What happens to the glucose now? Where does it go? (Refer back to visual aid 
1) Does anybody wish to put the glucose label and glucose molecules (yellow circles) iii 
the right place? 
Make sure that the glucose arrow points from the stomach to the blood vessel and the 
glucose molecules are in the blood vessel. 
Tutor: What should happen to the glucose now? Why do we need glucose? 
Answer: We need glucose for energy -just like we put petrol in the car to allow the 
car to run, human beings need a constant supply of glucose to provide them with the 
energy to breathe, move and function every day. 
Tutor: So how do we get energy from glucose? Where does the glucose have to go? 
What is required for this process to happen? Have a look at the remaining labels and 
see if you can piece together the remaining picture. 
Encourage the group to place the following labels in the correct place: the insulin arrow 
from the pancreas to the blood vessels; the insulin (black and white check shape) in the 
blood vessel; an arrow to show that both the glucose and insulin travel to the cell wall; 
the insulin fitting like a key onto the cell wall allowing glucose to enter the cell; the 
glucose being converted to energy. 
Tutor: So now we know that the glucose from carbohydrate food passes into the blood 
vessel and is then carried to body cells with insulin. The insulin allows the glucose to 
pass into the cell where it is converted into energy. What happens then if the pancreas 
stops producing enough insulin? 
Answer: Blood glucose levels will rise above the normal range for the general 
population (3-7 mmol l) and the person will feel tired because they are no longer 
producing enough energy. 
Tutor: Alternatively, people may be producing enough insulin bist because they are 
overweight, their fat cells are bigger. How do you think bigger fat cells effect the lock 
and key action of insulin? Try to fit the insulin to the cell wall of the overweight cell, 
what do you notice? 
The participants will see that the insulin does not fit properly to the cell wall of the large 
cell. 
Tutor: You have probably heard the term insulin resistance. Well, when the insilli/l /lo 
langer fits properly on the cell wall, it becomes less efficient at allowing the glucose to 
pass through into the cell and glucose builds up in the blood just like it does when the 
125 
pancreas stops producing enough insulin. So what happens to the extra glucose in the 
blood? Where does it go? Which labels / images describe what happens? 
Encourage the participants to look at the labels/images that still remain and choose the 
image that best describes what happens to the glucose. Steer the participants towards 
choosing the picture of the waterfall. Discuss how the extra glucose flows out in the 
urine drawing out with it extra water. Link these actions to the symptoms of diabetes i. e. 
tiredness, thirst, dry mouth, frequent urination etc. 
Tutor: Now we know that if there is a shortage of insulin or the insulin does not work 
properly, blood glucose levels rise in the blood and can spill out in the urirre causing 
symptoms of diabetes i. e. dry mouth, thirst, frequent urination and lack of energy Once 
diabetes has been diagnosed it is important to have regular blood tests to see if blood 
glucose levels are being controlled There are different methods for assessing blood 
glucose levels: random blood glucose; fasting blood glucose; and glycated 
haemoglobin or HbAlc. What are these tests and what do they mean? 
Support the group in exploring the differences between the various blood glucose tests 
and develop an understanding within the group of the necessity for each one. 
Answer: Blood glucose tests give an indication of the amount of glucose in the blood 
at the time when the blood sample is taken. Therefore it does not give information 
about how well that individual's diabetes is controlled overall. One way to perform a 
blood glucose test involves pricking the finger and placing a drop of blood on a test 
strip. The test strip is then analysed by a blood glucose meter. Alternatively, a blood 
sample may be taken from a vein in the arm and analysed at the hospital. A fasting 
blood glucose test is taken when the person has not eaten anything overnight or for 
approximately 12 hours. A random blood glucose test is taken any time. 
Tutor: What is the ideal pre-meal blood glucose range in people with diabetes? 
Answer: The ideal pre-meal blood glucose range in people with diabetes is 4-7 
mmolli 
Tutor: A blood glucose test takelt two hours after a meal gives an indication of how 
well the body is controlling the glucose from the last meal. What would a reading above 
10 mmol/l suggest? 
Answer: Either the carbohydrate portion of the meal is too large or the individual is 
not using enough glucose due to inactivity or the tablettnsulin are not controlling 
blood glucose levels adequately and a review is requirecL 
Tutor: What is the glycated haemoglobin (HbAlc) test? 
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Answer: This blood test is normally taken from the vein in your arm and sent to the 
hospital laboratory to he analysed It is the most important tool to help You and your 
diabetes care team understand how well your diabetes is controlled. The test shows 
the average level of glucose in your blood over the last two or three months. Pople 
without diabetes usually have an HhA lc of between 4.0% and 6.3%. A person with 
diabetes is considered to have excellent diabetes control if the, have an HhA le below 
6.5%. Generally speaking the lower the HbA 1 c, the lower the rick of developing 
problems due to diabetes. Depending on your own circumstances it is recommended 
that you aim for a level below 7% but for some people a level up to 7.5"', mal, he 
acceptable. 3 You will need to discuss an appropriate level of diabetes control ºw'ith 
your diabetes care team. 
One easy way of visualising glycated haemoglobin is to think about glucose sticking 
to red blood cells (draw diagram on flipchart or show visual aid 3- figure 4.4). 
Figure 4.4 Glycated haemoglobin (HbAlc) model 
Glucose-. 
Q0 zo 
a Red 
Oe-" 
Blood 
°' ö 
HbA1c6% F1hA1c 10% 
(visual aid 3) 
Tutor: Can anybody suggest why there may he a problem if there is too much glucose 
attached to the red blood cells for too long? 
Answer: If too much glucose remains in the blood for too long, the blood mnº' 
become too thick or too sticky. This increases the future risk of developing health 
problems due to diabetes. The potential longer-term complications of diabetes will he 
discussed in week five of the course. 
Medication and insulin 
Tutor: Initially most c? f you will have been advised io follow it healthier diet and do 
more physical activity as a means (? f controlling your diabetes. Some of ou will . still 
he 
controlling your diabetes solely through maintaining a healthier life. tityle. Others may 
3 National Institute for Clinical Excellence. Afanagemenl of Tvpe 2 d, aheles" (. 1lanagement of hlºxºd 
glucose). September 2(X)2. 
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be taking medication and/or insulin in addition to a healthier lifestyle. At what point 
would somebody require medication or insulin and how do these treatments work? 
Answer: If a healthier lifestyle - through sensible eating and increased physical 
activity - are unsuccessful in controlling blood glucose levels, with the result that the 
majority of blood glucose tests score above 7 mmol/l (IlbAlc result above 7%), that 
would suggest the pancreas is either not producing enough insulin or the insulin it is 
making is not working properly i. e. insulin resistance. 
Tutor: There are many different diabetes medications. Can anybody name medications 
that have been shown to reduce insulin resistance? 
Answer: The glitazones eg. roseglitazone (Avandia®) or piogliterzone (Actos®). 
Metformin (Glucophage®) has also been shown to help insulin work better. Most 
medications have two names, the general name and the trade name. This can be quite 
confusing, but generally both names will be on the packet. It may help you if you are 
familiar with both names. 
Tutor: If you are overweight, which medication is recommended as first line treatment? 
Answer: Metformin because it is one of the few diabetes medications that actually 
aids weight loss rather than promoting weight gain. Acarbose (Glucobay®) is 
another diabetes medication that may help people to lose weight. 
Tutor: Does anybody known how metformin and acarbose work? 
Answer: The main target of metformin is prevention of the liver from releasing too 
much glucose back into the blood We all store glucose in the liver. Between meals we 
release glucose back into the blood to keep blood glucose levels stable. However, 
people with diabetes have been shown to release too much glucose causing the blood 
glucose levels to rise too high. Meformin also helps insulin to work more effectively. 
Symptoms of bloating, wind and reduced appetite are all known side effects of 
metformin. You can reduce these side effects by starting on a small dose and 
gradually increasing it. Acarbose works in a different way to nietformin. It slows 
down the digestion of carbohydrate food Blood glucose levels therefore rise more 
slowly, allowing the insulin more time to clear the glucose. This medication helps 
weight control because the food stays in the stomach for longer, thereby reducing the 
appetite. 
Tutor: Which medications have we not discussed yet? 
Answer: A class of medications called sulphonylureas, the most commonly prescribed 
one is gliclazide (Diamicron®, Diaglyk®). They work mainly by stimulating the 
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pancreas to make more insulin. They are normally taken before meals once or twice a 
clay. 
Tutor: There is one more type of diabetes medication that we have not discussed Does 
anybody know what it is? 
Answer: A newer class of tablets called prandial glucose regulators. There are 
currently two medications in this category: repaglinide (NovoNorm®) and 
nateglinide (Starlix®). These work in a similar way to sulphonylureas but they are 
usually taken with a meal and they only work whilst the food is digesting, thereby 
reducing the risk of hypoglycaemia. 
Tutor: In week one of your manual you will see a Diabetes UK summary of 
medications. Have we discussed all of the diabetes medication that you are currently 
taking? Any questions? There is also an information sheet about different types of 
insulin. Because there are only a few participants taking insulin, we haven't the time to 
discuss each possible regimen today. Most of you will get specific information 
regarding your insulin from your diabetes care team. Hotii'cter, if you have questions, 
please ask after the session. 
If individuals ask questions and you are not absolutely sure of the correct answer, it is 
advisable to inform them that you will find out before the next session. 
Tutor: Before we move on, what happens if you forget to take your tablets? 
Answer: If it is only one or two hours since you missed a dose, then take the tablet(s) 
as soon as you remember. However, if it is longer than two hours then leave them and 
take your next tablets at the usual time. Do not double your next (lose - Why not? 
Answer: You would be at an increased risk of developing low blood glucose 
levels/hypoglycaemia. 
Tutor: These recommendations are only a guideline. Your diabetes care team may 
recommend another course of action depending on your personal circumstances. 
However, missing your tablets on a regular basis will affect your diabetes control. What 
can you, or do you, do to remind yourself to take your medication correctly? 
Ideas may include purchasing a dispensary container, keeping the medication by the 
kettle, setting an alarm clock etc. 
Activity two: Diabetes Health Profile 
Tutor: You will see a section in your manual called 'diabetes health profile' (figure 
4.5). The diabetes health profile form shows you the main factors that your diabetes 
care team (doctor, nurse, dietitian etc. ) take into consideration when they monitor your 
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diabetes. These are your health results and it may hell) voºu to self-manage your 
diabetes if you know what these health results area and what they mean 
EXPLANATION OF HEALTH RESULTS AND NORMAL RANGES 
Body Mass Index (refer participants to the BMI handout in their manuals, an example of 
which is shown in figure 4.6 below) 
Tutor: (an anybody fell a. s why these health results are recorded anti who! lhcr meal' 
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Answer: KMI is an assessment of people's weight for height and gires an indication 
of whether somebody is underweight (BM1 belon, 20), normal weight (BMI 20-25). 
overweight (BMI 25-30) or very overweight (Bill over 30). Ask participants to turn to 
the relevant page in their manual and use the chart to estimate their own 13MI. 
Waist circumference 
Tutor: If we can calculate IM'!!, which you have. just told me is an indicator (? f whelhcr 
you are a healthy weigh! for 
. 
your height. ihre whey is Ah(' %1'(11.1'/ mru. cllr('m('lll (l/%O 
u sejlll? 
Answer: If people gain weight around their middle, they are at a greater rick of 
developing heart disease However, if people are more prone to storing excess weight 
on their bottom and thighs, they are less likely to develop heart disease. 
There is no time scheduled into the expert patient programme sessions for a waist 
measurement exercise to be performed, but you could quickly explain the correct way to 
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take the measurement at home: the appropriate measurement site is midway between the 
lower rib and hip bone. Tell your group not to pull the tape too tight, stand relaxed and 
breathe out gently. Demonstrate. 
Blood glucose levels 
Tutor: We have already discussed how a single blood glucose test does riot give a fill 
picture of overall diabetes control. Therefore the diabetes health profile form uses the 
glycated haemoglobin (HbA1c) lest. What does this mean again? 
Answer: The test is an indication of the average blood glucose level over the last 8-12 
weeks (2-3 months). 
Tutor: What would happen to your diabetes control if you kept your activity levels and 
diabetes medication the same but ale twice as much carbohydrate e. g. bread and 
potatoes throughout the day? 
Answer: All carbohydrates (sugars and starches) break down to glucose in the gut 
and raise blood glucose levels. If twice as much carbohydrate is eaten compared to 
the usual intake you would expect blood glucose levels to be much higher than 
normal. 
Blood pressure 
Tutor: Now we move onto blood pressure. What is blood pressure? 
Answer: It is the amount of force your blood exerts against the walls of your blood 
vessels. Tutor: What do the two readings mean? Wait for the group to respond and then 
summarise. 
Answer: The first and larger number (systolic pressure) is the pressure against the 
blood vessel wall when the heart beats and rumps the blood into the vessel. The 
second and smaller number (diastolic blood pressure) is the pressure against the 
vessel wall when the heart is at rest 
Take a modelling balloon and a small hand pump. Pump air into the balloon to 
demonstrate the heart pumping blood into the blood vessel and explain that the 
force/pressure on the side of the balloon would be equivalent to the systolic blood 
pressure. Now let the air out of the balloon and ask the participants to state what is the 
pressure in the `blood vessel' now? (refer to visual aid 4). 
Tutor. What is hyperteirsion? 
Answer: Hypertension is raised blood pressure. For people with diabetes this means 
readings above 140/80. For the general population hypertension is diagnosed when 
readings rise above 160190. The guidelines are stricter for people with diabetes 
because the combination of raised blood glucose levels and raised blood pressure can 
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lead to the development of longer-terns complications of diabetex If blood pressure 
readings are raised, another two readings should be taken over a two-month period to 
confirm the diagnosis. 
Tutor: Why is hypertension called the silent killer? 
Answer: Experiencing raised blood pressure on an ongoing basis does not hare any 
physical symptoms and therefore it is harder for people to understand the importance 
of obtaining blood pressure goals if they do not feel poorly. Raised blood pressure is 
very common in people with diabetes. however, controlling blood pressure is as 
important for preventing longer-term complications of diabetes as obtaining good 
blood glucose controL 
Tutor: What could you do to reduce your blood pressure? 
Answer: Reduce body weight, increase physical activity, reduce dietary salt intake, 
increase calcium intake from milk and dairyfoods, and have more fruit and vegetable 
to increase potassium intake- There is an information sheet on blood pressure in your 
manual. 
Blood fats 
Tutor: Finally what about blood fats? What is cholesterol? 
Answer: Cholesterol is a fat that is present in our bloo(k Often people with diabetes 
can have a raised cholesterol leveL This is caused by the body itself producing too 
much cholesterol or by an excess intake of animal (saturated) fat. 
Inform the group that identification of foods that contain high levels of saturated fat will 
take place during weeks two and four. 
Tutor: What is the difference behveen good and bad cholesterol? How can we have too 
much bad cholesterol in our blood? Why is this harmful? 
Answer: Your total cholesterol level is the combination of 'good' (/IDI. ) and 'bad' 
(LDL) cholesteroL Good (IIDL) cholesterol helps to clear the blood of bad (LDL) 
cholesterol (ask the group to refer to the relevant sections on the health profile sheet). 
Too much total cholesterol (above S romoll), or 'bad' cholesterol at a level above 3 
mmo! /1 or 'good' cholesterol less than 1.2 mmoM all increase the risk of heart 
disease. 
Inform participants that dietary modifications shown to improve the blood fat profile 
will be discussed during the supermarket tour. Advise also that cholesterol-lowering 
medications may also be necessary in conjunction with lifestyle change. 
Tutor: What are triglycerides? 
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Answer: Triglycerides are another type of fat in the blood Triglyceride levels are 
often raised in people with diabetes. There are specific changes you can snake 
to your 
lifestyle that help to reduce the triglyceride level. Examples are 
increased 
consumption of oily fish, weight loss and a controlled alcohol 
intake- These lifestyle 
changes will be discussed in more detail throughout the programnm e. 
Self-awareness 
Provide pencils to the participants and ask them to complete the diabetes health profile 
with their health results. If they do not know what their health results are, ask them to 
estimate what they think they might be. Encourage them to take the diabetes health 
profile with them when they next have an appointment with the diabetes care team and 
to complete it with their actual results. After all, they are their health results! 
If participants have specific questions regarding their own health profile, remember that 
you do not have access to their medical records and therefore can only give general 
advice. However, there is a section on the back of the diabetes health profile form where 
they can write down any personal queries and discuss these with their diabetes care 
team during subsequent visits. 
BREAK (15 minutes) 
If possible obtain a budget for refreshments as this will help to build a rapport between 
participants. This is also an excellent opportunity to encourage healthier snacks by 
providing natural nuts, dried fruit, oatcakes, malt loaf, etc. You could even encourage 
home baking of low fat fruit loaves for example by providing samples and 
photocopying the recipes. 
4.3.2 Lifestyle experiment 
Overview 
The final 30 minutes of each session is allocated to the "lifestyle experiment". 
Participants are encouraged to complete their diabetes health profile. The lifestyle 
experiment session is not didactic in nature and it is intended to enable people to make 
informed decisions regarding their health results. 
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Figure 4.7 Patient handout `so you want to........... 
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The participants receive a one- 
page handout called 'So you want 
to ..... ......... ...... 
' (see figure 4.7) 
If they wish to improve certain 
aspects of their health the 
checklists are useful pointers to 
help them make lifestyle changes 
that will bring about the desired 
effect. 
These sessions are intentionally 
named `lifestyle experiment' because `experimenting' is less likely to make people feel 
like a failure if they try something and it doesn't work. This section of the manual 
includes exercises intended to raise motivation, increase the driving forces for change, 
and remove or reduce the restraining ones. Each week people are encouraged to try a 
different experiment or to continue with one already started. Participants keep a record 
of any experiments undertaken and learn from past experiences (see figure 4.8 below). 
Fii-lure 4.8 Patient worksheet to encoura c monitoring of exne iment% 
Problem Lifestyle Experiment Start Stop T Result ('onuneuta 
Date Date 
1 'nti( e. g. Wall, for 20 mans, 3 times per 1.1 .i 1) 1 -1 .ioI OK Almost didn't make it once but 1'"I 
week better afterwards 
Will continue 
Overweight e. g. Change from full-fat milk to 21/4/01 28/4/01 Difficult! Couldn't stand it at first. its getting a 
semi-skimmed milk little better now. %1'ill to for one more 
week! 
Tired e. g. Will start monitoring blood 28/4/01 5/5/01 No (loco I got use how to do it - it didnt 
glucose levels 4 times / week before Problem take am time and mask nie feel more 
meals and 2 times / week 2 hours after in control of ms blood glucose levels. 
meals 
Each lifestyle experiment session to last 30 minutes every week 
Tutor: the lifestyle ex wrimen! ' section incorporales ! he goal-selli»g /lur! (? f the 
empowerment model. Me health service was developed at a time when acute illnc.,., ºº u., 
The main cause of ill health, such as ü fecliou. s" aid hacwrial diseases. Heal/h 
professionals were, at that lime, trained to take charge nj pxatienis ' health, ofieir 
because palie»ls were lou unwell 1o do anything themselves. 
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However, there has been a shift in the nation's health with a huge declüle in acute 
disease and an increase in chronic disease such as diabetes, heart disease, cancer annd 
arthritis. You all have diabetes but you may also have other chronic conditions. Oil 
average people with diabetes consult health professionals for just three hours each year 
and spend the other 8,757 hours self-managing their diabetes. Recent studies have 
shown that a didactic and prescriptive approach by health professionals may be 
effective in the short term but that it does not produce long-lasting positive results for 
people with chronic disease. 
How many of you have been told to do something by a health professional that you 
know will not work for you? (Discuss) 
Tutor: Who is the `expert' in how best to live with diabetes? 
Answer: The person with diabetes. You are all more experienced about living with 
diabetes than a professional who does not have the condition and each one of you will 
have a slightly different experience. 
Tutor: Therefore who is better placed to define problems and set goals to address those 
problems? 
Answer: A well-informed person with diabetes is in a better position to define and 
explore his/her own diabetes related problem, to identify possible solutions and to 
commit to action. 
Tutor: The theory attached to this part of the expert patient programme is that you can 
be encouraged to define your own problems associated with diabetes, identify possible 
solutions and commit to action. This way you are more likely to achieve your goal. We 
all have ideas about how we can make our lifestyle healthier but sometimes we have 
difficulty committing ourselves to change. 
In the lifestyle experiment section of your manuals you will see a goal selling form. 
Let's work through this. 
Goal setting 
1. Identify a problem 
Tutor: At the start of today's session you all shared with its two problems you were 
having with your diabetes. I'm handing out a sheet with four litles Under 'identifying a 
problem' write down what your main problem is. 
E. g. "Boring and restricted diet" 
2. Explore possible solutions 
Tutor: Based on what you've learnt today what do you think could be a possible 
solution to your problem? Write dowii as many ideas as possible. 
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E. g. "Based on what I have learnt today I am not going to confine myself to the foods I 
previously felt were good and safe. Instead I am going to try and increase the variety of 
foods in my diet. There are a lot more foods that are good for me like, dried fruit, but I 
was excluding them because I felt they were bad for my diabetes. " 
"I could also start to self-monitor my blood glucose levels to see how different meals 
affect my diabetes. " 
"I could try to be more active, this could help me burn off more calories and help me to 
worry less about my diet. " 
3. Commitment to action 
Tutor: Choose one or two possible solutions from the above list that yogi feel you could 
actually carry out and state how you are going to do it. 
"I am going to go to a supermarket next week with a friend who I've met on the course. 
We will attempt to purchase a more varied selection of food. I will also see my GP and 
request testing strips for my blood glucose meter and start to monitor my blood glucose 
levels. " 
"I am going to start walking with Mrs X for 10 minutes each day and to try to gradually 
build up to 20 -30 minutes each day. " 
4. Evaluation 
Tutor: Now state how Long you are going to commit to your chosen action for and when 
you may have an idea whether it has worked or not. 
"I have just had a blood test to assess my average blood glucose control. During the last 
2-3 months, my diabetes has not been well controlled. I will try my new approach and 
go back to my GP in three months and ask him if he will repeat the IlbAl c blood test. " 
Tutor: I will give you five minutes to complete this form and we will them discuss your 
responses. 
Tutor: How did you feel filling out the form? Have you identified possible solutions? 
This is a four-step approach to goal setting that was developed by Bob Anderson and 
Martha Fennell at the Michigan Diabetes Research & Training Centre. You will also 
notice in your manual the lifestyle experiment form with three examples provided by 
people with diabetes. The form allows you to log your experiments and there are three 
blank forms for your use. If you require extra forms please ask At the bottom you will 
notice that you are being encouraged to be SMART'. Be Specific - what are you going 
to do and when? Is it Measurable - can you measure the time it takes, how frequently 
you do it? Is it Achievable - on a scale of I to 10 how confident are you that you can 
SMART is an acronym for a process that encourages cflicicncy in timt management and conduct. 
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achieve the goal? If you are not very confident i. e. a score of only two or three, should 
you be choosing that goal? Is it Realistic - can it be continued long-term? Finally, time 
- set yourself a Tmescale for trying the experiment and if successful, a timescale to 
achieve the goal. Why do you think it is called an experiment? 
Answer: If it doesn't work out for you, you haven't failed It was an experiment, 
learn fron: your experience and try something else. 
Tutor: The other materials in the lifestyle section of your manual are there to hell) your 
set goals. We will quickly go through them now but hopefully you will look at them in 
more detail at home: 
'So you want to ............. 
' What does this handout give you? 
Answer: It offers some pointers in the right direction if you wish to improve your 
health results (Read out one or two examples if there is time). 
Tutor: 'Your health' ............... How will these questions help you? 
Answer: The list of questions will help you identify reasons and motivation for 
change. 
Tutor: Driving forces versus restraining forces'...... /What are driving and restraining 
forces? Can you give me an example? 
Answer: Driving forces are motivation for change and restraining forces are barriers 
to change. This exercise is really useful if you are not sure whether you can achieve 
the change. For example if the goal is weight loss, the necessary change may be 
eating less food and increasing physical activity. The motivation Le. driving forces to 
make the change may be looking and feeling healthier, improved diabetes control, 
fitting into clothes in your wardrobe that you haven't worn for several years etc. 
However, the restraining forces or barriers that are preventing you making a change 
may be friends tempting you with biscuits, feeling unsafe to go out for a walk or 
eating when you are bore! 
You may find that you can add things to your driving forces for example putting a 
picture of your grandchildren on your fridge. This may remind you that you want to 
stay healthy to see them grow up. You may remind yourself that you don't wish to 
increase your diabetes medication/have to take diabetes medication and you know 
that this is less likely to happen if you manage to lose weight. 
You may remove restraining forces by asking your friend to supply fruit when you 
visit instead of biscuits or even better ask her/him to go for a walk with you. You will 
see how small steps can help make change more acceptable. 
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Tutor: Finally `Qºieslions 1o help' ............. as 
I said we learn from our mistakes so Ihi. V 
exercise encourages you 10 evaluate and learn , 
from your goal selling. 
We will discuss goal selling in the lifestyle experiment session every week. 
We will 
either discuss these as one large group or split into smaller groups. We will learn 
from 
each another about what we each find useful, experiments that 
have worked and 
experiments that have been less successful. These discussions will 
hell) other groll) 
members set their own goals. Hopefully, these sessions will hell) you . 
feel more 
empowered By empowerment we mean feeling more knowledgeable. . skilful and 
confident to make informed decisions regarding your diabetes and life. stvh'. 
If there is time remaining, either have a general whole group discussion regarding goal 
setting or split the participants into groups of four or five and ask them to discuss 
possible goals. When the two-hour session comes to an end, thank the participants for 
coming and make sure they are clear about the arrangements for the following week. 
Ask participants to bring their manuals and name tags to every session. 
4.3.3 Week two - weight management 
Overview 
model Figure 4.10 Body story video 
vF 
!: 1. 
Visual aid 6 
A simple seesaw approach (see figure 4.9 above) clearly shows the concept of energy 
balance. Pictures of common foods eaten throughout the day and pictures of different 
physical activities, such as, dog walking, bowling, swimming, and gardening have been 
selected and laminated to illustrate an explanation of energy balance. A video recorded 
from the Channel 4 programme 'Body Story Pat Amick' is also used (see figure 4.10 
above). It presents as a light hearted picture, drawing out the disadvantages of `crash 
dieting' while emphasising the advantages of physical activity and sensible eating when 
trying to lose weight. 
`7he Balance of Good Heal/h' (see figure 4.11 overleaf) should then be discussed and 
the participants encouraged to analyse their own diet, including estimating the number 
of portions of food they consume from each food group on a typical day and how that 
Visual aid 5 Visual aid 5 (repeated) 
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deviates from government recommendations. Simple exercises are provided if 
participants wish to set themselves experiments to work towards improving their diet 
Visual aid 
The final part of the weight management session takes the form of a discussion about 
the benefits of physical activity. A local exercise consultant is invited to talk to the 
participants about the `exercise on prescription' scheme. 
Activity one: energy balance (10 minutes) 
Present the handout pack to the participants as they arrive and advise them to place it in 
the `week two' section of their manuals. Welcome the group and inform them that you 
are going to cover weight management, the balance of good health and the benefits of 
physical activity. Use visual aid 5 (seesaw model) to demonstrate energy balance. 
Tutor: In theory, energy balance is simple. If the calories required from fixxI and drink 
are equal to the calories burnt during the breathing process, physical activity and 
general living, what happens to a persons weight? 
Demonstrate this by quickly using the laminated illustrations to place a similar number 
of food pictures and physical activity pictures on the respective sides of the seesaw to 
indicate that weight remains stable. 
Answer: Their weight remains stable. What happens if the person starts eating more? 
Add to the illustration the pictures of extra large food portions, the whole packet of 
biscuits and the whole bottle of wine. Watch the weight gain side of the seesaw rise. 
Answer: Their body weight increases. 
Now remove the extra food until the seesaw is stable again and add more pictures 
showing physical activity. Watch the weight loss side of the seesaw rise. 
Tutor: What happens if somebody starts being more active? 
Answer: They burn more calories and this helps them to lose weight 
Tutor: What do you think is the best way to lose weight? 
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Answer: A combination of reducing food intake by 500 calories per day and an 
increase in physical activity has been shown to be the most successful way of 
reducing weight. A common approach to weight loss is to go on a diet for a limited 
period of time. However, more permanent changes to lifestyle are required for long- 
term success. 
Tutor: On average, a women requires 2000 calories each day to maintain her weight 
and a man requires 2500 calories. In the handout pack you received today you have a 
copy of the Schofield equation. This allows you to calculate your exact calorie 
requirement using your age, current body weight and physical activity level. There is an 
example that shows you how to do the calculation. I will demonstrate this in the lifestyle 
experiment session after the break 
Activity two: fat attack video (20 minutes) 
Tutor: We will now watch a video recorded from Channel 4 which clearly shows, in 
quite a humorous fashion, that crash diets don't work ................................. 
Visual Aid 6: Body Story - Fat Attack video (show the video and discuss afterwards). 
Tutor: What are the main messages in this video? 
Answer: That going on a strict diet can appear to be successful initially but the 
weight loss is mainly water. Before long the weight loss slows down because losing fat 
is a much slower process than losing water. Also, the body detects that food intake has 
been dramatically reduced and stops burning as many calories to guard against 
famine. Generally it is only a matter of time before the person starts craving high fat 
and sugary food and a struggle develops to fight those cravings. It is rare for people to 
resist such cravings for long with the result that the `diet' is broken. A sensible eating 
plan (as opposed to a diet), which allows people to continue to eat their favourite 
foods in small amounts, and simultaneously increase their physical activity levels has 
been shown to be a more successful and desirable approach. 
Activity three: balance of good health (20 minutes) 
Tutor: We have learnt that a sensible eating pattern is more effective than going on a 
diet. What does "sensible eating" mean? We will use the 'Balance of Good Health' 
model to explore a sensible approach to eating. 
Display Visual Aid 7: Balance of Good Health tabletop model with plastic food models 
and empty food cartons. 
Tutor: What are the five main food groups that contribute to our daily intake? 
Answer: Fruit and vegetables, starchy carbohydrates, milk and dairy food, protein 
foods, and fatty/sugary foods. 
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Tutor: How many portions of each of these food groups should we have each day and 
what is a portion? 
Work through each food group asking the participants to place relevant food models on 
the correct section of the 'Balance of Good Health' and to state the recommended range 
of daily portions. Use the `Balance of Good Health' information sheet in the 'week two' 
section of the manual as a guideline. After the activity, refer the participants to the 
information and example sheets in their manual. The example sheets give suggestions as 
to how many portions from each food group would constitute a total daily intake of 
1100 calories, 1600 calories, 1800 calories, 2100 calories and 2800 calories 
respectively. 
Tutor: You will notice a blank 'Balance of Good Health' sheet in your manual. During 
the lifestyle experiment session after the break, I will ask you to choose a typical day 
and complete this form to assess how many portions from each group you are currently 
eating. You can then use the Dietary Action Plait to compare your diet with current 
recommendations and estimate how many calories you are consuming on a daily basis. 
You will be able to decide whether you think this is appropriate or not. The Dietary 
Action Plan may help you to experiment with healthy patterns of eating in order to find 
a combinations that is suitable or you. 
Activity four: low fat versus high fat diet (10 minutes) 
Tutor: As you will know, high fat diets contain a lot more calories than low fat diets 
The yellow sheet in this week's section of your manual describes two diets, ohne oil 
either side of the page. Which diet is the low fat one and which is the hlgh fat one? can 
anybody estimate the number of calories in each diet and guess the percentage 
contribution offal? 
Answer: Diet number one is the low fat diet providing 1,871 calories and 19% fat; 
diet two provides 4,420 calories and 48% fat. 
Tutor: I am handing out the answer sheet with the analysed diet and you may agree 
that both diets could be typical diets consumed by many. Why have I shared this 
information with you? 
Answer: You don't have to starve yourself to lose weight The quantity of fool) in the 
low and high fat diet is similar. Making small changes to reduce the quantity offal in 
the diet will dramatically reduce calories. 
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Activity five: physical activity (15 minutes) 
Tutor: We all kiow that physical activity is good for us. Can you state some of the 
benefits? 
Write responses on a flip chart and briefly go though them: 
Q more energy; 
Q improved sleep at night; 
Q increased strength Igreater stamina; 
Q lower risk of heart disease or stroke; 
Q reduces depression; 
Q healthier bones; 
Q helps weight control; 
Q improves blood glucose control; 
Q improves blood cholesterol levels; 
Q reduces blood pressure. 
Tutor: Ok, we all know that being more active will improve our health. Recent research 
has shown that 30 minutes of walking each day has tremendous benefits to health. Very 
quickly can you give me other ideas of how you can become more active ............... 
?. 
Add these to a separate list on the flipchart and briefly discuss them. Provide leaflets to 
inform participants about the local `exercise on prescription' courses if these are 
available locally or invite a local `exercise on prescription' facilitator to come and talk 
to the participants after the session. 
Tutor: What do you need to be aware of if you do start to take more exercise? 
Answer: If we are more active, we use more glucose (fuel) to make the extra energy 
that the body requires. Therefore, more glucose is drawn out from the blood into body 
cells. If the physical activity is either prolonged or vigorous and people are taking 
insulin or certain tablets for their diabetes, they may find that their blood glucose 
levels drop below 4 and this is classed as a 'hypo. Preventing hypoglycaemia is 
possible by either reducing insulin/medication before exercising or having an extra 
carbohydrate snack before and after exercising (Warn participates that an extra snack 
may not be necessary for less intensive activity). You should discuss with your diabetes 
care team which of the two is the better option for you. Symptoms of, and treatment 
for, hypoglycaemia are discussed in more detail during week five. 
BREAK (15 minutes) 
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Lifestyle experiment (30 minutes) 
Discuss the experiments that participants have attempted during the past week and ask 
if' 
they have found goal setting useful. What have they learnt from the experience' 
Ask for a volunteer who is prepared to give their weight, age and activity level (if 
nobody volunteers, use your own or invent one). Demonstrate, by writing on the flip 
chart, how to calculate individual calorie requirements. Inform participants that you are 
unable to calculate everybody's daily calorie needs during the session but that they can 
either stay behind at the end of the session if they need your help, or calculate their own 
at home. State that you will check the calculations next week if anybody would like 
that. 
Now ask for a volunteer to provide an example of their daily food and drink intake (If 
nobody volunteers, ask the participants to invent a typical diet). Draw the `Balance of 
Good Health' model on the flip chart and, with active participation from the group, 
demonstrate how to complete the exercise. Split the participants into groups of four or 
five and ask them to write down a typical day's food and drink intake. Working together 
as a group, ask the participants to complete the `Balance of Good Health' forms (as you 
did on the flip chart) writing the foods in the correct section and identifying the number 
of portions from each food group. The group can then discuss their dietary action plans, 
identifying goals and setting themselves experiments to improve their diet. 
The tutor and the tutor's assistant: You should move around the groups, giving 
assistance where necessary. At the end of the session ask people to continue working on 
their dietary action plans at home and invite them to contact you by phone with any 
queries. Inform the group that you will discuss the plans again next week. 
4.3.4 Week three - glycaemic index 
Overview 
Fi, 
_-urc 
4.12 (: I\u acmic index %isual and 
.......... 
Visual aid 8 
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The glycaemic index is the ranking of foods based on their immediate effect on blood 
glucose levels. The theory that different carbohydrate foods exhibit different effects on 
blood glucose levels is now well researched and dispels the myths surrounding the 
`sugar free' diet. Frost and Dornhorst have reviewed the evidence base for the 
glycaemic index and concluded that consideration of it when making dietary 
recommendations may lead to additional health benefits (Frost & Dornhorst 2000). 
Diabetes UK has provided patient information recommending the use of the glycaemic 
index (GI) (Diabetes UK 2001 a). 
Models have been developed to increase understanding of the GI concept (see figure 
4.12 on page 139). The models were made from small balls connected with cocktail 
sticks and that structure was intended to show how all carbohydrate foods are made 
from building blocks of glucose. In simple terminology, the difference between high 
and low glycaemic foods is that the latter are constructed more securely; they break 
down more slowly and therefore release glucose more slowly into the blood. A quiz has 
also been developed. Photographs were taken of 120 common food and drink items. 
These were downloaded onto a computer, printed, cut out and laminated. In this session 
the participants are split into four teams and each team is provided with an envelope 
containing the pictures. The teams are asked to rank each food as high, intermediate or 
low GI, and to estimate for each type of food how big the portion size would have to be 
to provide the same carbohydrate as one slice of bread (10-15g). An important concept 
for the participants to understand is that for optimum diabetes control it is not the 
amount of sugar in food or drink that they need to be aware of, but the quantity and 
quality of carbohydrate. 
Activity one: explanation of glycaemic index (35 minutes) 
Have Visual Aid 8 `The Glycaemic Index Display' set up at the front of the room where 
all the participants can see it. Welcome the participants as they arrive. 
Tutor: Today we are discussing how the quantity and quality of carbohydrate affects 
blood glucose levels. If we refer back to week one, what is carbohydrate? 
Answer: Starchy and sugary foods 
Tutor: When starches and sugars digest in our stomach and small intestine, what do 
they break down into? 
Answer: Glucose 
Tutor: If the carbohydrate food breaks down quickly, how will this affect blood glucose 
levels? 
Point to the red chart as you discuss the answer. 
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Answer: There will be a surge of glucose f lowing into the blood The body will not be 
able to cope with the glucose and therefore there will be a sharp rise in blood glucose 
levels. 
Tutor: Alternatively, if the carbohydrate foods break down slowly, how will blood 
glucose levels be affected? 
Point to the blue chart as you discuss the answer. 
Answer: There will be a much slower rise in blood glucose levels, which will allow 
the body to handle the glucose load and produce energy a lot more efficiently. The 
glucose levels will be less likely to rise too high. 
Tutor: There has been a lot of research into carbohydrates over the last few years. 
Originally we were led to believe that all starchy foods broke down and released 
glucose slowly and that sugary food released glucose much more quickly. Is this 
correct? 
Answer: No, we now know that some starchy foods release glucose much more 
quickly than sugary foods. 
Tutor: We can demonstrate this with models (pick up the red ball model). Lets pretend 
that this is a fast releasing carbohydrate. Carbohydrate is just lots of glucose stuck 
together. You can see that the structure is quite flimsy and pulls apart quite easily. So 
when this carbohydrate is eaten it releases its glucose into the blood quickly (point to 
the red chart). When would eating this type of carbohydrate be advantageous? 
Answer: When an individual is having a `hypo' i. e. experiencing low blood glucose 
levels and therefore needs to raise then: quickly. 
Tutor: Can you give me some examples of quick releasing carbohydrale foods? 
Answer: Lucozade , glucose tablets, old potatoes, white & wholemeal bread, 
cornflakes etc. You will probably get participants stating sugar, jam, pop etc. You 
should advise that these are intermediate carbohydrates, not quick releasing ones. 
Tutor: Many of you probably think that sugar is a quick releasing carbohydrate. That 
is not entirely correct. Sugar, or sucrose to give its correct name, is made up from 
glucose and fnictose whereas starch is made up purely from glucose. The fructose part 
of the sugar slows down its digestion and it is therefore classed as an intermediate 
releasing carbohydrate. Therefore most sugar containing foods such as jam and pop 
are also intermediate releasing However, next week when we do the supermarket tour, 
we will look at food labels and you will see that some sugary food still has a high GI 
because, instead of containing sugar, it has a large quantity of glucose or glucose syrup 
added 
145 
As a general rule of thumb, the more processed the food, the quicker it digests and 
releases its glucose. People are often surprised to find that white and wholemeal bread 
release glucose at the same rate - why is this? 
Answer: The modern milling grinders process flour to a veryfine consistency. Brown 
and wholemeal flour is ground to the same very fine consistency as white flour and 
therefore bread made front these flours release glucose at the same rate. Granary and 
stone ground flours produce bread that release glucose more slowly. 
Tutor: This model (pick up the blue model - throw it in the air and catch it) represents 
slow releasing carbohydrates. What is different about it? 
Answer: The structure is stronger and therefore tougher to break down. 
Consequently the glucose is released much more slowly into the blood (point to the 
blue chart). 
Tutor: Can you give me some examples of slow releasing carbohydrates? 
Answer: Fruits and vegetables; milk, yoghurts and frontage frais; nuts, seeds and 
pulses; All-Bran", Porridge and Museli ..................... 
Tutor: The ranking of carbohydrate foods according to their effect on blood glucose 
levels is called `Glycaemic Index. Carbohydrate foods that release glucose quickly are 
called high glycaemic index foods or high GI foods Slow releasing carbohydrate foods 
are called low glycaemic index or low GI foods. Research has shown that individuals 
that eat more low GI foods have better diabetes control, better weight control and 
reduced heart disease risk 
However, a note of caution: just because two teaspoons of sugar has less effect aH 
blood glucose levels than a slice of bread or baked potato, does this mean we should 
encourage people to eat sugar instead of bread and potatoes? 
Answer: No. Many quick releasing or high GI foods are nutritious foods that provide 
the body with many nutrients. You may wish to replace white or wholemeal bread 
with granary or seeded bread; or cornflakes for museli; old potatoes for new potatoes, 
but to simply swap a high GI food for intermediate releasing sugar would not be a 
healthy choice. However, the GI concept does allow people more freedom with their 
diet and does dispel the myth that the diet has to be sugar free. People with diabetes 
can incorporate fresh fruit, dried fruit, malt loaf, cakes and desserts into a healthy 
balanced diet without feeling guilty. 
Activity two: alvcaemic index quiz (40 minutes) 
Split the group into four teams. Using Visual Aid 9 `The GI Quiz' give each team an 
envelope (A, B, C or D) with the relevant quiz sheet. 
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Tutor: We have discussed how the quality of carbohydrate is important for good 
health and optimum diabetes control. Does the quantity of carbohydrate also matter? 
Answer: All carbohydrate food breaks down into glucose and passes into the blood 
where it raises blood glucose levels. The higher the consumption of carbohydrate, the 
greater an effect it will have on blood glucose levels. 
Tutor: An average slice of bread or piece of fruit contains around 10-15g of 
carbohydrate. It is easy to compare the quantity of other carbohydrates to a slice of 
bread. For example, how much table sugar would give its the same quantity of 
carbohydrate as a slice of bread? 
Answer: 2-3 teaspoons. 
Tutor: Each group has been given an envelope. In the envelope you will find 16 
pictures of food or drink Working as a group, make an educated guess as to whether 
each item has a low, intermediate or high GI. Also estimate the portion size that would 
be needed to give you the same carbohydrate as a slice of bread Just before we break 
for refreshments I will give you the answer sheet. You can swap your quiz sheet with 
another team and they will mark it for you. You will receive one point for the correct GI 
and one point for the correct portion size. The maximum points awarded are 32. The 
four answer sheets will be included in your `week three' handouts, which will be 
distributed during the break 
BREAK (15 minutes) 
Consume refreshments and distribute the week three handouts for the manual. Display a 
copy of the book `A Pocket Guide to the Glucose Revolution for People with Diabetes' 
which has been reviewed by Diabetes UK. The review is included in the handouts. 
Lifestyle experiment (30 minutes) 
For the first 15 minutes, discuss how the participants have been doing with their 
`Dietary Action Plans' during the last week and ask if anybody wishes to share their 
experiments/goal setting experiences with the group (10 minutes). 
After the discussion, ask the participants to re-assemble into the same groups as the 
previous week and refer them back to their completed `balance of good health' sheets. 
Now ask them to observe their typical day's diet and mark each food/drink with either 
`H' for high GI, `I' for intermediate GI or `L' for low GI. By way of assistance, invite 
them to consider the quiz answers and the GI charts displayed in `week three' of their 
manuals. The groups should then be encouraged to discuss how they would be able to 
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lower the overall GI of their diet by swapping some high GI foods for low or 
intermediate ones. Inform the groups that they should experiment with this over the 
following two weeks and that you will discuss the lifestyle experiment session further in 
week five. 
For the next 5 minutes, refer participants to the self-management forms in their 
manuals. 
Tutor: In week one we said that achieving oplimum diahe'le'. s control mean! obtaining a 
glycated haemoglobin or HbA Ic of 65% or less. However, for some individuals 
achieving an HhA Ic of 7.5% or less may he more advisable. Has airyhcxly 
. 
found omil 
what his or her glycated haemoglobin is? If not then I'm sure that your diabetes care 
team will he happy to give you your las! blood lest result. If your result is too high what 
can you do about it? 
Answer: Working through this self-management form may help you to improve your 
diabetes management. 
Read through the form and answer questions as they arise. 
Tutor: As we discussed in week one, self-management is the key to healthy living and 
good diabetes control. If you wish to improve your blood glucose levels their completing 
this form will help you. Try experimenting over the next two weeks. If you have a, v 
queries then please telephone me or ask me after the supermarket tour next week. We 
will discuss your progress in week five. 
Before participants leave make sure that everybody is aware of the time and meeting 
place for their supermarket tour. Also inform the group that it will not be necessary for 
them to bring their manuals. 
4.3.5 Week four: supermarket tour 
Overview 
Fi re 4.13 Example of supermarket tour Fi. urc 4.14 (: ui(le in food IaIºcllim-, 
Guide to Food Labelling 
A lot A Little 
lO. Og of sugars 2.09 of sugars 
20. og of fat 3.09 of fat 
5.0g of saturates 1.09 of saturates 
3. Og of fibre 0.59 of fibre ý 
0.5a of sodium 0.10 of sodium 
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The supermarket tour (see figure 4.13 on page 144) has been a successful development 
in diabetes service provision within Burnley, Pendle and Rossendale, East Lancashire. 
Evaluations from previous tours have shown that it provides participants with the 
practical knowledge they desire whilst dispelling the myth that people with diabetes 
need a special diet. The learning process is a two-way one because it also helps the tutor 
to gain insight into the nutritional habits of different ethnic groups. 
The tour 
Welcome the participants and inform them that the tour will take between 1'/i and 2 
hours. As you progress around the supermarket, encourage people to ask questions as 
they arise. Reassure participants that you will be available afterwards to answer any 
queries regarding their lifestyle experiments. Have a GI pocket book for diabetes 
available and refer to it as necessary. Distribute Visual Aid 10 `Guide to Food 
Labelling' (see figure 4.14 on page 144) which has been adapted from the British Heart 
Foundation literature. 
Tutor: You will probably find this leaflet useful for reading and understanding food 
labels. The handy reckoning card helps you to identify whether food and drink contains 
`a little' or `a lot' of total fat, saturated fat, sugar, fibre and salt. When you look at a 
food label, if the food is something you will eat in large amounts such as a ready 
prepared meal, you would look at the `amount per serving. However, for snacks, other 
foods and drinks you would look at the per 100g' information. 
For your diabetes and blood glucose control, which is of greater importance: total 
carbohydrate or total sugars? 
Answer: You will recall from the session on glycaemic index last week that the 
quality and quantity of carbohydrate is more important than sugar intake 
Encourage participants to read food labels, looking in particular at fat, total 
carbohydrate and fibre. Explain that the ingredients are listed in order so that the one 
there is most of is at the top of the list and the one there is least of is at the bottom of the 
list. Having discussions around the points below will help people to obtain a better 
understanding of nutrition, health and diabetes. 
Cereals 
Tutor: Which cereal contains more sugar and which cereal has the largest effect On 
blood glucose levels - Cornflakes or All Bran7M? 
Answer: All Bran" (20g sugar/100g) contains more sugar than Cornflakes (8g 
sugar/100g). However, Cornflakes are a highly processed cereal with low fibre 
content and so they digest into glucose quickly. Whereas All Bran"' breaks down into 
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glucose much more slowly, resulting in a much more gradual increase in blood 
glucose levels. 
Look at the food labels of other cereals and point out that the lower GI and healthier 
cereals generally tend to be the ones with either oats, fruit and/or nuts, for example, 
museli, Fruit & Fibre, porridge, Fruitful Shreddies1M, FruitabixTM etc. Weetabix, 
Shredded Wheat and Special KT" are not quite as processed as Cornflakes and Rice 
Krispies and are therefore intermediate GI. 
Fresh fruit, dried fruit and fruit juice 
Tutor: Should people with diabetes have a restricted intake of these foods? 
Answer: These foods were previously restricted due to their sugar content. We now 
know that fruit and fruit products break down into glucose slowly and therefore have 
less of an impact on blood glucose levels than we previously thought. Therefore fruit 
is encouraged and people do not need to worry about meeting the five a day 
recommendations for fruit and vegetables. As with the general population, fruit juice 
should remain at one glass per day, as it is less nutritious than the whole fruit. 
Regular meals and snacks 
Tutor: Why are regular meals important? Are snacks necessary for everybody with 
diabetes? 
Answer: Although it has been shown that regular meals help to achieve better 
diabetes control It appears that snacks are not necessary for all people with diabetes. 
Each individual should decide whether snacks between meals are important for them. 
They should base this decision on individual preference, their daily activity levels, and 
their treatment of their diabetes. 
Red meat 
Tutor: We are frequently led to believe that red meat is bad for its - is this true? 
Answer: No, several cuts of red meat are now less than 5% fat and half of this fat is 
monounsaturated fat, which does not increase blood cholesterol levels. Therefore 
there is no need for people to `cut-out' red meat fron: their diet. Individuals may 
choose leaner cuts of meat and cook it in a suitable manner (grill, bake, fry with 
monounsaturated oil) and still obtain a healthy and varied diet. 
Fats 
Tutor: Why are we advised to reduce saturated (animal) fat? Which foods are the maifit 
sources of saiziraled fat? 
Answer: Saturated fats are found in butter, lard, cream, cheese, fatty cuts of meat etc- 
These fats raise bad (LDL) cholesterol levels and increase the risk of heart disease- 
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Polyunsaturated fat e. g. sunflower margarines and oils have been shown to reduce 
total cholesterol levels but also have been shown to reduce the good (IIUL) 
cholesterol. A common misconception is that polyunsaturated fat contains less 
calories - however all fats contain saute amount of calories (1 tablespoon oil =100 
calories). 
Tutor: What effect does monounsaturated fat have on the body and which oils/spreads 
contain a greater proportion of monounsaturated fat? 
Answer: Monounsaturated fat has been shown to reduce total cholesterol levels but, 
unlike polyunsaturated fat, it is beneficial for good (IIDL) cholesterol, 
Monounsaturated fat is also a lot more stable in the body and less likely to cause cell 
damage. Therefore individuals are advised to use oils and margarines, which contain 
a greater proportion of monounsaturated fat. 
Tutor: Look on the food labels for margarines and oils. Which ones contain more 
monounsaturated fat? 
Answer: Olive and rapeseed oil (many vegetable oils are pure rapeseed oil), Oliviorm, 
Utterly Butterly , and supermarkets own brand of olive oil/rapeseed margarines are 
sonic popular choices. 
Tutor: Most of you have probably heard about margarines that claim to reduce 
cholesterol level e. g Flora Pro-Activem and Beneco! M. Are these sensible choices? 
Answer: Research studies have shown that when the daily recommended quantity of 
these spreads are consumed, total blood cholesterol levels are reduceiL Ilowerer, the 
daily recommended amount is 25-30g. Therefore people may actually end up eating 
more fat and calories in their diet Further studies are required to assess the long- 
terns impact. Individuals therefore need to decide themselves whether the extra cost 
for these products is necessary. 
Remind people that there are other dietary modifications that reduce blood cholesterol 
levels. 
Eggs and prawns 
Tutor: Should the number of eggs eaten each week be restricted for people With 
diabetes? Do you need to avoid prawns? 
Answer: Cholesterol in food does not increase blood cholesterol levels - saturated fat 
is the culprit. Eggs do contain cholesterol but they are not too high in saturated fat. 
Therefore eggs may be incorporated into a healthy, varied diet as a protein portion 
and do not have to be restricted to only 2 per week. Also, although prawns contain 
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cholesterol, they are actually very low in fat and a great source of selenium - it's just 
the prawn sauce that you should be careful )º'ithl 
Fibre 
Tutor: Which fibrous foods have a beneficial effect on blood glucose and blood 
cholesterol levels? 
Answer: There are two types of fibre. Insoluble fibre, found in wholemeal bread and 
wholegrain cereals, has little effect on blood glucose levels but helps to prevent 
constipation. However, soluble fibre, found in oats, beans, peas, pulses, fruit and 
vegetables, delays fat and glucose absorption into the bloo(L These foods can help to 
control both blood glucose and blood cholesterol levels. 
Oily fish 
Tutor: Why are we encouraged to eat more oily fish? 
Answer: Oily fish has been shown to reduce blood fats (triglycerides). Two or three 
portions of oily fish each week reduce the risk among people with existing heart 
disease of having a heart attack: The omega-3 fatty acids in oily fish have also been 
shown to reduce pain and morning stiffness associated with rheumatoid arthritis. 
If people prefer to take supplements, it may be advantageous to take the higher 
strength capsules or high strength fish oil to ensure adequate intake of the fatty acids. 
Tutor: You will receive an information sheet on omega-3 fatty acids next week. 
Reduce salt 
Tutor: Reducing salt in the diet will help to do what? 
Answer: Reducing salt intake helps to control blood pressure. This is not always easy 
as many manufactured foods have high levels of salt eg bread and cereals It is 
however possible to omit salt in home cooking or certainly to reduce it. You should be 
aware of heavily salted foods such as smoked products and savoury snack and 
processed fool Ensuring an adequate intake of calcium eg milk and dairy food, and 
potassium from fruit and vegetables also helps to reduce sodium (salt) levels in the 
blood and can therefore be beneficial to blood pressure levels. 
Make sure that people have time to ask their own questions as you move around the 
store. At the end of the session, give all the participants a summary handout of the tour 
and advise them to place it in week four of their manuals. Thank everybody for coming 
and remind participants that you are back at the normal venue at the normal time next 
week for session number five. 
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4.3.6 Week five: possible complications of diabetes 
Overview 
This session is intended to be informative without being too alarming. The session starts 
with a group activity to define hypoglycaemia, hyperglycaemia and to discuss how to 
reduce the risk of these short-term complications of diabetes. Activity Two aims to 
present the facts of the potential longer-term problems of diabetes. Participants are 
presented with the evidence that optimum blood glucose and blood pressure control, 
along with healthy living, reduces the risk of developing secondary complications. 
(Stratton et al. 2000). Visual aids (see figures 4.15 & 4.16 below) have been developed 
to explain cardiovascular disease, nephropathy, neuropathy and retinopathy in simple 
terms. Individuals are also informed about Diabetes UK guidelines that indicate what to 
expect from an annual review, which procedures to follow in order to detect early signs 
of complications and the treatments available for such complications. The session is 
based on patient activation and participants are encouraged to be as involved as 
possible. 
4 iýurc 4.15 \Litc"rials used in the session 
Ow 
low 0ý 
Visual aids 13 to 16 
Figure 4.16 display board 
Activity one: short-term complications (15 minutes) 
Hypoglycaemia 
Tutor: What is hypoglycaemia and what increases the risk of having a 'hypo' (Write 
responses on the flipchart). 
Answer: Hypos occur when the blood glucose level drops too low. This can happen if 
the person with diabetes does any of the following (add extra points to the list if 
necessary): 
Q misses a meal; 
o doesn't eat enough carbohydrate e g. an omelette with salad contains very 
little carbohydrate; 
a is a lot Hore active than nornud; 
Visual aid 11 
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o takes too many tablets l injects too much insulin by mistake; 
o drinks alcohol on an empty stomach or drinks too much alcohol. 
Hot weather may also cause hypoglycaemia in individuals injecting insulin, as the heat 
causes it to be absorbed quicker. 
Tutor: What are the symptoms? 
Answer: These are different for everybody but the following are common symptoms: 
Q shaking; 
Q sweating; 
Q confusion; 
Q tingling in mouth, 
Q headache, 
Q mood changes (often bail temper); 
Q blurred vision; 
o hunger; 
Q unsteadiness. 
Tutor: What is the quickest way to treat hypos? 
Answer: Pure glucose because it is immediately released into the bloo(L A glass of 
Lucozade or three glucose (Dextrose) tablets are good examples. Other 
carbohydrates (sugar and starch) will work but not quite as quickly. If glucose is not 
available, high GI foods are recommendecb Once the hypoglycaemia has been treated, 
it is advisable to have your meal as soon as possible. Failing that, a carbohydrate 
snack such as apiece of fruit, slice of malt loaf or yoghurt would be of benefit If you 
still feel `hypo' have more glucose and if possible test your blood to make sure that 
the blood glucose level has risen above 4 mmol/b 
Hyperglycaemia 
Tutor: OK, we Imow what hypoglycaemia is - what is /hyperglycaemia? 
Answer: Persistent raised blood glucose levels, above 7 mmolll before meals and 
above 10 mmol/l after meals. 
Tutor: How can blood glucose levels rise too high? 
Prompt the group to respond with the following and briefly discuss each one: 
Q eating too much carbohydrate Le. starches or sugars; 
Q illness (being ill causes body cells to release more glucose from storage. You 
need to continue to take diabetes medication even if not eating and contact 
your diabetes care team for further advice if the problem persists); 
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Q being less active than normal (less energy used s less carbohydrate needed - 
compare to a car, the, fewer miles travelled, less petrol is used! ): 
Q forgetting to take your insulin or diabetes tablets or taking them incorrect/i': 
Q requiring more medication (you may arrive at this conclusion if you have 
worked through the self-management form distributed in week three). 
Activity two: longer-term complications (60 minutes) 
Figure 4.17 Complications poster 
ti 
Hºqh blood pressure 
<td-*y disease 
Have visual aid 19 the longer-term 
complications display board' (see 
figure 4.16 on page 149) set up at the 
front of the room but conceal it until 
after the next activity. 
Attach visual aid 12. It is a poster 
(see figure 4.17 opposite) showing a 
diagram of a body with its major 
organs. In addition there are seven 
red arrows. Attach the poster to the 
wall or flip chart and ask participants 
to state what the possible long-term 
complications of diabetes are. Then 
Pan or loss of the lower 
leg(s) due to impaired blood 
flow 
Periphiwal neurooathy 
ineive Clisease; 
ask them to attach the red arrows so 
that they point to the areas of the 
body that are affected by those 
complications. The arrows need to 
point to the head (stroke); eyes 
(retinopathy); heart (heart attack); circulation (blood pressure and peripheral vascular 
disease), kidneys (nephropathy); feet and legs (sensory neuropathy); stomach, gut, 
bladder and sex organs (autonomic neuropathy). Try to cover the following points in the 
discussion while putting the emphasis on prevention. 
Heart and Circulation 
Tutor: One of the main causes of heart and circu/Moil problem, is Ilhr result of Ihr 
build up cf fatty deposits (cholesterol) on the /iniiºg. v ojthe blood ressc'/s. 
Demonstrate this by putting a small quantity of lard down a drinking straw (Visual Aid 
13 `Atherosclerosis). Now try to pour Ribena1~ down the straw. 
«R© 
Complications 
of Diabetes 
Eye dost+ase Over tme, high glucose levels can 
lead to the foibwmg 
oompi ons 
Heart disease 
Tutor: Lets assume that the straw is a blood vessel, the lard represents fclltº' cholesterol 
deposils in the blood vessel and the Rihelia"' is blood. Whal happens lo the blood flovi'ý 
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Answer: The blood flow becomes impaired This can cause further damage to the 
blood vessels. 
Tutor: What can happen then? 
Answer: The blood vessel can become completely blockeiL If this occurs in the brain 
it is known as a stroke- If it happens in the blood vessels leading to the heart it is a 
heart attack or in the leg, thrombosis. 
Pass around visual aid 14 `The atherosclerosis plaque' 
Tutor: If your diabetes is not controlled and your blood glucose levels remain high for 
a long period of time, will this affect blood flow? 
Answer: Yes, this will further impair the flow of blood around the body. Raised blood 
cholesterol levels, raised blood glucose levels and raised blood pressure levels all 
increase the risk of developing the longer-term complications of diabetes. W hen two 
or three of these conditions are present, the risk increases. 
Eve problems 
Tutor: Why might a person with diabetes develop problems with their eyes? 
Show participants the model of the eye (visual aid 14). 
Answer: Damage to the tiny blood vessels at the back of the eye is caused as a result 
of raised blood glucose levels and raised blood pressure levels. The tiny blood vessels 
become damaged and leaky, affecting eyesight (Use the model to point to the blood 
vessels at the back of the eye). This can progress unnoticed until eyesight is affecteck 
The medical term used is `Retinopathy . You need to have an eye check at least once a 
year by a trained person, e. g. an optometrist, who will usually use a retinal-screening 
camera to take a picture of the blood vessels at the back of your eye 
Use visual aid 10 and show the participants the two pictures of the back of the eye and 
ask the group which is the normal eye and which is the damaged eye (The correct 
answer is written on the back of the respective photos). 
Tutor: If the eye is damaged can anything be done? 
Answer: Yes, laser treatment is very effective at sealing the leaky blood vessels and 
preventing the damage from getting any worse. However, early treatment is vital 
before too much damage has been clone 
Foot problems 
Tutor: Diabetes may cause problems to your lower legs and feet. if'hy is this? 
Answer: Diabetes can cause nerve damage to the legs and feet (sometimes also to the 
arms and hands). This is called neuropathy and can result in numbness, tingling and 
pain. 
Tutor: What are people advised to do to reduce their risk of developingfo of problems? 
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Answer: Nerve damage may cause a loss of sensation in the feet and lower legs, and 
therefore people are advised to check their feet daily for any injury that may have 
occurred and gone unnotice(L To reduce the risk of damage occurring, it is also 
advisable to have well fitting shoes, not to walk around in bare feet and not to put feet 
on heated appliances (hot water bottles/radiators). People with diabetes have the right 
to see a chiropodisdrodiatrist free of charge and need to have their feet and legs 
checked at least once a year by a trained health professional to detect nerve or 
circulation problenm Many treatments are available if you are experiencing pain. 
Please ask your diabetes care team. 
Kidney problems 
Tutor: Why would the body not work properly without kidneys? What is the function of 
the kidneys? 
Answer: In simplistic terms, the kidney is basically a filter, filtering waste and excess 
water out of the body and retaining blood and nutrients like protein. 
Tutor: Why might somebody with diabetes have an increased risk of developing kidney 
damage? 
Answer: Raised blood pressure and raised blood glucose levels damage the tiny blood 
vessels that supply the kidneys and therefore damage the filtering system. 
Show visual aid 15, `three sieves' (one perfect, one with tiny holes in it that allow small 
particles through e. g. chick peas, and the third sieve that has a large tear in it that allows 
a `ping-pong' ball through). Ask the group what these show and prompt them to 
respond with: 
o the perfect sieve equates to a healthy kidney; 
Q the sieve with the tiny holes equates to a kidney becoming leaky and letting 
small amounts of protein (microalbuminuria) into the urine; 
o the sieve with large tear equates to a large quantity of protein leaking into the 
urine causing kidney disease (Nephropathy). 
Tutor: How are your kidneys checked to see if there is damage? 
Answer: All that is required is a simple urine test The urine is tested to see if there is 
any protein present Protein is present in the urine of approximately 50% of people 
with diabetes. Depending on the level of protein in a simple urine test you may be 
asked to collect your urine for a 24 hour period It is important to have a urine check 
for protein at least once a year, because if there is damage to the kidneys, treatments 
are available to reduce the risk of the problem becoming worse 
Stomach. Gut. Bladder and Sex Organs 
Tutor: Has anybody heard of autonomic neuropathy? Does anybody know what it is? 
157 
Answer: This is damage to the nerves that control involuntary activities such as 
digestion, 
Tutor: How can damage to these nerves affect the body? 
Answer: If the nerves to the stomach become damaged, that may delay digestion 
resulting in bloating and nausea. Damage to the nerves in the gut may result in either 
diarrhoea or constipation. If the nerves in the bladder are affected, you may not be 
able to tell if your bladder is full of urine. Both men and women may be affected by 
nerve damage to their sex organs resulting in dryness for women and erectile 
dysfunction for men. There are treatments for all of these conditions and you should 
speak to your diabetes care team if you are currently experiencing any of them. 
Prevention 
Tutor: All the longer-term complications of diabetes are largely preventable. What 
could you do to reduce your risk? Or if you are already experiencing problems how can 
you reduce the risk of then getting worse? (Write down the responses on a flipchart 
making sure that all the options below have been discussed): 
Q obtain good blood glucose and blood pressure control; 
C3 achieve optimum blood cholesterol levels; 
Q lose weight if necessary; 
o stop/reduce smoking, 
Q reduce saturated (animal) fat; 
Q use monounsaturated oils/spreads in preference to saturated/polyunsaturated 
ones; 
o increase physical activity levels, aiming for 30 minutes of walking each day or 
equivalent; 
Q eat more fruit and vegetables, aiming for at least five portions each day; 
o eat more wholegrain food and less processed food; 
o eat more soluble fibre. 
Tutor: It is also very important to undergo all the regular investigations and tests. If 
complications are detected early, treatments, combined with healthy lifestyle changes 
will help prevent the problem(s) becoming worse. 
BREAK (15 minutes) 
Utter refreshments and distribute the `week five' packs, informing participants to place 
them in the relevant section of their manuals. Encourage participants to observe and 
discuss the complications display board. 
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Lifestyle experiment (30 minutes) 
Ask how many participants have completed the self-management form Facilitate group 
discussion regarding individual experiments that have arisen from the Dietary Action 
Plans, glycaemic index exercise and self-management forms Alternatively, if the group 
prefers, split into smaller working groups. Ideally, participants will have more 
confidence to share their experiences (positive and negative). They may then acquire 
new ideas from other group members. Continue for 30 minutes if the group is having a 
lively discussion. However if, after 15 minutes, discussions are subsiding, split the 
participants into smaller groups and hand out one of the three case studies. Ask the 
group to read through the case study and answer the questions at the bottom. Give the 
groups around five minutes to do this and then discuss each case study before 
concluding the session. 
Remind participants that next week is the final session. Invite participants to bake a low 
fat/high fibre cake and bring it along to the session for other participants to sample. 
4.3.7 Week six: questions and evaluation 
Overview 
Figure 4.18 `Living with Diabetes' game 
For the last session, participants have been encouraged to adapt recipes by reducing 
saturated fat and increasing fibre content. Some individuals may bring in a sample of 
home baking for the group to taste (see figure 4.19 above). The participants play the 
`Living Kith 1)iaheles' board game (see figure 4.18 above). The group is split into 
teams. Questions have been developed on the topics covered during the previous five 
weeks. Correct answers allow the team to progress down the board stumbling across 
"penalties" and "rewards" in place of snakes and ladders. The winning team is the first 
one to make it to the final. Feedback from these sessions is very positive because 
Source: American Diabetes Association 
Figure 4.19 Participants sampling 
adapted rede % 
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participants are able to reflect on how much they have learnt. Everybody that completes 
the programme is awarded a certificate. Each participant is asked to complete an 
evaluation sheet to rate the expert patient programme. The questions ask about 
enjoyment of the sessions, their usefulness and the perceived effect on participants' 
health. 
Activity one: resources (15 minutes) 
Welcome the participants as they arrive and inform them that you have brought along a 
selection of information leaflets that they may find useful including: Diabetes UK 
resources and membership details, pharmaceutical literature, recipes, local Diabetes UK 
branch programme, Exercise on Prescription information, and MedicAlert" flyers. 
Allow the group 15 minutes to browse through the leaflets and select the ones they will 
find useful. Make sure there is a hole punch available to enable leaflets to be filed in the 
manuals. 
Activity two: Living with Diabetes game (60 minutes) 
Split the group into six teams. 
Tutor: This game has beeil purchased from the American Diabetes Association. It is a 
game that resembles other board games seich as Snakes and Ladders. However, in order 
to progress down the board your team must ai: swcr the diabetes related questions 
correctly. The first team to arrive at the finish receives a prize. If ill the time allocated, 
»o team manages to finish, their the team who is fiirthest dowii the board will win. 
Sort the American question cards and remove the questions that do not directly relate to 
European recommendations and guidelines or those that use different measurement 
levels for biomedical results. Instead, use question cards that question and reinforce the 
information delivered during the diabetes expert patient programme. 
Tutor: Please also use this time to ask questions and discuss any of the topics that 
arise. 
Participants will generally be surprised at how much information they have absorbed 
over the preceding six weeks. Present each individual in the winning team with a prize 
such as a small packet of dried apricots or pharmaceutical freebies (BMI calculator, 
waist circumference tape measure etc. ). 
BREAK (15 minutes) 
utter retreshments together with any healthy eating cakes supplied by the participants. 
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Lifestyle experiment (20 minutes) 
Whole group or a number of smaller group discussions regarding the Dietary Action 
Plans, glycaemic index exercise, self-management forms, physical activity and other 
goals, and the way forward. Ask whether participants intend to continue with these 
experiments? 
Evaluation forms (10 minutes) 
Hand out the expert patient evaluation forms. 
Tutor: We are handing out an evaluation form for the diabetes expert patient 
programme. For each week we are asking you to score each week for ei joyment, 
usefulness and the perceived impact on your health. A score of zero indicates the most 
negative response, whereas a score of 10 indicates a very positive evaluation. These 
evaluations are important as they allow future programmes to be modified and 
improved where necessary: If possible please complete the form before you leave. 
However, if this is Brot possible, please take a pre paid envelope and eise this to retuiril 
the evaluation form. 
4.4 Summary 
This chapter has presented the scripted tutor's manual for the delivery of the diabetes 
expert patient programme "X-PERT". The effectiveness of the programme has been 
evaluated by a randomised controlled trial and this evaluation is the subject of the 
remaining three chapters. Chapter 5 discusses the development and detail of the clinical 
trial. Chapter 6 presents the results and Chapter 7 highlights the strengths and 
limitations of the programme and clinical trial before conclusions and recommendations 
for future practice and research are drawn. Although the programme has been designed 
to enable the programme to be delivered in a similar manner to the clinical trial, it is 
appreciated that different patient groups may have slightly different needs and the 
manual will need to be adapted accordingly. The manual will also need to be updated as 
new evidence-based guidelines become available. 
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EXPERT PATIENT EDUCATION VERSUS ROUTINE TREATMENT 
5.1 Introduction 
This chapter presents the research proposal for the randomised controlled trial. A brief 
background summary is followed by a description of the development of the X-PERT 
trial, the demographic aspects of Burnley, Pendle and Rossendale and the research 
design. An argument for and against an epistemological approach to the research design 
than follows. The X-PERT trial tests the hypothesis that delivery of a professional-led, 
community based, diabetes-specific expert patient programme for adults with Type 2 
diabetes based on the theories of patient empowerment and patient activation will: (1) 
develop the skills and confidence needed for patients to be able to make informed 
decisions regarding their diabetes self-management; (2) improve biomedical, lifestyle 
and psychosocial outcomes both in the short term (four months) and longer-term (14 
months); (3) meet the International Diabetes Federation (IDF) structure and process 
standards regarding diabetes education. 
5.2 Background 
5.2.1 Type 2 diabetes 
The background section summarises previous material for those who read this chapter 
in isolation. Diabetes is a chronic condition that arises when the pancreas does not 
produce enough insulin or when the body cannot effectively use the insulin produced. It 
is one of the most challenging health problems of the 21' century, currently affecting 
194 million people worldwide and estimated to affect 333 million by 2025 (Sicree, 
Shaw, & Zimmet 2003) (see Chapter 1 for more detailed information about Type 2 
diabetes). 
It is well recognised that obesity is a major factor in the aetiology of Type 2 diabetes 
and it contributes to poor glycaemic control, hypertension and dyslipidaemia (Wilding 
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2000). A 10% reduction in body weight has been shown to significantly improve 
glycaemic control, blood pressure and lipid measurements, and reduce diabetes 
mortality by 30% (Lean et al. 1990). It has also been shown that social deprivation leads 
to a poor diabetes outcome (Evans et al. 2000). Over recent years, it has been the health 
and well-being of people living in the most run-down communities that has suffered the 
most (Acheson 1998). Successful health education programmes in the past have tended 
to widen inequality because they targeted the more affluent and better educated sector 
of society who were likely to take more notice and change their behaviour (13011 1999). 
A large proportion of patients with lower socio-economic status have never received 
diabetes education (Coonrod, Betschart, & Harris 1994). Attendance at patient 
education classes in diabetes management has been positively related to self-testing 
(Lennon et al. 1990). It has also been suggested that there may be less adequate 
provision of services for those with social deprivation, and strategies in diabetes 
services should be considered in order to improve the standards of care offered (Ward 
1994). 
5.2.2 Health behaviour change 
It is now recognised that effective diabetes management lies almost entirely in the hands 
of the patient who lives with the condition (D4l1 & Diabetes UK 1995). However, as 
discussed in Chapter two, present health care delivery is often based on the acute model 
of care. Within this framework the health professional is the `expert' and informs the 
`patient' what they feel is the correct treatment for optimal care. The patient is often 
viewed as a recipient and performer of regimens that are to be accepted and obeyed. 
Present diabetes education is largely theory based and delivered to individuals within a 
clinical setting. Follow-up is infrequent due to the increasing numbers of people with 
diabetes and limited availability of resources. Many people with diabetes find the 
current delivery of service inadequate and have difficulty putting the theory into 
practice (Pooley & Gerrard 1999). Those findings may be one of the reasons why, 
although the benefits of good control are known, there is still a large percentage of 
individuals whose overall glycaemic control is unsatisfactory (Clark 2000). 
Descriptive articles exploring patient empowerment and a more autonomous approach 
to patient education have started to emerge in healthcare journals (Skinner & Cradock 
2000). Although international reports have acknowledged that the consultation with the 
health professional should become a `dialogue between experts' based on an 
empowerment model and learner centred education, (DOIl & Diabetes UK 1995) little 
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work has been done in this area. Education is not merely about giving information, it 
must be designed to enable patients to self-manage the treatment of their condition 
while maintaining or improving their quality of life. It is not the case that many people 
arc unwilling to change their behaviour but that they arc unwilling to 1 changed 
(Anderson & Funnell 2000c). (For more information about health and health behaviour 
change, see Chapter 2). 
5.2.3 Diabetes education 
A report to Diabetes UK recognised that the majority of studies evaluating diabetes 
education programmes for people with diabetes have been based within secondary care 
in America (see Chapter 3) (Griffin et al. 1998). The report recommends that more 
research should be carried out within primary care in the United Kingdom. A systematic 
review of group-based diabetes education programmes is presented in Chapter 3. 
5.2.4 Public health policy 
In 1997 the Government set out its plans for the modernisation of the NITS in a White 
Paper The New NHS: Modern and Dependable (DOH 1997). It outlined a ten year 
programme for the development of health and social care, which described a vision of 
the Health Service as one that: 
o tackles the causes of ill-health and health inequalities; 
U removes barriers between services; 
E3 ensures uniformly high standards; 
v guarantees that services are cost ef'f'ective; 
El makes services more accessible and more convenient for patients. 
That was followed by Saving lives: our healthier nation (DOH 1999), which recognised 
that as many as 17.5 million adults may be living with a chronic disease. It set out a 
vision for a new, more patient-centred NITS and confirmed a commitment to help 
people living with long-term conditions to take more control over their health and 
improve their quality of life through an Expert Patients Programme. (Refer to Chapter 2 
for a full history and discussion regarding public health policy). The Expert Patients 
Task Force was set up, chaired by the Chief Medical Officer, to make recommendations 
for such a programme. The task force published a report: `The Expert Patient: A New 
Approach to Chronic Disease Management for the 21" Century' (DOH 2001c). 
However, there remains much uncertainty about the most appropriate and 
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effective strategy for educating and empowering people with diabetes to 
accomplish beneficial behavioural changes. There is, as yet, no published empirical, 
study that has tested the empowerment model in its entirety and, until such data emerges 
the model, although promising, can only be argued for on philosophical grounds 
(Skinner & Cradock 2000). 
5.2.5 Development and reflection 
The research proposal was developed in 1999 based on the dietetic service evaluations 
(reported in Chapter 4, section 4.2). That was prior to the government's publication of 
its intentions with regard to expert patient programmes. The research proposal `Eiert 
Patient Education versus Routine Treatment' with the acronym `X-PERT' proposed a 
plan to deliver a professional-led diabetes expert patient programme to adults with Type 
2 diabetes and to compare outcomes with those resulting from routine treatment. The 
overriding aim was to ensure that the education programme was patient-centred and 
provided an opportunity for individuals with diabetes to increase self-empowerment by 
developing the skills and confidence to take more control over, and to self-manage their 
diabetes. This study aimed to recruit individuals with Type 2 diabetes who live within 
deprived areas. The proposed group-based diabetes education sessions had potential to 
add value to the present diabetes care system. It was thought that they could improve 
diabetes control, reduce the risk of developing secondary complications and positively 
impact on diabetes knowledge, treatment satisfaction and quality of life. 
Registration for a PhD was initially at The Institute for Health, Lancaster University. 
The proposal involved action research and initially did not include a control group. 
However, with such a complex intervention, it would be difficult to assess the size of 
any Hawthorne effect. Advice was sought from experts in the field and emails were sent 
to the following: 
1) Dr Steve Morton (steve. mortonnelancs-ha nwcst nhs uk) 
2) Dr Melanie Davies (research na. ] ri. org k) 
3) Professor Kinmonth (ALK25 a, h1edschl. cam. ac. uk) 
4) Mr Chas Skinner (chas a r. d. dircon. co. uk) 
5) D. Barker (d. barkernman. ac. uk) 
6) Pete Bower (pete. bowernman. ac. uk) 
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Several helpful responses were received and Dr Morton, Director of Public Health for 
East Lancashire Health Authority suggested that the proposal should be presented to the 
Public Health Department. The presentation took place in July 2000 and constructive 
feedback was received. 
The gold standard method for evaluating interventions at the level of the individual is 
the randomised controlled trial. While it is argued that randomised trials arc the optimal 
design for evaluating interventions to improve the organisation of health services, they 
should only be considered when there is genuine uncertainty about the effectiveness of 
an intervention (Grimshaw et al. 2001). Critics of randomised trials frequently express 
concerns that the tight inclusion criteria of trials, or the artificial constraints placed upon 
participants, limit the generalisability of the findings (Victora et at. 2004). While this is 
a particular concern in efficacy (explanatory) studies of health technologies, it is likely 
to be less of a problem when studying pragmatic trials (Stephenson & lmrie 1998). 
In non-randomised designs, there are potentially greater threats to internal validity and 
less ability to account for them. The design and conduct of non-randomised studies are 
at least as methodologically challenging as the design and conduct of randomised trials. 
As with randomised trials, the external validity of non-randomised trials may also be 
poor if they are conducted in a small number of study sites that are not representative of 
the population to which the researcher wishes to generalise (Grimshaw et al. 2001). 
Therefore it was decided, in this instance, that an epistemological methods were 
appropriate to either accept or reject the research hypothesis. 
It was suggested by Dr Andrew Clark that Professor Rhys Williams at the Nuffield 
Institute for Health, University of Leeds would a suitable person to offer expert advice. 
The Institute for Health Research, Lancaster University has an excellent reputation for 
qualitative research but did not tend to evaluate health using quantitative approaches 
and randomised controlled trials. Therefore, after consultation with Proffessor Janet 
Cade at the Nuffield Institute for Health, University of Leeds, PhD registration was 
transferred to the Nuffield Institute for Health with supervision provided by Professor 
Cade and Professor Williams. Final minor amendments were made to the research 
proposal following presentation to the Public Health Division and Nutrition and 
Epidemiology Group at the Nuffield Institute for Health in November 2000. 
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5.2.6 Funding 
Several databases were examined in the search for appropriate funding organisations, 
the most helpful database was `RD Info -A Digest of Health-Related Research Funding 
and training Opportunities'. In total, 13 applications were made to nine funding 
organisations and three applications were made to two local health care organisations. 
Table 5.1 above summarises those applications. The majority of applications were made 
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whilst the author was working full-time as a state registered diabetes dietitian at East 
Lancashire Hospitals NHS Trust (formerly Burnley Healthcare NILS Trust). 
From the applications described above, £124,338 was awarded towards the project. 
Enquiries were also made of industrial companies supplying nutritional products and 
diabetes/obesity medications to the NHS. Nutricia, a clinical nutrition company, 
donated £75 towards the project for the blood pressure monitoring device and Roche 
Diagnostics donated £500 for the transportable height measure and body weight/body 
fat scales. The local branch of Diabetes UK awarded £250 towards books and 
equipment. 
5.2.7 Setting, ethnicity and deprivation scores 
The setting for the study was the Burnley, Pendle and Rossendale area in East 
Lancashire in the North West of England (see figure 5.1 and figure 5.2 below). There is 
a GP registered population of 254,527 (ELHA 2001 a) and the prevalence of diagnosed 
diabetes is estimated at between 6,000 and 8,000 people. The ethnic minority population 
in Burnley, Pendle and Rossendale has increased from 6.4% in 1991 (ELHA 1999) to 
9.6% in 2001 (Office for National Statistics 2003) (see table 5.2 overleaf). The 
prevalence of Type 2 diabetes has been shown to be up to six times more common in 
people of South Asian decent (DOH 2001 a). 
Figure 5.2 Map of Burnley, 
Pendle & Rossendale 
Figure 5.1 Map of the United Kingdom 
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When compared to the rest of the country, Burnley, Pendle and Rossendale have 
relatively poor health and within each locality there are examples of exceptionally poor 
health. That is reflected in the high figures for premature death in the area as a whole 
(see figure 5.3 below). 
The major causes of premature death in Burnley, Pendle and Rossendale are heart 
disease, respiratory disease and injury. For example, deaths from ischaemic heart 
disease are 34% above the national average; 15.9% of the population in Burnley, Pendle 
and Rossendale report a long term illness, and the number of people admitted to hospital 
with a diabetes related illness is greater than the national average (ELHA 2001 a). 
Figure 5.3 Standardised mortality ratios for under 75 years, 19%-1998 
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There are significant differences in the living standards experienced within the Burnley, 
Pendle and Rossendale areas. For example, using the DETR 2000 method described 
below on page 168, Daneshouse in Burnley is ranked the sixth most impoverished ward 
in the country, whereas Fence in Pendle is ranked 7788'h out of 8414 in terms of 
nationwide poverty ratings (see figure 5.4 overleaf) (ELHA 2001a). Daneshouse is an 
area largely populated by people from a South Asian background. It has been shown 
that ethnic minority populations have higher rates of unemployment and are more likely 
to be housed in either overcrowded or poorer quality accommodation (ELHA 1999). 
Source: Office of National Statistics 
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Although there is a range of deprivation across the area, 56% of the wards in Burnley, 
Pendle and Rossendale fall within the worst 25% of wards nationally in terms of 
housing conditions and unemployment related poverty. This is reflected in unhealthy 
lifestyles with higher than average levels of smoking and poor diets (ELHA 2001 a). 
Figure 5.4 Indices of deprivation 2000 
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There are three common methods used to estimate deprivation; the Jarman Score, the 
Townsend Score, and the Department of the Environment, Transport and the Regions 
(DETR) indicators. Most methods try to measure geographical populations rather than 
individuals or social groups (Avon NHS 2003; National PCG/T Database 2003). 
Jarman Score 
The Jarman score was developed 20 years ago as a measure of General Practice 
workload and is often used as an assessment of deprivation. It has been used by the 
Department of Health to determine additional "deprivation" payments to GPs. The 
scores were re-calculated for the 1991 census, using the same census variables as 1981. 
The calculation of the Jarman score consists of the three stages: data identification, 
weighting and aggregation. Eight census variables, each of which is individually 
weighted, are used in the calculation: 
L3 percentage of people in households who are aged 65 or over and living alone 
(weighted at 6.62 ); 
o percentage of the people living in households who are aged under 5 (weighted at 
4.64); 
o persons in households of one person over 16 with one or more children under 16 
as a percentage of all persons in households (weighted at 3.01) 
Q persons in households headed by a person in socio-economic group 11 
(unskilled workers) as a percentage of all residents in households (weighted at 
3.74); 
o economically active persons aged 16 and over who are unemployed and seeking 
work (weighted at 3.34); 
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a persons in households with more than one person per room as a percentage of all 
residents in households (weighted at 2.88); 
u persons aged one year or over with a usual address one year before the census 
that is different from the present usual address as a percentage of total residents 
(weighted at 2.68); 
o people in households headed by a person born in the new Commonwealth or 
Pakistan as a percentage of all residents in households (weighted at 2.50). 
The mean for England and Wales is 0. An area with a high score has a greater demand 
for primary care, based on the characteristics of the resident population, than an area 
with a low score. Extreme scores are those above 32 (rounded to 30 by the Department 
of Health). 
Townsend Material Deprivation Score 
The Townsend score is made up by looking at four census variables: 
o unemployment - percentage of economically active residents aged between 16 
and 59 for women and 16 and 64 for men who are unemployed; 
o car ownership - percentage of private households who do not possess a car; 
v owner occupation - percentage of households not owner occupied; 
o overcrowding - percentage of private households with more than one person per 
room 
The data is taken from the 1991 census. The variables combine to form an overall score 
ranking a particular area relative to others. The higher the score, the more deprived the 
area. The average is 0. 
DETR 2000 
The Department of the Environment, Transport, and the Regions (DETR) have 
produced several ward and local authority level deprivation scores looking at different 
aspects of deprivation. The six domains they have used are: 
o income; 
o employment; 
o health deprivation and disability; 
o education; 
o skills and training; 
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Q housing and geographical access to services. 
In addition, there is an overall score and rank for every ward in England called the 
Index of Multiple Deprivation 2000 and a supplementary score and rank on Child 
Poverty. The combined score is a combination of all six domains. Each of the six 
domains uses a variety of data, mainly taken from social services, which are then 
weighted according to importance and combined to create a score. The score is then 
used to rank the wards so that `1' is the most deprived and 8414 is the least deprived in 
England. It is the rank, and not the score that should be used. 
are identified in Table 5.3 (above). As it is a national priority to tackle health 
Each method for assessing deprivation has its advantages and disadvantages and those 
172 
inequalities (DOH 1997; DOH 1999) (Evans et al. 2000) and as it has been suggested 
that low socio-economic status leads to poor diabetes outcomes, an attempt was made to 
recruit participants from socio-economic deprived areas throughout Burnley, Pendle and 
Rossendale. Since the intention was to recruit participants for the study from general 
practices, it was decided that tracking the number of deprivation payments made to GPs 
based on Jarman scores would be an effective way of identifying practices with a higher 
percentage of registered patients who were classed as socio-economically deprived. 
5.3 Methods 
The study was carried out in three phases: phase one commencing in January 2001 in 
the Burnley district; phase two commencing in July 2001 in the Pendle district; phase 
three commencing in January 2002 in the Rossendale district. 
5.3.1 Hypothesis 
Health professional led, group-based and patient-centred expert patient programmes for 
adults with Type 2 diabetes improve self-empowerment, self-management skills and 
positively impact on diabetes control. 
Aim of the expert patient programme (X-PERT): 
to develop, monitor and evaluate a community based expert patient programme for 
adults with type 2 diabetes. 
Immediate objective: to empower patients to have more responsibility, better self- 
management skills and better personal control over their diabetes. 
Longer-term objective: to improve diabetes specific quality of life and diabetes control 
and promote a healthier lifestyle. 
Sub-group analysis: to assess the effectiveness of the education programme for South 
Asian participants with diabetes. * 
* Although the study was not powered for sub-group analysis, the high percentage of 
South Asian residents within Burnley, Pendle and Rossendale and the increased 
prevalence of diabetes among that ethnic group, encouraged the view that a sub-group 
analysis for the primary outcome (glycated haemoglobin) would be of interest. 
5.3.2 Ethical approval 
The original research proposal based on action research (with no control group) was 
submitted to the Burnley, Pendle and Rossendale Local Research Ethics Committee in 
June 2000. It was accepted subject to one or two minor amendments. However, the 
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application was re-submitted in September 2000 with the revised proposal for a 
randomised controlled trial. Although ethical approval was obtained, the committee 
expressed concern regarding the feasibility of recruiting 300 adults with Type 2 
diabetes. A response was returned to the chairman of the committee stating that the high 
prevalence of diabetes in the district (between 6,000 and 8,000 people) indicated that 
problems with recruitment would be unlikely. The final correspondence from the Ethics 
Committee dated 106' October 2000 stated `I am satisfied with your comments 
regarding recruitment of subjects to the study and formal ethical approval is now 
granted for the study to proceed' (Appendix 3). 
5.3.3 Recruitment 
Recruitment of general practices 
An application was made to the Family Health Services Manager at the former East 
Lancashire Health Authority seeking the number of deprivation payments by band by 
GPs for Burnley, Pendle and Rossendale. Deprivation payments data was received for 
Burnley and Pendle but details regarding deprivation payments for Rossendale were 
held by the former Rossendale Primary Care Group and not East Lancashire Health 
Authority. A formal application to Rossendale Primary Care Group requesting such 
information was refused on the ground of GP confidentiality. There was an opportunity 
for appeal through the Local Medical Committee but that process would have taken 
several months and the timescale for the study could not accommodate such action. 
General practices from the Rossendale area were therefore invited to take part in the 
study if they were situated in one of the wards in the poorest quartile for housing based 
on the DETR Index of Deprivation (see figure 5.4 on page 169) (ELHA 2001 b). 
When a practice was identified as receiving a high volume of deprivation payments 
(Burnley and Pendle) or noted to be situated in a deprived ward (Rossendale), the 
practice was contacted and a meeting arranged with the practice manager, lead GP 
and/or practice nurse. The details of the study were discussed and a practice information 
sheet (Appendix 4a) provided, stating both the aims and objectives of the study and 
what was required from the practice. If the practice agreed to participate in the study, a 
practice consent form (Appendix 4b) was supplied for completion. Participating 
practices then provided a list of names, addresses and telephone numbers of all 
registered patients with Type 2 diabetes. 
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Recruitment of participants 
On receipt of the patient list from participating practices, an invitation letter with a 
patient information leaflet (Appendix 5a) was sent to patients who met the inclusion 
criteria (see section 5.2.4 below). If the patient had a name suggesting that they were 
from a South Asian background, two letters and information leaflets were sent, one 
written in English and one written in Urdu. Recruitment was based on the presumption 
of a 20% response rate. The information leaflet was adjusted from the template 
produced by the UK Multi-Centre Research Ethics Committees and stated: 
Q the purpose of the study; 
o why individuals had been chosen; 
o whether individuals had to take part; 
o what would happen if they did take part; 
Q information regarding programme one (control group) and programme two 
(intervention group) and how individuals would be randomly placed; 
o the benefits of taking part; 
o what happens when the research stops; 
o what happens if an individual has a complaint 
o whether involvement in the study would be kept confidential; 
o what would happen to the results of the study; 
o who had reviewed the study; 
o contact details for further information. 
Patients were requested to register their interest before a specified date by returning a 
tear-off slip with their name, address and telephone number in the supplied pre-paid 
envelope. Contact was then made with the patient, usually by telephone, providing an 
opportunity for the patient to ask questions and discuss the study in more detail and for 
the principal researcher to check that each individual met the inclusion criteria. 
Afterwards, if they were still willing to take part in the study, a home visit was arranged 
to obtain written consent (patient consent form, Appendix 5b) and collection of the 
baseline outcomes. If patients did not have access to a telephone, a letter was sent 
informing them that a home visit would be made on a certain date and at a certain time 
and requesting that they contact the researcher at the dietetic department if the date or 
time was inconvenient. 
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5.3.4 Participants 
Inclusion Criteria 
Adults with diagnosed Type 2 diabetes who could speak and understand English or 
Urdu and were registered with a general practice that had consented to take part in the 
study. 
Exclusion Criteria 
In the interests of a pragmatic study, exclusion was restricted only to those patients with 
Type 2 diabetes who met the following criteria: 
a below the age of 30 years (as those individuals were more likely to have Type 1 
diabetes or childhood Type 2 diabetes; 
o housebound, terminally ill with a pre-existing medical condition or living with 
severe learning difficulties that would prevent diabetes self-management; 
o unable to understand or speak English or Urdu languages. 
5.3.5 Study Design 
Well-designed and properly conducted randomised controlled trials (RCTs) provide the 
best evidence on the efficacy of health care interventions (Ford, Giles, & Dietz 2002). 
However, trials may either be explanatory or pragmatic. Explanatory trials generally 
measure efficacy i. e. the benefit a treatment produces under ideal conditions, often 
using carefully defined subjects in a research clinic. Pragmatic trials measure 
effectiveness i. e. the benefit the treatment produces in routine clinical practice (Roland 
& Torgerson 1998). Educational interventions tend to be complex interventions which 
are built from a number of components. It is not easy to define the "active ingredients" 
of a complex intervention and it is recommended that all components are described 
clearly to allow replication of the intervention without defining the active ingredient(s) 
(Medical Research Council 2000). 
The study design involved a prospective, pragmatic randomised controlled trial to 
evaluate the complex intervention. An intention to treat analysis collected and analysed 
data, where possible, from all participants regardless of whether they completed the 
intervention or control education programme. 
Power calculation 
The primary outcome was glycated haemoglobin (libAlc) and it was calculated that 64 
participants were required in each group in order to have 80% power to detect an 
absolute difference in HbAlc levels of one percentage point between groups. That 
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assumed the 5% significance level with a standard deviation of 2%. However, the aim 
was to recruit 300 participants (150 in each group) to allow for attrition and smaller 
differences in glycated haemoglobin between the two groups. A one percent difference 
between groups was thought to be worthwhile as it may significantly reduce the risk of 
developing diabetes complications (Stratton et al. 2000). 
Randomisation 
Patients had an equal probability of assignment to the intervention group or the control 
group. Individual randomisation, as opposed to cluster randomisation, was performed 
separately for each education programme using computerised random permuted blocks 
generated by a statistician. The block size was 30 with a ratio of 1: 1 for allocation to the 
intervention or control group. In order to maintain blinding to allocation, the patient 
information leaflet stated that the study was designed to compare the effectiveness of an 
individual approach to diabetes education (diabetes education programme one) with that 
of a group approach (diabetes education programme two). Sealed opaque envelopes 
containing a study identification number and allocation into programme one or 
programme two were prepared, sealed and signed by a person not involved in the 
research project and they were opened in the presence of the patient during the home 
visit in order to conceal allocation from the principal researcher who was responsible 
for enrolling participants. 
Blinding 
As described above, an attempt was made to blind participants to treatment assignment. 
However, it was not possible to blind those administering the routine treatment 
intervention for the control group, nor was it possible to blind the principal researcher 
who was delivering the diabetes expert patient programme to the intervention group. 
Outcome assessments were carried out in the main by a community nurse and a health 
care assistant who were blinded to treatment assignment, although, as a result of time 
and funding constraints, some assessments were carried out by the principal researcher. 
All outcome data was entered onto a computerised database anonymously using the 
participant identification number. Biomedical outcomes were entered by the principal 
researcher and the lifestyle and psychosocial outcomes, collected via validated 
questionnaires, were double entered by a private company, Bureau Support Services. 
All statistical analysis was carried out by the principal researcher using the anonymous 
database. 
177 
5.3.6 Interventions 
Control Group (diabetes education programme one) 
Described in the patient information leaflet as `diabetes education programme one' this 
was actually routine treatment for individuals with Type 2 diabetes. Participants 
received an individual appointment from a GP or practice nurse and a state-registered 
dietitian within the three-month active intervention period. That provided an 
opportunity for participants to be updated about recent developments, have routine 
assessments and discuss any concerns about their diabetes care. 
Diabetes expert patient programme (diabetes education programme two) 
Members of the intervention group were invited to attend the six-week diabetes expert 
patient programme in addition to informal routine treatment. Once the expert patients 
had participated in the course they once again received routine care, as there was no 
formal follow-up arranged. 
The diabetes expert patient programme involved six, weekly sessions, each lasting two 
hours (for a brief overview see Table 5.4 on page 178 and for a detailed description see 
the scripted manual presented in Chapter 4). All sessions were based on the theoretical 
models of patient activation and empowerment and aimed to develop skills and build 
confidence to enable patients to make informed decisions regarding their diabetes self- 
care. 
Each programme was delivered within the community. The venues were easily 
accessible to all participants and had facilities available for the preparation of 
refreshments. Separate sessions were held for Urdu speaking South Asian participants, 
where a translator was present. If participants failed to attend one session, they received 
a telephone reminder. If they failed to attend two sessions, no further contact was made 
during the programme, but an intention-to-treat analysis was carried out to collect 
outcome data. 
The expert patient programme was designed and delivered by a diabetes research 
dietitian (TD) who took on the role of a diabetes educator based on the USA model. The 
dietitian had engaged in extra training in adult education (PGCE); diabetes treatments; 
behaviour change and empowerment, and venepuncture. Lesson plans were prepared for 
each session to provide structure, but the pace of learning and specific discussions were 
guided by the needs of the participants. 
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Critical components 
u The theoretical models `patient-activation' and `empowerment' that underpin the 
programme. 
Q Group sessions. 
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o Intensive education. 
Secondary components 
o Standard education. 
o Accessibility. 
Secondary components will be controlled for. The control group will receive routine 
treatment involving standard education delivered by a multidisciplinary team (practice 
nurse or GP and a dietitian). Those individual appointments will be equally as 
accessible as the X-PERT Programme i. e. provided within a primary care setting. 
Potential confounders 
There are several potential confounders such as age, sex, diabetes treatment, BMI, pre- 
existing medical conditions, educational history, the standard of existing diabetes care 
and socio-economic background. However, the randomisation of 150 participants into a 
control group should be an adequate strategy to control for those factors. 
5.3.7 Detailed plan 
At the recruiting home visit, the following steps took place: 
o participants were asked to provide their written consent to the research project 
by signing a patient consent form; 
a data collection sheet was completed for each patient and the following 
information was recorded: GP name and practice; the year diabetes was 
diagnosed; treatment history for diabetes; treatment history for any conditions 
associated with diabetes such as blood pressure; any existing known diabetes 
complications; 
u an opaque signed and sealed envelope was opened to reveal whether the patient 
had been allocated to diabetes education programme one (control) or diabetes 
education programme two (intervention). The patients' identification number for 
the trial was also stated and that was written on their consent form and data 
collection sheet; 
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o the participants were also informed that their details would be passed onto the 
surgery so that the individual appointment with the practice nurse or GP could 
be arranged. If the patient had been allocated to programme two, they were able 
to choose which of the diabetes expert patient programmes in that locality they 
would like to attend. They received an information sheet with the venue, dates 
and times of the six sessions. South Asian participants were invited to attend a 
session to be delivered with the help of an Urdu speaking translator. Two 
translators were involved in the delivery of the X-PERT Programme to South 
Asian participants, one of which was an NHS employee and was experienced in 
translating during group-based education sessions. The other translator was a 
dietetic student with less experience and due to funding and time limitations 
training was not possible; 
u biochemical baseline outcomes (see section 5.4.3, page 183) were collected and 
a questionnaire distributed to enable collection of the lifestyle and psychosocial 
baseline outcomes (see section 5.4.3, page 184). The patient's trial identification 
number was written in the top left hand corner of the questionnaire and the 
importance of completing the full questionnaire was explained. The questions 
that were deemed to be difficult or confusing were drawn to the attention of the 
patient and guidance for completion was given. Questionnaires were available in 
English or Urdu for South Asian participants. Participants were asked to return 
the questionnaire in the pre-paid envelope before commencing the education 
programme. If the questionnaire was not returned, the participants received a 
gentle telephone or written reminder, 
v all subjects were informed that they may attend their respective programmes 
with a family member or close friend; 
o four months from baseline (two-month post diabetes education programme) and 
14 months from baseline (12 months post diabetes education programme), the 
biomedical, lifestyle and psychosocial outcomes were repeated (see the 
timetable in figure 5.5 overleaf). 
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5.4 Evaluation: structure, process and outcome 
Evaluation of the diabetes expert patient programme was based on the International 
Standards for Diabetes Education (IDF Consultative Section on Diabetes Education 
(DECS) 2003) and was split into three sets of standards: structure, process and outcome. 
Structure and process evaluation is a qualitative and descriptive assessment whereas 
outcome evaluation is a quantitative evaluation that compares the mean results from the 
intervention group with those of the control group. 
5.4.1 Structure 
Structure provides the framework for a diabetes service and describes the personnel, 
resources and physical environment that should be in place in order to provide a 
diabetes education programme. The diabetes expert patient programme was evaluated 
against the following standards: 
o there is documented evidence of organisational/institutional support for 
education as an integral part of diabetes care; 
0 one person will be identified as having responsibility for the organisation and 
administration of the diabetes education service to ensure that the process and 
outcome standards can be met; 
o physical space and education resources are conducive to learning and based on 
individual/community needs; 
o an advisory committee is established to ensure that the views and values of all 
stakeholders are represented in the ongoing planning and delivery of diabetes 
education; 
o teamwork and communication are evident among those providing diabetes 
education and management; 
13 personnel involved in diabetes education have a sound clinical understanding of 
diabetes, are knowledgeable about teaching and learning skills and diabetes self- 
management practices; 
o the competence and performance of personnel involved in diabetes education is 
reviewed at least annually; 
o diabetes education covers topics based on individual assessment and fosters 
acquisition of knowledge leading to self-management of diabetes; 
o relationships are fostered with available community resources such as diabetes 
associations, blind society, social services. 
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5.4.2 Process 
Process standards describe the process of diabetes education and the steps required to 
prepare, implement and evaluate the education programme. The diabetes expert patient 
programme was evaluated against the following standards: 
Q diabetes education is based on the ongoing learner-centred needs assessments of 
individuals and/or communities; 
o plans for diabetes education programmes are learner-centred and subject to 
ongoing review and modification; 
a implementation of diabetes education that is learner-centred and facilitates 
cognitive learning, behaviour change and self-management and that extends to 
families, caregivers and communities, where appropriate; 
o education is provided in a professional and ethical manner and is learner-centred 
and evidence-based where possible; 
o the diabetes education service will be recognised by, and accessible to, the 
community; 
o the effectiveness and quality of education will be annually assessed and linked 
to outcomes and the services will be reviewed on the basis of the assessment; 
Q educational and clinical research are undertaken to provide an evidence base for 
practice. 
5.4.3 Outcome 
Outcome evaluation is based on the premise that, if the diabetes education programme 
had been successful, patient biomedical, lifestyle and psychosocial measurements would 
have improved. 
Biomedical 
Venous blood samples were analysed at a central laboratory. The primary outcome, 
glycated haemoglobin (HbA, j was measured using the diabetes control and 
complications aligned method. The reference range for people without diabetes was 4.0 
- 6.3%. A full lipid profile included total, LDL and HDL cholesterol and triglycerides. 
Blood pressure was measured, conforming to accepted methods (Ramsay et al. 1999), 
using a digital blood pressure monitor. Acceptable ranges for blood lipids and blood 
pressure were obtained from recent guidance reports (NICE 2002a). Body weight was 
measured using the calibrated electronic scales. Participants were asked to remove shoes 
and wear light clothing. The same scales were used throughout the study. A portable 
sonic machine was used to measure height. BMI (Kg/m2) was calculated from height 
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and weight measurements. The Tanita body fat monitor measured body fat to ±0.5% 
precision using bioelectrical impedance analysis. The recommended technique for 
measuring waist circumference was used (Desprds, Lemieux, & Prudhomme 2001). 
Lifestyle 
Validated questionnaires (Appendix 6) were used to measure diabetes knowledge 
(Fitzgerald et al. 1998), food intake (Little et al. 1999), and Diabetes Self-Care 
Activities (SDSCA) (Toobert & Glasgow 1994). Diabetes knowledge was assessed by 
14 multiple choice questions, the lowest possible score being zero and the highest, 14. 
Food intake assessment obtained information about portion size (small, medium, large) 
and frequency of consumption (number of times eaten per day, week or month) for 42 
common food items. The SDSCA questionnaire is a self-report measure of the 
frequency of completing different regimens activities over the preceding seven days. It 
measures: diet (four questions); exercise (two questions); blood testing (two questions); 
foot care (five questions); medication taking (three questions). Raw scores from each 
measure were converted to standard scores. Those were then averaged to form a 
composite score for each regimen behaviour. 
Psychosocial 
Validated questionnaires (also shown in Appendix 6) were used to measure Diabetes 
Treatment Satisfaction (DTSQc) (Bradley 1994), Audit of Diabetes-Dependent Quality 
of Life (ADDQoL) (Bradley et al. 1999), and diabetes empowerment (Anderson et al. 
2000). Diabetes treatment satisfaction was determined at baseline with eight questions 
(scored 0-36). Two individual items measured perceived frequency of hypoglycaemia 
and hyperglycaemia (scored 0-6) in which higher scores indicated greater frequency of 
low or high blood glucose levels. Change in treatment satisfaction was measured using 
the same questions with different scoring: `much more satisfied' and `much less 
satisfied' (scored -18 to +18). The ADDQoL questioned 18 important aspects of life 
including dietary enjoyment and freedom. Each question was scored for impact on life 
and importance with a range from -9 (maximum negative impact of diabetes) to +9 
(maximum positive impact of diabetes). Three individual questions relating to food and 
drink were analysed individually together with a mean quality of life score. The 
Diabetes Empowerment Scale (DES) measured the patients' self-efficacy related to 
managing the psychosocial aspects of diabetes (9 statements); assessing dissatisfaction 
and readiness to change (9 statements); setting and achieving diabetes goals (10 
statements). Statements were scored `strongly disagree' (1 point) through to `strongly 
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agree' (5 points). Average scores were calculated for each subscale, followed by an 
overall empowerment score. 
Justification for choice of outcomes 
Type 2 diabetes affects all aspects of life. Previous research has, however, focused 
mainly on biochemical outcomes (Griffin et al. 1998). The measurement of diabetes 
control and other important clinical outcomes in people with Type 2 diabetes is 
necessary if the of ectiveness of the diabetes expert patient programme is to be properly 
evaluated. However, in order to test the hypothesis that the theories underpinning the 
education programme - empowerment and patient activation - increase the skills and 
confidence to make informed decisions regarding diabetes self-management, 
measurements of patient self-empowerment and lifestyle changes (self-care activities 
and food intake) are necessary. Although it is recognised that knowledge on its own 
does not change behaviour, knowledge of diabetes remains an important outcome, since 
a patient needs to have knowledge in order to make informed choices about his or her 
actions and activities (Walker 1998). Quality of life and satisfaction with treatment have 
recently become more important outcomes in health care evaluations, as it is 
increasingly being acknowledged that "health" encompasses the whole person, and not 
just clinical variables (Ewles & Simnett 2003) and that living with diabetes may have a 
detrimental effect on quality of life scores (Rubin 2000). 
5.5 Statistical analysis 
It is important to be able to detect whether any observed difference in treatments is 
genuine or could reasonably have arisen by chance. Significance tests measure 
statistical inference. However, the estimate of the magnitude of treatment differences 
should also be measured and confidence limits are a useful method of statistical 
estimation. The statistical software package SPSS for Windows version 11.0 was used 
for all analysis. Outcome data from the expert patient and routine treatment groups was 
compared at baseline, four and 14 months. An intension-to-treat-analysis was carried 
out. For normally distributed data, unpaired, two tailed t-tests were used and for non- 
normal data, non-parametric tests were used (Mann-Whitney). 
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5.6 Summary 
Although it has now been recognised that effective management of Type 2 diabetes lies 
in the hands of the person with the condition, the most effective method of encouraging 
diabetes self-management is still unknown. This study tests the theories of patient 
empowerment and patient activation by delivering a diabetes expert patient programme 
to patients with Type 2 diabetes. Evaluation of biomedical, lifestyle and psychosocial 
outcomes were assessed by carrying out a randomised controlled trial that, where 
possible, conformed to the CONSORT statement. The research proposal was developed 
following reflection about current services for people with diabetes, enlistment of 
patients' views, liaison with the local branch of Diabetes UK and consultation with 
experts in the field. The diabetes expert patient programme was also assessed against 
diabetes education international standards for structure and process. General practices 
and patients were recruited from socio-economic deprived areas of Burnley, Pendle and 
Rossendale, East Lancashire. Statistical analysis used both parametric and non- 
parametric tests to compare the mean results from patients allocated to receive the 
diabetes expert patient programme and those allocated to receive routine treatment. 
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Chapter 6: Results 
6.1 Introduction 
This chapter presents the results from the randomised controlled trial. It starts with the 
recruitment statistics, followed by a detailed description of baseline characteristics and 
flow of the participants throughout the trial. The findings from the structure and process 
evaluation are then presented, followed by the biomedical, lifestyle and psychosocial 
outcomes, which have been assessed both in the short term (four months) and longer 
term (14 months). Unplanned outcomes are discussed and the chapter concluded with an 
overview of presentations undertaken at scientific meetings. 
6.2 Recruitment 
6.2.1 General practices 
Four practices in Burnley and six practices in Pendle were invited to take part in the 
study. The sole criterion for selection was that they received the highest percentage of 
deprivation payments per total list size (see Table 6.1 on page 188). In Rossendale, six 
practices situated in the top 15% of deprived wards nationally were invited to be 
involved in the study (see Table 6.2 on page 189). All were supportive of the study, 
completed the practice consent form and provided a list of registered patients with Type 
2 diabetes. However, the majority of practices classified diabetes as either insulin 
dependant or non-insulin dependant as opposed to Type 1 or Type 2 diabetes. To 
identify whether individual patients had Type 2 diabetes based on the WHO criteria 
(WHO Working Group 1999), diagnostic and treatment data for each patient was 
obtained from either the GP, practice nurse or the patients' medical records. Information 
regarding total list size was available for the practices in Burnley and Pendle and the 
mean prevalence of diagnosed and registered Type 2 diabetes was calculated for the 10 
practices as 2.7% (range 1.8% to 5.0%). 
6.2.2 Adults with Type 2 diabetes 
Although ethical approval had been obtained, which meant that it was permissible to 
contact patients by letter or telephone, two of the practices (practices two and three in 
Table 6.1 overleaf) requested that their patients be contacted only by letter. Mailshots 
were sent to all patients initially, but in two practices (Burnley 1 and Burnley 4) the 
recruitment process was helped by following-up the letter with a telephone call. That 
was found to be the most successful way of recruiting South Asian participants. Where 
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prospective participants did not have a telephone, verbal communication about the 
research was given by making a home visit. 
Burnley 2, which did not want the recruiting invitation letters to display the Burnley 
Healthcare NHS Trust logo, supplied its own letterhead paper and had the lowest 
recruitment rate for the Burnley area. The GP or practice nurse at many practices edited 
the list of patients with Type 2 diabetes by crossing off patients that they felt would be 
unsuitable to participate in the research. The main reasons for unsuitability were old age 
(above 80 years), residency in a nursing home, or being confused or immobile. Some 
practices were happy for mailshots to be sent to all patients so that individuals could 
make the decision whether to participate or not. Burnley 4 is situated in an area with a 
high population of South Asian people originating from Pakistan and Bangladesh. As 
materials for the study were available in Urdu and English, mailshots were only sent to 
Urdu-speaking South Asian people and not Bengali speaking South Asians. 
Table 6.1 Detailed 
5,920 461 (7.8%) 1 18 (2.0%) 111 33 (29.7%) 
5,800 535 (9.2%) 107(1.8%) 80 12 (15. (%) 
4,336 49501.4%) 84 (1.9%) 49 16 (32.7.0%) 
Bu ic 3,109 2,647 (85.10/6) 155 (5.0°, /0) 79 30 (40.0%) 
-=' 10,387 2,334 (22.5%) 256(2.5%) 256 36(14.1%) 
' .. ` 3,692 1,071 (29.0%) 67(l. 8%) 67 15(22.4%) 
Pet, 2,726 914(33.5%) 69(2.5%) 54 9(16,7%) 
3,578 1,251 (35.0%) 118(3.3%) 116 18(15.5%) 
2,775 1,016 (36.6%) 87(3.1%) 84 12(14.3%) 
3,412 1,366 (40.0%) 145 (4.2%) 145 3](21.3%) 
45,735 12,090 (26.4%) 1,216 1041 212(20.4%) 
(2.7%) 
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Worsley 
Worsley 
885 
885 
23 7 
Worsley 885 37 25 6 
Greensclough 1087 155 127 30 
Stacksteads 1217 85 78 7 
Longholme 1257 130 64 22 
" 688 503 102 (20.3%) 
* IMD Index o! 'Multiple Deprivation. I most deprived, 8414 (east deprived 
In Rossendale, six practices were recruited, providing a total of 688 qualifying patients. 
As only 1% of the Rossendale population belong to the Pakistan South Asian ethnic 
group (ELHA 1999) it was perceived that it would be difficult to recruit either 30 
female or 30 male Urdu or English speaking participants. Mailshots were therefore sent 
only to Caucasian patients. 
6.3 Participant flow 
A summary of participant flow can be seen in figure 6.1 on page 190. Letters of 
invitation were sent to 1544 adults with Type 2 diabetes. Notification was received in 
respect of 13 people who had either died or moved out of the area. There were 336 
(21.8%) replies from people who wished to take part in the study, of which 314 (93.5%) 
provided written consent. Baseline assessments were carried out for all 3 14 participants. 
In total, 314 participants were randomized to intervention group (expert patient 
programme) or control group (routine treatment). Eight participants did not attend the 
six-week programme: three owing to illness, two owing to work and one owing to 
holiday commitments; two Asian women did not wish to attend mixed sex sessions. 
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5 died 
I terminally ill 
1 refused, too iII 
I severe psychiatric ill 
3 refused, didn't want 
I in Pakistan 
2 unable to contact 
2 moved out of area 
Of the 149 (95%) participants who did attend, 128 (81.5%) attended four or more 
sessions. For those receiving routine care, 103 (65.6%) attended individual dietetic 
appointments. An intention to treat analysis was carried out and data was analysed from 
307 participants at the four month follow-up. Data was unavailable in respect of seven 
participants owing to: refusal of follow-up (1), inability to follow-up owing to illness 
54 (34 4%) did 
not attend 
individual 
dietetic 
appointments 
Participant follow-up 
not possible (n"5). 
2 died 
I terminally ill 
I refused, too ill 
I refusod, didn't want 
follow-up assessment 
Follow-up: 4 months 
with 'intcntion to 
treat analysis' 
(n^' 152,96.8%) 
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(3); extended trip to Pakistan (1); death (3). At 14 months, outcomes were collected and 
analysed from 291 (92.7%) participants. Data was unavailable in respect of 23 
participants due to: refusal of follow-up (4); inability to follow-up due to illness (2); 
terminal illness (1); severe psychiatric illness (1); an extended trip to Pakistan (2), death 
(7); moving out of the area (3); inability to make contact (3). 
Validated questionnaires were given to all participants at each data collection follow-up 
to collect lifestyle and psychosocial outcomes and participants were asked to return 
completed questionnaires in the pre-paid envelopes provided. There were 260 (82.8%) 
questionnaires returned at baseline, 209 (66.6%) at the four month follow-up and 191 
(60.8%) at the 14 month follow-up. 
6.4 Baseline characteristics of participants 
6.4.1 Comparison between the intervention group and control group 
Demographic variables for the participants in the intervention group and control group 
are shown in Table 6.3 on page 192. Baseline outcomes (biomedical, lifestyle and 
psychosocial) for both groups are shown in Tables 6.7,6.9 and 6.10 in section 6.5.3. 
There were no statistically significant differences between the intervention group and 
control group for either the demographic or outcome variables. The randomisation 
process had therefore been effective. 
6.4.2 Demographic variables for all participants 
Demographic variables for all randomised participants are shown in Table 6.4 on page 
193. Baseline diabetes treatment and biomedical outcomes for all participants are shown 
in Table 6.5 on page 194. Both tables also show the data for each individual ethnic 
group: white Caucasian and South Asian. 
The mean age of the participants at recruitment was 61.5 years (SD 10, range 30-85) 
and there were slightly more males, 162 (52%), than females 152 (48%). The mean 
duration of living with diabetes was 6.7 years (SD 6.5, range 0-36). Eighty-three (26%) 
participants were being treated with diet alone, 178 (57%) with tablets, and 53 (17%) 
with insulin. Of those treated with tablets, 110 (61.8%) received one type of diabetes 
medication, 67 (37.6%) two types and one (0.6%) three types. 
Table 6.3 
(Yrs) 
Time with 
diabetes (yrs) 
Age left full time 
education 
Qualifications 
-mean score* 
Employment 
between the intenention and control group for demographic %iariahies 
(, I 3(1)7) 618(Il(1) 05 
n 157 n-157 (08 to 21) P= 464 
6.7 (6.4) 6.7 (6.7) 0.0 
n 157 n=157 (-1.4 to 1.5) P- 0.96 
15 , (2.0) 16.2(5.4) 0.9 
n 122 n=1 12 (-0.5 to 1.9) P -0.10 
1.4 (2.2) 1.5 (2.2) 0.1 
n-=107 n=103 (-0.4to0.7) P -0.55 
-ever had a job' 1I (0.3) 1.1 (0.2) 0.0 
n=133 n=120 (-0. I to 0.0 ) 
-job at present2 1.84 1.76 0.1 
n=118 n=105 (-0.2 to 0.0) 
-mean job score3 5.74 (1.5) 5.53 (1.5) -0.2 
n=130 n=1 17 (-0.6 to 0.2) 
Marital status 1.65 (1.1) 1.74 (1.0) 0.1 
-mean score+ n=133 n-121 (-0.2 to 0.4) 
*Qualification codes: CSE=1. GSE=2. GCSE=3. CitN & Guilds=4. 'A' Levels- i. Teaching 
diploma/HNC=G. Degree=7 
' ever had a job: I =yes, 2=no. 
-do you have a job at the moment: I=yes, 2=no. 
3retired: 1=vcs. 2=no 
'job code: 1=manager, 2=supervisor, 3=forcman/woman. 4=self-employed. 5=other. 6=retired 
7=housewife. 8=unemplov cd 
+Marital status: 1=marricd/living as married. 2=divorced. 3=widowed. 4=single. 5=separated 
P=O.? 1 
P-0.15 
P=0.27 
P=0,46 
Out of the 234 participants who responded to the question, 195 (83%) had left full time 
education at the age of 16 or younger. Only 15 participants (7%) had continued in full 
time education beyond the age of 19 years. The majority of participants did not hold any 
academic qualifications (128 participants, 61%). Six participants (3%) reported their 
highest qualification to be of CSE standard, while 13 (60/%ö) participants had obtained a 
degree. 
Although 235 participants (90%) reported that they were, or had previously been, in 
paid employment, only 89 of the 186 participants who responded to the question, 
indicated that they had worked during the previous 10 years. Only 44 participants (17%) 
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were working when they entered the study. The reasons for not working were retirement 
(157 part ici pants, 60°%), being, a housewife (28 participants, 1100) and UnenlllloVment 
Takle 6.4 Demographic variables for all participants. %% hits Caucasians & SniitIi A%ians 
Number. n 114 234 80 
Mean age (SD)(yrs) 61.5 (10.4) 64.1 (9.7) 54.0 (8.5) 
Range (yrs) 30-85 30-85 42-82 
30 < 40 years 3(1%) 3 (1%) - 
40 < 50 years 45 (14%) 13(6%) 32 (40%) 
50 < 60 years 84 (27%) 57 (24%) 27 (34%) 
60 < 70 years 107(340/60 90 (39%) 17(21%) 
70 < 80 years 65 (21%) 62 (26%) 3 (4%) 
> 80 years 10 (3%) 9 (4%) 1 (1%) 
Age left full time education 
Number of responses, n 234 208 26 
Mean (SD) (years) 15.8 (4.2) 15.6 (3.9) 17.2 (5.8) 
:5 16 years 195 (83%) 179 (86%) 16 (62%) 
17 - 18 years 24 (10%) 18(9%) 6(23%) 
> 19 years 15(7%) 11 (5%) 4(15%) 
Highest qualification 
Number of responses 210 179 31 
None 128 (61%) 106 (59%) 22 (71%) 
CSE 6 (3%) 5 (3%) 1 (3%) 
'0' level 26 (12%) 25 (14%) 1(3%) 
GCSE 3 (2%) 1 (1%) 2(7%) 
'A' level 5 (2.5%) 5 (3%) - 
City & Guilds 24 (11%) 22 (12%) 2(7%) 
Teaching diploma/HNC 5 (2.5%) 4 (2%) 1 (3%) 
Degree 13(6%) 11(6%) 2(7%) 
Employment history 
Number of responses 260 216 44 
Ever had a paid job 235 (90%) 209 (97%) 26 (59%) 
- Manager 40 (15%) 36 (17%) 4 (9%) 
- Foreman 5 (2%) 5 (2%) - 
- Supervisor 30(12%) 27 (13%) 3(7%) 
- Self-employed 41(16%) 35 (16%) 6 (14%) 
Presently working 44 (17%) 36 (17%) 8 (18%) 
If not, 
- Housewife 28 (11%) 14 (7%) 14 (32%) 
- Unemployed 12(5%) 3(1%) 9(21%) 
- Retired 157(60%) 149(69%) 8 (18%) 
- Student - - - 
- Other 19 (7%) 17 (8%) 2 (5%) 
Last paid employment 
Number of responses 186 166 20 
-< last 10 years ago 89 (48%) 83 (50%) 6 (30%) 
- 10 to 20 years ago 62 (33%) 59 (36%) 3 (15%) 
-? 20 years ago 25 (13%) 22 (13%) 3(15%) 
- never worked 10(5%) 2(1%) 8 (40%) 
Marital status 
Number of responses 254 212 42 
Married/living as married 167 (66%) 129 (61 %) 38(91%) 
Divorced 19(7%) 18(9%) 1(2%) 
Widowed 50 (20%) 47 (22%) 3 (7%) 
Separated 3(1%) 3(1%) - 
Single 15 (6%) 15 (7%) - 
194 
(12 participants, 5%). In respect of questions relating to marital status, 167 out of' the 
254 participants who provided information (66%) stated that they were either married or 
living together as married. Fifty (20%) were widowed, 19 (7%) divorced, 3 (1%) 
separated and 15 (6%) were single. 
Only 38 participants (12%) had a BMI within the healthy weight range (BMI 20 to 24.9 
Kg/r2), and just 11 (7%) females and 37 (23%) males had a waist circumference within 
the healthy range (less than 80cm and 94 cm respectively). Levels of obesity were high, 
with 146 participants (47%) being in the obese (BMI > 30 Kg/m2) or very obese range 
(BMI > 40 Kg/r2), and 124 females (83%) and 83 males (52%) had waist 
circumferences within the highest tertile (greater than 88 cm for females and greater 
than 102 cm for males). 
Table 6.5 Biomedical and treatment %ariables 
Number, n 314 234 80 
Females 152(48%) 115(49%) 37(46%) 
Males 162(52%) 119(51%) 43(54%) 
Time with diabetes 
Mean (SD) (years) 6.7 (6.5) 7.0 (6.9) 5.6 (5.3) 
Range (years) 0-36 0-36 0-21 
Treatment of diabetes 
Lifestyle alone 83 (26%) 65 (28%) 18 (22%) 
Lifestyle and tablets 178 (57%) 124 (53%) 54 (68%) 
Lifestyle and insulin 53 (17%) 45(19%) 8(10%) 
Body Mass Index n 310 230 80 
Mean (SD) (Kg/m2) 30.7 (5.5) 30.9 (5.5) 30.1 (5.5) 
Range 19.9-52.0 19-52 21-50 
< 24.9 Kg/m2 38 (12%) 26(11%) 12 (15%) 
25 to 29.9 Kg/m2 126 (41%) 88 (39%) 38 (48%) 
30 to 39.9 Kg/m2 131 (42%) 105 (46%) 26 (32%) 
40 Kg/m2 15(5%) 11(5%) 4(5%) 
Waist circumference n 150 114 36 
Mean female cm (SD) 102 (15) 100 (15) 108 (14) 
Range cm 71-152 71-152 76-140 
< 80 cm female 11(7%) 10 (9%) 1 (3%) 
80 to 88 cm female 15 (10%) 15 (13%) - 
>88 cm female 124 (83%) 89 (78%) 35(97%) 
Number n 161 118 43 
Mean male cm (SD) 104(11) 104(11) 102(10) 
Range cm 81-132 81-132 86-124 
<94 cm 37 (23%) 26 (22%) 11(26%) 
94 to 102 cm 4](25%) 26 (22%) 15 (35%) 
>102 cm 83 (52%) 66(56%) 17(40%) 
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Glycated haemoglobin n 314 234 80 
Mean%(SD) 7.7(1.6) 7.7(1.5) 7.7(1.6) 
Range 5.1 - 14.0 5.1-13.6 5.4-14.0 
< 6.0% 39(12%) 3](13%) 8(10%) 
6.1%-7.0% 83 (27%) 58 (25%) 25(31%) 
7.1%-8.0% 88 (28%) 63(27%) 25 (31%) 
8.1%-9.0% 60 (19%) 47 (20%) 13 (16%) 
9.1%-100/0 21(7%) 17(7%) 4(5%) 
>10% 23(7%) 18 (8%) 5 (6%) 
Systolic blood pressure n 313 233 80 
Mean (SD) (mmHg) 148 (22) 150 (21) 139 (23) 
Range 88 - 240 88-233 101-240 
< 140 mmHg 123 (39%) 76(33%) 47(59%) 
Diastolic blood pressure n 313 233 80 
Mean (SD) (mmHg) 82 (12) 82 (12) 84 (10) 
Range 53- 122 53-122 63-1 17 
< 80 mmHg 138(44%) 110(47%) 28 (35%) 
Total cholesterol n 304 229 75 
Mean (SD) (mmol/1) 5.0 (1.0) 5.1 (1.1) 4.8 (0.9) 
Range 1.4-9.3 1.4-9.3 2.9-6.8 
<5 mmol/1 167 (55%) 122 (53%) 45 (60%) 
LDL cholesterol n 277 212 65 
Range 0.6-5.6 0.6-5.6 0.6-4.3 
Mean (SD) (mmoUl) 2.7 (0.8) 2.8 (0.9) 2.6 (0.8) 
<3 mmol/1 174 (63%) 126 (59%) 48 (74%) 
HDL cholesterol n 301 227 74 
Range 0.6-2.8 0.6-2.8 0.7-1.7 
Mean (SD) (mmol/1) 1.3 (0.3) 1.3 (0.4) 1.2 (0.2) 
> 1.1 mmol/1 194 (65%) 152 (67%) 42 (57%) 
Triglycerides n 299 226 73 
Range 0.4-8.4 0.4-8.4 0.7-7.2 
Mean (SD) (mmol/1) 2.4 (1.3) 2.4 (1.2) 2.5 (1.4) 
< 2.3 mmoVl 172(58%) 130(58%) 42 (58%) 
There were 39 participants (12%) who had excellent diabetes control with glycated 
haemoglobin levels within the normal non-diabetic range (below 6%). Eighty three 
participants (27%) had good diabetes control with glycated haemoglobin levels between 
6.1% and 7.0%. However, 81 participants (26%) had poor diabetes control (HbA lc 
above 8%) and 23 participants (7%) had very poor control with glycated haemoglobin 
levels above 10%. Only 123 participants (39%) had systolic blood pressure levels 
within the recommended range and 138 (44%) had diastolic blood pressure within the 
recommended range. Between 55% and 65% of participants met the targets for lipid 
profile variables. 
s Comparison between the white Caucasian participants and South Asian participant 
The South Asian participants were, on average, 10 years younger than the white 
Caucasian participants with the majority (74%) being in their 40s and 50s. South Asian 
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participants had, however, been diagnosed with diabetes for a similar number of years 
as the white Caucasian participants. Less than 50% of South Asian participants 
completed all the questions regarding education, employment history and marital status 
(see Table 6.4 on page 193). Those who did were, on average, one and a half years older 
than the white Caucasian participants when leaving full time education (17.2 years and 
15.6 years respectively) with 15% remaining in full time education beyond the age of 19 
years. A greater percentage of the South Asian participants indicated that they did not 
hold any formal qualifications (71% compared to 59% of white Caucasians). 
South Asian participants were less likely than the white Caucasian participants to have 
ever been in paid employment (59% and 97% respectively). A greater percentage of 
them were housewives (32% as against 7% of white Caucasians) or unemployed (21% 
and 1% respectively). South Asian participants were more likely to be married (91% 
and 61% respectively) and fewer South Asian participants were divorced (2% and 9% 
respectively), widowed (7% and 22% respectively) or single (0% and 7% respectively). 
With regard to treatment for diabetes, more South Asians participants were prescribed 
tablets (68% compared to 53% of white Caucasians) and fewer were prescribed insulin 
(10% and 19% respectively). Mean BMI was slightly less for the South Asian 
participants than it was for the white Caucasians (30 Kg/m2 and 31 Kg/m2 respectively) 
with more South Asian participants in the overweight range (48% and 39% 
respectively) and less in the obese range (37% and 51% respectively). South Asian 
females were more likely to have a waist circumference in the highest tertile (97% 
compared to 78% of white Caucasians) whereas South Asian males were less likely to 
have a waist circumference in the highest tertile (40% compared to 56% of white 
Caucasians). Mean glycated haemoglobin levels were the same in both ethnic groups 
and there was similar distribution across the ranges. Mean systolic blood pressure 
measurements were lower in the South Asian participants than the white Caucasians 
(139 mmHg and 150 mmHg respectively) with 59% of South Asians compared to 33% 
of white Caucasians having readings below 140 mmHg. However, South Asian 
participants were less likely to meet diastolic blood pressure targets (35% compared to 
47% of white Caucasians). Mean total and LDL cholesterol were lower in the South 
Asian participants than the white Caucasian participants (total cholesterol 4.8 mmol/l 
and 5.2 mmolll respectively; LDL cholesterol 2.6 mmol/l and 2.8 mmol/l respectively) 
with a greater percentage of South Asian participants meeting national 
recommendations (total cholesterol, 60% compared to 53% of white Caucasians; LDL 
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cholesterol, 74% and 59% respectively). However, HDL cholesterol was lower in the 
South Asian participants compared to the white Caucasians (1.2 mmol/1 and 1.3 mmol/I 
respectively) with less South Asian participants meeting national targets (57% and 67% 
respectively). Triglyceride levels were similar in both ethnic groups. 
6.5 Evaluation: structure, process and outcome 
6.5.1 Structure 
The diabetes expert patient programme and its impact on local diabetes serivces was 
evaluated against the `structure' standards of the International Diabetes Federation 
(described in Chapter 5, section 5.4.1). Those standards are stated below along with the 
results from the evaluation. 
a) There is documented evidence of organisational/institutional support for education 
as an integral part of diabetes care. 
As a result of national guidelines (DOH 2001a) and the local X-PERT project, the 
author of this thesis was asked by Burnley, Pendle and Rossendale Primary Care Trust 
(BPR PCT) to chair a patient empowerment and education subgroup for the Local 
Diabetes Services Implementation Group (LDSIG). A representative sample of 
empowered expert patients and their carers, a member of the local branch of Diabetes 
UK and two health care professionals met for five focus groups within a six-month 
period and devised a report stating recommendations for the delivery of diabetes 
education locally (Appendix 7). The X-PERT Programme was put forward as an 
example of good practice and as a result, the PCT intends to support diabetes education 
as an integral part of diabetes care. 
b) One person will be identified as having responsibility for the organisation and 
administration of the diabetes education service in such a way that the process and 
outcome standards can be met. 
The author of the thesis designed, developed and delivered the X-PERT programme 
throughout Burnley, Pendle and Rossendale and has therefore taken the lead in the 
organisation and administration of diabetes education in the locality. These 
programmes have been funded by a research grant and so the future delivery of 
diabetes education programmes, including assessment of process and outcome 
standards, is not guaranteed. 
c) Physical space and education resources are conducive to learning and based on 
individual/community needs. 
There are several, easily accessible, health centres and community venues within 
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Burnley, Pendle and Rossendale that were available for the delivery of the diabetes 
education programmes. Education resources, such as the visual aids, patient manuals, 
display board, flip chart, and television with video, were either hand made, purchased 
or borrowed. All educational materials have been developed to encourage learning 
through patient activation and these have, where necessary, been adapted for use with 
the local South Asian population. 
d) An advisory committee is established to ensure that the views and values of all 
stakeholders are represented in the ongoing planning and delivery of diabetes 
education. 
Stakeholders involved in the design, development and delivery of the X-PERT 
programme were the patients, the local branch of the Diabetes UK, BPR PCT dietetic 
department and the Nuffield Institute for Health, University of Leeds. Since the 
implementation of the X-PERT programme, the LDSIG and BPR PCT management 
team has taken a vested interest in diabetes education and will be involved in the future 
planning of diabetes education programmes. 
e) Teamwork and communication are evident among those providing diabetes 
education and management. 
There is currently little teamwork and communication between individual general 
practices, the specialist diabetes team based at the acute Trust (East Lancashire 
Hospitals NHS Trust) and the local branch of Diabetes UK. Diabetes education is often 
provided in an inconsistent and `ad hoc' fashion that results in many patients receiving 
conflicting advice. Although the X-PERT programme was implemented to address 
those issues by delivering structured education, it has not addressed teamwork and 
communication issues. Because the programme was delivered within a very tight time 
schedule, the involvement from each practice was minimal. Each practice nurse was 
invited to participate in the programme but only one nurse was able to attend the 
sessions owing to volume of work. 
#) Personnel involved in diabetes education have a sound clinical understanding of 
diabetes, are knowledgeable about teaching and learning skills and diabetes self- 
management practices. 
The author of the thesis and the tutor of the X-PERT programme is a diabetes specialist 
dietitian who has taken extra training in adult education, health behaviour change 
principles and the aetiology, treatments and complications of diabetes. There is 
currently no standardised certification of training programmes for primary and 
secondary care staff involved in the delivery of diabetes education and therefore health 
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professionals receive training in an ad hoc fashion with few being knowledgeable 
about adult education principles. 
g) The competence and performance of personnel involved in diabetes education is 
reviewed at least annually. 
There is currently no system in place within BPR PCT to review the competence and 
performance of health professionals involved in diabetes education. 
h) Diabetes education covers topics based on individual assessment and fosters 
acquisition of knowledge leading to self-management of diabetes. 
The X-PERT programme is a group education programme designed to facilitate the 
identification by participants of individual problems associated with diabetes. It was 
envisaged that participants wishing to explore possible solutions to their respective 
problem would acquire more knowledge and improve their self-management of the 
condition. For individual appointments with patients, the dietetic department uses a 
locally written protocol, which involves making an individual assessment and 
providing information to encourage diabetes self-management. Recommendations for 
the management of diabetes in primary care are available (Guy et al. 1997) but these 
are outdated. Neither local implementation nor evaluation has been evident. 
i) Relationships are fostered with available community resources such as diabetes 
associations, blind society, social services. 
Both the diabetes management team within BPR PCT and the author of the X-PERT 
programme have an excellent relationship with the local branch of Diabetes UK. 
Venues belonging to social services were used in Burnley for the implementation of the 
X-PERT programmes with possibilities for joint working projects in the future. 
6.5.2 Process 
The X-PERT programme was evaluated against the process standards described in 
Chapter 5.4.2. Those process standards and the results of the evaluation are shown 
below: 
a) Diabetes education is based on the ongoing learner-centred needs assessments of 
individuals and/or communities. 
The X-PERT programme was designed taking into consideration the learner-centred 
needs of individuals with Type 2 diabetes and the community in which they live. As 
the diabetes education programme is based on theories of empowerment and patient 
activation, patients identified their own needs and developed the skills and 
confidence to explore possible actions to increase diabetes self-management. 
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b) Plans for diabetes education programmes are learner-centred and subject to 
ongoing review and modification. 
Ten X-PERT programmes have been delivered and each programme was modified 
slightly in order to meet the needs of the participants. For example, participants 
attending a programme in Burnley elected to miss out the supermarket tour because 
several of them had mobility problems. The tour was replaced with an activity 
whereby participants brought empty food cartons, wrappers and labels to the session 
and discussions similar to those forming part of the supermarket tour took place. Any 
participants from the group who would have liked to attend a supermarket tour were 
invited to attend one of the tours arranged for another programme. Each programme 
was evaluated using a patient evaluation form (Appendix 8). Participant evaluation is 
covered in more detail on pages 201 to 204. 
c) Implementation of diabetes education is learner-centred and facilitates cognitive 
learning, behaviour change and self-management and is extended to families, 
caregivers and communities where appropriate. 
As shown in the outcome results (section 6.5.3, starting on page 204) the X-PERT 
programme facilitated skill development, self-directed behaviour change and diabetes 
self-management. Participants were encouraged to attend the programme with a 
family member or friend and approximately one quarter to one third of participants 
brought somebody with them. Whole communities were not directly involved 
although `word of mouth' was a powerful indicator of community interest. This is 
discussed further in Chapter 7. 
d) Education is provided in a professional and ethical manner and is learner-centred 
and evidence-based where possible. 
The X-PERT programme was delivered in a high quality and professional manner 
and was adapted to be suitable for the local Urdu speaking South Asian population. 
The content was prepared from the latest evidence-based guidelines and was updated 
as appropriate. 
e) The diabetes education service will be recognised by and accessible to the 
community. 
As the X-PERT programme was evaluated with a randomised controlled trial, only 
16 practices were invited to take part in the research and half of the participants 
received the control education programme, which was routine care. Therefore the 
education programme service is currently not available to all those with Type 2 
diabetes. The programme has been recognised as an example of good practice and, in 
201 
2003, it won national awards from Diabetes UK and the National Obesity Forum. It 
is hoped that BPR PCT will implement the programme as routine treatment in the 
future. 
f) The effectiveness and quality of education will be annually assessed, linked to 
outcomes, and the services will be reviewed on the basis of the assessment. 
A participant evaluation was carried out after each programme. Biomedical, lifestyle 
and psychosocial outcomes were collected at four months and at 14 months. Future 
programmes will be reviewed based on that assessment. 
g) Educational and clinical research are undertaken to provide an evidence base for 
practice. 
Participant outcomes were collected at baseline, four and 14 months and compared to 
a control group. The results of the randomised controlled trial have provided, and 
will continue to provide an evidence base for the future delivery of diabetes 
education. If the X-PERT programme is implemented as routine treatment, it is 
hoped that educational and clinical research will continue. 
Participant evaluation 
Attendance registers were taken for each X-PERT programme. Participants were 
classed as attendees if they attended at least four out of the six sessions and those 
participants received an attendance certificate. For a summary of attendance for each 
programme see Table 6.6 on page 202. In total, 128 (81.5%) participants attended four 
or more sessions. The attendance rate was greater for the white Caucasian participants 
than for the South Asians (100 (86%) and 28 (68%), respectively; P=0.01). The reasons 
for that finding are discussed in Chapter 7. In 51% of cases, the tutor was informed in 
advance if individuals were unable to attend a future session. 
Process evaluation was carried out upon completion of the programme in order to assess 
acceptability, enjoyment and usefulness of the intervention and its perceived impact on 
health. Participants were asked to complete the evaluation questionnaire and the results 
were as follows (see figure 6.2 on page 203): 
Q 129 participants (82%) returned the questionnaire; 
0 97% (95% CI: 94% to 100%) enjoyed the whole programme, with weight 
management being the most popular session; 
202 
Q 99% (95% Cl: 95% to 100%) found the programme useful, diabetes 
complications being the most useful topic, 
Q 96% (95% Cl: 93% to 99%) perceived that attending the expert patient 
programme would improve their health with 99% stating that the time spent on 
goal setting would have the greatest impact, 
Q Six weekly sessions were reported `just right' for 72% of participants (95% Cl: 
64% to 80%) with 16% requesting more sessions. 80% were satisfied with 2- 
hour sessions (95% CI: 73% to 87%); 
Q 91% stated that knowledge gained equipped them with the skills to help other 
people with diabetes (95% Cl: 86% to 96%). 
T; 
11 8 11 8 6* 8 
13 13 15 9 13 14 
16 14 15 11 13 9 
87 7 7 8 10 
11 10 10 11 10 10 
. .. `: ý:. 15 13 13 15 13 12 .'.,, 
14 12 11 13 9 12 
16 18 16 16 16 17 
130 123 122 113 112 114 
(83%) (78%) (78%) (72%) (71%) (73%) 
"Male and female South Asian participants 'Male Sout h Asian partici pants only `Female 
South Asian participants only *Racial riots in B urnley 
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Figure 6.2 Summary of participant evaluation 
Participant Evaluation 
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Setting 
  Enjoyment Q Usefulness   Perceived Improvement to Health 
Participants often wrote additional comments on the evaluation forms, a sample of 
which can be seen below: 
`1 his is the 
, 
first time in 10 years of being a diabetic that anybody has told nie these 
things 
'I am certain that 1 would not have gained more than 20% c? f the knowledge I have 
about diabetes had I not attended this course. I believe that diabetics will respond heiler 
to education delivered in this way, rather than the ad hoc information handed out by 
busy ('01isullams'GPs Practice Nurses. This course should he essential. for all »ew/y 
diagnosed diabetics' 
'I feel l have gained a lot more knowledge ahoiii diaheles, which I can eise for myself 
and a/ the ho pilal, wish elderly palienis. 1 will show my. file tv the hass' 
' 6'ery glad to be offered the course, much appreciated ('1 hank you NHS. 9. heel much 
encouraged in dealing With myself and more understanding with hu/es/ knowledge' 
'Some very useful information gleaned. from this course. Will cerlainiy change ni 
allihide lo diaheles control and lifestyle' 
`I realised by coming to the sessions, how little I knew about diabetes. I found these 
sessions really useful ' 
`I any more at ease with diabetes from what I have Ieariit and able to control it better' 
`I was very impressed the sessions had heen delivered in a manner that had ohvioUsly 
gone beyond that required to make them understandable' 
'The course was really enjoyable and educational and has helped nie to rinderstarrt/ 
diabetes more fully regarding my husband and also in helping other people ºi'itir 
diabetes who I come into contact with ill my, work ill the cOmmnni! v and in helping 
myself to adopt a healthier lifestyle. Wish we had this education year. ago ' 
; ýl 
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Don't feel as frightened as I did .............. feel more confident in myself..... things 
explained so that anybody & everybody can understand' 
'I think this course was really helpful in helping me understand diabetes as all 
demonstrations were in laymen's language' 'Tipis programme should have been 
implemented years ago' 
6.5.3 Outcome 
There were no significant differences between the two groups at baseline in terms of 
patient characteristics. The intervention group perceived that their blood glucose levels 
had recently been high compared with the perception of the control group. However, 
there was no difference in baseline glycated haemoglobin levels and that result may 
therefore have been due to increased diabetes awareness before commencing the 
X-PERT programme. 
BIOMEDICAL OUTCOMES (see Table 6.7 on page 206) 
At four months, there was a significant difference (0.4%; 95% Cl: 0.1% to 0.7%; 
P=0.02) in the mean HbAI,, between the expert patient and routine treatment groups. 
There was a greater significant difference at 14 months (0.7%; 95% Cl: 0.3% to 1.0%, 
P<0.001) (see figure 6.3 overleaf). Systolic blood pressure was 5 mmHg lower in the 
intervention group (95% Cl: 0-9mmHg; P=0.06) at four months with borderline 
statistical significance. At 14 months the expert patient group showed a7 mmHg 
reduction in systolic blood pressure. The control group also experienced a reduction (4 
mmHg) at 14 months and there was therefore no statistically significant difference 
between the two groups (difference 3.1 mmHg; 95% Cl: -1.6 to 7.9, P=0.19) (see figure 
6.4 overleaf). The expert patient group experienced a small reduction in diastolic blood 
pressure at both four and 14 months with a 1.7 mmHg difference between the 
intervention and control group that was neither clinically nor statistically significant 
(see figure 6.5 overleaf). There was no statistical difference between the groups in the 
short or longer term in respect of lipid profile. Although not statistically significant, 
body weight, BMI and body fat showed a general trend towards a reduction compared 
to controls and waist circumference showed a borderline statistically significant 
reduction at 14 months (see figures 6.6 to 6.9 overleaf). 
I 
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Figure 6.3 Glycated haemoglobin 
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Figure 6.4 Systolic blood pressure 
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Figure 6.5 Diastolic blood pressure 
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Figure 6.6 Body weight Figure 6.7 BMI 
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Figure 6.8 Waist circumference Figure 6.9 Body percentage fat 
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Subgroup Analysis 
The primary outcome glycated haemoglobin was analysed separately for the white 
Caucasian and South Asian participants (sec Table 6.8 below). At baseline there were 
no significant differences between the expert patients and the control groups for either 
of the white Caucasian or South Asian participant subgroups. At four months, the white 
Caucasian expert patients showed a slight but statistically non-significant difference in 
glycated haemoglobin levels compared to the control group (difference 0.2%; 95% CI: - 
0.2% to 0.6%, P=0.25). However, there was a highly significant statistical difference 
between the expert patients and the control group in the South Asian subgroup 
(difference 1.0 %; 95% CI: 0.3% 1.7%, P=0.004). At 14 months expert patients in both 
subgroups showed a statistically significant improvement in glycaemic control 
compared to the control group (white Caucasian subgroup difference 0.6%; 95% CI: 
0.3% to 1.0%, P=0.001 and South Asians subgroup difference 0.8%; 95% CI: 0.1% to 
1.5%, P=0.02). 
Table 6.8 Sub-group analysis comparing white Caucasian and South Asian participants 
All participants White Caucasian Participants South Asian Participants 
Expert Control Dilrerence Expert Control Diference Expert Control Dillerence 
patients patients (%) patients patients (%) patients patients (%) 
% (SD) % (SD) P value % (SD) % (SD) P value % (SD) % (SD) P value 
Baseline 7.7 7.7 7.7 7.6 7.5 7.8 
HbAlc (1.6) (1.6) 0 (1.6) (1.5) 0.1 (1.5) (1.8) 0.3 
n=157 n=157 P=0.85 n=115 n=119 P-0.70 n=42 n=38 P=0.36 
4 mths 7.4 7.8 7.4 7.6 7.5 8.5 
MAU (1.3) (1.6) 0.4 (1.4) (1.4) 0.2 (1.0) (1.9) 1.0 
n=152 n=149 P=0.02 n=112 n=113 P=0.25 n=40 n=36 P=0.004 
14 mths 7.1 7.8 7.0 7.6 7.5 8.3 
libAlc (1.1) (1.6) 0.7 (1.1) (1.5) 0.6 (1.0) (1.9) 0.8 
n=150 n=141 P<0.001 n=109 n=106 11-0.001 n=41 n-34 P=0.02 
LIFESTYLE OUTCOMES (see Table 6.9 on page 209) 
Diabetes knowledge scores improved in the expert patients compared with those of the 
control group at both four (P<0.001) and 14 months (P=0.04). The number of days each 
week that the expert patients were exercising, performing blood glucose monitoring and 
foot care self-management activities significantly increased in comparison with the 
frequency of those activities within the routine treatment group at four months 
(difference 0.9 day, P<0.001; 0.7 day, P=0.008; 0.9 day, P=0.009; respectively). That 
increase remained statistically significant in respect of exercise and foot care at 14 
months (difference 0.9 day, P=0.02; 0.6 day, P=0.003; respectively) but not in respect of 
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self-monitoring of blood glucose levels (difference 0.5 day, P=0.17) (see figures 6.10 to 
6.12 below). 
Figure 6.10 Exercisefrcquency 
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Figure 6.11 Foot care frequency 
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Figure 6.12 Self-monitoring blood glucose frequency 
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The in-depth food frequency questionnaire indicated that the intervention group was 
consuming one extra portion of fruit and vegetables each day (95% Cl: 0.2 to 1.8 
portions; P=0.01) at four months and two extra portions each day (95% Cl: 1.1 to 3.2 
portions; P<0.001) at 14 months (see figure 6.13 on page 210). That contributed to a 
greater percentage of energy from sucrose, total sugars, and carbohydrate at four months 
(difference 2.2%, P=0.001; 5.1%, P<0.001,4.1%, P=0.03; respectively) and 14 months 
(difference 2.7%, P<0.001,6.6%, P<0.001,3.3%, P=0.07; respectively) (see figures 
6.14 to 6.16 on page 210). However, the percentage of energy from starch remained 
unchanged at four months (difference 1.0%, P=0.6) and was reduced at 14 months 
(difference -3.4 %, P=0.04) (see figure 6.17 on page 210). The amount of added table 
sugar reduced in both the expert patient group and the routine treatment group with no 
statistical differences between the groups at four months (difference 0.4g, P=0.82) or 14 
months (difference 1g, P=0.85) (see figure 6.18 on page 210). Fibre (non-starch 
polysaccharide) intake increased in both groups, with a statistically significant 
difference between the expert patients and control group at 14 months (difference 3.8g, 
P=0.05) (see figure 6.19 on page 210). There was a trend towards reduced fat intake in 
the expert patient group that became borderline statistically significant at 14 months for 
total fat (difference 2.7%, 95% CI: -0.3% to 5.6%, P=0.07) and statistically significant 
for saturated fat (difference 1.1%, 95% Cl: 0% to 2.3%, P=0.05) (see figures 6.20 to 
6.21 on page 210). 
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Figure 6.13 Fruit & vegetable intake 
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Figure 6.17 Starch intake 
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Figure 6.18 Added sugar intake 
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Figure 6.19 Fibre intake Figure 6.20 Total fat intake 
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Figure 6.21 Saturated fat intake 
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PSYCHOSOCIAL OUTCOMES (see Table 6.10 on page 212) 
Expert patients were "much more satisfied" with their diabetes treatment at four months 
(P<0.001) and 14 months (P=0.002) than were controls. Self-reported frequency of 
hypoglycaemia or hyperglycaemia did not change and there were no differences 
between groups at four and 14 months. The expert patients showed significant 
improvements, compared with controls, in the negative impact of diabetes on freedom 
to eat (four months P<0.001,14 months P=0.04) and drink (four months P=0.005; 14 
months P=0.01) and enjoyment of food (four months P=0.05,14 months P=0.05), but 
not on overall quality of life (four months P=0.77; 14 months P=0.59) (figures 6.22 to 
6.25). 
Figure 6.22 Freedom to eat 
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Figure 6.23 Freedom to drink 
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Figure 6.24 Enjoyment of food 
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At four months there were significant statistical differences between the expert patients 
and the controls for the total empowerment score (P<0.001) and for subscales 
comprising the total empowerment score: psychosocial adjustment (P=0.002), readiness 
to change (P<0.001), goal setting (P<0.001). At 14 months significant statistical 
differences between the two groups remained: total empowerment score (P=0.006), 
psychosocial adjustment (P=0.005), readiness to change (P=0.001), goal setting 
(P=0.03) (figures 6.26 to 6.29). 
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Figure 6.26 Psychosocial adjustment 
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Figure 6.27 Readiness to change 
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Figure 6.28 Setting and achieving goals 
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Figure 6.29 Total empowerment score 
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Diabetes medication 
Self-reported medication prescribed for the treatment of diabetes was reviewed at 14 
months and compared to that prescribed at baseline. A medication increase was defined 
as either of the following: progression from the treatment of diabetes with diet alone to 
a prescription for oral hypoglycaemic agents (OHAs); an increase in dose or change in 
type of OHA; progression onto insulin injections or an increase in the number of units 
of insulin injected. The numbers of expert patients and control patients requiring 
medication increase is shown in Table 6.11 below. A medication decrease was defined 
as a reduction in the type or quantity of OHAs prescribed or the number of units of 
insulin injected. Medication was classed as remaining the same if no changes had been 
made to the original baseline regimen. The number of expert patients and control 
patients receiving a medication decrease is shown in Table 6.12 overleaf. 
Increase in diabetes medication 
Table 6,1 1 Number of an irºcr"i": rce in their tli: ºhw icy merliv: ºlirºn 
Did not increase Entered 
medication medication 
Expert patients 31 I 19 I ýU 
Control patients 65 76 141 
TOTAL 96 195 291 
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The risk of the expert patients increasing diabetes medication was 31 / 150 = 0.21 (Pi) 
The risk of the control patients increasing diabetes medication was 65/141 - 0.46 (P2) 
The risk ratio (RR) is P, / P2 = 0.21/0.46 = 0.45 (95% Cl: 0.31 to 0.64) 
The relative risk of increasing medication for patients who had attended the X-PERT 
programme was 0.45. Thus the X-PERT programme reduced the risk of increasing 
diabetes medication by 55%. 
The risk difference (RD) is P1- P2 = 0.21 - 0.46 = -0.25 (95% Cl. -0.36 to -0.1.5) 
Expert patients were 25 absolute percentage points (95% Cl: 15% to 36%) less likely to 
have their diabetes medication increased than controls. 
Number needed to treat (NNT) is 1/RD = 1/0.25 =4 patients (95% Cl: 3 to 7) 
For every four patients who participated in the X-PERT programme, one patient could 
be spared an increase in their diabetes medication by the time of the 14-month follow- 
up. 
Reduction in diabetes medication 
Table 6.12 Number of patients whose diabetes medication ww as re(luced 
Reduced Did not reduce Entered 
medication medication 
Expert patients 
Control patients 1 140 141 
TOTAL ')5 266 291 
The likelihood of the expert patients reducing medication was 24/150 = 0.16 (Pi) 
The likelihood of the control patients reducing medication was 1/141 = 0.007 (P2) 
The risk ratio (RR) is PI/ P2 = 0.16/0.007 = 23 (95% Cl: 3 to 165) 
The relative risk of reducing medication for patients who had attended the X-PERT 
programme was 23. Thus expert patients are 23 times more likely to reduce diabetes 
medication compared with control patients. 
The risk difference (RD) is P1- P2 = 0.16 - 0.007 = 0.15 (95% Cl: 0.09 to 0.21) 
Expert patients were 15 absolute percentage points (95% CI: 9% to 211%) more 
likely to 
reduce diabetes medication than controls. 
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Number needed to treat (NNT) is 1/RD = 1/0.15 =7 patients (95% CI: 5 to 11) 
For every seven patients who participated in the X-PERT programme one patient could 
expect to have reduced their diabetes medication by the 14-month follow-up. 
6.6 Unplanned outcomes 
The randomised controlled trial collected individual biomedical, lifestyle and 
psychosocial outcomes and the participant evaluation assessed the content and delivery 
of the X-PERT programme for enjoyment, usefulness and perceived impact on health. 
The evaluation questionnaire also asked participants whether they believed that 
attending the programme might help other people with diabetes and 91% answered in 
the affirmative (see participant evaluation on page 201). Unplanned outcomes that 
resulted from patients attending the diabetes expert patient programme and that are 
likely to help other people with diabetes were as follows: 
o lending diabetes expert patient manuals to relatives, friends and health 
professionals regardless of whether they themselves were living with diabetes; 
o training as peer educators for the Department of Health lay-led chronic 
conditions expert patient programme; 
o becoming a peer educator for their local general practice; 
Q forming a diabetes empowerment and education subgroup for the local diabetes 
services implementation group (LDSIG), writing a report with recommendations 
for the delivery of diabetes education within the locality, and making a 
presentation of the report to LDSIG and Primary Care Trust management; 
o developing local support groups in Nelson and Haslingden; 
o sitting on health care delivery committees and making presentations to give a 
laypersons perspective to aid the development of local and national diabetes 
services. 
ß. 7 Presentation at scientific meetings 
The X-PERT project has been presented at several national and international 
conferences: 
Q the participant evaluation data was presented at the European Association for the 
Study of Diabetes (EASD) Professional Annual Conference, Budapest, 
September 2002 (Deakin et al. 2002); 
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Q the four month results were presented at the 2003 Diabetes UK Professional 
Annual Conference, Glasgow, March 2003 where the X-PERT project won the 
2003 Diabetes Education Award (Deakin et al. 2003c); 
Q (Deakin 2003b) those four month results were also presented at the American 
Diabetes Association 63`d Scientific Session, New Orleans, June 2003 (Deakin 
et al. 2003b); 
o the full results (four month and 14 month) were presented at the International 
Diabetes Federation Conference, Paris, August 2003 (Deakin et al. 2003a). 
There has therefore been considerable national and international interest in the X-PERT 
programme. 
6.8 Summary 
The X-PERT project was well received from the start, with all 16 practices approached 
agreeing to take part in the research. Recruitment of participants met the predicted 20% 
response rate; 314 participants provided written consent; that was 14 more than the 300 
participants originally proposed. The mean age of the participants was 62 years, 
although the South Asian participants were, on average, ten years younger. The mean 
duration of diabetes was 6.7 years. The participants were generally obese, with a waist 
circumference in the `unhealthy' range (highest tertile). Although mean blood pressure 
readings were above the recommended level, mean lipid profiles were acceptable. 
Ten diabetes expert patient (X-PERT) programmes were delivered to 157 participants, 
of which three programmes were delivered to Urdu-speaking South Asian participants 
through a translator. Attendance rate was excellent and participant evaluation showed 
that the patients had enjoyed the sessions, had found the information useful and felt that 
the programme would improve their health. Structure and process evaluation based on 
the International Diabetes Federation standards showed that the delivery of the diabetes 
expert patient programme allowed many standards to be met that otherwise would not 
have been addressed within Burnley, Pendle and Rossendale. 
Outcome evaluation was carried out at four months and at 14 months and showed many 
biomedical, lifestyle and psychosocial health gains for participants who were assigned 
to the X-PERT programme. At baseline, one quarter of participants were advised to 
control their diabetes with lifestyle alone, just over half of the participants were 
prescribed hypoglycaemic tablets and almost one in five participants was injecting 
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insulin. Participants assigned to the X-PERT programme were more likely to reduce 
their diabetes medication and less likely to have an increase in prescribed medication 
compared to the control group. 
The primary outcome, glycated haemoglobin, was significantly improved at four 
months and that improvement was not only maintained at 14 months, but glycaemic 
levels were further reduced. There were greater differences in glycated haemoglobin 
levels between the South Asian expert patients and the South Asian controls owing 
primarily to deterioration in the glycaemic control of the control group. 
The expert patients increased self-management of diabetes by exercising, self- 
monitoring blood glucose levels and performing foot care more regularly, and they 
consumed a healthier diet consisting of more fruit, vegetables, and fibre and less 
saturated fat. They also became significantly more knowledgeable about their diabetes. 
Psychosocial variables improved with greater freedom to eat and drink, and increased 
enjoyment of food. Expert patients reported feeling more empowered by virtue of 
having improved psychosocial adjustment to diabetes, increased readiness to change 
and more likelihood to set and achieve goals. Attending the X-PERT programme also 
significantly improved treatment satisfaction scores. 
1. 
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Chapter 7: Discussion, Conclusion & 
Recommendations 
7.1 Introduction 
The final chapter of this study will commence with a brief resume of its findings. This 
will be followed by a discussion of the strengths and possible limitations of the research 
methods and evaluation (structure, process and outcome) employed. The general 
application of the study will then be considered before conclusions are derived. 
Thereafter, by way of a refresher regarding the content of the thesis, a brief summary of 
each chapter will be presented, superseded by review of the overall evidence in favour 
of an empowerment approach to patient education. The chapter and thesis will draw to a 
close with a discussion about future implications of the study, from investigation to 
practice, and about the need for more research before effective patient education 
programmes can be further developed. 
7.2 Resume of findings 
The X-PERT trial tested the hypothesis that delivery of a professional-led, community 
based, diabetes-specific expert patient programme for adults with Type 2 diabetes based 
on the theories of patient empowerment and patient activation would: 
(1) develop the skills and confidence needed for patients to be able to make informed 
decisions regarding their diabetes self-management; 
(2) improve biomedical, lifestyle and psychosocial outcomes both in the short term 
(four months) and longer-term (14 months); 
(3) meet the International Diabetes Federation (IDF) structure and process standards 
regarding diabetes education. 
The study has not refuted any of the three aspects of the hypothesis. The expert patients 
became more knowledgeable about their diabetes and increased their self-management 
skills by exercising, taking care of their feet and choosing a healthier diet both in the 
short and longer-term. Although the frequency (number of days per week) of self- 
monitoring blood glucose levels was statistically significantly greater than that of the 
control group at four months, the half-day difference at 14 months may have occurred 
by chance. The empowerment score assessed patients' self-efficacy (perceived 
confidence) to self-manage their diabetes and it showed statistically highly significant 
differences between the expert patient and the control group in respect of the total 
empowerment score and the three subscales (psychological adjustment, readiness to 
change and goal setting) both in the short and in the long term. 
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The increased knowledge, skills and confidence impacted on biomedical measurements, 
significantly improving diabetes control at four months and further reducing glycaemic 
levels at 14 months. Although not statistically significant, the results indicated a trend 
towards reduced blood pressure, body fat and body weight. A3 cm reduction in waist 
circumference is a clinically significant finding, although statistically a borderline 
significant difference (95% confidence intervals: 0 to 6 cm). Although there were no 
differences between the expert patients and the control group in respect of lipid profile, 
that was not surprising, as those mean readings were within the recommended range for 
total, LDL and HDL cholesterol. 
As indicated above, the diabetes expert patient programme significantly improved 
lifestyle outcomes at both four months and at 14 months through physical activity 
levels, self-management skills and nutritional intake. It also positively impacted on 
psychosocial outcomes, both in the short and longer-term, through enhanced treatment 
satisfaction, improved quality of life through freedom to eat and drink and enjoyment of 
food, and as stated above, increased self-empowerment. Although expert patients 
experienced greater freedom to eat and drink, their energy intake did not increase and 
they did not gain weight. Extra carbohydrate was consumed by the expert patients in the 
form of total sugars, including sucrose, and that consumption may have resulted in a 
slight reduction in fat intake. Sucrose intake remained within healthy eating guidelines 
and it did not lead to a deterioration in diabetes control. Those findings accord with 
current dietary guidelines, further dispelling the myth of the sugar free diet (Nutrition 
Subcommittee of the Diabetes care Advisory Committee of Diabetes UK 2003). There 
were no differences between the expert patients and the control group in respect of table 
sugar intake. The extra fruit and vegetables consumed daily by the expert patients will 
have contributed to the increased sucrose and total sugar intake. 
At baseline, both the expert patient group and the control group were consuming a 
similar quantity of fruit and vegetables each day (2.8 portions and 2.9 portions 
respectively) and those quantities compared with the mean national intake (2.7 portions 
for men and 2.9 portions for women) (Department for Environment 2000). At four 
months both the expert patient group and the control group had increased fruit and 
vegetable intake compared to the national average, although the expert patient group 
was consuming significantly more fruit and vegetables than the control group (4.4 
portions and 34 portions respectively) At 14 months the expert patients were 
consuming two extra portions of fruit and vegetables each day compared with the 
control group (5.2 portions and 3.1 portions respectively) The X-11 . RT programme 
has 
therefore appeared to be an example of a successful health promotion strategy 
1.3 Strengths and limitations of the study 
7.31 Methods 
The following table summarises strengths and limitations in relation to the research 
design 
I. iI)II -1 `11 111111ar. of the st IL II tli. , tali 
Ii init, tti1 oii Ini the nictIii k . ind ik iyin if Ilic 
The research design was achievable and 
appropriate to answer the research 
i question. 
Randomisation of individuals was still 
thought to introduce less bias than 
performing cluster randomisation. 
A waiting list control group may have a 
more ethical approach but time 
constraints prevented this 
Cross-contamination did occur between 
the intervention and control groups 
An attempt was made to conceal 
i allocation of participants to the 
intervention or control group by 
describing the two programmes as 
individual or group education. 
Although total separation of 
implementation and evaluation of the 
study was not possible, two outcome 
assessors, not involved in the delivery of 
the diabetes education, were blinded to 
treatment allocation. The outcome 
database was also anonymous. 
Only the expert patients were intended to 
receive their own health results, but due 
to the blinding of outcome assessors, all 
participants had access to them. 
Therefore, the control patients received 
more attention and better care than 
routine treatment, 
The CONSORT statement was 
acknowledged and followed where 
possible. 
Total separation of implementation and 
evaluation of the study was not possible 
due to practicalities, time and funding 
constraints This limitation was 
acknowledged and addressed Due to the 
nature of the interventions (education 
programmes), it was not possible to blind 
the health professionals to group 
allocation and this may have resulted in 
performance bias. 
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Attempts were made to present the 
programme in a manner that enables the 
intervention to be transported to, and put 
into operation in other contexts 
(Chapter 4) 
Minimum exclusion criteria. 
differences between the intervention and 
Recruitment from mailshots rather than 
advertisement in the health centre or 
through local media. 
20% response rate acceptable for clinical 
trials. 
Telephone recruiting increased the 
response rate for the South Asian 
participants, especially when an Urdu 
speaking student was available. 
control group showing that the 
randomisation had been effective. 
Trial participants were a typical sub- 
group of people with Type 2 diabetes as 
the age at diagnosis and percentage of 
overweight or obese patients were the 
same as in the UKPDS study. 
The study was a complex intervention and 
it is not possible to identify the active 
ingredients with total precision. 
Process evaluation using qualitative 
methods was not possible due to funding 
and resource constraints 
Practice staff screening and excluding 
some patients. 
Practice registers sometimes incorrect and 
not always up-to-date 
Limited time to take advantage of word- 
of-mouth recruiting. 
Different methods to assess socio- 
economic deprivation at ward level had to 
be used for Rossendale compared to those 
used for Burnley and Pendle. However, 
both methods identified practices that had 
great diversity in the socio-economic 
status of registered patients. Such 
diversity did not appear to effect group 
dynamics. 
The differences in demographic variables Poorer return rate for the questionnaires 
between white Caucasian and South 
Asian participants supported previous 
findings. 
from the South Asian participants may 
have biased the results, as more literate 
and educated participants may have 
responded, resulting in the South Asian 
sub-group appearing to be better educated 
than the true results may have shown. 
as facts, due to the small percentage 
(25%) of South Asian participants. 
Sub-group comparisons between the 
white Caucasians and South Asians, 
although interesting and supportive of 
previous findings. cannot be interpreted 
INu impurranr stansncauy signincant 
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Research design 
Although it has been suggested that randomised controlled trials arc problematic in 
practice, with particular problems occurring regarding recruitment and randomisation 
(Pringle & Churchill 1995), the prospective, pragmatic randomised controlled trial used 
to evaluate the X-PERT programme was thought to be an achievable and appropriate 
research design to answer the research question. However, there was some cross- 
contamination between the two groups. Participants were randomised as individuals to 
receive either the X-PERT education programme or routine treatment. Therefore, for 
each general practice, there were some participants receiving the intervention and some 
allocated to the control group. There are many small communities within Burnley, 
Pendle and Rossendale and patients registered at the same practice tend to be 
acquainted. There were several instances where participants attending the group 
education programme shared the content of their course with control participants. Some 
expert patients even lent their X-PERT programme manuals to control patients. Many 
control patients subsequently requested a swap to the group education programme. 
Cross contamination might have been reduced if the trial had used cluster randomisation 
i. e. the general practice had been randomised to intervention or control rather than 
individual patients. That method of randomisation was considered when designing the 
trial but it was felt that some design features of a cluster trial may make it especially 
vulnerable to a range of threats that can introduce selection bias (Puffer, Torgerson, & 
Watson 2003) and it was decided that, even with the risk of cross contamination, 
individual randomisation was more appropriate for this study. 
In an attempt to conceal allocation of the participants to the intervention or control 
group, the patient information leaflet described a group-based education programme and 
an individual education programme. Blinding of patients was important because 
knowledge of group assignments could influence responses to treatment. Patients who 
knew that they had been assigned to a new treatment might have displayed favourable 
expectations or increased anxiety, and patients assigned to routine treatment could feel 
discriminated against or reassured (Altman et al. 2001). Many of the individual 
education (control) patients complained that they were not benefiting from their 
programme. That was not a surprising finding as they were, in fact, the control group, 
receiving routine treatment. For other control group participants, the individual 
education programme specified in the study (i. e. individual appointments with the 
dietitian, practice nurse and GP) was an improvement on the `routine treatment' 
previously received, which had not included referral to a dietitian. There was therefore a 
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mixed reaction from those in the control group depending on the standard of care that 
they were previously accustomed to. 
Both groups received health assessments at baseline, four and 14 months and although it 
was intended that only the expert patients were to obtain their own health results, the 
control group patients also benefited from those assessments. The outcome assessors, 
blinded to treatment allocation (with the exception of the author, who delivered the X- 
PERT programme), discussed patients' results openly with all patients and answered 
queries regarding those results. Copies of the blood results for glycated haemoglobin 
and the lipid profile were sent to the respective GPs and, in many cases, treatment was 
changed as a result of those blood tests. Control patients therefore received better care 
and more attention than had previously been provided via routine treatment. In some 
instances, it may be deemed unethical to have half the participants in a clinical trial 
receiving routine treatment. A randomised controlled trial with a waiting list control 
group would have addressed this possible limitation. However, as outcomes were 
collected at 14 months from baseline, it was not possible within the time constraints to 
have a waiting list control. 
Overwhelming evidence now indicates that the quality of reporting randomised 
controlled trials (RCTs) is less than optimal and that weakness arises from biased 
estimates of treatment effects. A group of scientists and editors developed the 
CONSORT (Consolidated Standards of Reporting Trials) statement (Altman et al. 2001) 
that facilitated critical appraisal and interpretation of RCTs by providing guidance to 
authors about how to improve the reporting of trials. That statement provided guidance 
for reporting the methods and the results of the trial that is the subject of this thesis. 
Ideally, total separation of delivery and evaluation is recommended for randomised 
controlled trials. However in this instance, practicalities and funding did not permit such 
separation and that has to be recognised as a possible limitation of the study. Also, 
although blinding of group allocation is recommended, not only for the patients, but 
also for all health professionals and researchers involved in the study, it was not 
possible in this study to blind the health professionals to group allocation. Performance 
bias might have occurred in respect of this, with the GP, practice nurse or dietitian 
providing routine treatment to the control patients, especially if the health professionals 
perceived that the trial was comparing the effectiveness of their treatment with that of 
group education. The author of this thesis was the diabetes educator who delivered the 
X-PERT programme. Although blinding to group allocation had not been possible, 
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performance bias was less likely because the content of the education programme was 
standardised, with weekly lesson plans, and the programme had been delivered to a 
group of patients rather than to individuals. 
The author of this thesis was also the data analyst, which could potentially introduce 
bias. In an attempt to avoid bias, an anonymous database was used to analyse the results 
whereby the intervention group and control group were compared at baseline, four and 
14 months. Statistical tests were performed on any differences between the two groups 
to detect whether those differences were likely to have occurred by chance or as a result 
of attending the X-PERT programme. T-tests were used for parametric data and the 
Mann-Whitney test was used for non-parametric data. 
Educational programmes are often described as complex interventions where it is 
difficult to define the 'active ingredient' (Medical Research Council 2000). The 
effectiveness of the X-PERT programme may be due to several factors: the theoretical 
models used; the skills and motivation of the educator; the rapport between the 
participants; the patient manuals; the sharing of health records; goal setting; or a 
combination of all of these. This could be described as the black box theory i. e. the 
individual components of the intervention were identified before its implementation and 
outcomes were collected and analysed at time points after implementation, but the 
specific ingredients leading to the success of the education programme remain 
unknown. Process evaluation using qualitative methods may have identified the content 
of the `black box' and strengthened the evaluation. However, funding and resource 
limitations prevented further evaluation on this occasion and may be seen as a limitation 
of the study. The use of the empowerment model successfully facilitated the process of 
self-empowerment in the patients, although the extent to which increased empowerment 
contributed to improved outcomes cannot be identified. Other recognised `active 
ingredients' in the complex intervention were the visual aids, patient manuals and the 
participants' ability to obtain and understand their own health results. The author 
recognised that the sessions needed to be fun and refreshments were required to 
encourage the group to interact. Refreshments were also important to address 
`Maslow's hierarchy of needs' (Benson & Dundis 2003) that physiological needs such 
as hunger and thirst need to be met before effective learning can take place. One lesson 
learnt regarding the supermarket tour was that no more than 10 participants could 
feasibly be invited to attend each tour. 
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The precise mechanism of action is likely to be a combination of all components. An 
attempt has therefore been made to present the programme in a manner that enables the 
intervention to be transported to, and put into operation in, other contexts (Sec Chapter 
4 for a scripted description of the X-PERT programme). 
Recruitment 
All adults with Type 2 diabetes were invited to take part unless physical or cognitive 
restrictions prevented them from attending and actively taking part in the programme. 
The mean glycated haemoglobin of the participants at baseline was 7.7% with a 
standard deviation of 1.6%. That result revealed that many of the participants did not 
have poor diabetes control at the start of the trial and was considered a strength of the 
study. The recruitment criteria differed from many other diabetes education 
interventions that recruited only participants with poor diabetes control and who were 
therefore more likely to experience a positive outcome (Norris, Engelgau, & Narayan 
2001). The sample size was also generous in comparision to other education studies 
(Griffin et al. 1998). 
Although participants had been diagnosed with diabetes for a mean of seven years, 
individual patient data was diverse, with some participants having been diagnosed for 
less than one year and others having lived with diabetes for 36 years. Duration of 
diabetes was not specified in the inclusion or exclusion criteria as it was thought that 
people with Type 2 diabetes could learn to improve self-management skills and 
confidence in self-management regardless of how long they had lived with diabetes. 
Also, in the interest of a pragmatic study, the level of glycaemia was not specified in the 
inclusion or exclusion criteria. Type 2 diabetes is classified as a progressive condition 
and it was perceived that even if individuals had excellent diabetes control, attending 
the X-PERT programme might prevent deterioration in glycaemic control and might 
also prevent an increase in diabetes medication. Also, as outcomes other than glycated 
haemoglobin such as blood pressure, body weight, lipid profile, lifestyle, self- 
management skills, self-confidence, treatment satisfaction and quality of life, are also 
important health determinants for people with Type 2 diabetes, it was not justifiable to 
exclude potential participants on the basis of glycaemic control alone. 
The recruitment response of 20% was typical of a randomised controlled study although 
the sample size was generous compared to other educational interventions (see the 
systematic review in Chapter 3). After the recruitment stage was over, volunteers who 
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had heard about the programme via word of mouth asked to be included in the study. 
Although they could not be accommodated on this occasion, such interest could serve to 
illustrate the effectiveness of "word of mouth" as a means of stimulating public interest 
and aiding recruitment. Two practices in Burnley gave consent for the initial mailshot to 
be followed-up with a telephone call which, although time consuming, improved the 
response rate. Telephone recruitment was shown to be particularly beneficial for the 
South Asian participants. For Burnley practice 4 (see Table 6.1, Chapter 6), telephone 
recruitment predominated and a random number table was used to select telephone 
numbers from the list of patients provided by the practice. In Pendle, 70 white 
Caucasian patients were recruited from the mailshot alone and telephone follow-up was 
only required to meet the target of 50 patients for the South Asian individuals. 
A possible limitation of the study is that not all patients with Type 2 diabetes and 
registered with one of the 16 general practices were invited to take part in the study. At 
some practices, staff screened the list of patients and deleted the names of those they felt 
would be unsuitable to participate. Unsuitability was due mainly to old age or infirmity. 
Although the intention was to keep the study as pragmatic as possible and to let patients 
decide whether it was feasible for them to take part in it, the preferences of the 
individual practices were respected. Interestingly, in practices that allowed all patients 
to be contacted, some recruits were historic non-attendees and others were living with 
severe socio-economic deprivation. The homes of the latter individuals were frequently 
dirty with little or no working sanitation, often damp with no heating and containing 
little furniture. 
Some of the patient lists received from the general practices were either incorrect or out 
of date. Notification was received in respect of several invitees that they had either 
passed away, moved out of the area or did not have Type 2 diabetes. 
Participants 
There were no statistically significant differences in demographic variables between the 
participants in the intervention group and the participants in the control group. The 
mean age of the participants was similar to that reported in other diabetes education 
studies involving patients with Type 2 diabetes (see the systematic review in Chapter 3). 
The mean age of the participants at diagnosis of diabetes (54 years) was the same as the 
mean age of participants newly diagnosed with Type 2 diabetes in the United Kingdom 
Prospective Diabetes Study (UKPDS Group 1998b). The fact that the South Asian 
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participants were, on average, ten years younger than the white Caucasian participants 
was not surprising as there is evidence that South Asian individuals develop Type 2 
diabetes at an earlier age due to increased prevalence of central obesity and 
hyperinsulinaemia (Chaturvedi & Fuller 1996). 
Although the aim of the study was to recruit patients from socio-economically deprived 
neighbourhoods, there was considerable diversity in the socio-economic status of the 
participants. However, such diversity did not appear to affect group dynamics (see the 
process evaluation discussion below in section 7.3.2). As stated in Chapter 5 (Table 5.3) 
the disadvantages of assessing the deprivation of a population using either the Jarman 
score or the DETR rank is that data is not available below ward level and there is often 
great variation within a particular ward. 
The majority of participants left full-time education at the age of 16 or younger and 
compared with the national average of 16% (Office of National Statistics 2002), only 
6% of participants had been educated to degree level. Although the mean age of leaving 
full time education was slightly higher for the South Asian participants, only 33% of 
them had completed the education questions compared with 89% of the white 
Caucasian participants. It may be surmised that better educated South Asian participants 
remained in full time education for a longer period, and those participants were more 
likely to read Urdu and/or English and complete the questionnaire, thereby biasing the 
results. 
The response rate was better in respect of questions concerning employment, with 92% 
of white Caucasian and 55% of South Asian participants responding. Although not 
directly relevant to the study, there were major differences between the two ethnic 
groups. White Caucasian participants were more likely to have been in paid 
employment and to have held a managerial position. Although 17% of white Caucasian 
and 18% of South Asian participants were working when they were recruited into the 
study, of those not working, female South Asian participants were more likely to be 
housewives and overall, South Asian participants were 21 times more likely to be 
unemployed, whereas white Caucasian participants were almost four times more likely 
to be retired. South Asian participants were also more likely to be married, less likely to 
be divorced and less likely to be widowed, whereas the white Caucasian participants 
were more likely to be single. Those findings may reflect different cultural practices, 
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particularly the lower socio-economic status of the South Asian participants and their 
younger age. 
Treatment of diabetes differed slightly for each ethnic group. A greater percentage of 
white Caucasian participants treated their diabetes with insulin (19% of white Caucasian 
compared with 10% of South Asians) and a correspondingly smaller percentage with 
tablets (53% and 68% respectively). There was, however, no difference in mean 
glycated haemoglobin levels or in the distribution of glycated haemoglobin levels 
between the two ethnic groups. That observation indicates that treatment differences 
between ethnic groups were probably not due to reluctance of the GPs to commence 
insulin in the patients who may have a language barrier and supports previous findings 
that South Asian individuals with Type 2 diabetes have greater insulin resistance and 
less insufficiency of insulin than white Caucasian individuals (Burden 1996; Chaturvedi 
2000). Another interesting observation was that the South Asian participants had lower 
systolic blood pressure readings and were also more likely than white Caucasian 
participants to meet recommendations for total cholesterol and LDL cholesterol but less 
likely to meet HDL cholesterol recommendations. Once again those observations 
support previous findings (Shaukat 1996), (UKPDS Group 1998a). 
Currently, over half of women and two-thirds of men in the UK are either overweight or 
obese (Campbell 2003). As explained in Chapter 1 (section 1.6.4), being overweight is a 
risk factor for developing Type 2 diabetes (Chan et al. 1994; Colditz et al. 
1995). (Despres, Lemieux, & Prudhomme 2001) The majority of individuals with Type 
2 diabetes are obese (WHO Working Group 1999). The participants in this study appear 
to conform to national statistics: 88% of participants had a BMI of 25 Kg/rn 2 or above. 
There was a greater percentage of South Asian participants in the overweight range 
(48% of South Asians compared with 39% of white Caucasians) and smaller percentage 
in the clinically obese range (32% and 46% respectively). Taking into consideration the 
increased prevalence of Type 2 diabetes and greater central obesity at lower BMI levels 
amongst South Asian adults, there have been recommendations that either the 
diagnostic criteria for obesity be lowered for South Asian participants to BMI ? 27 
Kg/m2 (Shaukat 1996) or that the healthy weight recommended range be lowered to 
BMI 20 to 23 Kg/m2 as opposed BMI 20 to 24.9 Kg/m2 (WHO 2004). 
Interestingly there are also important gender and ethnic differences for waist 
circumference. The baseline characteristics for the participants in this study showed that 
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83% of women compared with 52% of men had a waist circumference in the `high risk' 
tertile. That difference was more pronounced for South Asian participants with 97% of 
women having a waist circumference in the `high risk' tertile compared with 40% of 
South Asian males. Those gender differences in waist circumference may be explained 
by age and menopause-related changes in body fat distribution (Pascot et al. 1999, Toth 
et al. 2000). South Asian older females tend to be much more sedentary. Not only are 
they more likely to stay at home, but the younger female relatives also carry out the 
domestic work. `Plumpness' is accepted as a sign of good health and affluence in the 
Asian culture (Hawthorne, Mello, & Tomlinson 1993). In comparison, not only do the 
Asian men appear to have increased occupational and leisure time physical activity 
levels, they also seem to be a lot more conscious about their body weight than their 
female counterparts. 
7.32 Evaluation: structure, process and outcome 
The table below summaries strengths and limitations for the study in respect of 
evaluation. 
Table 7.2 Stren-ths and limitations of the 
BPR PCT taken the lead in 
implementation of a structured and 
empowering approach to diabetes 
education. 
in respect of c%aluatim) 
Secondary Care Diabetes Team 
uninvolved in the development and 
delivery of the X-PERT Programme. 
PCT keen to support the 
inuation of the X-PERT Programme. 
Funding has now come to an end. 
X-PERT Programme has received Used on isolated the X-PERT programme 
national awards. may not be effective. Health professional 
training alongside implementation is 
essential. 
D successful development of visual aids 
l patient manuals especially for the X- 
RT Programme. Translation of the 
ient manuals found to be unnecessary. 
Continued production of the patient 
manuals would require sponsorship for 
bulk printing. 
network of lay-experts are now 
ntributing to health service 
velotment. 
Tension between empowered patients and 
practice staff clearly a predictable 
situation in a non-specialist environment 
and the need for professional training is 
paramount. 
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The project gained tremendous support 
from the Nutrition & Dietetic 
Department, BPR PCT, Clinical 
Effectiveness Department, local branch of 
Diabetes UK, patients and their carers. 
Participants have identified that they 
would like an annual follow-up and this 
should be incorporated into any future 
j programme. 
Both intervention and control education 
programmes arranged at easily accessible, 
community venues. 
Attendance to the X-PERT Programme 
excellent. 
Intention-to-treat analysis carried out to 
reduce attrition basis. 
Lesson learnt from holding a mixed sex 
programme for South Asian participants 
and the 2°d and 3`d programmes were 
single sex resulting in better attendance. 
Semi-structured interview carried out to 
seek the views of the South Asian expert 
patients. 
Teamwork between professionals 
providing diabetes education could be 
better. 
Only one practice nurse managed to 
attend the X-PERT Programme. 
No formal follow-up arrangements within 
the current X-PERT Programme with 
participants returning to routine 
treatment. 
No programmes held during the evenings 
or weekends therefore making it difficult 
or impossible for full-time workers to 
attend. 
Attendance rate for the control group not 
as good as that for the X-PERT 
Programme. 
Initial programme for South Asian group 
were not single sex sessions resulting in 
less good attendance rates. 
Time and funding constraints prevented a 
semi-structured interview being carried 
out for all participants 
return rate for the questionnaires was 
teen 61% and 83% (and similar 
Anse from intervention and control 
p leading to an equal comparison). 
important statistically significant 
erences between the intervention 
up and control group for baseline 
nes collected in the short and 
term. 
Teen 93% and 100% biomedical 
>mes collected. 
Some questions in the questionnaire left 
unanswered which may be due to the 
length of the questionnaire or sections 
that the participants had difficulty 
understanding. Extra funding may have 
improved the questionnaire response rate 
by employing a research assistant blinded 
to treatment allocation and able to help 
participants in the completion of the 
questionnaires. 
No time or funding to `double' translate 
and then re-validate the Urdu version of 
the questionnaire. However, only 30 of 
Di 
The results of the study have not refuted Multiple comparisons may have resulted 
any of the three aspects of the hypothesis. in experimentwise (type 1) errors. 
Biomedical outcomes collected and 
analysed conforming to standardised and 
accepted methods. The use of validated 
questionnaires. 
The three trained outcome assessors 
collected the biomedical outcomes but the 
percentage measurement error cannot be 
estimated although any errors are likely to 
be distributed equally between the 
intervention and control group. 
ie empowerment score and respective 
b-scales was shown to be consistently 
eater in the expert patients at both four 
d 14 months which may further validate 
e empowerment questionnaire. 
expert patients experienced improved 
ity of life by increased freedom to eat 
drink whilst at the same time 
roving other health variables 
. ding glycaemic control. 
e longer-term assessment (14 month) 
glycated haemoglobin improved from 
short term assessment (4 month). 
The validation of the HEA3 FFQ had 
shown under-reporting of energy intake in 
obese participants and this was likely to 
be the case in this study. However, the 
validation had shown that the percentage 
energy from macronutrients was both 
valid and reliable. 
The expert patients experienced both 
increased treatment satisfaction and 
improved metabolic control although it 
cannot be identified whether one 
contributed to the other or whether the 
improvements occurred in synergy. 
The South Asian expert patients 
maintained their level of glycaemia whilst 
the metabolic control in the control group 
deteriorated. Due to sub-group analysis 
with small numbers it cannot be identified 
whether this was a chance result or 
Structure 
Burnley, Pendle and Rossendale Primary Care Trust (BPR PCT) is at the forefront in 
implementation of a structured and empowering approach to diabetes education as 
recommended by the Department of Health (DOH 200la), (DOH 2003a), (N ICE 2003b). 
Its action has largely taken the form of support for the X-PERT Programme. To some 
degree the PCT has achieved its position by reacting to the demands of the expert 
patients themselves and the national awards received from Diabetes UK and the 
National Obesity Forum. 
Funding for the X-PERT Programme of research is however now at an end. 
Continuation will depend upon safeguarding further funding in order that national and 
international objectives in diabetes education may be met. Discussions have been held 
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with the Director of the NHS Modernisation Agency, the Lancashire with Cumbria 
Workforce Development Confederation and a business case has been presented to the 
BPR PCT. 
The education/empowerment programme developed for this research depended heavily 
on the purpose created visuals designed to explain complex and scientific information in 
a simplistic but accurate manner (see Chapter 4). Those proved invaluable to the 
participants, along with the patient manuals, which were still in regular use at the 14 
month stage and beyond. The value of the manuals was illustrated by the fact that they 
were lent to, and copied for, relatives and friends. A network of lay-experts has begun to 
develop without external prompting. 
Production of the 157 manuals by hand was an arduous task. The manuals included 
literature from national bodies such as Diabetes UK (Diabetes UK 2003c) and the Food 
Standards Agency (FSA 2003), together with information sheets produced by the 
Michigan Diabetes Research and Training Centre (MDRTC 2003) and adapted for the 
UK population. Sponsorship will be required to support bulk printing and/or production 
of a CD-Rom to facilitate any expansion of the project. Translation into Urdu was found 
to be unnecessary in that South Asian participants able to read Urdu could also read 
English. Illiterate participants were normally able to rely on younger members of the 
family to assist. 
The Nutrition and Dietetic Department and the Clinical Effectiveness Team of the 
former Burnley Healthcare NHS Trust were enthusiastic supporters of the X-PERT 
project, alongside the local branch of Diabetes UK and the patients and their carers. A 
presentation to the public health department at the former East Lancashire Health 
Authority resulted in some positive criticism of the research design. That feedback led 
to the study taking the form of a pragmatic randomised controlled trial instead of the 
previously envisaged uncontrolled action research design. That change was a major one 
but it has benefited the project and its evaluation. 
As a novel and experimental approach, the study did not however gain automatic 
support in all quarters. A presentation to the Secondary Care Diabetes Multidisciplinary 
Team resulted in the team electing to distance themselves from the project. A request 
for one of their specialist diabetes nurses to assist with the project was rejected due to 
lack of resources for primary care. The team's decision to remain uninvolved in the 
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study had some slight negative impact on the project, in that a few participants 
experiencing dual care received advice delivered from two very different theoretical 
frameworks. Clearly, any future continuation or extension of the project will need to 
overcome those problems. 
Overall, teamwork and communication between health professionals providing diabetes 
education within the BPR district could be improved upon. Hard pressed general 
practice has many calls on its time and diabetes education is often provided on an ad 
hoc basis within routine appointments and is based on the knowledge and beliefs of 
those responsible. Group education programmes, in the few instances where they exist 
are unstructured with no evaluation. There is little consistency, neither between nor 
within practices. Invitations to practice nurses to attend the X-PERT Programme in all 
16 practices involved resulted in one attendee. She gained greatly from the programme, 
as did participants under her care from improved quality and consistency of advice. This 
is not to criticise those who did not attend. Many said they would have liked to do so 
but, with many other responsibilities, were unable to justify the time input. Coordination 
of resources is an area where improvements would need to be made if X-PERT patient 
empowerment was to become more widely available and meet IDF standards, safeguard 
NHS resources currently expended on secondary complications and, most importantly, 
improve the quality of life for patients with Type 2 diabetes. 
Since returning to routine care there have been some examples of tension between 
practice staff and newly empowered patients. Where inconsistent or contradictory 
advice from practice staff has been queried by better informed patients, they have, in 
some instances, been told that `they know too much for their own good' and have been 
forced to return to a more prescriptive regime that has defeated the empowerment 
gained. Clearly, although not foreseen, that consequence is an entirely predictable 
situation where professional staff unable to keep abreast of every new development in 
every field, may feel threatened by increasingly informed patients. It indicates an 
important principle: the need for professional training and awareness to run alongside 
any new development such as the X-PERT Programme as presented here. 
The scripted manual was written to increase the generalisibility of the clinical trial. 
However, that manual could be a limitation of the empowerment model if used in 
isolation without health professional training. Although the manual is scripted, it will 
also be necessary for health professionals to be familiar with the theoretical base in 
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behaviour change and the principles of adult learning, group education, the patient- 
centred approach, empowerment and discovery learning (sec Chapter 2). Lack of 
understanding regarding the theoretical base of the programme could result in the 
manual being delivered in a didactic manner with individual concerns and queries being 
ignored and should be avoided. 
Process 
The X-PERT programme has met the IDF process standards where possible. However, 
one possible limitation is that once the programme had ended, there was no formal 
follow-up arranged and participants were returned to routine treatment. To assess the 
ongoing learner-centred needs of the participants (process standard (a)), they were asked 
at the 14-month assessment whether they believed that the six-week programme was 
sufficient to meet their long-term needs or whether they felt that a follow-up session 
was required. The overwhelming majority of participants stated that an annual follow- 
up session would be useful to pose queries and to receive an update about the latest 
recommendations. That suggestion will be incorporated into any future development of 
the programme. 
In respect of the IDF process standard (e), the diabetes education service has been 
acknowledged and accessed by the X-PERT programme participants but not by the 
remainder of the diabetes community within Burnley, Pendle and Rossendale. There are 
48 practices within BPR PCT, with just 16 practices (33%) involved in the study. 
Implementation of the X-PERT or a similar programme throughout all practices is 
clearly needed for process standard (e) to be met. Educational and clinical research is 
not currently routinely practiced within the PCT but it is the ambition of the author to 
develop a research climate that would help to provide an evidence base for practice. 
Attendance 
As stated in Chapter 6, attendance at the X-PERT programme was excellent, with just 
eight participants (5%) not attending any session and 128 (82%) attending four or more 
sessions. One factor that aided the good attendance rate was that, although the 
participants were from a wide range of backgrounds, an excellent rapport developed 
between them. Bonds may have developed because all of the patients and their carers 
had something in common: they all lived with diabetes. However, some participants 
were engaged in full-time work and were therefore unable to attend every session. In 
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addition, several people who had initially been interested in the study could not 
participate at all due to work commitments. If the delivery of the X-PERT programme is 
to be continued, a more flexible approach to healthcare delivery may be required with 
evening and/or weekend courses being available. The attendance rate for the control 
group (103 patients, 66%) was not as good. The individual appointments were arranged 
within community venues to ensure that they were equally as accessible as the X-PERT 
programme and participants were given a choice of date and time. It has not been 
possible to ask the non-attendees in the control group why they chose not to attend. One 
explanation may be that they perceived the appointment would be no different to routine 
treatment previously received and therefore saw no benefit in attending. 
Attendance at the first X-PERT programme delivered to the South Asian participants 
was not as good as the attendance rates for the white Caucasian sessions. Only nine 
participants (60%) attended more than half the sessions. Even though sensitivity had 
been shown towards cultural issues (seating had been appropriately arranged, it being 
unacceptable for South Asian women to sit adjacent to unrelated South Asian males) 
many women did not feel comfortable and dropped out of the programme. Later 
sessions for the South Asian participants proved more popular because single sex 
programmes were arranged. Another cultural difference observed between the two 
ethnic groups was that approximately one third of South Asian participants requested a 
telephone reminder the day before each session, whereas no such requests were made by 
white Caucasian participants. The importance attributed to time keeping was also 
notably different between ethnic groups: white Caucasian participants typically arrived 
at the venue either early or on time. If they were going to be late, an advance phone call 
was normally received. In contrast, the South Asian participants frequently entered the 
sessions up to 30 minutes late with apparent lack of concern. Although punctuality is a 
reflection of good manners within the white Caucasian culture, it would not appear to 
carry the same importance within the South Asian culture. Those findings could explain 
why, within the health care setting, South Asian patients are classed as poor attendees. 
A dietetic student on placement conducted a qualitative semi-structured telephone 
interview with the South Asian participants to identify possible successful and 
unsuccessful strategies that could aid the future development and delivery of education 
programmes for the South Asian ethnic group. Although an attempt was made to 
contact all South Asian participants who had been invited to attend the X-PERT 
programme, the semi-structured interview was only conducted with 30 participants 
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(71%). It was Ramadan and many people were sleeping during the day. The student was 
an Urdu speaking South Asian female and she was therefore able to communicate with 
the participants in their own language. 
X-PERT programme attendees (defined as participants who had attended four or more 
sessions) reported that their reason for attendance was to seize the opportunity to learn 
more about their diabetes and how to control it. All sessions were reported to have been 
enjoyable; participants enjoyed different aspects of the programme. One female found 
the timing of the sessions (1pm to 3pm) inconvenient, as she had to leave early to 
collect her children from nursery. Overall however, participants felt that the sessions 
had greatly improved their understanding of diabetes and they reported that they had 
subsequently made significant changes to their lifestyle in an attempt to self-manage 
their diabetes. The majority of changes concerned dietary intake, with several 
participants reporting an increased consumption of fruit and vegetables, replacement of 
butter or gee with vegetable or olive oil and introduction of portion size control. Many 
had also started a daily walking regime. Knowledge sharing with relatives and friends 
living within the community was also a common response: 
` ............. I told everyone at home, I also told my wife, who also has diabetes but who 
didnt'1 attend the sessions. Her control improved.... ' 
`.... I have mentioned this to others and they seemed very happy and pleased for me. 
They also thought it was a very good idea............ . 
'I have told other members of the family. They found the paperwork very interesting 
and liked reading the information ................. ' 
The South Asian participants reported unanimously that the group-based diabetes 
education sessions were a 'good and fror way to leant'. One gentleman said: from 
attending the sessions I have found that I have learnt more than going to my annual 
appointments. I'm therefore very sure that others will also benefit'. Comments 
regarding the written information were: 'the notes were very good. Since I cannot read 
or write, I got my children to read them and translate them to me' and 'Tey [the 
information sheets in the patient manual] were very useful, I can always refer back to 
them'. These quotes suggest that provision of the patients manuals, even if they were 
not translated into Urdu, were very worthwhile. No suggestions were made with regard 
to changing the content of the programme. 
The findings from the non-attendees (participants attending less than four sessions) 
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further emphasised the need for single sex sessions. The South Asian women who only 
attended one or two sessions stated '1 did not attend the sessions because men were also 
present and I did not find that comfortable ' if there had been separate sessions for 
women and men I would have attended the sessions' 'I didn't like the sessions because 
they were mixed I wanted to ask questions but fell shy'. Other reasons for non- 
attendance were: '1 had work commitments and therefore I could not attend. However, I 
did learn fron other members of the community who did attend' and 'I wasn't able to 
attend because I was not feeling well'. Even non-attendees believed that the X-PERT 
programme approach to diabetes education was necessary 'I think that there should be 
more of these education sessions, since the dietitian went into a lot of detail, which I 
never got fron: my normal appointments'. Two non-attendees were less supportive of 
the group-based education approach 'I prefer home visits.... ' 'I think that attending the 
clinic appointments are a good way to be informed about diabetes, since you gel a one- 
to-one session with the dietitian, rather than learning in groups'. The majority of non- 
attendees felt that they had benefited from the sessions they had attended. One 
participant said: 'The session about different foods and their effect on blood glucose 
levels was very good, I was so afraid of a lot of foods ... ... .... 
learning about portion 
sizes was also very useful 
An intention-to-treat analysis was undertaken to reduce the possibility of attrition bias 
and at four months, 153 participants (97.5%) assigned to the intervention group and 152 
participants (96.8%) assigned to the control group received an outcome assessment. At 
14 months, it proved more difficult to obtain outcome data for everyone and more 
especially for some individuals in the control group. However, 150 participants (95.5%) 
in the intervention group were assessed, along with 141 (89.8%) in the control group. 
Throughout the outcome assessment periods, some South Asian participants made 
extended visits, lasting several months, to relatives in Pakistan and it was therefore not 
possible for them to be included in the assessment. The difference between the number 
of participants in the intervention and control group receiving an assessment at 14 
months was mainly due to death and refusal to participate in the outcome assessment 
(see Chapter 6, figure 6.1). Although the higher death rate in the control group 
compared with the expert patient group was probably a chance occurrence, the greater 
number of participants refusing the assessment in the control group may have been due 
to them being less satisfied with the treatment they received. It was not possible to make 
contact with three participants (one expert patient and two controls) at the 14-month 
assessment, although telephone calls were made on several occasions and, if possible, 
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messages left on answering machines. Several visits were also made to their homes, but 
with no success. The patient administration services were contacted at nearby hospitals 
to enquire whether they had been admitted to hospital and the GPs were also contacted. 
However, the whereabouts of all three patients remains unknown. 
Outcomes 
Thirty-eight outcomes were collected at baseline, 4 and 14 months. When several 
separate tests are performed the risk of experimentwise (or familywise) error increases. 
Therefore when the dependant variables are correlated with each another, such as 
weight, height, BMI, waist circumference and body fat, the use of discrete t-tests may 
not give the most accurate picture of the data due to type l errors (false positive). This 
may have been addressed by using a smaller P-value to define whether any differences 
between the two groups were due to chance or not i. e. P<0.01 instead of P<0.05. 
Alternatively a multivariate analysis of variance (MANOVA) may have been 
performed. However, statistics are designed to identify probabilities not certainties and 
many results from the t-tests and Mann-Whitney analyses were shown to be highly 
significant, in excess of P<0.001. Confidence intervals were also calculated as another 
measure to assess the significance of differences between the two groups. Analysing the 
data by t-test or Mann-Whitney analyses also permitted the results to be compared with 
other research trials. 
The number and percentage of data collections for each biomedical outcome were 314 
(100%), 305 (97%) and 291 (93%) respectively (see Chapter 6, Table 6.7). During each 
patient follow-up assessment, a questionnaire was given to each participant to complete 
and return in a pre-paid envelope. The questionnaire collected responses to the validated 
questions for the lifestyle and psychosocial outcomes. Although the return rate of the 
questionnaires at baseline, four months and 14 months was 83%, 67% and 61% 
respectively, the numbers of responses to each assessment score were progressively 
lower (see Chapter 6, Tables 6.9 and 6.10). That result indicates that although the 
importance of answering each question was explained to participants, some questions 
were nevertheless left unanswered. The full questionnaire, being the synthesis of several 
validated questionnaires, was lengthy. Participants reported that it took between 20 
minutes and one-hour 30 minutes to complete. Some participants did not understand 
some of the questions and had therefore left them blank; others returned the 
questionnaire, stating that they had spent a certain amount of time on the questions and 
were not prepared to spend any longer; some participants refused outright to complete 
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the questionnaire. In ideal circumstances and with extra funding, a research assistant 
blinded to treatment allocation would have been employed to help participants complete 
the questionnaire. However, a similar number of responses for each variable were 
extracted from both the expert patient group and the control group. Those allowed a fair 
comparison to be made between the two groups, although non-response bias may have 
been present since it cannot be assumed that the characteristics of the responders and 
non-responders were the same. 
The advantage of using structured questionnaires is the ability to collect unambiguous 
and easy to count answers leading to quantitative data for analysis. However, this 
method of data collection assumes that the questions are worded and ordered in such a 
way that will be understood by all respondents (Bowling 1997). That assumption was 
clearly not satisfied in this instance. Several of the questionnaires originated from 
America and it is possible that the slight difference in terminology confused some of the 
participants. Minor alterations had been made to the knowledge questionnaire and, with 
hindsight, some of the words or phrases should have been altered in other 
questionnaires to make them more comprehensible by the UK participants. Such 
amendment had not been done to avoid the possibility of affecting validation of the 
questionnaire. However, the whole questionnaire was translated into Urdu for those 
South Asian participants who could not complete the English questionnaire themselves 
and who had no family member aiding them. It was explained to the South Asian 
participants that completion of the English version was preferred. Very few Urdu 
questionnaires were returned (30 questionnaires out of the 660 questionnaires, 4.5%). 
The overall return rate of the questionnaires in general was, not surprisingly, much 
lower for the South Asian participants owing to the language barrier and the higher 
percentage of illiterate participants. The translated version of the questionnaire was not 
re-validated and presents a possible flaw in the collection and analysis of data although, 
owing to the low number of Urdu questionnaires received and the reduced responses 
within each questionnaire, that factor is unlikely to affect the overall findings. 
It was important that the questionnaires were both reliable (able to consistently obtain 
the same results) and valid (successful in measuring what they were supposed to 
measure). The reliability and validity of the brief 14-item diabetes knowledge test has 
been examined in two populations and has been shown to be appropriate for a variety of 
settings and patient populations (Fitzgerald et al. 1998). As discussed above (see 
"Outcomes" section on page 238) minor changes were made to the questionnaire to 
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make it appropriate for the UK population. For example, the phrase `the way most 
American people eat' was changed to `the way most people eat'. 
The food frequency questionnaire (HEA3) was developed by the former Health 
Education Authority and has been validated in general practice (Little et al. 1999). One 
of the advantages of the HEA3 compared to other food frequency questionnaires is that 
it is easy to assess the balance of food types, such as portions of fruit and vegetables, 
compared with recommended guidelines. A disadvantage is that there is no feedback to 
identify which foods contribute the most to different macronutrient intakes such as fat 
or saturated fat. The HEA3 questionnaire was compared with an accepted standard, a 
seven-day weighed dietary record that had been validated using biomarkers and test- 
retest reliability. Percentage energy from consumption of fat and saturated fat, non- 
starch polysaccharides, fruit and vegetables and starchy foods consumed showed 
acceptable agreement with the standard. The validation had shown that the 
questionnaire was suitable for clinical work and research, although under-reporting of 
energy intake was common with up to 60% under-reporting of calorie intake if the 
participants were obese. As the mean BMI in the X-PERT study was 31Kg/m2, it can be 
assumed that energy intake was under-reported by 60%. Rather than participants 
consuming a daily energy intake of around 1500 calories, which would have resulted in 
weight loss, they may have been consuming around 2400 calories per day. 
The reliability and validity of the Summary of Diabetes Self-Care Activities Measure 
(SDSCA) has been reviewed (Toobert, Hampson, & Glasgow 2000). The validation 
involved seven different studies including a total of 1,988 people with diabetes. 
Participants in those studies were typically mature people who had lived with Type 2 
diabetes for a number of years. The average inter-item correlations within scales were 
high, with the exception of specific diet and test-retest correlations, which were 
moderate. Based on those findings, recommendations were made by Toobert cl al not to 
include questions about medication taking owing to lowered test-retest reliability and to 
omit the specific diet scale as it lacked internal consistency. Exclusion of those 
questions did not alter the findings in the X-PERT study as no significant differences 
were found between the expert patient group and the controls, neither at baseline, four 
months nor 14 months. It is very difficult to assess nutritional intake from just four 
questions and the findings from the detailed food frequency questionnaire offer much 
more information about the nutritional intake of the participants than does the SDSCA 
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questionnaire. Therefore, the only valid and reliable results from the SDSCA were those 
concerning exercise, foot self-care and self-monitoring of blood glucose levels. 
A study has assessed the validity, reliability and utility of the Diabetes Empowerment 
Scale (DES) (Anderson et at. 2000). That scale is a measure of diabetes-related 
psychosocial self-efficacy. There are three subscales: 
(1) managing the psychosocial aspects of diabetes: that subscale assesses the patient's 
perceived ability to obtain social support, manage stress, be self-motivating, and make 
appropriate diabetes-related decisions; 
(2) assessing dissatisfaction and readiness to change: that subscale evaluates the 
patient's perceived ability to identify aspects of caring for diabetes that they are 
dissatisfied with and their perceived ability to determine when they are ready to change 
their diabetes self-management plan; 
(3) setting and achieving goals: that subscale assesses the patient's perceived ability to 
set realistic goals and to reach them by overcoming obstacles. 
The validation study involved 375 people living with diabetes and the psychometric 
properties of the DES were calculated. Although preliminary support for the reliability 
and validity of the DES was obtained, it was recommended that further research be 
carried out with different samples of people with diabetes to confirm the factor structure 
and subscale reliability (Anderson et al. 2000). The DES appeared to be a strong 
predictor of self-empowerment scores in the X-PERT trial. There were no differences 
between the expert patient and control groups at baseline and statistically significant 
differences between the two groups at both four and 14 months for the total 
empowerment score and the three subscales. 
The Diabetes Treatment Satisfaction questionnaire (DTSQc) is an eight-item assessment 
that was originally developed for people with Type I diabetes and tablet-treated Type 2 
diabetes, but it has more recently been used with a mixed general practice sample 
including those who treat their diabetes with diet alone. The DTSQc has proved to be 
highly reliable, with good validity and sensitivity to change. It has been identified as 
being most effective when used as one of a profile of important outcome measures, 
including metabolic control. Used in this manner, the DTSQc can help to identify 
instances where patient satisfaction is achieved at the expense of metabolic control or 
where metabolic control is only achieved at the expense of patient satisfaction (Bradley 
1994). In the X-PERT trial the improvement observed in respect of the expert patients 
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in treatment satisfaction complimented the improvement in metabolic control and other 
clinical, lifestyle and psychosocial variables. What cannot be identified is whether the 
increased treatment satisfaction contributed to the improvement in the other outcomes, 
such as metabolic control, or whether the improvement in the other outcomes 
contributed to the increased treatment satisfaction. 
The Audit of Diabetes Dependant Quality of Life (ADDQoL) is a reliable and valid 
measure of the effects of diabetes and its treatment on quality of life (QoL) (Bradley et 
al. 1999). Weighted scores allow identification of those domains of life that are 
important to a patient and that are negatively affected by diabetes. Bradley found that 
individual variation in response to ADDQoL items was considerable and there could be 
no automatic assumption that the impact of diabetes on quality of life was negative. 
Diabetes had greater reported impact on diabetes-specific domains such as enjoyment of 
food, worries about the future and travel, than on standard quality of life domains such 
as work, social life, friends and family. Insulin-treated patients and people living with 
diabetes complications reported a significantly greater negative impact of diabetes on 
most domains. The ADDQoL was found to demonstrate evidence of internal 
consistency reliability and preliminary evidence of validity and sensitivity to change. 
Within the X-PERT trial the ADDQoL showed sensitivity to change for the food and 
drink variables and those were the only domains found to be statistically significant 
between the expert patient and control group post-intervention. Improved quality of life 
regarding freedom to eat and drink, and enjoyment of food may have occurred owing to 
the emphasis placed on nutrition and lifestyle throughout the X-PERT programme. 
Increased knowledge may have encouraged participants to accept that the diet for 
people with diabetes need not be a special diet and that all foods are acceptable if the 
balance of foods in a meal/over a day is examined. Increased self-empowerment may 
have contributed to greater freedom to eat and drink, as expert patients were able to 
make decisions that were `right for them' rather than following a prescribed diet from a 
health professional. 
The biomedical variables collected during the X-PERT trial were generally both reliable 
and valid. All the blood samples were analysed at the same laboratory using 
standardised methods. As stated in Chapter 5 (section 5.4.3), blood pressure and waist 
circumference were measured using accepted methods: body weight was measured 
using the same scales, calibrated on a regular basis, and body fat was measured to ± 
0.5% precision. Three outcome assessors collected the biomedical outcomes from the 
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patients and each had been trained to use the standardised methods stated above. The 
percentage error involved in collecting the measurements is not known. However, any 
differences in the measurement method are likely to have been distributed equally 
between the intervention and control groups and would therefore be unlikely to affect 
the comparison and significance of findings between the two groups. 
Although there were no statistically significant differences between the two groups in 
respect of blood pressure, there were clinically important reductions in both systolic and 
diastolic blood pressure in the expert patients. The same was true for the 
anthropometrical measurements, with the expert patients experiencing a trend towards 
reduced body weight, BMI, body fat and waist circumference compared with the 
outcomes for the control group patients. The clinically important three-centimetre 
reduction in waist circumference in the expert patients, although of statistical borderline 
significance, did suggest by the 95% confidence intervals (0 cm to 6 cm) that the X- 
PERT programme had impacted on waist circumference. The reduced waist 
circumference in expert patients may have resulted from the increased exercise 
frequency and is likely to have resulted also in an increase in insulin sensitivity, 
improved diabetes control and reduced requirement for diabetes medication. 
The primary outcome, glycated haemoglobin, showed greater improvement at the 
longer-term follow-up (14 months) than the short-term follow-up (four months). That 
finding differed from previous research evaluating the effect of diabetes education 
programmes (Norris et al. 2002) and may be due to the theoretical models, 
empowerment and patient activation underpinning the X-PERT programme. Standard 
diabetes education programmes that instruct patients what to do and then measure 
success based on compliance can often lead to patients initially making changes to 
please the health professional, but because those changes may not be intuitive for that 
patient, they may not be continued in the long-term. The longer-term success of the X- 
PERT programme may be because patients developed the skills, knowledge and 
confidence to identify their own problems regarding their diabetes self-management and 
they were consequently able to experiment with behaviour and lifestyle change to 
identify what worked for them. 
The only variable that showed a statistically significant result between the expert 
patients and control group at four months but not at 14 months was self-monitoring of 
blood glucose levels. One possible reason for that may be that the expert patients 
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initially increased self-monitoring of blood glucose whilst experimenting with their 
diabetes but as their understanding of factors affecting their blood glucose levels 
increased, they were able to reduce the frequency of blood glucose monitoring. Another 
possible reason is that a strict prescribing policy for blood glucose monitoring strips has 
been implemented locally, with many patients being told that they could only obtain 
enough monitoring strips to self-monitor their blood glucose levels once a day. Such 
changes to prescribing policies have probably resulted from the recent controversy 
about the benefits of self-monitoring of blood glucose levels (NHS Centre for Reviews 
and Dissemination 2002). 
When analysing the results from the X-PERT programme, the only subgroup analysis 
performed was the primary outcome (glycated haemoglobin) by ethnic group and some 
interesting findings emerged (see Chapter 6, Table 6.8). There were no differences 
between the expert and control patients at baseline for either ethnic group. At four 
months, there were no significant differences between the expert and control patients in 
the white Caucasian subgroup, but there was a difference in glycated haemoglobin of 
1.0% in the South Asian subgroup. That difference was statistically highly significant. 
At 14 months, expert patients in both subgroups experienced statistically significant 
differences in glycated haemoglobin compared with the control group. Therefore it can 
be deduced that attending the X-PERT programme had an immediate impact on the 
diabetes control of the South Asian participants, whereas benefits took longer to become 
apparent for the white Caucasian participants. Another difference between ethnic groups 
was that the white Caucasian expert patients experienced an improvement in diabetes 
control. The South Asian expert patients only maintained their glycaemic level at 7.5% 
although the South Asian control participants experienced a deterioration in glycaemic 
control. Explanations for that finding cannot be identified. 
7.4 Generalisability 
The X-PERT programme is more likely to be generalisable to all people with Type 2 
diabetes because: 
o the X-PERT trial was a pragmatic trial with minimum exclusion criteria; 
o it recruited people with Type 2 diabetes from a mixture of socio-economic and 
ethnic backgrounds; 
Q it was delivered under normal conditions within the community; 
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o it differed from many randomised controlled trials that were conducted under 
extremely controlled conditions that bore very little resemblance to routine 
practice. 
As with all trials, there is a risk that people change their behaviour as a result of being 
involved in research. They may become more interested in the topic, pay more attention 
to it or may change behaviour simply because someone (the investigator) is paying 
attention to them (Bowling 1997). This is called the Hawthorne effect and although it 
might be said that the expert patients may have produced better results because they 
were involved in a trial, the same could be said of the control patients, who received 
exactly the same treatment and attention apart from the intervention. Therefore, one 
would still expect the differences between the expert and control patients in the 
biomedical, lifestyle and psychosocial outcomes to remain if the X-PERT programme 
was delivered outside of research conditions. 
7.5 Conclusions from this study 
a To the author's knowledge, this is the first randomised controlled trial to 
evaluate (both in the short and longer term) a health professional-led diabetes 
expert patient programme for individuals with Type 2 diabetes based on the 
theories of empowerment and patient activation. 
o The study design encouraged the findings to be as transferable as possible by 
keeping the exclusion criteria to a minimum. All adults with Type 2 diabetes 
were invited to take part unless either physical or cognitive restrictions 
prevented them from attending and actively taking part in the programme, or 
primary care staff felt that it was inappropriate for a particular individual to 
participate. 
v The X-PERT programme was shown to improve biomedical outcomes (glycated 
haemoglobin, blood pressure and waist circumference), lifestyle outcomes 
(diabetes knowledge, exercise and foot care frequency, diet) and psychosocial 
outcomes (treatment satisfaction, food and drink related quality of life and self- 
empowerment) both in the short and longer term. 
o No adverse effects were reported and expert patients were more likely to reduce 
diabetes medication and less likely to increase diabetes medication than control 
patients. 
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o The expert patients enjoyed the programme, found it useful and, immediately 
after attending the course, perceived that it would result in improvement to their 
health. The majority of expert patients believed that the knowledge and 
confidence gained from the programme would equip them with the skills to help 
others with diabetes. 
o Many expert patients went on to become peer educators, to set-up diabetes 
support groups and to contribute to the Patient Empowerment and Education 
Sub-Group for the Local Diabetes Services Implementation Group (LDSIG). 
Several expert patients have become lay representatives of the Local Diabetes 
Services Advisory Group, and are helping to develop local diabetes services. 
These findings provide an insight into possible solutions for treating what is a serious, 
expensive and increasing national problem. Pressures on NHS resources from diabetes 
and its complications are large (Williams et al. 2001). Any method of equipping people 
living with diabetes with the skills and confidence to self-manage their condition offers 
immense benefits, both to those with the condition and to the NHS. 
7.6 Brief overview of the thesis 
This thesis started with an overview of the epidemiology of Type 2 diabetes and 
recognised that although there have been major developments over the years in 
identifying and treating diabetes, people with diabetes are still dying prematurely and 
the quality of their life is still poor in comparison to those without the condition. 
Chapter 1 acknowledged that evidence now exists to show that achievement of optimum 
blood glucose and blood pressure levels dramatically reduce both morbidity and 
mortality. Chapter 1 also illustrated that criteria and frameworks exist that aim to 
improve diabetes care and that new and innovative health care delivery systems are 
required if improvements to patient health and well-being are to be delivered. 
This thesis then discussed, in Chapter 2, health and health behaviour change. It 
acknowledged that health is a complex concept that lends itself to subjective 
interpretation, meaning different things to different people, and that the World Health 
Organisation (WHO) definition of health has evolved over time to encapsulate an 
increasingly holistic view. Chapter 2 went on to explain that although different 
approaches and models to health behaviour change are available, current knowledge is 
insufficient to predict the ideal circumstances for behaviour change and few evidence- 
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based guidelines exist. This chapter acknowledged that expert patient programmes are a 
relatively new concept within the UK and that there are two types of programmes: first, 
are the ones delivered by health professionals, these are condition specific, and aim to 
develop knowledge and skills associated with that condition; second, are the lay-led 
programmes that address how the illness impacts on daily life. Chapter 2 concluded by 
acknowledging that although most countries are in the experimental stage of developing 
therapeutic and self-management education programmes, routine patient education in 
Europe and the United States is still based on the biomedical model. 
Chapter 3 concerned a review of the experimental stage of developing therapeutic and 
self-management education programmes. An extensive search strategy identified 5497 
papers, of which 13 papers describing 11 studies had been included in the systematic 
review. The review assessed the effects of group-based, patient-centred diabetes 
education in adults with Type 2 diabetes. The results revealed that this type of approach 
to diabetes education improved diabetes control and knowledge of diabetes and reduced 
the requirement for diabetes medication. There was also some evidence to suggest that 
group-based therapeutic education increased self-management skills, self- 
empowerment, quality of life and treatment satisfaction, although it recommended that 
further research be carried out to confirm those findings. The review concluded that 
evidence currently exists to support the delivery of group-based self-management 
education programmes for the treatment of Type 2 diabetes. 
The tutors manual for the X-PERT programme was presented in Chapter 4. The manual 
has been written to encourage the delivery of the X-PERT programme to adults living 
with Type 2 diabetes. Although the active ingredients of the X-PERT programme are 
difficult to identify, the scripted manual ensures that the delivery and content of the six- 
session, group-based, professional-led diabetes expert patient programme could 
replicate the programme delivered during the research trial. The manual clearly 
illustrates the theories of empowerment and patient activation that the education 
programme was based on. It discusses what diabetes is and explains weight 
management, glycaemic index, the supermarket tour, possible diabetes complications, 
the `learning about diabetes' board game and the goal setting lifestyle experiment. It 
also describes the materials and visual aids that are an inherent part of the programme 
delivery. 
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The research proposal for the randomised controlled trial was presented in Chapter 5. 
Background information acknowledged that effective management of Type 2 diabetes 
lies in the hands of the person with the condition. As the research proposal had been 
written prior to undertaking the systematic review, Chapter 5 concluded that the most 
effective method of encouraging diabetes self-management was still unknown. The 
chapter then discussed the development of the X-PERT trial and the attempts to secure 
funding for it. Demographic information for Burnley, Pendle and Rossendale was also 
presented. The form that the research took was a prospective, pragmatic randomised 
controlled trial in which the intervention group was invited to attend the X-PERT 
programme whilst the control group received routine diabetes treatment. The hypothesis 
stated that the X-PERT programme would develop skills and confidence in adults with 
Type 2 diabetes and lead to informed decision-making about their diabetes self- 
management. The hypothesis went on to state that increased diabetes self-management 
would improve patients' biomedical, lifestyle and psychosocial outcomes. It was also 
hypothesised that delivery of the X-PERT programme being based on the criteria and 
standards from the International Diabetes Federation would improve the structure and 
process of diabetes education in the locality. Information about recruitment, 
interventions for the expert patient and control group, the timescale for the project, 
evaluation (structure, process and outcomes) and methods of statistical analysis, were 
also presented in Chapter 5. 
Chapter 6 presented the results of the trial and those are discussed above in the section 
7.2 (`Resume of findings') and in section 7.5 (`Conclusions from this study'). 
7.7 Overall evidence for this approach 
There is now clear evidence that therapeutic group-based diabetes education 
programmes for adults with Type 2 diabetes based on the theories of empowerment and 
patient activation are effective methods of health care delivery. The results from the X- 
PERT project, along with the findings from the systematic review, support the national 
(DOH 2001a; DOH 2001b; DOH 2003a; NICE 2003b) and international (IDF 
Consultative Section on Diabetes Education (DECS) 2003; WHO Working Group 
1998) guidelines which are starting to emerge. 
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7.8 The Future Implications of this Study 
7.8.1 Implications for Policy and Organisations 
Extending the X-PERT programme so that it becomes routine treatment for adults with 
Type 2 diabetes would go a long way towards implementing the national (DOIl 2001a; 
DOH 2001b; DOH 2003a; NICE 2003b) and international guidelines (IDF Consultative 
Section on Diabetes Education (DECS) 2002; IDF Consultative Section on Diabetes 
Education (DECS) 2003). The author has been liaising with BPR PCT for 12 months 
with regard to the future of diabetes education services within the district. Business 
cases have been submitted, meetings attended with representatives from the Workforce 
Development Confederation, and presentations delivered to the PCT briefing board. A 
workshop was presented at the NHS Modernisation Agency Conference, which resulted 
in a meeting with David Fillingham, Director of the Modernisation Agency. That 
workshop facilitated communication with Sue Roberts, Howard Arthur and Bev 
Bookless from the National Diabetes Support Team, Sarah Squire who takes the lead on 
Patient Involvement and Ruth Kennedy, the Chief Executive of the National Primary 
Care Development Team. BPR PCT has now formally acknowledged the X-PERT 
programme and the Chief Executive of the Trust is committed to ensuring delivery of 
the programme throughout the district. 
7.8.2 Implications for Health Professional Training 
The X-PERT tutor for the purposes of this study is a diabetes dietitian with specialist 
training in adult education who had also acquired other skills necessary for adoption of 
the role of `diabetes educator' based on the US model. Introducing a diabetes educator 
to the healthcare team may also be a cost effective approach to diabetes education: only 
one health professional is required for delivery of the six-week programme to 16 
participants. 
Primary care health professional training is strongly recommended in order to avoid 
disempowerment of expert patients by the provision of conflicting, outdated, and 
prescriptive advice, and to develop skills to enable the delivery of an adult-centred 
group education programme. The empowerment model encourages the provision of 
evidence-based diabetes education in a less prescriptive manner, whilst facilitating and 
encouraging patients to accept more autonomy. However, caution must be taken to 
retain a balance between structured education and the patient-centred approach, as over- 
emphasis on either model has been shown to be ineffective (Kinmonth et al. 1998). 
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Certified diabetes educators (CDEs) exist in other countries but not in the UK. 
Developing the role of CDEs within the UK would help to address the problems arising 
from the delivery of inconsistent, conflicting and outdated messages. The introduction 
of CDEs would also allow the IDF process standards (fj, (g) and (h) to be met. Those 
standards are explained in more detail in Chapter 6, Section 6.5.2. CDEs would also 
help to transform the current prescriptive approach to diabetes treatment favoured by 
some health professionals to one that is more empowering. 
7.8.3 Implications for lay Involvement In health services 
Diabetes UK has recommended that informed patients can greatly contribute to the 
development of health care services (Wheeler 2002). The Department of Health advises 
that patients with chronic conditions should be invited to attend an expert patients 
programme where they could train to become expert patients. Expert patients have, 
themselves, potential to help other patients with chronic conditions develop the skills 
and confidence to live more effectively with their condition (DOH 2001c). This study 
delivered a diabetes expert patient (X-PERT) programme and developed `expert 
patients' who were sufficiently confident and informed to be able to assist other people 
with diabetes and contribute to diabetes services development. BPR PCT, impressed 
with the working of the Patient Education and Empowerment Subgroup for the LDSIG, 
has stated its intention to develop a managed patients' network. The continuation of the 
X-PERT project will develop a community of expert patients who, if they wish, will be 
able to join and develop the patient network. 
7.9 From Research to Practice 
As stated in section 7.8.3 above, it would appear likely that the X-PERT programme 
will be implemented into routine practice within Burnley, Pendle and Rossendale. It is 
the intention to implement it at general practice level, with the plan that it would remain 
a primary care initiative delivered in the community. Practice staff, either GPs or 
practice nurses would be trained to deliver the programme to patients registered with 
Type 2 diabetes at their practice, possibly with help from a dietitian or health care 
assistant. 
Numerous health professionals working in other geographical areas within the UK have 
enquired whether a scripted manual will become available for purchase and if so, when. 
Preliminary discussions have taken place with BPR PCT about the possibility of 
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developing national training courses for health professionals to enable them to learn the 
skills required to deliver the X-PERT programme. Participants attending the training 
programme would also receive a copy of the X-PERT programme manual and a set of 
the accompanying visual aids. 
7.10 Future Research 
1) The systematic review recommended that, as the review was based on only II 
studies and many lifestyle and psychosocial outcomes resulted from the synthesis of 
just two or three studies, further research would be needed to confirm that group- 
based education programmes are: 
Q more effective if the theoretical models underpinning the programmes are based 
on therapeutic patient education, empowerment, patient participation and adult 
learning principles; 
o effective at lowering blood pressure readings; 
Q effective at increasing treatment satisfaction and quality of life scores; 
Q appropriate and effective for all ethnic groups; 
o effective at reducing the secondary complications of diabetes; 
Q cost effective; 
o equally effective if delivered partly or solely by peer educators. 
2) If certified diabetes educator roles are to be developed within the UK, that process 
would need to be piloted and evaluated as a research project in order to assess their 
impact on the education received by people with diabetes and to provide justification 
and an evidence base for new workforce development. 
3) Participants who had attended the X-PERT programme clearly enjoyed greater 
freedom to eat and drink, whilst at the same time improving their metabolic control. 
However, the programme did not educate participants to adjust medication 
according to the carbohydrate content of the meal. Developing a `dose adjustment 
for normal eating' (DAFNE) expert patient programme for individuals with Type 2 
diabetes may add further benefits to glycaemic control and quality of life for those 
people. 
4) Relevance for the self-management of a wide variety of other chronic conditions 
such as coronary heart disease, pre-diabetes and obesity. 
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Appendix la: Characteristics of excluded studies 
1 
Characteristics of excluded studies 
Study ID Reason for eiduafon 
ADA 2001 Not a controlled clinical trial, a descriptive paper 
Agun-Collies 1997 The control group received a group-based diabetes education 
provanvi 
Araajo 19x9 Not a controlled clinical trial, a descriptive paper (translated 
Portuguese paper) 
Argus 1997 Length of follow-up less than six months (translated Spanish paper) 
Arauz 2001 No control group (translated Spanish paper) 
Arf. z2001 Duplicate paper (Arauz 2001) 
Assal 1193 Not a controlled clinical trial. a descriptive paper 
Barcdo 2001 Recruited participants with both Type 1 and Type 2 diabetes 
Barnard 1132 1. No control group 
2. No group-based diabetes education programme 
3. Length of follow-up lea than six months 
Barnard 1992 No control group 
Bass 1995 No control group 
Badna 2002 Editorial reviewing effectivenesa of diabetes management with no 
intervention 
Beter 1996 Descriptive paper of previous study with no control group 
Berger 1999 No intervention, descriptive paper 
Block 1994 Behavioural weight loss programme with ecerciu sessions and not a 
SrP-basod diabetes education e 
Boehm 1993 Not comparing group-bond diabetes oducttion prograMIW with 
routine tratmendwaiting hit or no intervention 
Boaidin 2002 Review of clinical guidelines with no Intervention 
Bradshaw 1999 Not a group-bayed diabetes education programme 
Brown 19EU Meta, analysis of educational interventions in diabetes care but not 
comparing group based sessions with individual 
Brown 1!! S 1. No control group 
2. Length of follow-up lea than six months 
Brown 1999 Not study for paper included in the review. Descriptive paper with no 
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2 
data presented. 
Banda 1993 A letter to respond to a previous paper and not a clinical controlled 
trial (translation of Spanish paper) 
Barden I0001 Not a controlled clinical trial. a descriptive paper 
Caballero 1993 Descriptive study with no control group 
Cabrera-Pivaral 2004 Both intervention and control group received group-based diabetes 
education programme 
Cabrera-Pivaral 2001 1. The eon rol group also received group-based diabetes education 
Progmnme 
Z. Only outcomes LDL cholesteroUfasdng blood glucose (translated 
Spanish Paps) 
cage-pawed im 1. No primary outcome (HbAI c) 
2. Research design unclear 
3. Control group received group-based diabetes education programme 
Campbell 19U Both intervention and control group received group-based diabetes 
education programme 
Campbell 1990 The control group received a group-based diabetes education 
programme 
Campbell 1996 Trial comparing four interventions with the primary intervention being 
individual (not group-based) behavioural programme 
Cetti 2002 Not a controlled clinical trial (translated Spanish paper) 
Clark 1999 Descriptive paper not a controlled clinical trial 
Clark 2001 Not a group-based diabetes education programme 
Clement 199ä Review of dabetes self-management interventions and not group-based 
programmes 
Cobea 19ä2 1. Involved people with Type 1 and Type 2 diabetes 
2. Length of follow-up less than nix months 
3. No MAI c outcome 
4. Majority of outcomes collected from intervention group only 
Cooper 2001 Descriptive paper comparing meta-awiyses on chronic disease patient 
education 
Corablan Systematic review of patient education in the management of Type 2 
diabetes but not comparing group with individual sessions 
Corbett 1999 1. No control group 
2. No group-based diabetes education programme 
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3 
3, Study remiited people with Type 1 and Type 2 diabetes 
D'Eramo-Maws 1992 Diabetes education programme included group and individual usiions. 
de Weerdt 1991 The trial included people with both type I and type 2 diabetes 
D!? Research Group Not a cotnlled clinical trial 
Donn 198a Not a controfed clinical ttial. A desmiptive chapter on diabetes 
Eakin 2002 Review of diabetes self-management interventions in disadvantaged 
populations but not comparing group with individual sessions 
Elshaw 1994 1. Length of follow-up less than six months 
2. Outcomes assessment only included BMI and dietary intake 
Fzeawaka 2002 Not a controlled clinical trial 
Failcasberg 1986 Control group also received group-based diabetes education 
p 
Fan 1999 Chide paper unable to obtain through the British tAb any or 
inter-library loans 
FEND 2000 Not a controlled clinical trial 
Ferrdn 2001 No control group 
Fiabbein 1993 Not a clinical trial, an observational papa 
Fritsche 1999 1. No control group 
2. In-patient diabetes education programme 
Fulcuda 1999 1. Study recruited people with Type 2 diabetes and impaired gkkose 
tokranoe 
2. In-patient diabetes education programme 
Fmd1199S Diabetes education programme included group and individual sessions. 
Gaede 2001 Diabetes education programme included group and individual sessions. 
Gagfiardino 2001 Not a clinical controlled trial 
Camua 2002 No control group 
Garcia 19% No control group 
Ganda 1997 Not a controlled clinical trial 
Cihlbrand 2001 Diabetes education prograoune for nursing stafi, not patients 
Girard 2936 No control group (translated French paper) 
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4 
Glasgow 19E9 1. Unclear outcomes 
2. Length of follow-up teas than six months 
Glasgow 1992 Immediate group had outcome assessment follow-up at six months but 
delayed group only received posttest follow-up at three months. 
Glasgow 2002 Intervention is not a group-based diabetes education programme 
Gough 1990 1. Not a controlled trial 
2. Length of follow-up less than six months 
GriAla 1999 Not a controlled clinical trial, in editorial 
Haapa 1999 1. Research design unclear 
2. Both groups received group-based diabetes education programme. 
Intervention evaluated a follow-up module 
Haiseh 1991 1. Not a group-based diabetes education programme 
2. Length of follow-up less than six months 
3. Research design not appropriate (translated German paper) 
Hatsch 2000 Both groups received group-based diabetes education programme 
(German Paper) 
Hatsch 2002 No control group (tr nslated Genpan paper) 
Bak 1999 1. No control group 
2. No group-based diabetes education programme 
Halle 1999b 1. No control group 
2. Length of follow-up less than six months 
3. Diabetes education programmes Includes both group-based and 
individual sessions 
Hampton 19" An audit and not a clinical trial 
Haaefeld 1991 1. Diabetes education programmes includes both group-based and 
individual sessions 
2. No primary outcome (HbAlc) 
Hanefeld 19% 1. Diabetes education programmes includes both group-based and 
individual sessions 
2. No primary outcome (HbAlc) 
3. German paper (translated) 
Hansen 2002 Danish summary of Cochrane review on health professional diabetes 
education (Renders 2000) 
Hardla=haas 19% German papa (translated) with no control group 
Hartwell 1936 The control group received a group-based diabetes education 
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5 
Heath 1991 Weight loss competition with no control group 
Henry 1997 1. Length of follow-up less than six months 
2. Lese than 6 participants in each diabetes education progrArnne 
Hughes 1999 1. Trial included people with both type 1 and type 2 diabetes 
2. Research design unclear 
3. Individual appointments (control) not routine treatment. 
Hunter 1999 Not a controlled clinical trial, a descriptive paper 
Jaber 19% 1. No group-based diabetes education programme 
2. Length of follow-up less than six months 
Jacobs 2000 1. No control group 
2. Length of follow-up less than six months 
3. No sta istical tests 
Jennings 1990 1. The trial design and outcomes don't meat the systematic review 
criteria 
2. Length of follow-up less than six months 
Jiang 1999 Length of follow-up less than six months 
Julies 1993 The primary outcome is work absenteeism 
Jungmain 1997 No control group (translated German paper) 
Jungmann 1997b No control group (translated German paper) (some paper as Jungmann 
1997) 
Jungmann 1997e No control group (translated German paper) (same paper as Jungmann 
1997) 
Kaplan 19115 1. The control received it group-based diabetes education programme 
2. Length of follow-up less than six months 
Kaplan 19a7 1. The control group received a group-based diabetes education 
programs 
2. Outcomes not relevant 
Kaplan 19x76 1. The control group received a group-based diabetes education 
ro ramme p g 
2. Research design not clear 
Kendall 1937 Trial comparing two diferwA group-based diabetes education 
programmes with no routine treatment group 
Kendall 1990 1. Both groups received a group-based diabetes education programme 
2. Only nutritional outcomes 
Review Manager 4.2.2 1801/2004 
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6 
Kcyseeiing 2000 1. Intervention is individual behaviour counseling 
2. Outcomes not appropriate 
Keyserting 2002 Intervention included three group sessions and 12 monthly phone calls. 
Not possible to detect whether any a% cu we due to the group aspect 
or telephone calls 
Krier 1999 The intervention group also received individual appointments as part of 
the intervention 
Lacey 2000 Literature review of CHD ride management in diabetes education 
interventions 
Linnen 1993 The intervention group also received individual appointments as part of 
the intervention 
Laidnen 1994 The intervention group also received individual appointments as part of 
the intervention 
Lime 1998 Not a controlled clinical trial, a descriptive paper 
Lazcaso 1999 1. Length of follow-up less than six months 
2. Only outcome data reported is fasting blood glucose 
Levenson 2002 Both groups received group-based diabetes education program= 
Ligtenberg 199$ 1. Not a group-based diabetes education programme, exercise training 
2. Length of follow-up less than six months 
ILmss 2001 1. No control group 
2. Length of follow-up unclear 
Lo 1996 1. No group-based education programme 
2. Length of follow-up less than six month` 
Losen 19% Length of follow-up less than sae months (translated Spanish Paper) 
Lass Miola 1994 Spanish dissertation unable to obtain 
Madjarof 2001 1. No control group 
2. Less than 6 participants in education programme 
3. Length of follow-up unclear 
MaiJanian 2002 1. No control group 
2. Less than 6 participants in education programme 
3. Length of follow-up unclear 
Mannino 2002 No group-based diabetes education programme 
Martinez 1999 Unable to obtain paper from the British Library or inter-library loans 
Maxwell 1992 Unable to obtain papa from the British Library or inter-library loans 
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7 
Maya-Davis 2001 1. Both groups received 8 week education programme 
2. Intervention is the type of evahuation. 
3. Few outcomes & follow-up leas than 6 months. 
Maiaa 1966 1. Study recruited people with Typo I and Type 2 diabetes 
2. Diabetes education programme included group and individual 
seances. 
McMurray 2002 1. No control group 
2. No group-based education programme 
McNabb 1993 Trial design not appropriate and outcomes not reported for the 
- BMW 
Miller 1999 1. Length of follow-up less than six months 
2. The only outcome is knowledge 
Miller 2002 Length of follow-up less than we months 
Maler 2002b Length of follow-up less than six months 
Miller 2002c Length of follow-up less than six months 
Morgan 19" Not a group-based diabetes education programme 
Mahlbanser 2002 Not a clinical controlled trial, descriptive paper 
Mnlrow 19117 Number of participants in each group-based education programme less 
than 6 
Nod 199% The control group received a group-based diabetes education 
programme 
Norris 2001 Systemic review of diabetes self management programmes but not 
reviewing group-based programmes 
Norris 2001 b Short report of systematic review of self-management training and not 
group-based progmn= 
Norris 2002 Systematic review of diabetes adf-msnagemeat programmes with a 
meta-analysis of the effect on glycacmic control but not reviewing 
group-based programmes 
Norris 2002b A systematic review of disease and can management and not 
group based diabetes education programmes 
Norris 2002c A systematic review of diabetes self-management education in the 
oommuity but not group-based diabetes education programmes 
Pacyk 2001 1. No control group 
2. Length of follow-up less than six months 
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8 
Padgett 1985 Meta-analysis of education/psychosocial interventions on management 
of diabetes but not comparing group-sermons with individual 
Rabldn 1993 Length of follow-up less than six months 
Rachauznl 2002 Not a group-based diabetes education programme 
Raja 2002 Recruited people with Typal and Type 2 diabetes 
Ras 1923 Diabetes education programme included group and individual sessions. 
Rebell 2002 In-patient group-based diabetes education programme 
Garman paper (translated) 
Residers 2000 Systematic review on health professional diabetes education 
Ridgeway 1999 Diabetes education programme included group and individual teaýioos. 
Rivera Tejada 1996 Not a controlled clinical study, a descriptive paper 
Rabin 1991 1. The study includes people with Type 1 and Type 2 diabetes 
2. No control group 
Saenz IIernaä 1992 Spanish paper unable to obtain via inter-läroy loans or the British 
library 
Samaras 1997 The intervention was structured exercise sessions and not a 
group-based diabetes education programme 
Sarkadi 2001 1. No control group 
2. Retrospective paper 
Scala 1966 1. No control group 
2. Retrospective paper 
Schiel 1999 1. In-patient diabetes education programme 
2. Main outcome is self-monitoring of blood glucose levels 
Scott 1914 Length of follow-up less t1 as six months 
Simmons 1992 Evaluation compared outcomes between attenders and non-attenders 
Simmons 19% 1. Primary intervention is an exercise programme 
2. Unclear research design 
Steed 2003b Length of follow-up leas than six months 
Sarwit 2002 Both the intervention. and the control group received a group-based 
diabetes education programme 
Swenson 2000 Not a controlled clinical trial 
Tankova 2001 1. No control group 
2. Study recruited participants with both Type I and Type 2 diabetes 
Review Manager 422 18/101/2004 
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9 
Toobert 2002 Outcome measures not relevant 
Unknown 1994 Short report of diabetes education programme 
Unknown 2002 Not a controlled clinical trial 
Uusitupa 1993 The intervention group received individual appointments as part of the 
intervention 
Unsitupa 1996 No group-based diabetes education programme 
Vaaler 2000 A review evaluating methods of achieving optimal glycaemic control 
and not group-based diabetes education programmes 
Van 2000 1. No primary outcome (HbAl c) 
2. Four interventions with two group programmes but no routine 
treatment or waiting list controls 
Vannineo 1992 The intervention group received individual appointments as part of the 
intervention 
Vanninea 1993 Not a group-based diabetes education programme, intensive diet and 
exercise delivered on an individual basis 
Vazquez 199* 1. Length of follow-up less than six month3 
2, Nutrition outcomes only 
Veldhamen199S All three groups received a group-based diabetes education 
programme. The Intervention was a pharmaceutical. care model 
Wang 1998 1. No control group 
2. The study recruited participants with Type I and Type 2 diabetes 
Wheeler 2001 Not a clinical controlled trial, a descriptive paper 
White 1936 The control group received a group-based diabetes education 
progrIMM 
Wierenga 1990 Not a controlled clinical trial, a qualitative study 
Wilson 1957 length of follow-up less than six months 
Wing 1995 The control group received a group-based diabetes education 
pm9rumm 
Wing 19äs Intervention involves self-monitoring blood glucose training and not a 
group-based diabetes education programme 
Wing 1993b Not a trial evaluating a group-based diabetes education programme 
Wroe 1995 Not a controlled clinical trial, a conference report 
Wrae 2000 Not a control ed clinical trial. a conference report 
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10 
Wree 2000b Not a controlled clinical trial, a conference report 
Wroe 2001 Not a controlled db icd trial, a conference report 
Wroe 2001b Not a controlled clinical trial. a conference report 
Wroe 2001e Not a controlled clinical trial, a conference report 
Wroe 2002 Not a controlled clinical tiial, a conference report 
Wroe 2002b Not a controlled clinical trial, a conference report 
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Appendix 3: Ethical approval 
ý".. - .,,. Aý 
ý' 
East Lancashire ýi 
Direct Line: 01282 610227 
Your Ref: 
Our Ref: SSP/AK/LRECDPR267 
10 October 2000 
Ms T Deslcin 
Nutrition & Dictctic Department 
Burnley Genaal Hospital 
BURNLEY GENERAL HOSPITAL 
Dear Ms Deakin 
Health Authority 
31133 Kenyon 9o44 
Lon Kaye Wate 
Nelson 
Lanc.. hhe 
bat SSt 
Telephone: 01282 619909 
Faalmiw.. 01282 61022) 
Website: www. elancs-ha. nwutnM. uk 
RHadN IN oar 2000 
EXPERT PATIENT EDUCATION VERSUS ROUTINE TREATMENT (X"PERT) 
Thank you for your letter of 28 September 2000.1 write to advise you that I am satisfied with your 
comments regarding recruitment of subjects to the study and formal ethical approval is now granted fa 
the study to proceed in the district. 
The study has been given approval only in rcbtion to its acceptability from an ethical point of view. I 
depaitu e fron the methodology outlined in your application is contemplated, the Ethics Committee mußt 
be advised and the proposed changes approved. 
Members are interested in following the progress of research projects and Mould welcome receipt of 
a final report when the work has been completed which will be received in confidence. 
Please quote the above reference number on any future contspondence. 
Yours sincerely 
Dr SS Paadltaratae 
Chairman 
Barsky, Pendle A Roaeadale 
Local Research Ethics Committee 
Chair " Mrs Kath Read. MA f GCE " Chief E, acutiw " Mr David A Put BA CPFA FCCA MHSM 
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Appendix 4a: Practice information letter 
Burnley, Pendle & Rossendale WO 
NUTRITION A DIETETIC DEPARTMENT 
Telephone: 012821474632 
Facsimile: 01282/47412$ 
E-mail: trudi@bdeakin. fsret. co. uk 
Practice Infornutios Letter 
Dear 
Primary Care Trust 
I am a diabetes specialist dietitian based at Burnley l leahhcare Ni S Trust. I am currently undertaking a 
clinical trial looking at the impact of diabetes education programmes on self-management skills and 
diabetes control in adults with type 2 diabetes. Patients will be identified from 10 GP practices. The 
purpose of this letter is to invite your practice to take part in the study. This research study is likely to 
benefit your patients and your practice as a whole, since you will have access to a diabetes specialist 
dietitian delivering diabetes education programmes at your health centre. 
The collaborators are Profcssor Rhys Williams and Dr Janet Cade from the Nuffield Institute for Ikahh. 
University of Leeds. Please see the attached research proposal for full details. The study is funded by 
Burnley Healthcare NILS Trust and The British Dietetic Association. The diabetes education 
programmes will be delivered to those adults with type 2 diabetes who are more likely to live within a 
socially deprived area. Your surgery has been selected as one which may be able to supply subjects 
meeting those criteria. 
Your participation in the study would involve the following 
1) Identifying patients with type 2 diabetes who presently receive their treatment within primary care. (I 
am prepared to do this with the help from staff within the practice). 
2) Giving permission for the researcher to approach individuals who n cet the inclusion criteria and 
invite them to take part in the study. The patient will be provided with a letter, information kauet 
and consent form (see attached). Thirty people will be recruited from each practice. 
3) The Practice Nurse and / or OP seeing 13 of the 30 rocruitod Iwticipants in the diabetes education 
, programme I for a routine care appointment within a3 month period and referring the patient to the dietitians' department (if they are not already receiving dietetic care). 
4) If possible providing a room for the delivery of the diabetes education programme 2 (8 weekly 
sessions lasting 2 hours). 
All information gai will be held in the strictest confdcncc and the names of neither the practice nor 
the patients will appear in any publicly accessible documentation. The research to be carried out has 
been approved by the Local Research Ethics Committee appointed by the Health Authority. 
If you have any queries or if you would like to discuss any aspect of the study with me, then you arc 
welcome to contact me by telephone 01282 / 474632. Please do feel free to discuss this letter with your 
colleagues. I would be obliged if you could inform one if your surgery is wiWn` to take part by 
completing the enclosed consent form. I will then call at the surgery to collect it during the week 
commencing ................................ 
Thank you in anticipation of your time and help in this study, 
Yuan siacerely 
Trudi A Deakin (principal researcher) 
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Appendix 4b: Practice consent form 
Burnley, Pendle & Rossendale EM 
Primary Caro trust 
PRACTICE: 
........... 0.. 0.0.0 1111111111111111111 111111111111111/11111111111111/11111111111- 
ADDRESS: .......................................... ............................................. 
"ýýýýýýýýýýýýýýýýýýýýý..... 0... 1o. S... ýýýýýNýýN 
".. n.. o. 1l. s... o.. *f.. "00""".... ". """""ý"ý"ý""I"""t"S"ý""a1""""""*". ""*1"ý""Y 
j-"j I/ we wish to accept the invitation and take part in the study by providing a list of 
IJ patients who meet the inclusion criteria. 
QI 
have read the practice information letter and understand that information gained will 
be held with strict confidentiality. No personal identifiers will appear on any publicly 
accessible doctuncntation. 
The e GP / practice nurse will make a routine appointment to see the 15 patients in the 
control group (diabetes education prograrrune 1) within the 3 month active intervention 
stage. 
DI run a small practice and feel that there will not be 30 adults with type 2 diabetes who 
will agree to participate in the study. However, 1 do not mind supplying the patient 
information, which may then be clustered with another small local practice. 
We have a room available for the group-based diabetes education programme. 
I/ we do not wish to take pert is the study. 
Reason: .......................................................................................... 
"ýýýýýý0 .................... 0.. *.............. 0 5.. 10............... ,............. 4 
................................................................................................... 
................................................................................................... 
............................................................................................. .... 
Signed ........................................................................................... 
Name (please print) ........................................................................... 
Date .......................................... 
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Appendix 5b: Patient consent form 
Date 
P6msry Ciro Trust 
CONSENT FORM 
Title of Project: DIABETES EDUCATION FOR PEOPLE WITH TYPE 2 DIABUES 
None of Reseorcber: TRUDI DEHN 
m 
Please tkk is the box 
1. I confirm that I have read and understand the information lealkt for the above study 
and have had the opportunity to ask questions. 
2.1 understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical carp or legal rights being aifcctaL 
3. I understand that sections of my medical rata may be looked at by responsible 
individuals from Burnley Healthcare NHS Trust and my name will not appear on any 
publicly accessible documentation. I give permission for these individuals to have access 
to my records. 
4.1 consent to 4 samples of blood being taken during the 15 month period. I understand 
that these will be analysed to assess my diabetes control and blood cholesterol level 
S. I agree to any unused blood being retained for possible inclusion in further studies. (If 
the remaining blood were to be used for future research we would contact you again in 
order to obtain written consent). 
6.1 agree to take part in the above study. 
Name of Patknt 
RCxarcher Date 
Bumley, Pendle & Rossendale 
Signature 
Signature 
I for patient; l for rcxarc}Kr; 1 to be kept with OP notes 
Patieet Identification Number ............... 
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Appendix 6: Validated questionnaires 
Burnley, Pendle & Rossendale 
Primary Care Trust 
PLEASE ANSWER THE FOLLOWING QUESTIONS 
BACKGROUND: 
1. Sex: Male Q 
2. How old are you? 
Female Q 
years old 
3. How long ago were you told by a doctor that you had diabetes? years 
4. Which type of diabetes did your doctor say that you have? 
LY I no 
D insulin-dependent diabetes, also called juvenile or type I diabetes 
Q non insulin-dependent diabetes, also called adult onset or type 2 diabetes 
(some people with non insulin-dependent diabetes take insulin) 
5. How often does your diabetes prevent you from doing your normal daily activities (eg: could 
not work)? Circle one number. 
Frequently Never 
7654321 
6. Have you ever attended a diabetes patient education program (a series of lasses)? 
Q No Q Yes (If "Yes", how many years ago? ) 
309 
7. How would you rate your understanding of diabetes and its treatment? Circle one number. 
Excellent Poor 
7654321 
8. Are you now taking diabetes pills? Q Yes Q No 
9. Are you now taking insulin? Q Yes Q No 
10. Have you always treated your diabetes with insulin? Q Yes Q No 
11. What is your height? 
12. How much do you weigh? 
13. Please circle the number that indicates how able you are to fit diabetes into your life in a 
positive manner. 
Very Not At 
Able All Able 
7654321 
14. Please circle the number that indicates how comfortable you feel asking your doctor 
questions about diabetes. 
Very Not At All 
Comfortable Comfortable 
7654321 
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15. How old were you when you finished full time education? [-j yrs old 
16. Do you have any of the following qualifications? Tick all applicable 
CSE 0 "A" Level, Highers [] 
GCE "O" Level Teaching diploma, HNC 
GCSE I Degree 
City & Guilds I None of these II 
Other 0 Describe: 
17. Have you ever had a paid job? Yes 0 No II 
If yes, please answer for your current or most recent job 
What is/was your job title? 
Are/were you a Manager? 0 Foremantwoman? 
Supervisor? II None of these 
Aretwere you self-employed? Yes 0 No 0 
Do you have a job at present? Yes No 0 
If no, how would you describe yourself? 
Housewife 0 Unemployed (I 
Retired 0 Student (I 
Other Describe 
When did you last have paid employment 19 (year) or Never J1] 
19 What is your marital status? 
Married or living as married 0 Divorced CI 
Widowed 0 Single I] 
Separated [ý 
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Diabetes Knowledge Score (please circle the correct answer) 
1. The diabetes diet is: 2. Which of the following is highest 3. Which of the following Is highest 
in carbohydrate? In fat? 
a. the way most people eat a. Chicken a. Low fat milk 
b. a healthy diet for most people b. Cheese b. Orange juice 
c. too high in carbohydrate for most c. Baked potato c. Corn 
people d. Peanut butter d. Honey 
d. too high in protein for most people 
4. Which of the following has the 5. Glycosylated haemoglobin 6. Which is the best method for 
smallest effect on blood sugar? (haemoglobin All) is a test that is testing blood glucose? 
a measure of your average 
blood glucose level for the past: 
a Any unsweetened food a. day a. Urine testing 
b. Any dietetic food b. week b. Blood testing 
c. Any food that says "sugar free" on c. 8-10 weeks c. Both are equally good 
the label d. 6 months 
d. Any food that has less than 20 
calories per serving 
7. What effect does unsweetened 8. Which should tobe used to 9. For a person in good control of 
fruit juice have on blood glucose? treat low blood glucose? their diabetes, what effect does 
exercise have on blood glucose, 
a. Lowers it a. 3 hard candies a. Lowers it 
b. Raises it b. 1/2 cup orange juice b. Raises it 
c. Has no effect c. 1 cup diet soft drink c. Has no effect 
d. 1 cup skim milk 
10. Infection is likely to cause: 11. The best way to take care of 12. Eating foods lower in 
your feet is to: decreases your risk for. 
a. an increase in blood glucose a. look at and wash them each day a. nerve disease 
b. a decrease in blood glucose b. massage them with alcohol b. kidney disease 
c. no change in blood glucose each day c. heart disease 
c. soak them for one hour d. eye disease 
each day 
c. buy shoes a size larger than 
usual 
13. Numbness and tingling may be 14. Which of the following is 
symptoms of: usually not associated with diabetes: 
a. kidney disease a. vision problems 
b. nerve disease b. kidney problems 
c. eye disease c. nerve problems 
d. liver disease d. lung problems 
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Food Frequency Questionnaire 
Code No: 
REA3 
Please mark YOUR 'AVERAGE' SERVING/PORTION SIZE (small, medium, large) for different 
foods, and HOW OFTEN you eat them. If you do not normally eat the food, please put a -cro (0) 
in the month column. 
EXAMPLE SHOWN AT TOP OF TABLE: This person eats a large bowl of cereal fbur times a 
week and two slices of bread a day. 
TBLSP = rounded tablespoon TSP = roundcd tcaspoon 
Food Medium Servings Your Servin g Sizc How Often 
S NI I. Da ' 1t'ß u1, Month 
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Brcad/toast 2 medium slices 
Breakfast cereal Avera e bowl (3 TBLSP 
Crackers/Cri bread 3 crackers/slices crispbread 
Bun/roll I bun/roll 
ý- - Pittakha ati I small piece notmini 
Rice/pasta/noodles Average serving (6 TBLSP _ 
Plantains/green 
bananaslswccx potatoes 
l plantain or green banana/ 
2 swed potatoes 
Potatoes OT chip; ) 3 egg sized toes 
1.... w-« ... 
b.... le5: 
. ý. f... t. ý.., 
"'. 
-.. i. 2i 
e :... a :. ": it 
iii-ýii" ý": .. 1.. ý.. ý/B. ýÄ. i. 
i.: 1ýlýi 
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_:::. tý . -' 
A. 
t ý! 
^ý 
ý- 
u 
.. 
i .:, 
'\il" fYfl 
,ý; "ý, ý ,: fLLr Vegetables 
(fresh/frozen/tinned) 
Medium serving (2 TBLSP) 
Salad Medium serving (3 TBLSP) 
Stewed or tinned fruit Medium serving (3 TBLSP 
Fresh fruit I apple, orange, banana/ ~ 
small bunch grapes/slice 
melon 
--~ 
Fruit juice 
" ý': LFI f7: WO W- 
Avers ass 160 ml 
:ýC 
IFNI 
'1t, ß '+f' .7 
Lean meat/fish/chicken (no 
skin) 
4 oz/4 fish fingers (-small 
pack of playing cards) 
_ _. ..... 
Sausages/burgers! 
luncheon meat etc. 
3 small sausages, 2 burgers. 
2 slices luncheon meat 
All other meat (e g. beef, 
chops etc. with visible fat, 
chicken with skin, bacon 
OtO 
4 oz (=small pack of 
playing cards) 
Sausage rolls/ meat pies 1 individual pie 
1 sausa rolls 
Eggs _ 2 medium eggs 
Beans/lentils/dhal 3 TBLSP 
Nuts/ Peanut butter I tblsp/small bag 
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Food Frequency Questionnaire III; A3 
Code No: 
314 
Food Frequency Questionnaire 
Code No: 
ADDITIONAL QUES77ONS 
1) Do you usually use wholemeal/high fibre/granary bread Yes Q NO 
O 
If yes, please specify type: 
2) Do you use a high fibre breakfast cereal? Yes Q NoQ 
e. g. Alpen, muesli, all bran, Jordan's crunchy shredded wheat, 
weetabix, porridge oats, shroddics, fruit and fibre 
]f yes, please specify type! 
3a) Do you usually use brown or wholegrain rice or Yes Q NoQ 
pasta or cat potatoes with skins on? 
b) If yes, please tick whichever you normally eat: 
1). Wholegrain rice Yes Q NoQ 
1I). Wholewheat pasta Yes Q NoQ 
II0). Potatoes with skin yes Q NoD 
4a) Do you use low fat'spread, low fat cheese or Yes Q No 11 
low fat yoghurt? 
b) If yes, please tick whichever you normally eat/use: Specify typo: 
1). Low fat hard cheese yes Q NoD 
II). Low fat soft cheese Yes Q NoQ 
110. Low fat yoghurt Yes Q No Q 
M. Low fat spread yes Q No D 
V). Very low fat spread Yes Q NoD 
5) What sort of oil/fat do you usually use for frying? (please tick one only) 
1). Lard/dripping/butter or ghee Yes Q 
II). Blended vegetable oil - Yes 
Q 
III). Polyunsaturated oil e. g sunflower Yes Q 
M. Monounsaturated oil e. g. olive and nut Yes Q 
6) What kind of spreading fat do you usually use? (please tick one only) 
0. Butter Yes Q 
In. Ordinary margarine (e. g. Stork) Yes Q 
110. Polyunsaturated margarine (e. g. sunflower) Yes Q 
IV). Monounsaturated margarine (e. g. olive, rapeseed) Yes Q 
V). Low fat spread (e. g. Gold, Delight) Yes Q 
VI). Very low fat spread (e. g. Gold Lowest) Yes Q 
7) Do you use salt in cooking? Yes Q NoQ 
Do you add salt to food at the table? Yes Q No D 
If yes, do you add salt at the table without tasting Yes Q NoD 
II EA3 
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Diabetes Empowerment Score (DES) 
Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
In general, I believe that I: 
1. ... know what part(s) of taking care of my diabetes 
that I am satisfied with. ()()()()() 
2. 
... 
know what part(s) of 
taking care of my diabetes 
that I am dissatisfied with. ()()()()() 
3. ... 
know what part(s) of taking 
care of my diabetes that I am 
ready to change. ()()()()() 
4. 
... 
know what part(s) of taking 
care of my diabetes that I am 
not ready to change. ()()()()() 
5. ... can choose realistic diabetes goals. ()()()()() 
6. 
... know which of my diabetes goals are most 
important to me. ()()()()() 
7. ... know the things about 
myself that either help or 
prevent me from reaching 
my diabetes goals. ()()()()() 
8. ... can come up with good ideas to help me reach my 
goals. ()()()()() 
9. ... am able to turn my diabetes goals into a 
workable plan. ()()()()() 
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Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
In general, I believe that I: 
10. ... can reach my diabetes goals 
once I make up my mind. ()()() 
11. ... 
know which barriers 
make reaching my diabetes 
goals more difficult. ()()() 
12. 
... can think of 
different 
ways to overcome barriers to 
my diabetes goals ()()() 
13. ... can try out 
different ways 
of overcoming barriers 
to my diabetes goals. ()()() 
14. ... am able to decide which 
way of overcoming barriers 
to my diabetes goals works 
best for me. ()()() 
15. 
... can tell how I'm feeling 
about having diabetes. ()()() 
16. ... can tell how I'm feeling about caring for my 
diabetes ()()() 
17. 
... know the ways that having diabetes causes 
stress in my life. ()()() 
18. ... know the positive ways I cope with diabetes-related 
stress. ()()() 
19. 
... know the negative ways I cope with diabetes-related 
stress. ()()() 
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Strongly Agree Neutral Disagree Strongly 
Agree Disagree 
In general, I believe that 1: 
20. ... can cope well with 
diabetes- 
related stress. ()()()()() 
21. ... know where I can get 
support for having and 
caring for my diabetes. ()()()()() 
22. ... can ask for support for having and caring for my 
diabetes when I need it. ()()()()() 
23. ... can support myself in dealing with my diabetes. ()()()()() 
24. ... know what helps 
me stay motivated to 
care for my diabetes. ()()()()() 
25. .. can motivate myself to care for my diabetes. ()()()()() 
26.... know enough about 
diabetes to make self-care 
choices that are right for me. ()()()()() 
27. ... know enough about my- 
self as a person to make 
diabetes care choices that 
are right for me. ()()()()() 
28. 
... am able to figure out if it is worth my while to change 
how I take care of my 
diabetes. ()()()()() 
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Summary of Diabetes Self-Care Activities Measure (SDSCA) 
The question below ask you about your diabetes self-care activities during the past 7 days. If you 
were sick during the past 7 days, please think back to the last 7 days that you were not sick 
Diet 
How many of the last SEVEN DAYS have you followed a healthy eating plan? 
01234567 
On average over the past month, how many DAYS PER WEEK have you followed your eating plan? 
01234567 
On how many of the last SEVEN DAYS did you eat five or more servings of fruit and vegetables 
01234567 
On how may of the last SEVEN DAYS did you eat high-fat foods such as red meat or full-fat dairy 
products? 
01234567 
Exercise 
On how many of the last SEVEN DAYS did you participate in at least 30 minutes of physical activity? 
{Total minutes of continuous activity, including walking) 
01234567 
On how many of the last SEVEN DAYS did you participate in a specific exercise session (such as 
swimming, walking, biking) other than what you do around the house or as part of your work? 
01234567 
Blood Testing 
On how many of the last SEVEN DAYS did you test your blood? 
01234567 
On how many of the last SEVEN DAYS did you test your blood the number of times recommended by 
your healthcare professional? 
01234567 
Foot Care 
On how many of the past SEVEN DAYS did you check your feet? 
01234567 
On how many of the last SEVEN DAYS did you inspect the inside of your shoes? 
01234567 
Have you smoked a cigarette - even one puff - during the last SEVEN DAYS? 
0 NO 
1 YES If Yes, how many cigarettes did you smoke on an average day? Number 
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Self Care Recommendations 
1A. Which of the following has your health care team (doctor, nurse, dietician, or diabetes educator) 
advised you to do? Please check all that apply: 
Q a. Follow a low-fat eating plan 
Q b. Follow a complex carbohydrate diet 
Q c. Reduce the number of calories you eat to lose weight 
0 d. Eat lots of food high in dietary fibre 
Q e. Eat lots (at least 5 servings per day) of fruits and vegetables 
Q f. Eat very few sweets 
Q g. Other (specify): 
0 h. You have not been given any advice about your diet by your health care team. 
A. Which of the following has your health care team (doctor, nurse, dietician or diabetes educator) 
advised you to do? Please check all that apply: 
Q a. Take low level exercise (such as walking) on a daily basis. 
Q b. Exercise continuously for a least 20 minutes at least 3 times a week. 
Q c. Fit exercise into your daily routine (for example, take stairs instead of lifts, park a block away and 
walk, etc. ) 
Q d. Engage in a specific amount, type, duration and level of exercise. 
Q e. Other (specify): 
Q f. You have not been given any advice about exercise by your health care team. 
3A. Which of the following has your health care team (doctor, nurse, dietician, or diabetes educator) 
advised you to do? Please check all that apply: 
Q a. Test your blood glucose (sugar) using a drop of blood from your finger and a colour chart. 
Q b. Test your blood glucose using a machine to read the results. 
Q c. Test your urine for sugar. 
Q d. Other (specify): 
Q e. You have not been given any advice either about testing your blood or urine by your health care 
team. 
4A. Which of the following medications for your diabetes has your doctor prescribed? 
Please check all that apply. 
Q a. An insulin shot 1 or 2 times a day. 
Q b. An insulin shot 3 or more times a day. 
Q c. Diabetes pills to control your blood glucose level. 
0 d. Other (specify): 
0 e. You have not been prescribed either insulin or pills for your diabetes. 
Medications 
5A. On how many of the last SEVEN DAYS, did you take your recommended diabetes medication? 
01234567 
-OR- 
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6A. On how many of the last SEVEN DAYS did you take your recommended insulin injections? 
01234567 
7A. On how many of the last SEVEN DAYS did you take your recommended number of diabetes pills? 
01234567 
Foot Care 
8A. On how many of the last SEVEN DAYS did you wash your feet? 
01234567 
9A. On how many of the last SEVEN DAYS did you soak your feet? 
01234567 
10A. On how many of the last SEVEN DAYS did you dry between your toes after washing? 
01234567 
Smoking 
11A. (See Q8): If yes, at your last diabetes appointment, did anyone ask about your smoking status? 
O. No 
1. Yes 
12A. At your last doctor's visit, did anyone counsel you about stopping smoking or refer you to a stop- 
smoking programme? 
0. No 
1. Yes 
13A. When did you last smoke a cigarette? 
Q More than two years ago, or never smoked 
Q One to two years ago 
0 Four to twelve months ago 
Q One to three months ago 
Q Within the last month 
Q Today 
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ADDQoL 
This questionnaire asks about your quality of life and the effects of your diabetes on your quality of life. Your 
quality of life is how good or bad you feel your life to be. 
Please shade the circle which best indicates your response on each scale. 
There are no right or wrong answers; we just want to know how you feel about your life now. 
1) In general, my present quality of life is: 
OO00000 
excellent very good good neither good bad very bad extremely 
nor bad bad 
For the next statement please consider the effects of your diabetes, its management and any 
complications you may have. 
II) If I did not have diabetes, my quality of life would be: 
0000 
very much much better a little better the same 
better 
00 
a little worse much worse 
0 
very much 
worse 
Please respond to the 18 more specific statements on the pages that follow. 
For each statement, please consider the effects of your diabetes, its management and any 
complications you may have on the aspect of life described by the statement. 
In each of the following boxes: 
I a) shade a circle to show how diabetes affects this aspect of your life; 
b) shade a circle to show how important this aspect of your life is to your quality of life. 
Some statements have a "not applicable" option. Please shade this "not applicable" circle if that aspect of 
life does not apply to you. 
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la) If I did not have diabetes, my working life and work-related opportunities would be: 
0000000 
very much much better a little better the same a little much worse very much 0 better worse worse 
not 
1 b) This aspect of my life is: applicable 
0000 
very Important somewhat not at all 
important important important 
2a) If I did not have diabetes, my family life would be: 
0000000 
very much much better a little better the same a little much worse very much 
better worse worse 
0 
not 
2b) This aspect of my life is: applicable 
0000 
very Important somewhat not at all 
important important important 
13a) If I did not have diabetes, my friendships and social life would be: 
00000 
very much much better a little better the same a little 
better worse 
3b) This aspect of my life is: 
0 
very 
important 
0 
Important 
0 
somewhat 
important 
00 
much worse very much 
worse 
0 
not at all 
important 
ý_ 
4a) If I did not have diabetes, my sex life would be: 
0000000 
very much much better a little better the same a little much worse very much 0 better worse worse 
not 
4b) This aspect of my life is: applicable 
0000 
very Important somewhat not at all 
important important important 
s 
5a) If I did not have diabetes, my physical appearance would be: 
00000 
very much much better a little better the same a little 
better worse 
5b) This aspect of my life is: 
000 
very important somewhat 
important important 
00 
much worse very much 
worse 
0 
not at all 
important 
ý6a) If I did not have diabetes, the things I could do physically would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
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17a) If I did not have diabetes, my holidays or leisure activities would be: 
0000000 
very much much better a little better the same a little much worse very much 
better worse worse 
7b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
8a) If I did not have diabetes, ease of travelling (local or long distance) would be: 
0000000 
very much much better a little better the same a little much worse very much 
better worse worse 
8b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
If I did not have diabetes, my confidence in my ability to do things would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
9b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
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110a) If I did not have diabetes, my motivation to achieve things would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
10b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
111a) If I did not have diabetes, the way society at large reacts to me would be: 
00000 
very much much better a little better the same a little 
better worse 
11 b) This aspect of my life is: 
000 
very important somewhat 
important important 
00 
much worse very much 
worse 
0 
not at all 
important 
112a) If I did not have diabetes, my worries about the future would be: 
0 0 00 0 0 0 
very much much a little the same a little much very much 
decreased decreased decreased increased increased increased 
12b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
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113a) If I did not have diabetes, my finances would be: 
0000 
very much much better a little better the same 
better 
13b) This aspect of my life is: 
00 
very important 
important 
0 
a little 
worse 
0 
somewhat 
important 
00 
much worse very much 
worse 
0 
not at all 
important 
14a) If I did not have diabetes, my need to depend on others for things I would like to do 
for myself would be: 
0000000 
very much much a little the same a little much very much 
decreased decreased decreased increased increased increased 
14b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
115a) If I did not have diabetes, my living conditions would be: 
00000 
very much much better a little better the same a little 
better worse 
15b) This aspect of my life is: 
000 
very important somewhat 
important important 
00 
much worse very much 
worse 
0 
not at all 
important 
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116a) If I did not have diabetes, my freedom to eat as I wish would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
16b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
117a) If I did not have diabetes, my enjoyment of food would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
17b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
18a) If I did not have diabetes, my freedom to drink as I wish (e. g. sweetened hot and 
cold drinks, fruit juice, alcohol) would be: 
0 0 0 00 0 0 
very much much a little the same a little much very much 
increased increased increased decreased decreased decreased 
18b) This aspect of my life is: 
0000 
very important somewhat not at all 
important important important 
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The Diabetes Treatment Satisfaction Questionnaire: DTSQs 
The following questions are concerned with the treatment for your diabetes (including insulin, tablets, and 'or 
diet) and your experience over the past few months. Please answer each question by circling a number on each 
of the scales. 
1. How satisfied are you with your current treatment? 
very satisfied 65432 0 very dissatisfied 
2. 
3. 
4. 
5. 
6. 
How often have you felt that your blood sugars have been unacceptably high recently? 
most of the time 6543210 
How often have you felt that your blood sugars have been unacceptably low recently? 
most of the time 6543210 
none of the time 
none of the time 
How convenient have you been finding your treatment to be recently? 
very convenient 6543210 very inconvenient 
How flexible have you been finding your treatment to be recently? 
very flexible 6543210 very inflexible 
How satisfied are you with your understanding of your diabetes 
very satisfied 6543210 very dissatisfied 
7. Would you recommend this form of treatment to someone else with your kind of diabetes? 
Yes, I would 6543210 No, I would 
definitely definitely not 
recommend the recommend the 
treatment treatment 
8. How satisfied would you be to continue with your present form of treatment? 
very satisfied 6543210 very dissatisfied 
Please make sure that you have circled one number on each of the scales 
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Appendix 7: Patient empowerment and education group report 
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Forward 
The Patient Empowerment and Education Sub-Group of' the Local Diabetes 
Services Implementation Group (LDSIG) is represented mainly by patients and 
carers. 
In the past people who live with diabetes and people who care for them have not 
had a say in how local diabetes services are delivered. However, it has been shown L` 
that these people often know what they need to help them self-manage their 
condition. 
When asked to be chair of the Patient Empowerment and Education Sub-Group, I was delighted 
to have the opportunity to work closely with patients and carers in putting together this report I 
am extremely grateful to the members of the group for their time, commitment and contribution 
Trudi Deakin 
Chair, Patient Empowerment and Education Sub-Group 
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Executive Summary 
The LDSIG Patient Empowerment and Education Sub-group have met on five occasions. The 
group consists mainly of people with diabetes and carers. The following recommendations have 
been put forward to raise the quality of diabetes care people can expect locally within ßurnlcy, 
Pendle and Rossendale. It is appreciated that some practices are already delivering some of the 
recommendations but the group would like to see more uniformity across the district. 
o People with diabetes and their carers should be informed, when diagnosed, of local, 
national and electronic diabetes services and resources available. This may be in the form 
of a leaflet. 
o There is a need for uniform care across the district. It was identified that at the moment 
healthcare differs greatly depending on where people live and who they receive their 
diabetes care from. 
o Continuous health professional training is paramount. Conflicting messages from 
healthcare professionals were seen to be a major problem. 
o Consistent, empowering and structured education programmes should be available for all. 
Expert patient programmes were put forward as an example of good practice. The local health professional-led diabetes specific programme was felt to develop the skills and 
confidence required for people to self-manage their diabetes. The Department of Health 
generic lay-led programme aids people to live more successfully with a chronic 
condition. 
o The development of a `diabetes educator' within each practice would enable knowledge 
to circulate. A named health professional with a special interest in diabetes would take 
the lead in diabetes education and advice. The diabetes educator would provide up-to- 
date and evidence-based information, not only to patients but to other health 
professionals as well. 
oA reduction the multitude of appointments people have to attend could be replaced by 
delivery of diabetes education in the same place as a single package. 
oA district wide 24 hour phone line run by trained people with specialist diabetes 
knowledge would be a good way of dealing with general enquires and emergencies. 
oA fast track self-referral system for individuals to receive psychological care, if they 
should require it, to help them live more positively with their diabetes. Any service 
should be widely advertised throughout the district. 
oA variety of diabetes education materials to reflect different cultures and learning styles 
are required. These should include patient manuals, videos, audiotapes and visual aids to 
develop diabetes understanding. 
o Shared health records should be developed with people receiving a written copy of their 
health results: glycated haemoglobin, cholesterol profile, weight, ßM1, waist 
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circumference, body percentage fat and blood pressure etc. All too often people are told 
verbally `it's OK' without ever knowing the result. 
o Chronic condition communication training for healthcare professionals and patients is 
crucial. People would like to see the didactic and prescriptive healthcare delivery 
replaced with a more empowering and confidence building approach i. e. working 
together in a more equal relationship to share information and develop joint care plans 
that encourage people living with diabetes to set their own goals. 
o Local diabetes training events for both healthcare professionals and patients to attend 
would be an excellent way to build and share knowledge. 
oA protocol for having blood tests taken prior to attending the clinic would be beneficial. 
Health results would then be available during the appointment to encourage effective 
treatment and goal setting. 
o Flexible working depending on individuals' personal circumstances is necessary. For 
example, telephone appointments if people find it difficult to attend the clinic, email 
advice for those who are electronically minded, and evening/weekend appointments or 
education programmes for those who work full-time. 
o Targeting the general population by providing more information to the public, including 
school children, about diabetes would help reduce the stigma attached to the condition 
and symptom awareness would aid early diagnosis. 
o Allowing people with diabetes to continue self-management tasks while staying in 
hospital is an important aspect of self-empowerment. Presently, diabetes medication and 
insulin are handed out by staff on the ward, often at the incorrect time for that medication 
to be taken. This can be very frustrating and disempowering for people who are normally 
in charge of their own medication. 
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Introduction 
Patient empowerment and education is a priority of the National Service Framework for 
Diabctcs9. The Local Diabetes Sen'ices Implemeirlalioit Group (LDSIG) rccommcndcd that a 
sub-group be formed to address patient empowerment and education locally. Initially it was 
anticipated that membership would mainly reflect health professionals' opinions with one or two 
patient representatives. 
However, there is a need to ask patients and carers for their views and the government is 
encouraging this. It has been suggested that `more confident and knowledgeable people may 
become useful members of Local Diabetes Services Advisory Groups or future committees that 
are set up to implement the National Service Framework Delivery Strategy...... 10. Upon 
accepting the position of Chair for the group, I felt that patient representation would drive the 
group forward with a new dimension by gathering real thoughts from real people who have to 
live with the chronic condition from day to day. People with diabetes and their carers know how 
they may become more empowered to self-manage their diabetes and how they would like to 
receive effective diabetes education. 
Aims 
The tbliowma aims were presented to the 
1. Explore ways in which people would feel more confident to take personal 
control of their diabetes in order to deal with the following: 
a) Lifestyle changes in respect of diet, physical activity, weight control and 
smoking. 
b) Checking blood glucose and/or checking urine glucose levels to monitor and 
improve diabetes control. 
c) Understanding of blood glucose control and prevention of hypoglycaemia 
(low blood glucose level) and hyperglycaemia (high blood glucose level). 
d) Awareness and prevention of diabetes long-term complications to the eyes, 
feet, kidneys and heart. 
e) Taking medications in the correct way and in the correct doses. 
2. Express ideas and suggestions about how diabetes services can be improved, for 
example, how diabetes education should be delivered to people with diabetes 
and their families/carers. Discuss how these changes can be monitored and 
checked to see what differences they have made. 
3. Assist in the development of, or purchase of, patient education materials 
(leaflets, models, visual aids, booklets etc. ), which will be of use to people with 
diabetes of all ages and in all languages, and also for visually impaired people 
who have diabetes. 
9www. doh. goý-. uk/nsf/diabctcs 
10 Wheeler J (Editorial). Patients hold the key to success. Diabetes Update, Autumn 2002 
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4. Encourage people with diabetes, and also parents and carers where appropriate, 
to work confidently with diabetes health professionals in agreeing plans on how 
to share the care of their diabetes. These plans should be easy for everybody to 
understand and use. 
5. Seek the viewpoint of all local people with diabetes on current diabetes services 
and how they feel services could be improved to encourage confident self- 
management of diabetes. This will, hopefully, help to improve patient 
satisfaction within Burnley, Pendle and Rossendale. 
6. Link in with other Diabetes Sub Groups when necessary e. g. Health Professional 
Training Group, Diabetes Prevention Group, Foot Care Group etc. 
7. Provide feedback (written or verbal) to Local Diabetes Service Implementation 
Group regarding developments and progress made. 
Objectives 
It was decided to address the above aims by holding five monthly meetings. These were held at 
Burnley Town Hall and the Temple Street Resource Centre, Burnley. There was equal patient 
and carer representation from Burnley, Pendle and Rossendale. Although a strict agenda was not 
planned and free thinking was encouraged, the following structure enabled all of the above aims 
to be discussed. 
Meeting One (23`d October 2002): Aim 1 
Meeting Two (11th December 2002): Aim 2 
Meeting Three (15`h January 2003): Aim 3 
Meeting Four (12`x' February 2003): Aim 4 
Meeting Five (12th March 2003): Aim 5 
This report has been prepared for the LDSIG (Aim 7) but will be made available for other 
diabetes sub-groups as necessary (Aim 6). Members of the group would welcome the 
opportunity to present the findings verbally to the wider local diabetes network. 
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Meeting One 
Explore ways in which people would feel more confident to take personal control of 
their diabetes. 
Phrases from a `free thinking' session: 
`Lack of it formation - leaflets on their own are not enough. Leaflets should be available to 
inform what services and help are available. ' 
'A good experience of diabetes care. Newly diagnosed and immediately educated by expert 
patient programme - very glad ' 
`We need consistent advice - not conflicting. ' 
More health professional education. ' 
`Two-way communication required between patients and health professionals. ' 
'We need realistic goals - can not achieve everything ' 
'I formation and support that people receive when initially diagnosed is vital -- if delivered 
correctly, individuals more likely to control diabetes ' 
'Spouses, partners acrd family need lo be involved in the education. ' 
'There should be an education centre for people logo to ' 
'Health results should be shared between the health professional and the patient with 
explanations of what they mean and normal ranges. ' 
People with diabetes require support, group education, knowledge about diabetes and 
supermarket tours - i. e. a structured education programme. ' 
`Practice nurses need to be more approachable and have more with specialists at the hospital to 
provide consistent information. Practice nurses have the advantage qf knowing individuals and 
have the opportwrity to review every three months. However, patients need to take the 
responsibility for their diabetes ' 
Doesn't feel comfortable to phone up the practice to request an appointment or cask for health 
results. Would liase with general practice team more if thought it was OK to do so. ' 
'People need to be aware of services offered by the hospital. ' 
`Education steeds to be culture sensitive. Found expert patient scssionis useful because translator 
available and session used food models and supermarket tour. ' 
Difficult getting an appointment with a practice nurse - they're too bray: ' 
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'Would prefer to see all health professionals together - like at the hospital ' 
'Conflicting advice -a serious problem. ' 
'Several health professionals still giving 'sugar free' dietary advice. Should be trained to give 
yip-to-date information. ' 
`Outside diabetes care - counselling required to learn to live with diabetes. ' 
`Treatment needs to be individualised' 
`Pharmacist needs to be involved in diabetes care. Pharmacist staff need to be trained and more 
informed regarding issues like sharps tins. ' 
`Health professionals deed to take a personal interest in people with diabetes - and treat them as 
a whole person and 1101 just a diabetic. ' 
'Communication skills required for both health professionals, people with diabetes and carers. ' 
`People with diabetes need to have the knowledge to be able to access correct information e. g. 
on the Internet. ' 
'GP's need to inform people about Diabetes UK ' 
How do you feel that you could be helped in achieving some or all of the following: - 
a) Lifestyle changes in respect of diet. physical activity, weight control and smoking 
" Expert Patient Programmes including the 'Department of Health lays-led chronic 
conditions course' and the local `Health Professional-Led Diabetes Specific 
Course'. The former emphasises healthy living, fatigue management, living wills 
and communication with health professionals, whilst the latter encourages 
informed and knowledgeable diabetes self-management. Both programmes were 
seen to compliment one another. 
" Being informed that insulin is a weight promoting hormone and that some 
diabetes tablets encourage weight gain 
" Education visual aids e. g. video's (in all required languages) 
" Effective self-management diabetes specific education 
" Support from spouse, family and named health care professionals 
b) Checking blood glucose and/or checkin usw urine glucose levels to monitor and improve 
diabetes control. 
" Blood glucose meters uniformly being given to all patients who wish to sclf- 
monitor 
" Training provided to accurately monitor blood glucose levels 
c) Understanding of blood glucose control and prevention of hypoglycaemia (low blood 
glucose level) and hyperglycaemia high blood glucose level) 
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" Self-management education 
" Good relationship between patient and health care professional 
d) Awareness and prevention of diabetes long-term complications to the eyes fcct, kidncys 
and heart. 
" Access to podiatrist / optometrist 
" Communication with healthcare professionals regarding the reason for 
investigations, additional referrals etc 
" Early education in a manner that is understandable to all people 
" Expert patient education 
e) Taking medications in the correct way and in the correct doses 
" Regular contact with diabetes team when trying new regimens 
" Diabetes self-management training 
" Pharmacy support i. e. drug information, pre-packaged daily medication 
" Being allowed to take own medication whilst in hospital 
Summary 
Presently there is a postcode lottery with care differing greatly depending upon where 
individuals live and who is caring for their diabetes. Advice is often given in an ad hoc and 
prescriptive manner. Conflicting messages from healthcare professionals cause confusion and 
mistrust. Lack of information for people with diabetes and their carers about the local and 
national services available further hinders diabetes self-management. 
People with diabetes and their carers would feel more confident in controlling their diabetes if 
they received up-to-date, consistent and structured diabetes education. Individuals felt that 
communication with healthcare professionals could be improved to encourage joint goal setting 
and information sharing. 
The cry for: 
EDUCATION - of healthcare professionals to avoid conflicting messages 
EDUCATION - of people with diabetes and carers to encourage efFective 
diabetes self-management 
EDUCATION - of the media and general public to early diagnosis and 
reduce stigma 
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Meeting Two 
Express ideas and suggestions about how diabetes services can be improved, for 
example, how diabetes education should be delivered to people with diabetes and 
their families/carers. Discuss how these changes can be monitored and checked to 
see what differences they have made. 
People have to self-manage their diabetes for an average 8,757 hours each. ycar.. _i 
low_ cotuld 
people's knowledge and confidence be increased for successful diabetes self-manag Cc, ment? 
The right education delivered at the right time for the right duration by the right people! 
How could diabetes services be improved? 
People should be invited to attend a group-based education programme when initially diagnosed. 
All health professionals should have up-to-date knowledge regarding diabetes to prevent 
conflicting messages being given to the person with diabetes. It is generally felt that the 
consistency of advice is poor, especially regarding diet. Therefore it is recommended that 
practice nurse/GP training should be updated on a regular basis. Health professional training is 
paramount to the improvement of diabetes services. 
Presently in the UK health professionals arc `experts' in their trained area e. g. medicine, nursing, 
dietetics, podiatry. To some lay people, it appears that professionals are `precious' regarding 
their own subject area and do not wish other professionals to `step on their toes'. This can 
increase the number of appointments that individuals have to attend and be time consuming. The 
USA model of `diabetes educators' was put forward as a possible way of improving current 
services. A diabetes educator assigned to each general practice would take the education lead for 
all people with diabetes registered at that practice. 
It was felt that all individuals with diabetes should have a health check at least once every six 
months to assess their health status. The results should then be mailed to the individual with a 
brief summary of their present diabetes control, lipid profile, blood pressure and weight/waist 
circumference etc. Too many people felt that all too often they were labelled as a `diabetic' and 
the majority of health problems they sought advice for were often blamed on their diabetes. 
People feel that medical staff should take a holistic approach and recognise that, as with the 
general population, they do have other health problems as well. 
Communication should be two-way between patients and health professionals. Presently some 
people with diabetes feel that they are `instructed' what to do, but not `actively' listened too. It is 
felt that there should be a more equal relationship, with the health professional imparting 
knowledge regarding the condition, medication, diet etc. and the patient sharing knowledge 
about living with the condition on a day-to-day basis and the difficulties they may be 
experiencing with self-management of diabetes. Many patients are too intimidated to speak out 
to professionals and this is more likely to lead to poor self-management. Also, it is felt that 
communication between different health professionals is sometimes poor. 
Diabetes services may be improved if health professionals were better trained in communication 
and listening skills and patients were encouraged to actively participate in the consultation. Also, 
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having a regular meeting/training session so that all health professionals working within diabetes 
care can share experiences, discuss the latest research reports and up-date diabetes guidelines, 
may be beneficial. Some such meetings may include people with diabetes sharing their 
experience of living with the condition with health professionals. 
Some people who attend hospital clinics felt that too many appointments are cancelled and rc- 
arranged months ahead. Addressing this issue and reducing the frequency of this occurring was 
thought to improve diabetes services. 
It was felt that many of the recommendations probably do not require extra resources but some 
new guidelines and the re-organisation of services. For example, structured group education 
programmes and expert patients trained as peer educators. 
How should diabetes education be delivered? 
It is felt that diabetes education should be delivered by people who understand the condition, for 
example, a specialist diabetes educator. An overwhelming number of people felt that everybody 
should have an opportunity to attend the six-week diabetes education programme (expert patient 
programme). Individuals who had attended the health professional-led expert patients 
programme felt that it had resulted in a time saving by reducing in the need to phone other health 
professionals. However, this should be backed-up on an individual basis with one-to-one 
consultations with the practice nurse and /or GP to discuss action plans and any personnel issues. 
A video lending service to allow individuals, when diagnosed, to take an educational video home 
to watch with the family would further enhance the education process. 
Being given a blood glucose meter and taught how to use it was thought to increase people's 
control and confidence over their blood glucose levels and therefore increase successful self- 
management skills. Also, being informed upon diagnosis, of possible secondary complications in 
an informative / visual manner would be more effective than use scare tactics later. 
To improve the consistency of advice being given to patients it was felt that the six-week 
diabetes education programme should initially be delivered to practice staff. If this was not 
possible, then representatives from the practice should attend the programme when it was being 
delivered to people with diabetes. It was also felt that carers/ spouse should also be encouraged 
to attend, as diabetes does affect the whole family. 
The proper delivery of diabetes education through the media (televise the expert patient 
programme? ) and schools was thought to be important in the light of the anticipated future 
epidemic of diabetes and the ignorance that surrounds the condition generally. 
People felt that all education should be delivered in a manner that encourages self-management 
of the condition. Didactic and prescriptive advice does not encourage people to find possible 
solutions to their own problems and any advice is more likely to be ignored. The introduction of 
the governments lay-led `chronic disease self-management course' for people with chronic 
disease was felt to be a good example of a programme which helps people living with a chronic 
condition to find possible solutions and set goals to tackle their own health problems. 
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Presently, people felt that it was very difficult to receive back-up advice via the telephone. It was 
generally felt that telephones were either not answered, or that they delivered an instruction to 
leave a message on the answer machine. When messages were left, they were sometimes not 
acted upon. There was generally a demand for a 24-hour help line to be available for people with 
diabetes that was managed by people who were knowledgeable and up-to-date in diabetes 
management. 
Finally, education should be delivered in an informal and relaxed setting which is local and 
easily accessible for all. 
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Meeting Three 
To assist in the development of, or purchase of, patient education materials 
(leaflets, models, visual aids, booklets etc. ), which will be of use to people with 
diabetes of all ages and in all languages, and also for visually impaired people who 
have diabetes. 
Should educational materials be developed locally or purchased nationally c, g, Diabetes UK? 
It was appreciated that each individual with diabetes has different learning styles and finds 
different learning materials helpful. It was recommended that a variety of written and visual 
educational materials should be made available to local people with diabetes. 
Which education materials have you found useful? Why? 
The following educational materials were held in high regard: 
" Diabetes UK leaflets and booklets, although the cost implementation was appreciated. 
" Visual aids e. g. models and pictures developed for the local diabetes expert patient 
programme. 
" Patient diabetes self-management manual developed for the local diabetes expert patient 
programme. 
" The Internet e. g. `Diabetes UK' website, `Talking Diabetes' wcbsite. 
What type of education materials would you find useful? Why? 
"A general practice loaning service for diabetes education videos in several languages. 
" Video/website/CD ROM produced of the local diabetes expert patient programme (once 
again in languages that local people can understand). 
In addition it was felt that a named contact person should be available to answer general 
questions and queries. 
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Meeting Four 
Encourage people with diabetes, and also parents and carers where appropriate, 
to work confidently with diabetes health professionals in agreeing plans on how 
to share the care of their diabetes. These plans should be easy for everybody to 
understand and use. 
How can people with diabetes / parents / carers be encouraged to work confidently with health 
professionals in agreeing plans on how to share the care of their diabetes? 
People felt that adopting a non-hierarchical relationship with health professionals would give 
them more confidence to ask questions and to take more responsibility for their diabetes care. 
Some individuals already have blood tests 2 weeks prior to their appointment with the 
GP/Practice Nurse and this was felt to be an example of good practice. The appointment can then 
be used as an opportunity to discuss the results and agree on future goals. Alternatively some 
people felt that obtaining their health results over the phone would be advantageous. Further 
discussion led to recommendations for telephone appointments with a named contact e. g. 
practice nurse. For this to happen it was felt that there should be a dedicated practice manager 
and specialist diabetes nurses and doctors within primary care. 
Traditionally health professionals have been trained to instruct patients what to do and not to 
jointly discuss and agree targets. This approach has been shown not to be effective in the long 
term. However, concern was raised with regard to the reaction of health professionals having a 
more equal relationship with patients. If patients become more knowledgeable and informed 
about their condition, their expectation for good quality health care rises and they ask more 
questions. It was felt that some health professionals may not be familiar with this approach and 
provision of communication training should be made available. 
At the meeting, there was representation from individuals registered with different practices 
across the district (Burnley, Pendle & Rossendale). It was recognised how different current 
diabetes care was depending on who the GP was. There was strong agreement that there should 
be uniform care across the district. No matter where an individual lives; they should expect the 
same high quality care for their diabetes. It was suggested that district diabetes protocols with 
health professional training would help address this issue. 
How do you feel that the joint care plan / communication with the health professional Should be 
documented (Medical vs. patient owned aper vs. electronic)? Ilow can we ensure that these 
are easy for everybody to understand and use? 
Brainstorming raised several options. The most popular idea was to have `shared' health records, 
with the actual record remaining in the hands of the health professional but the patient having 
access whenever they wished. Alongside this, people would like to receive a copy of their health 
results every time they had a blood test, investigation etc. Some individuals who have Internet 
access at home would like to be able to view their health records electronically whenever they 
wished. 
People unanimously felt it was important as part of their self-management of their diabetes to know and understand their health results and have access to a joint care plan. 
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Two examples of joint care plans were discussed: 
Children / Adolescents Care Plan (Burnley Healthcare NHS Trust) 
An excellent example of a joint care plan but more specific for children and individuals with 
type 1 diabetes (Appendix 2). 
Opening the Door to Diabetes Self-Management-Care-Plan (NDC1. New Jersey. USA) 
Participants felt this was an excellent example for adults with diabetes and felt it could be 
modified for the local population (Appendix 3). 
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Meeting Five 
Seek the viewpoint of all local people with diabetes on present diabetes services 
and how they feel services could be improved to encourage confident self- 
management of diabetes. This will, hopefully, help to improve patient satisfaction 
within Burnley, Pendle and Rossendale. 
How would it be possible to seek the viewpoint fron all local people with diabetes, 
especially regarding present diabetes services; how services could be improved; how to 
increase confident self-management of diabetes; how to improve patient satisfaction within 
Burnley, Pendle and Rossendale. 
Several options were discussed: postal questionnaires; public meeting followed by feedback 
questionnaire; advertising in GP surgeries, hospital clinics or newspapers with free phone 
number for people to verbally discuss local diabetes services. 
Participants felt that they provided good representation across the district and at the moment it 
would be time consuming and not cost-effective to seek the viewpoint from all local people with 
diabetes. If the above recommendations were implemented, it may then be possible to evaluate 
local diabetes care to assess if it had made a difference. 
Out of the people with diabetes in the group the following statistics were observed: 
> 50% have a named contact person for their diabetes care 
90% have a dilated annual eye screen 
> 60% have a annual foot check 
> In those who require a glycated haemoglobin (HbAlc) test every 3 months due 
to poor control, change of medication etc, 75% had the test. 
In those who require a glycated haemoglobin (HbAI c) test every 6 months, 50% 
had the test. 
10% receive a paper print-out of their test results 
> 40% receive their health results verbally 
> 50% were referred to a dietitian when first diagnosed with diabetes 
> 50% have received advice regarding physically activity 
¢ 50% work with health professionals to jointly set goals 
N. B. These statistics were collected from members of the patient forum who arc obviously more 
informed, empowered and effective diabetes self-manages compared to the general diabetes 
population. 
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Appendix 8: Patient evaluation form 
Evaluation of Diabetes E pert Paticnt Progr ammo 
To allow future programmes to offer maximum benefits to people with diabetes, 
please take a few minutes to answer the questions below. 
For each weekly session: 
1) On a scale of 1-10 how did you enjoy the programme? 
2) On a scale of 1-10 how useful did you find the programme? 
3) On a scale of 1 -10, do you think that the information gained will improve 
your health? (P/ease circle the number that best fits your thoughts) 
Week 1: What is Diabetes? 
12345678 9 10 
Didn't Enjoy Really Enjoyed 
12345678 9 10 
Not Useful Really Useful 
12345678 9 10 
Won't improve my health Will improve my health 
Week 2: Weight Management 
12345678 9 10 
Didn't Enjoy Really Enjoyed 
12345678 9 10 
Not Useful Really Useful 
12345678 9 10 
Won't improve my health Will improve my health 
Week 3: Glycaemie Indent 
12345678 9 10 
Didn't Enjoy Really Enjoyed 
12345678 9 10 
Not Useful Really Useful 
12345678 9 10 
Won't Improve my health Will improve my health 
Week 4: Supermarket Tour / Session 
12345678 9 10 
bidn't Enjoy Really Enjoyed 
12345678 9 10 
Not Useful Really Useful 
12345678 9 10 
Won't improve my health Will improve my health 
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Week 5: Possible Complications of Diabetes 
123456 7 8 9 10 
Didn't Enjoy Really Enjoyed 
123456 7 8 9 10 
Not Useful Really Useful 
123456 7 8 9 10 
Won't improve my health Will improve my health 
Week 6: Living with Diabetes Some / Questions 
123456 7 8 9 10 
Didn't Enjoy Really Enjoyed 
123456 7 8 9 10 
Not Useful Really Useful 
123456 7 8 9 10 
Won't improve my health Will improve my health 
Life e Experiment: Setting yourself goals 
123456789 10 
Didn't Enjoy Really Enjoyed 
123456789 10 
Not Useful Really Useful 
123456789 10 
Won't improve my health Will improve my health 
Do you feel that 6 weekly sessions are: a) Too few b) Just right c) Too many? 
If your response was too few/too many - how many sessions do you think there 
should be? 
How do you feel about the length of the sessions (2 hours): a) Too short b) 
Just right c) Too long? 
If you think the sessions were too short/too long - how long do you feel the 
sessions should be? ............................................. 
Do you feel that the information you have gained would enable you to help 
somebody else with diabetes? a) Yes b) No c) bon't know 
Any other comments ................................................................ 
....................................................................................... 
....................................................................................... 
....................................................................................... 
....................................................................................... 
rho* y+ov for jr aNinal 
